false --03-31 2026 Q2 0001879001 Unlimited Unlimited Unlimited Unlimited 0001879001 2025-04-01 2025-09-30 0001879001 2025-11-14 0001879001 2025-09-30 0001879001 2025-03-31 0001879001 VRSSF:ClassASubordinateVotingStockMember 2025-09-30 0001879001 VRSSF:ClassASubordinateVotingStockMember 2025-03-31 0001879001 VRSSF:ClassBProportionateVotingStockMember 2025-09-30 0001879001 VRSSF:ClassBProportionateVotingStockMember 2025-03-31 0001879001 VRSSF:ClassASubordinateVotingStockMember 2025-04-01 2025-09-30 0001879001 VRSSF:ClassASubordinateVotingStockMember 2024-04-01 2025-03-31 0001879001 VRSSF:ClassBProportionateVotingStockMember 2025-04-01 2025-09-30 0001879001 VRSSF:ClassBProportionateVotingStockMember 2024-04-01 2025-03-31 0001879001 2025-07-01 2025-09-30 0001879001 2024-07-01 2024-09-30 0001879001 2024-04-01 2024-09-30 0001879001 VRSSF:ClassASubordinateVotingStockMember 2025-07-01 2025-09-30 0001879001 VRSSF:ClassASubordinateVotingStockMember 2024-07-01 2024-09-30 0001879001 VRSSF:ClassASubordinateVotingStockMember 2024-04-01 2024-09-30 0001879001 VRSSF:ClassBProportionateVotingStockMember 2025-07-01 2025-09-30 0001879001 VRSSF:ClassBProportionateVotingStockMember 2024-07-01 2024-09-30 0001879001 VRSSF:ClassBProportionateVotingStockMember 2024-04-01 2024-09-30 0001879001 us-gaap:CommonStockMember VRSSF:ClassASubordinateVotingStockMember 2024-03-31 0001879001 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001879001 VRSSF:ObligationToIssueSharesMember 2024-03-31 0001879001 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001879001 us-gaap:RetainedEarningsMember 2024-03-31 0001879001 2024-03-31 0001879001 VRSSF:ClassBProportionateVotingStockMember 2024-03-31 0001879001 VRSSF:ClassASubordinateVotingStockMember 2024-03-31 0001879001 us-gaap:CommonStockMember VRSSF:ClassASubordinateVotingStockMember 2024-04-01 2024-06-30 0001879001 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001879001 VRSSF:ObligationToIssueSharesMember 2024-04-01 2024-06-30 0001879001 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001879001 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001879001 2024-04-01 2024-06-30 0001879001 VRSSF:ClassASubordinateVotingStockMember 2024-04-01 2024-06-30 0001879001 VRSSF:ClassBProportionateVotingStockMember 2024-04-01 2024-06-30 0001879001 us-gaap:CommonStockMember VRSSF:ClassASubordinateVotingStockMember 2024-06-30 0001879001 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001879001 VRSSF:ObligationToIssueSharesMember 2024-06-30 0001879001 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001879001 us-gaap:RetainedEarningsMember 2024-06-30 0001879001 2024-06-30 0001879001 VRSSF:ClassBProportionateVotingStockMember 2024-06-30 0001879001 VRSSF:ClassASubordinateVotingStockMember 2024-06-30 0001879001 us-gaap:CommonStockMember VRSSF:ClassASubordinateVotingStockMember 2024-07-01 2024-09-30 0001879001 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001879001 VRSSF:ObligationToIssueSharesMember 2024-07-01 2024-09-30 0001879001 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001879001 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001879001 us-gaap:CommonStockMember VRSSF:ClassASubordinateVotingStockMember 2024-09-30 0001879001 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001879001 VRSSF:ObligationToIssueSharesMember 2024-09-30 0001879001 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001879001 us-gaap:RetainedEarningsMember 2024-09-30 0001879001 2024-09-30 0001879001 VRSSF:ClassBProportionateVotingStockMember 2024-09-30 0001879001 VRSSF:ClassASubordinateVotingStockMember 2024-09-30 0001879001 us-gaap:CommonStockMember VRSSF:ClassASubordinateVotingStockMember 2025-03-31 0001879001 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001879001 VRSSF:ObligationToIssueSharesMember 2025-03-31 0001879001 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001879001 us-gaap:RetainedEarningsMember 2025-03-31 0001879001 us-gaap:CommonStockMember VRSSF:ClassASubordinateVotingStockMember 2025-04-01 2025-06-30 0001879001 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001879001 VRSSF:ObligationToIssueSharesMember 2025-04-01 2025-06-30 0001879001 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001879001 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001879001 2025-04-01 2025-06-30 0001879001 VRSSF:ClassASubordinateVotingStockMember 2025-04-01 2025-06-30 0001879001 us-gaap:CommonStockMember VRSSF:ClassASubordinateVotingStockMember 2025-06-30 0001879001 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001879001 VRSSF:ObligationToIssueSharesMember 2025-06-30 0001879001 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001879001 us-gaap:RetainedEarningsMember 2025-06-30 0001879001 2025-06-30 0001879001 VRSSF:ClassBProportionateVotingStockMember 2025-06-30 0001879001 VRSSF:ClassASubordinateVotingStockMember 2025-06-30 0001879001 us-gaap:CommonStockMember VRSSF:ClassASubordinateVotingStockMember 2025-07-01 2025-09-30 0001879001 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001879001 VRSSF:ObligationToIssueSharesMember 2025-07-01 2025-09-30 0001879001 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0001879001 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001879001 us-gaap:CommonStockMember VRSSF:ClassASubordinateVotingStockMember 2025-09-30 0001879001 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001879001 VRSSF:ObligationToIssueSharesMember 2025-09-30 0001879001 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001879001 us-gaap:RetainedEarningsMember 2025-09-30 0001879001 VRSSF:VersesTechnologiesUSAIncMember 2025-04-01 2025-09-30 0001879001 VRSSF:VersesTechnologiesUSAIncMember 2025-09-30 0001879001 VRSSF:VersesTechnologiesUSAIncMember 2025-03-31 0001879001 VRSSF:VersesOperationsCanadaIncVOCMember 2025-04-01 2025-09-30 0001879001 VRSSF:VersesOperationsCanadaIncVOCMember 2025-09-30 0001879001 VRSSF:VersesOperationsCanadaIncVOCMember 2025-03-31 0001879001 VRSSF:VersesLogisticsIncVLOGMember 2025-04-01 2025-09-30 0001879001 VRSSF:VersesLogisticsIncVLOGMember 2025-09-30 0001879001 VRSSF:VersesLogisticsIncVLOGMember 2025-03-31 0001879001 VRSSF:VersesRealitiesIncVRIMember 2025-04-01 2025-09-30 0001879001 VRSSF:VersesRealitiesIncVRIMember 2025-03-31 0001879001 VRSSF:VersesIncVINCMember 2025-04-01 2025-09-30 0001879001 VRSSF:VersesIncVINCMember 2025-09-30 0001879001 VRSSF:VersesIncVINCMember 2025-03-31 0001879001 VRSSF:VersesHealthIncVHEMember 2025-04-01 2025-09-30 0001879001 VRSSF:VersesHealthIncVHEMember 2025-03-31 0001879001 VRSSF:VersesGlobalBVVbvMember 2025-04-01 2025-09-30 0001879001 VRSSF:VersesGlobalBVVbvMember 2025-09-30 0001879001 VRSSF:VersesGlobalBVVbvMember 2025-03-31 0001879001 VRSSF:VersesSolutionsIncVSIMember 2025-04-01 2025-09-30 0001879001 VRSSF:VersesSolutionsIncVSIMember 2025-09-30 0001879001 VRSSF:VersesSolutionsIncVSIMember 2025-03-31 0001879001 VRSSF:GrantAgreementMember 2024-07-24 2024-07-24 0001879001 VRSSF:GrantAgreementMember 2025-09-30 0001879001 VRSSF:GrantAgreementMember 2025-03-31 0001879001 VRSSF:GrantAgreementMember 2025-04-01 2025-09-30 0001879001 VRSSF:GrantAgreementMember 2024-04-01 2024-09-30 0001879001 2024-04-01 2025-03-31 0001879001 us-gaap:TransferredAtPointInTimeMember 2025-07-01 2025-09-30 0001879001 us-gaap:TransferredAtPointInTimeMember 2024-07-01 2024-09-30 0001879001 us-gaap:TransferredAtPointInTimeMember 2025-04-01 2025-09-30 0001879001 us-gaap:TransferredAtPointInTimeMember 2024-04-01 2024-09-30 0001879001 us-gaap:TransferredOverTimeMember 2025-07-01 2025-09-30 0001879001 us-gaap:TransferredOverTimeMember 2024-07-01 2024-09-30 0001879001 us-gaap:TransferredOverTimeMember 2025-04-01 2025-09-30 0001879001 us-gaap:TransferredOverTimeMember 2024-04-01 2024-09-30 0001879001 2020-06-05 2020-06-05 0001879001 2020-06-05 0001879001 VRSSF:InactiveEmployeeMember 2025-09-30 0001879001 VRSSF:ConsultantBMember 2025-07-24 2025-07-24 0001879001 VRSSF:ConsultantBMember 2025-09-30 0001879001 VRSSF:ConsultantBMember 2025-04-01 2025-09-30 0001879001 VRSSF:EmployeesAndIndependentContractorsMember 2025-09-19 2025-09-19 0001879001 VRSSF:EmployeesAndIndependentContractorsMember 2025-09-19 0001879001 VRSSF:EmployeesAndIndependentContractorsOneMember 2025-09-19 0001879001 VRSSF:EmployeesAndIndependentContractorsOneMember 2025-09-19 2025-09-19 0001879001 2025-09-19 2025-09-19 0001879001 VRSSF:StrategicConsultantsMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantBMember 2025-09-04 2025-09-04 0001879001 VRSSF:ConsultantBMember 2024-12-23 0001879001 VRSSF:ConsultantBMember 2025-09-04 0001879001 VRSSF:ConsultantBMember VRSSF:CanadianDollarMember 2025-09-04 2025-09-04 0001879001 VRSSF:ConsultantBMember 2025-07-24 0001879001 VRSSF:ConsultantBMember VRSSF:CanadianDollarMember 2025-07-24 2025-07-24 0001879001 VRSSF:ConsultantEMember 2025-05-26 2025-05-26 0001879001 VRSSF:ConsultantFMember 2025-05-26 2025-05-26 0001879001 VRSSF:FinancialConsultantEAndFMember 2025-05-26 0001879001 VRSSF:FinancialConsultantEAndFMember 2025-05-26 2025-05-26 0001879001 VRSSF:FinancialConsultantEAndFMember VRSSF:CanadianDollarMember 2025-05-26 2025-05-26 0001879001 VRSSF:FinancialConsultantEAndFMember VRSSF:CanadianDollarMember 2025-07-24 2025-07-24 0001879001 VRSSF:EmployeesAndIndependentContractorsMember 2024-12-23 2024-12-23 0001879001 VRSSF:EmployeesAndIndependentContractorsMember 2024-12-23 0001879001 VRSSF:EmployeesAndIndependentContractorsMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantsMember 2024-12-23 2024-12-23 0001879001 VRSSF:ConsultantsMember 2024-12-23 0001879001 VRSSF:ConsultantsMember VRSSF:DecemberTwoThousandTwentyFourMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantsMember 2024-07-03 2024-07-03 0001879001 VRSSF:ConsultantsMember 2024-07-03 0001879001 VRSSF:EmployeesAndIndependentContractorsMember 2024-07-03 2024-07-03 0001879001 VRSSF:EmployeesAndIndependentContractorsMember VRSSF:JulyTwoThousandTwentyFourMember 2025-04-01 2025-09-30 0001879001 VRSSF:EmployeesAndIndependentContractorsMember 2024-04-15 2024-04-15 0001879001 VRSSF:EmployeesAndIndependentContractorsMember 2024-04-15 0001879001 VRSSF:EmployeesAndIndependentContractorsMember VRSSF:AprilTwoThousandTwentyFourMember 2025-04-01 2025-09-30 0001879001 VRSSF:EmployeesAndIndependentContractorsMember 2023-12-15 2023-12-15 0001879001 VRSSF:EmployeesAndIndependentContractorsMember 2023-12-15 0001879001 VRSSF:EmployeesAndIndependentContractorsMember VRSSF:DecemberTwoThousandTwentyThreeMember 2025-04-01 2025-09-30 0001879001 us-gaap:RestrictedStockUnitsRSUMember 2025-09-19 2025-09-19 0001879001 us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-09-30 0001879001 us-gaap:RestrictedStockUnitsRSUMember 2025-07-28 2025-07-28 0001879001 VRSSF:ConsultantsEMember us-gaap:RestrictedStockUnitsRSUMember 2025-07-28 2025-07-28 0001879001 VRSSF:ConsultantsFMember us-gaap:RestrictedStockUnitsRSUMember 2025-07-28 2025-07-28 0001879001 us-gaap:RestrictedStockUnitsRSUMember 2025-07-03 2025-07-03 0001879001 us-gaap:RestrictedStockUnitsRSUMember VRSSF:ConsultantsBMember 2025-07-03 2025-07-03 0001879001 us-gaap:RestrictedStockUnitsRSUMember VRSSF:ConsultantsBMember 2025-07-28 2025-07-28 0001879001 VRSSF:ConsultantsFMember 2025-07-03 2025-07-03 0001879001 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2025-07-03 2025-07-03 0001879001 us-gaap:RestrictedStockUnitsRSUMember VRSSF:ConsultantsBMember 2025-05-06 2025-05-06 0001879001 VRSSF:ConsultantsBMember us-gaap:RestrictedStockUnitsRSUMember 2025-05-26 2025-05-26 0001879001 VRSSF:ConsultantsBMember us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-09-30 0001879001 us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2025-03-31 0001879001 VRSSF:JuneSixteenTwoThousandTwentySevenMember 2025-04-01 2025-09-30 0001879001 VRSSF:JuneSixteenTwoThousandTwentySevenMember 2025-09-30 0001879001 VRSSF:SeptemberFourTwoThousandTwentySevenMember 2025-04-01 2025-09-30 0001879001 VRSSF:SeptemberFourTwoThousandTwentySevenMember 2025-09-30 0001879001 VRSSF:SeptemberSixteenTwoThousandTwentySevenMember 2025-04-01 2025-09-30 0001879001 VRSSF:SeptemberSixteenTwoThousandTwentySevenMember 2025-09-30 0001879001 VRSSF:AprilTwentyEightTwoThousandTwentyEightMember 2025-04-01 2025-09-30 0001879001 VRSSF:AprilTwentyEightTwoThousandTwentyEightMember 2025-09-30 0001879001 VRSSF:DecemberFifteenTwoThousandTwentyEightMember 2025-04-01 2025-09-30 0001879001 VRSSF:DecemberFifteenTwoThousandTwentyEightMember 2025-09-30 0001879001 VRSSF:DecemberTwentyThreeTwoThousandTwentyEightMember 2025-04-01 2025-09-30 0001879001 VRSSF:DecemberTwentyThreeTwoThousandTwentyEightMember 2025-09-30 0001879001 VRSSF:AprilFifteenTwoThousandTwentyNineMember 2025-04-01 2025-09-30 0001879001 VRSSF:AprilFifteenTwoThousandTwentyNineMember 2025-09-30 0001879001 VRSSF:JulyThreeTwoThousandTwentyNineMember 2025-04-01 2025-09-30 0001879001 VRSSF:JulyThreeTwoThousandTwentyNineMember 2025-09-30 0001879001 VRSSF:MayTwentySixTwoThousandThirtyMember 2025-04-01 2025-09-30 0001879001 VRSSF:MayTwentySixTwoThousandThirtyMember 2025-09-30 0001879001 VRSSF:SeptemberNineteenTwoThousandAndThirtyMember 2025-04-01 2025-09-30 0001879001 VRSSF:SeptemberNineteenTwoThousandAndThirtyMember 2025-09-30 0001879001 VRSSF:EmployeesAndIndependentContractorsMember 2025-05-26 0001879001 VRSSF:EmployeesAndIndependentContractorsMember VRSSF:CanadianDollarMember 2025-05-26 2025-05-26 0001879001 VRSSF:EmployeesAndIndependentContractorsMember 2025-05-26 2025-05-26 0001879001 VRSSF:ConsultantAMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantAMember 2025-03-31 0001879001 VRSSF:ConsultantAMember 2025-09-30 0001879001 VRSSF:ConsultantBMember 2025-03-31 0001879001 VRSSF:ConsultantCMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantCMember 2025-03-31 0001879001 VRSSF:ConsultantCMember 2025-09-30 0001879001 VRSSF:ConsultantDMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantDMember 2025-03-31 0001879001 VRSSF:ConsultantDMember 2025-09-30 0001879001 VRSSF:ConsultantEMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantEMember 2025-03-31 0001879001 VRSSF:ConsultantEMember 2025-09-30 0001879001 VRSSF:ConsultantFMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantFMember 2025-03-31 0001879001 VRSSF:ConsultantFMember 2025-09-30 0001879001 VRSSF:ConsultantGMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantGMember 2025-03-31 0001879001 VRSSF:ConsultantGMember 2025-09-30 0001879001 VRSSF:ConsultantHMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantHMember 2025-03-31 0001879001 VRSSF:ConsultantHMember 2025-09-30 0001879001 VRSSF:ConsultantIMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantIMember 2025-03-31 0001879001 VRSSF:ConsultantIMember 2025-09-30 0001879001 VRSSF:ConsultantJMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantJMember 2025-03-31 0001879001 VRSSF:ConsultantJMember 2025-09-30 0001879001 VRSSF:ConsultantKMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantKMember 2025-03-31 0001879001 VRSSF:ConsultantKMember 2025-09-30 0001879001 VRSSF:ConsultantLMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantLMember 2025-03-31 0001879001 VRSSF:ConsultantLMember 2025-09-30 0001879001 VRSSF:ConsultantMMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantMMember 2025-03-31 0001879001 VRSSF:ConsultantMMember 2025-09-30 0001879001 VRSSF:ConsultantNMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantNMember 2025-03-31 0001879001 VRSSF:ConsultantNMember 2025-09-30 0001879001 VRSSF:ConsultantOMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantOMember 2025-03-31 0001879001 VRSSF:ConsultantOMember 2025-09-30 0001879001 VRSSF:ConsultantPMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantPMember 2025-03-31 0001879001 VRSSF:ConsultantPMember 2025-09-30 0001879001 VRSSF:ConsultantQMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantQMember 2025-03-31 0001879001 VRSSF:ConsultantQMember 2025-09-30 0001879001 VRSSF:OtherConsultantMember 2025-04-01 2025-09-30 0001879001 VRSSF:OtherConsultantMember 2025-03-31 0001879001 VRSSF:OtherConsultantMember 2025-09-30 0001879001 VRSSF:StrategicConsultantsMember 2025-03-31 0001879001 VRSSF:StrategicConsultantsMember 2025-09-30 0001879001 VRSSF:ConsultantAMember us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantAMember us-gaap:RestrictedStockUnitsRSUMember 2025-03-31 0001879001 VRSSF:ConsultantAMember us-gaap:RestrictedStockUnitsRSUMember 2025-09-30 0001879001 VRSSF:ConsultantBMember us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantBMember us-gaap:RestrictedStockUnitsRSUMember 2025-03-31 0001879001 VRSSF:ConsultantBMember us-gaap:RestrictedStockUnitsRSUMember 2025-09-30 0001879001 VRSSF:ConsultantEMember us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantEMember us-gaap:RestrictedStockUnitsRSUMember 2025-03-31 0001879001 VRSSF:ConsultantEMember us-gaap:RestrictedStockUnitsRSUMember 2025-09-30 0001879001 VRSSF:ConsultantFMember us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantFMember us-gaap:RestrictedStockUnitsRSUMember 2025-03-31 0001879001 VRSSF:ConsultantFMember us-gaap:RestrictedStockUnitsRSUMember 2025-09-30 0001879001 VRSSF:ConsultantLMember us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-09-30 0001879001 VRSSF:ConsultantLMember us-gaap:RestrictedStockUnitsRSUMember 2025-03-31 0001879001 VRSSF:ConsultantLMember us-gaap:RestrictedStockUnitsRSUMember 2025-09-30 0001879001 VRSSF:OtherConsultantMember us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-09-30 0001879001 VRSSF:OtherConsultantMember us-gaap:RestrictedStockUnitsRSUMember 2025-03-31 0001879001 VRSSF:OtherConsultantMember us-gaap:RestrictedStockUnitsRSUMember 2025-09-30 0001879001 VRSSF:StrategicConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-09-30 0001879001 VRSSF:StrategicConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-06-30 0001879001 VRSSF:StrategicConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2025-03-31 0001879001 VRSSF:StrategicConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2025-09-30 0001879001 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0001879001 us-gaap:RestrictedStockUnitsRSUMember VRSSF:AprilFifteenTwoThousandTwentyFourMember 2024-04-01 2025-03-31 0001879001 us-gaap:RestrictedStockUnitsRSUMember VRSSF:JuneTwentyTwoThousandTwentyFourMember 2024-04-01 2025-03-31 0001879001 us-gaap:RestrictedStockUnitsRSUMember VRSSF:JulyThreeTwoThousandTwentyFourMember 2024-04-01 2025-03-31 0001879001 us-gaap:RestrictedStockUnitsRSUMember VRSSF:SeptemberThirteenTwoThousandTwentyFourMember 2024-04-01 2025-03-31 0001879001 us-gaap:RestrictedStockUnitsRSUMember VRSSF:DecemberTwentyThreeTwoThousandTwentyFourMember 2024-04-01 2025-03-31 0001879001 us-gaap:RestrictedStockUnitsRSUMember 2025-03-31 0001879001 us-gaap:RestrictedStockUnitsRSUMember VRSSF:MayTwentySixTwoThousandTwentyFiveMember 2025-04-01 2025-09-30 0001879001 us-gaap:RestrictedStockUnitsRSUMember VRSSF:SeptemberNineteenTwoThousandTwentyFiveMember 2025-04-01 2025-09-30 0001879001 us-gaap:RestrictedStockUnitsRSUMember 2025-09-30 0001879001 VRSSF:StockOptiosMember 2024-04-01 2024-06-30 0001879001 us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-06-30 0001879001 VRSSF:StockOptiosMember 2024-07-01 2024-09-30 0001879001 us-gaap:RestrictedStockUnitsRSUMember 2024-07-01 2024-09-30 0001879001 VRSSF:StockOptiosMember 2025-04-01 2025-06-30 0001879001 us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-06-30 0001879001 VRSSF:StockOptiosMember 2025-07-01 2025-09-30 0001879001 us-gaap:RestrictedStockUnitsRSUMember 2025-07-01 2025-09-30 0001879001 VRSSF:MichaelBlumMember 2025-09-30 0001879001 VRSSF:MichaelBlumMember 2025-03-31 0001879001 VRSSF:JamesHendricksonMember 2025-09-30 0001879001 VRSSF:JamesHendricksonMember 2025-03-31 0001879001 VRSSF:KevinWilsonMember 2025-09-30 0001879001 VRSSF:KevinWilsonMember 2025-03-31 0001879001 VRSSF:JamesHendricksonMember 2024-12-23 2024-12-23 0001879001 VRSSF:JamesHendricksonMember 2024-12-23 0001879001 VRSSF:December2024Member 2025-04-01 2025-09-30 0001879001 VRSSF:TwoIndependentDirectorsMember 2024-12-23 2024-12-23 0001879001 VRSSF:GordonScottPatersonMember 2024-12-23 2024-12-23 0001879001 VRSSF:JonathandeVosMember 2024-12-23 2024-12-23 0001879001 VRSSF:GordonScottPatersonMember us-gaap:RestrictedStockUnitsRSUMember 2024-12-23 0001879001 VRSSF:JonathandeVosMember us-gaap:RestrictedStockUnitsRSUMember 2024-12-23 0001879001 us-gaap:RestrictedStockUnitsRSUMember VRSSF:TwoIndependentDirectorsMember 2025-04-01 2025-09-30 0001879001 VRSSF:MichaelBlumMember us-gaap:RestrictedStockUnitsRSUMember 2024-09-13 2024-09-13 0001879001 VRSSF:MichaelBlumMember us-gaap:RestrictedStockUnitsRSUMember 2024-09-13 0001879001 us-gaap:RestrictedStockUnitsRSUMember VRSSF:MichaelBlumMember 2025-04-01 2025-09-30 0001879001 VRSSF:JamesHendricksonMember 2024-07-03 2024-07-03 0001879001 VRSSF:KevinWilsonMember 2024-07-03 2024-07-03 0001879001 VRSSF:KevinWilsonMember 2024-07-03 0001879001 VRSSF:July2024Member 2025-04-01 2025-09-30 0001879001 VRSSF:KevinWilsonMember us-gaap:RestrictedStockUnitsRSUMember 2024-07-03 2024-07-03 0001879001 VRSSF:ThreeIndependentDirectorsMember us-gaap:RestrictedStockUnitsRSUMember 2024-07-03 2024-07-03 0001879001 VRSSF:GordonScottPatersonMember us-gaap:RestrictedStockUnitsRSUMember 2024-07-03 2024-07-03 0001879001 VRSSF:JonhatandeVosMember us-gaap:RestrictedStockUnitsRSUMember 2024-07-03 2024-07-03 0001879001 VRSSF:JaySamitMember us-gaap:RestrictedStockUnitsRSUMember 2024-07-03 2024-07-03 0001879001 VRSSF:ThreeIndependentDirectorsMember us-gaap:RestrictedStockUnitsRSUMember 2024-07-03 0001879001 us-gaap:RestrictedStockUnitsRSUMember VRSSF:KelvinWilsonMember 2025-04-01 2025-09-30 0001879001 VRSSF:KevinWilsonMember 2023-12-23 2023-12-23 0001879001 VRSSF:JamesHendricksonMember 2023-12-23 2023-12-23 0001879001 VRSSF:JamesHendricksonMember 2023-12-23 0001879001 VRSSF:December2023Member 2025-04-01 2025-09-30 0001879001 VRSSF:GordonScottPatersonMember us-gaap:RestrictedStockUnitsRSUMember 2025-09-30 2025-09-30 0001879001 VRSSF:GordonScottPatersonMember us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-09-30 0001879001 VRSSF:YearsOneThroughTenMember 2025-04-01 2025-09-30 0001879001 VRSSF:YearsElevenThroughFourteenMember 2025-04-01 2025-09-30 0001879001 VRSSF:YearsFifteenThroughSeventeenMember 2025-04-01 2025-09-30 0001879001 VRSSF:YearsEighteenAndNineteenMember 2025-04-01 2025-09-30 0001879001 VRSSF:YearsTwentyToTwentyFiveMember 2025-04-01 2025-09-30 0001879001 2021-07-20 2021-07-20 0001879001 us-gaap:CommonClassBMember 2024-05-30 2024-05-30 0001879001 us-gaap:CommonClassAMember 2024-05-30 2024-05-30 0001879001 us-gaap:CommonClassAMember 2025-09-26 2025-09-26 0001879001 us-gaap:CommonClassBMember 2025-09-26 2025-09-26 0001879001 2025-07-09 2025-07-09 0001879001 2025-07-28 2025-07-28 0001879001 2025-07-11 2025-07-11 0001879001 2025-07-11 0001879001 us-gaap:WarrantMember 2025-07-11 0001879001 VRSSF:FinancialAdvisorMember 2025-07-11 2025-07-11 0001879001 2025-07-03 2025-07-03 0001879001 2025-05-09 2025-05-09 0001879001 2025-04-28 2025-04-28 0001879001 2025-04-28 0001879001 VRSSF:WarrantShareMember 2025-04-28 0001879001 srt:MaximumMember 2025-04-28 0001879001 srt:MinimumMember 2025-04-28 0001879001 VRSSF:CompensationWarrantsMember 2025-07-11 0001879001 us-gaap:WarrantMember 2025-05-09 0001879001 VRSSF:CompensationWarrantsMember 2025-05-09 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputSharePriceMember 2025-07-11 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember VRSSF:CanadianDollarMember 2025-07-11 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-07-11 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputExpectedTermMember VRSSF:CanadianDollarMember 2025-07-11 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2025-07-11 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputOptionVolatilityMember VRSSF:CanadianDollarMember 2025-07-11 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputOptionVolatilityMember 2025-07-11 0001879001 VRSSF:CompensationWarrantsMember VRSSF:MeasurementInputGrantDateFairValueMember 2025-07-11 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputSharePriceMember 2025-05-09 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember VRSSF:CanadianDollarMember 2025-05-09 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-05-09 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputExpectedTermMember VRSSF:CanadianDollarMember 2025-05-09 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2025-05-09 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputOptionVolatilityMember VRSSF:CanadianDollarMember 2025-05-09 0001879001 VRSSF:CompensationWarrantsMember us-gaap:MeasurementInputOptionVolatilityMember 2025-05-09 0001879001 VRSSF:CompensationWarrantsMember VRSSF:MeasurementInputGrantDateFairValueMember 2025-05-09 0001879001 us-gaap:WarrantMember 2024-03-31 0001879001 us-gaap:WarrantMember 2024-04-01 2025-03-31 0001879001 us-gaap:WarrantMember 2025-03-31 0001879001 us-gaap:WarrantMember 2025-04-01 2025-09-30 0001879001 us-gaap:WarrantMember 2025-09-30 0001879001 VRSSF:WarrantsExpireOneMember 2025-09-30 0001879001 VRSSF:WarrantsExpireOneMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireTwoMember 2025-09-30 0001879001 VRSSF:WarrantsExpireTwoMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireThreeMember 2025-09-30 0001879001 VRSSF:WarrantsExpireThreeMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireFourMember 2025-09-30 0001879001 VRSSF:WarrantsExpireFourMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireFiveMember 2025-09-30 0001879001 VRSSF:WarrantsExpireFiveMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireSixMember 2025-09-30 0001879001 VRSSF:WarrantsExpireSixMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireSevenMember 2025-09-30 0001879001 VRSSF:WarrantsExpireSevenMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireEightMember 2025-09-30 0001879001 VRSSF:WarrantsExpireEightMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireNineMember 2025-09-30 0001879001 VRSSF:WarrantsExpireNineMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireTenMember 2025-09-30 0001879001 VRSSF:WarrantsExpireTenMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireElevenMember 2025-09-30 0001879001 VRSSF:WarrantsExpireElevenMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireTwelveMember 2025-09-30 0001879001 VRSSF:WarrantsExpireTwelveMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireThirteenMember 2025-09-30 0001879001 VRSSF:WarrantsExpireThirteenMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireFourteenMember 2025-09-30 0001879001 VRSSF:WarrantsExpireFourteenMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireFifteenMember 2025-09-30 0001879001 VRSSF:WarrantsExpireFifteenMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireSixteenMember 2025-09-30 0001879001 VRSSF:WarrantsExpireSixteenMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireSeventeenMember 2025-09-30 0001879001 VRSSF:WarrantsExpireSeventeenMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireEighteenMember 2025-09-30 0001879001 VRSSF:WarrantsExpireEighteenMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireNineteenMember 2025-09-30 0001879001 VRSSF:WarrantsExpireNineteenMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyMember 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyOneMember 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyOneMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyTwoMember 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyTwoMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyThreeMember 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyThreeMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyFourMember 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyFourMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyFiveMember 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyFiveMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentySixMember 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentySixMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentySevenMember 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentySevenMember 2025-04-01 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyEightMember 2025-09-30 0001879001 VRSSF:WarrantsExpireTwentyEightMember 2025-04-01 2025-09-30 0001879001 VRSSF:PreConsolidationExerciseTermsMember srt:ScenarioForecastMember 2026-07-06 2026-07-06 0001879001 VRSSF:PostConsolidationExerciseTermsMember srt:ScenarioForecastMember 2026-07-06 2026-07-06 0001879001 us-gaap:FairValueInputsLevel1Member 2025-09-30 0001879001 us-gaap:FairValueInputsLevel2Member 2025-09-30 0001879001 us-gaap:FairValueInputsLevel3Member 2025-09-30 0001879001 us-gaap:FairValueInputsLevel1Member us-gaap:RelatedPartyMember 2025-09-30 0001879001 us-gaap:FairValueInputsLevel2Member us-gaap:RelatedPartyMember 2025-09-30 0001879001 us-gaap:FairValueInputsLevel3Member us-gaap:RelatedPartyMember 2025-09-30 0001879001 us-gaap:RelatedPartyMember 2025-09-30 0001879001 us-gaap:FairValueInputsLevel1Member 2025-03-31 0001879001 us-gaap:FairValueInputsLevel2Member 2025-03-31 0001879001 us-gaap:FairValueInputsLevel3Member 2025-03-31 0001879001 us-gaap:FairValueInputsLevel1Member us-gaap:RelatedPartyMember 2025-03-31 0001879001 us-gaap:FairValueInputsLevel2Member us-gaap:RelatedPartyMember 2025-03-31 0001879001 us-gaap:FairValueInputsLevel3Member us-gaap:RelatedPartyMember 2025-03-31 0001879001 us-gaap:RelatedPartyMember 2025-03-31 0001879001 us-gaap:RelatedPartyMember VRSSF:UnsecuredLoanMember 2025-09-30 0001879001 us-gaap:RelatedPartyMember VRSSF:UnsecuredLoanMember 2025-03-31 0001879001 us-gaap:AccountsPayableMember 2025-09-30 0001879001 us-gaap:AccruedLiabilitiesMember 2025-09-30 0001879001 us-gaap:LoansPayableMember 2025-09-30 0001879001 us-gaap:OtherCurrentLiabilitiesMember 2025-09-30 0001879001 us-gaap:ForeignExchangeMember 2025-09-30 0001879001 us-gaap:ForeignExchangeMember VRSSF:Plus10percentageFluctuationMember 2025-04-01 2025-09-30 0001879001 us-gaap:ForeignExchangeMember VRSSF:Minus10percentageFluctuationMember 2025-04-01 2025-09-30 0001879001 VRSSF:FairValueConcentrationOfRiskAllFinancialInstrumentMember 2025-09-30 0001879001 VRSSF:FairValueConcentrationOfRiskAllFinancialInstrumentMember 2025-09-30 0001879001 VRSSF:FairValueConcentrationOfRiskAllFinancialInstrumentMember VRSSF:Plus10percentageFluctuationMember 2025-04-01 2025-09-30 0001879001 VRSSF:FairValueConcentrationOfRiskAllFinancialInstrumentMember VRSSF:Minus10percentageFluctuationMember 2025-04-01 2025-09-30 0001879001 2022-07-13 2022-07-13 0001879001 VRSSF:CyberlabLLCMember 2024-05-17 2024-05-17 0001879001 VRSSF:CyberlabVTUMember 2024-05-17 2024-05-17 0001879001 VRSSF:CyberlabVTUMember VRSSF:GabrielReneAndDanielMapesMember 2024-05-17 2024-05-17 0001879001 us-gaap:SubsequentEventMember VRSSF:ConsultantPMember us-gaap:RestrictedStockUnitsRSUMember 2025-10-01 2025-10-01 0001879001 us-gaap:SubsequentEventMember VRSSF:ConsultantPMember 2025-10-01 2025-10-01 0001879001 us-gaap:SubsequentEventMember VRSSF:ConsultantEMember 2025-10-01 2025-10-01 0001879001 us-gaap:SubsequentEventMember VRSSF:ConsultantFMember 2025-10-01 2025-10-01 0001879001 us-gaap:SubsequentEventMember VRSSF:ConsultantIMember 2025-10-01 2025-10-01 0001879001 us-gaap:SubsequentEventMember VRSSF:ClassACommonSharesMember 2025-10-01 0001879001 us-gaap:SubsequentEventMember VRSSF:ClassACommonSharesMember 2025-10-01 2025-10-01 0001879001 us-gaap:SubsequentEventMember 2025-10-01 2025-10-01 0001879001 us-gaap:SubsequentEventMember us-gaap:RestrictedStockUnitsRSUMember 2025-10-01 2025-10-01 0001879001 us-gaap:SubsequentEventMember VRSSF:XYZGlobalTechnologiesIncMember 2025-10-20 0001879001 us-gaap:SubsequentEventMember VRSSF:XYZGlobalTechnologiesIncMember 2025-10-20 2025-10-20 0001879001 us-gaap:SubsequentEventMember VRSSF:SorbieBornholmLPMember 2025-11-10 2025-11-10 0001879001 us-gaap:SubsequentEventMember VRSSF:SorbieBornholmLPMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2025-11-10 2025-11-10 0001879001 us-gaap:SubsequentEventMember VRSSF:SorbieBornholmLPMember VRSSF:ShareBasedCompensationAwardTrancheMember 2025-11-10 2025-11-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CAD iso4217:CAD xbrli:shares iso4217:EUR

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended: September 30, 2025

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from:

 

Commission File Number: 000-56692

 

VERSES AI INC.

(Exact name of registrant as specified in its charter)

 

British Columbia, Canada   88-2921736
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

2121 Avenue of the Stars, 8th Floor, Los Angeles, CA   90067
(Address of principal executive offices)   (Zip Code)

 

(310) 988-1944

(Registrant’s telephone number, including area code)

 

Not applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

The number of the issuer’s Class A Subordinate Voting Shares, without par value, outstanding at November 13, 2025 was 12,611,275.

 

 

 

 
 

 

Table of Contents

 

  Page
PART I - FINANCIAL INFORMATION  
ITEM 1. Financial Statements 4
  [Condensed Consolidated] Balance Sheets as of September 30, 2025 (Unaudited) and March 31, 2025 4
  [Condensed Consolidated] Statements of Operations and Comprehensive Loss for the Three and Six Months Ended September 30, 2025 and 2024 (Unaudited) 6
  [Condensed Consolidated Statements of Changes in Stockholders’ Equity] for the Three and Six Months Ended September 30, 2025 and 2024 (Unaudited) 7
  [Condensed Consolidated Statements of Cash Flows] for the Three and Six Months Ended September 30, 2025 and 2024 (Unaudited) 8
  Notes to Unaudited Condensed Consolidated Financial Statements 9
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 31
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk 48
ITEM 4. Controls and Procedures 48
     
PART II - OTHER INFORMATION  
ITEM 1. Legal Proceedings 49
ITEM 1A. Risk Factors 50
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 50
ITEM 3. Defaults Upon Senior Securities 50
ITEM 5. Other Information 50
ITEM 6. Exhibits 51
SIGNATURES 52

 

i
 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA

 

This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Any statements in this Quarterly Report on Form 10-Q about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as “believe,” “will,” “expect,” “anticipate,” “estimate,” “intend,” “plan” and “would.” For example, statements concerning financial condition, possible or assumed future results of operations, growth opportunities, industry ranking, plans and objectives of management, markets for our Class A Subordinate Voting Shares and future management and organizational structure are all forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement.

 

Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed in this Quarterly Report on Form 10-Q. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include, but are not limited to:

 

the competitive and business strategies of the Company (as defined below);
the Company’s research roadmap and expectations regarding the Company’s development of artificial intelligence (“AI”);
the Company’s participation in AI benchmark challenges and expectations regarding the public release timeline of Genius (as defined herein);
market prices, values and other economic indicators;
receipt and timing of any required governmental, regulatory and third-party approvals, licenses and permits;
the performance of the Company’s business and operations;
the intention to grow the business, operations and potential activities of the Company;
the Company’s competitive positioning;
the Company’s anticipated partnerships and agreements with third parties and the expected outcomes of such partnerships and agreements;
possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action;
timing, costs and potential success of future activities on the Company’s facilities and projects;
future outlook and goals relating to the Company’s strategy;
whether the Company will have sufficient working capital and its ability to raise additional financing required in order to continue development of its business and continue operations;
the Company’s expected reliance on key management personnel, advisors and consultants;
the Company’s intended compensation policy and practices and compensation structure;
the capabilities of Genius and Genius-based applications;
the development and roll-out of Genius and Genius-based applications;
the expected competitive aspects of Genius and Genius-based applications in the market;
the scalability of the Spatial Web (as defined herein) and Genius;
beliefs and intentions regarding the ownership or potential ownership of any material patents, trademarks and domain names used in connection with the Company’s products and services;
analyses and other information based on expectations of future performance and planned products;
planned expenditures and budgets and the execution thereof; and
anticipated results and developments in the Company’s operations in future periods and other matters which may occur in the future.

 

-1-

 

 

Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including, without limitation, assumptions about:

 

possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action;
general economic, financial market, regulatory and political conditions in which the Company operates;
general demand and consumer interest in the Company’s products;
the competitive environment in which the Company operate;
the ability of the Company to grow its market share and the Company’s growth outlook;
anticipated and unanticipated costs that the Company may face;
estimated contracted revenue, revenue structures and revenue from operations;
there being no significant delays in the development and commercialization of Genius and other products and services;
the ability of the Company to raise any necessary capital on acceptable terms;
the ability of the Company to anticipate future needs of clients and partners;
the ability of the Company to maintain and effect sufficient research and development capabilities;
the ability of the Company to execute the Company’s growth, sales and customer acquisition strategies;
the ability of the Company to attract and retain skilled personnel;
the ability of the Company to obtain qualified staff and in a timely and cost-efficient manner;
there being no significant barriers to the acceptance of the Company’s products and services;
the continued adoption and acceptance of the Spatial Web;
stability in financial and capital markets;
fluctuations in capital markets and share prices;
the accuracy of budgeted costs and expenditures;
future currency exchange rates and interest rates;
the timely receipt of any required governmental, regulatory and third-party approvals, license and permits on favorable terms and any required renewals of the same;
legislation and regulation favoring the furtherance of AI applications; and
requirements under applicable laws.

 

While the Company considers these assumptions to be reasonable, the assumptions are inherently subject to significant business, social, economic, political, regulatory, competitive and other risks and uncertainties, contingencies and other factors that could cause actual actions, events, conditions, results, performance or achievements to be materially different from those projected in the forward-looking information. Many assumptions are based on factors and events that are not within the control of the Company and there is no assurance they will prove to be correct.

 

Furthermore, by their very nature, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, events, results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. Such risks, uncertainties and other factors include, without limitation: industry-wide risks; fluctuations in capital markets and share prices; price volatility; risks related to the ability to obtain financing needed to fund the continued development of the Company’s business; changes in the Company’s business plans; risks related to the Company’s limited operating history; the Company requiring additional funding to maintain operations; risks related to the Company’s negative cashflow from operating activities; the Company’s failure to implement its growth strategy; risks related to conflicts of interest involving the Company’s management; risks related to the uncertainty of the Company’s use of available funds; risks related to proprietary AI algorithms; the failure of the Company to manage its growth; risks related to the Company’s reliance on strategic partnerships; risk associated with security breaches; risk associated with software errors or defects; risks associated with insufficient insurance coverage; the Company’s failure to maintain, promote and enhance its brand; the Company’s dependence on customer Internet access and use of Internet for commerce; risks associated with privacy and security of sensitive information; risks associated with changes in technology affecting the Company’s business and products; risks associated with the competitive environment of the Company’s industry; risks associated with the uncertainty of market opportunity estimates and growth forecasts; risks associated with reputational damage; the Company’s inability to protect its intellectual property; the volatility of the global economy; the Company’s dependence on management and key personnel; risks associated with government regulation affecting the Company; the Company being subject to civil or other legal proceedings; risks related to reporting requirements arising from the Company’s reporting issuer status; risks associated with future acquisitions; risks related to the maintenance of effective internal controls by the Company; the potential that no active or liquid market for the Class A Subordinate Voting Shares may develop or be sustained; the speculative nature of an investment in the Class A Subordinate Voting Shares; risk that the market price of the Class A Subordinate Voting Shares may not represent the Company’s performance or intrinsic value; risks associated with the influence of reports published by securities or industry analysts on the trading market of the Class A Subordinate Voting Shares; risks associated with price volatility of publicly traded securities; risks associated with the future dilution of the Company’s securities; risks associated the payment of dividends; and other risks discussed under “Risk Factors” below.

 

-2-

 

 

The foregoing is not an exhaustive list of the risks and factors that may affect the Company’s forward-looking information. Although the Company has attempted to identify important factors that could affect the Company and may cause actual actions, events, conditions, results, performance or achievements to differ materially from those described in the forward-looking information, there may be other factors that cause actions, events, conditions, results, performance or achievements not to be as anticipated, estimated or intended. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

 

The Company cautions that the foregoing lists of important assumptions and factors are not exhaustive. Other events or circumstances could cause actual results to differ materially from those estimated or projected and expressed in, or implied by, the forward-looking information contained in this Quarterly Report on Form 10-Q. You should read this Quarterly Report on Form 10-Q and the documents that we reference herein and have filed as exhibits to the Quarterly Report on Form 10-Q, completely and with the understanding that our actual future results may be materially different from what we expect. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. You should assume that the information appearing in this Quarterly Report on Form 10-Q is accurate as of the date hereof. Accordingly, readers should not place undue reliance on forward-looking information. Except as required by law, the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.

 

We qualify all of the information presented in this Quarterly Report on Form 10-Q, and particularly our forward-looking statements, by these cautionary statements.

 

This Quarterly Report on Form 10-Q may include market data and certain industry data and forecasts, which we may obtain from internal surveys, market research, publicly available information and industry publications. Such reports generally state that the information contained therein has been obtained from sources believed to be reliable, but the accuracy or completeness of such information is not guaranteed. Although we believe this information is reliable, we have not independently verified, nor can we guarantee, the accuracy or completeness of that information.

 

Throughout this Quarterly Report on Form 10-Q, the “Company,” “VERSES,” “we,” “us,” and “our” refers to Verses AI Inc., individually, or as the context requires, collectively with its subsidiaries.

 

-3-

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS.

 

 

VERSES AI INC.

Condensed Consolidated Interim Balance Sheet

(Expressed in United States dollars)

 

 

      September 30, 2025   March 31, 2025 
   Notes  (Unaudited)   (Audited) 
ASSETS             
CURRENT             
Cash and restricted cash  3  $1,209,908   $4,816,906 
Accounts receivable      296,700    - 
Deferred financing costs      -    118,546 
Work in progress      -    6,654 
Tax receivable      728,193    604,912 
Prepaid expenses  12   1,215,775    636,064 
Total current assets      3,450,576    6,183,082 
Due from related parties  8   69,657    68,080 
Equipment  6, 13   120,008    125,413 
TOTAL ASSETS     $3,640,241   $6,376,575 
LIABILITIES             
CURRENT             
Accounts payable  8  $1,508,247   $2,036,916 
Accrued liabilities      132,665    41,736 
Deferred grant  3   -    67,732 
Deferred revenue      -    100,000 
Provision for legal claim  19, 20   9,402,338    8,948,085 
Restricted share unit liability  7   1,776,600    3,911,823 
Total current liabilities      12,819,850    15,106,292 
Loans payable  6   139,722    139,039 
TOTAL LIABILITIES      12,959,572    15,245,331 
SHAREHOLDERS’ DEFICIENCY             
Class A Subordinate Voting Shares, without par value: unlimited authorized; 8,897,200 and 7,825,571 issued and outstanding, respectively  10   121,532,339    105,477,150 
Class B Proportionate Voting Shares, without par value: unlimited authorized; 198,517 and Nil issued and outstanding, respectively  10   -    - 
Additional paid-in capital  8, 10, 11   18,808,571    15,891,737 
Accumulated other comprehensive loss      (591,715)   (675,018)
Deficit      (149,068,526)   (129,562,625)
TOTAL SHAREHOLDERS’ DEFICIENCY      (9,319,331)   (8,868,756)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIENCY     $3,640,241   $6,376,575 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

-4-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Operations

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

 

   2025   2024   2025   2024 
   Three months ended   Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
REVENUE  $100,700   $155,000   $400,700   $155,000 
COST OF REVENUE   (70,490)   (145,000)   (254,551)   (145,000)
NET REVENUE   30,210    10,000    146,149    10,000 
                     
Operating expenses:                    
Selling, general and administrative expenses   (9,651,834)   (10,265,830)   (19,640,713)   (20,566,903)
                     
OPERATING INCOME (EXPENSE)   (9,621,624)   (10,255,830)   (19,494,564)   (20,556,903)
                     
Other income/(expense), net   (245,434)   1,687,108    (11,337)   1,427,476 
                     
NET LOSS   (9,867,058)   (8,568,722)   (19,505,901)   (19,129,427)
Loss Per Class A Subordinate Voting Shares - Basic and Diluted  $(1.00)  $(1.48)  $(2.12)  $(3.90)
Loss Per Class B Proportionate Voting Shares - Basic and Diluted  $(6.22)   -   $(13.26)   - 
Class A Subordinate Voting Shares Shares used in computing earnings per share - Basic and Diluted   9,861,001    5,780,312    9,166,869    4,905,748 
Class B Proportionate Voting Shares Shares used in computing earnings per share - Basic and Diluted   8,726    -    4,363    - 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

-5-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Comprehensive Loss

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

 

   2025   2024   2025   2024 
   Three months ended   Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Net Loss   (9,867,058)   (8,568,722)   (19,505,901)   (19,129,427)
                     
Change in foreign currency translation   (87,018)   (134,465)   83,303    (221,974)
                     
NET COMPREHENSIVE LOSS  $(9,954,076)  $(8,703,187)  $(19,422,598)  $(19,351,401)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

-6-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

   Number of Class B Proportionate Voting Shares   Number of Class A Subordinate Voting Shares   Share Capital   Additional paid-in capital   Obligation to Issue Shares   Accumulated Other Comprehensive Loss   Deficit   Total Shareholders’ Deficiency 
Balance, March 31, 2024   370,370    3,205,319   $62,472,187   $13,342,560   $-   $(920,958)  $(86,569,901)  $(11,676,112)
Exercise of options and warrants   -    74,143    2,056,857    (884,868)   -    -    -    1,171,989 
Stock options granted   -    -    -    337,045    -    -    -    337,045 
Conversion of Class B Proportionate Voting shares into Class A Subordinate Voting shares   (370,370)   2,314,815    -    -    -    -    -    - 
Shares issued for services   -    1,852    49,714    -    -    -    -    49,714 
Special warrants proceeds received (net)   -    -    -    181,394    6,758,974    -    -    6,940,368 
Foreign exchange difference   -    -    -    -    -    (87,509)   -    (87,509)
Net loss   -    -    -    -    -    -    (10,560,705)   (10,560,705)
Balance, June 30, 2024   -    5,596,129   $64,578,758   $12,976,131   $6,758,974   $(1,008,467)  $(97,130,606)  $(13,825,210)
Exercise of options and warrants   -    28,240    656,969    (102,675)   -    -    -    554,294 
Stock options granted   -    -    -    1,043,798    -    -    -    1,043,798 
Special warrants converted to shares   -    370,370    6,758,974    -    (6,758,974)   -    -    - 
Issuance of units for cash (net)   -    231,481    3,231,158    134,813    -    -    -    3,365,971 
Foreign exchange difference   -    -    -    -    -    (134,465)   -    (134,465)
Net loss   -    -    -    -    -    -    (8,568,722)   (8,568,722)
Balance, September 30, 2024   -    6,226,220   $75,225,859   $14,052,067   $-   $(1,142,932)  $(105,699,328)  $(17,564,334)
                                         
Balance, March 31, 2025   -    7,825,571   $105,477,150   $15,891,737   $-   $(675,018)  $(129,562,625)  $(8,868,756)
Stock options granted   -    -    -    557,003    -    -    -    557,003 
Additional interest convertible debenture   -    4,254    3,668    -    -    -    -    3,668 
Issuance of Units for cash (net)   -    916,666    6,616,192    495,635    -    -    -    7,111,827 
Foreign exchange difference   -    -    -    -    -    170,321    -    170,321 
Net loss   -    -    -    -    -    -    (9,638,843)   (9,638,843)
Balance, June 30, 2025   -    8,746,491   $112,097,010   $16,944,375   $-   $(504,697)  $(139,201,468)  $(10,664,780)
Exercise of options and warrants   -    250,000    2,900,227    (1,327,787)   -    -    -    1,572,440 
RSUs converted   -    133,686    1,137,392    -    -    -    -    1,137,392 
Stock options granted   -    -    -    2,531,083    -    -    -    2,531,083 
Issuance of Units for cash (net)   -    1,007,764    5,397,710    660,900    -    -    -    6,058,610 
Conversion of Class A Subordinate Voting shares into Class B Proportionate Voting shares   198,517    (1,240,741)   -    -    -    -    -    - 
Foreign exchange difference   -    -    -    -    -    (87,018)   -    (87,018)
Net loss   -    -    -    -    -    -    (9,867,058)   (9,867,058)
Balance, September 30, 2025   198,517    8,897,200   $121,532,339   $18,808,571   $-   $(591,715)  $(149,068,526)  $(9,319,331)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

-7-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Cash Flows

For the six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

 

For the period ended  September 30, 2025   September 30, 2024 
Cash provided by (used in):          
OPERATING ACTIVITIES          
Net loss  $(19,505,901)  $(19,129,427)
Adjustments to reconcile net losses to net cash used in operating activities:          
Depreciation   45,894    93,907 
Interest due from related parties loan   (1,577)   - 
Fair value gain on derivative liability   -    (2,464,873)
Foreign exchange effect on convertible debenture   -    216,334 
Provision for legal claim   454,253    - 
Provision for contract settlement   -    1,252,076 
Provision for losses on related party transactions   -    396,524 
Accretion expense   -    453,839 
Interest expense   12,254    293,038 
Issuance of shares for services   -    49,714 
Restricted shares units   (2,135,223)   581,010 
Share based payments   4,225,478    1,380,714 
Changes in operating assets and liabilities:          
Accounts receivable   (296,700)   (55,000)
Contract assets and unbilled revenue   6,654    - 
Tax receivable   (123,281)   (173,932)
Prepaid expenses   (579,711)   (255,289)
Deferred financing costs   118,546    80,993 
Accounts payable and accrued liabilities   (443,705)   1,112,197 
Deferred revenue   (100,000)   - 
Net cash used in operating activities   (18,323,019)   (16,168,175)
INVESTING ACTIVITIES          
Due from related parties   -    (398,099)
Investment in equipment   (40,489)   (30,579)
Net cash used in investing activities   (40,489)   (428,678)
FINANCING ACTIVITIES          
Deferred grant   (67,732)   176,030 
Repayments of loans   (1,938)   (2,003,876)
Proceeds from issuance of special warrants   -    7,306,000 
Special warrant issuance costs   -    (365,632)
Proceeds from issuance of equity instruments   1,572,440    1,726,283 
Proceeds from issuance of Units   14,930,232    1,643,693 
Private placement issuance costs   (1,759,795)   (320,029)
Proceeds from issuance of convertible debentures   -    10,000,000 
Net cash provided by financing activities   14,673,207    18,162,469 
Foreign exchange effect on cash   83,303    (221,845)
Net change in cash during the period   (3,606,998)   1,343,771 
Cash, beginning of the period   4,816,906    892,727 
Cash, end of the period  $1,209,908   $2,236,498 

 

Supplemental cash flow information (Note 16).

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

-8-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

1.NATURE OF BUSINESS AND GOING CONCERN

 

VERSES is a cognitive computing company specializing in next generation intelligence software systems. We are primarily focused on developing an intelligence-as-a-service smart software platform. Our business is based on the vision of the “Spatial Web” - an open, hyper-connected, context-aware, governance-based network of humans, machines and intelligent agents. We also intend to build tools that enable the Spatial Web and to become a leader in the transition from the information age to the intelligence age.

 

In early 2024, we launched a private beta program of our software platform with a few select users with whom we had existing business relationships. During the second half of 2024, we launched a public beta program for a broader number of developers.

 

On April 30, 2025, we announced the commercial launch of our flagship software platform, called Genius, which is designed to enable agentic intelligence for enterprises. Genius is designed to provide the tools necessary to build domain-specific models that are intended to improve decision-making (inference as a service) for third-party agents through our software development kits/application programming interfaces and model editor. We are implementing a “Lighthouse” go to market strategy that will focus on working with a small number of high-value, high-impact clients in sectors where success will have broad applicability, such as financial services, robotics, and smart cities. Each client will allow us to continue to develop and validate our Genius model that can then be applied to other clients in the same sector. During the coming quarters, we plan to expand from these initial sectors into others, such as logistics and infrastructure management.

 

On June 28, 2022, the Subordinate Class A shares of the Company were listed and started trading on the NEO Exchange in Canada (“NEO”) (“Listing”) under the symbol “VERS”.

 

On October 4, 2022, the Company announced that the Company’s Class A shares have commenced trading on the OTCQX® Best Market, an over-the-counter public market in the United States, under the ticker symbol “VRSSF”. VERSES will continue to trade on the NEO Exchange in Canada, as its primary listing.

 

On July 20, 2023, the Company was downgraded from the OTCQX and started trading on OTCQB® Venture Market under the same ticker symbol “VRSSF”.

 

The Company’s head office and registered and records office is located at 1111 West Hastings Street, 15th Floor, Vancouver, British Columbia, V6E 2J3, Canada.

 

For the six-month period ending September 30, 2025, the Company incurred a net loss of $19,505,901 (September 30, 2025 - $19,129,427), which was primarily funded by the issuance of Units and exercise of equity instruments (Note 10). As of September 30, 2025, the Company has an accumulated deficit of $149,068,526 (March 31, 2025 - $129,562,625). The Company’s ability to continue its operations and to realize its assets at their carrying values is dependent upon obtaining additional financing and generating revenues sufficient to cover its operating costs and working capital deficit.

 

The ability of the Company to raise additional capital sufficient to continue operations is dependant, in part, on the progress of its technology development and continued investor support. The material uncertainty of these items raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not give effect to any adjustments, which would be necessary should the Company be unable to raise additional capital to continue as a going concern. In such circumstances, the Company would be required to realize its assets and discharge its liabilities outside of the normal course of business, and the amounts realized could differ materially from those reflected in these consolidated financial statements.

 

-9-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

a)Basis of presentation

 

The condensed consolidated interim financial statements include the accounts of VERSES AI Inc. and its wholly owned subsidiaries (“Subsidiaries”) (collectively “VERSES” or the “Company”) have been prepared in accordance with U.S generally accepted accounting principles (“GAAP”) as defined by the Financial Accounting Standards Board (FASB).

 

b)Consolidation

 

These consolidated financial statements include the accounts of the Company and its wholly owned Subsidiaries. The results of the Subsidiaries will continue to be included in the consolidated financial statements of the Company until the date that the Company’s control over the Subsidiaries ceases. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. All intercompany transactions are eliminated on these consolidated financial statements.

 

Details of the Company’s Subsidiaries at September 30, 2025 and March 31, 2025 are as follows:

 

Name 

Place of

 Incorporation

 

September 30, 2025

Interest

 

March 31, 2025

Interest

Verses Technologies USA, Inc.

(formerly Verses Labs Inc.) (“VTU”)

  Wyoming, USA   100%   100%
Verses Operations Canada Inc. (“VOC”)  British Columbia, CA   100%   100%
Verses Logistics Inc. (“VLOG”)  Wyoming, USA   100%   100%
Verses Realities Inc. (“VRI”)  Wyoming, USA   Dissolved   100%
Verses Inc. (“VINC”)  Wyoming, USA   100%   100%
Verses Health Inc. (“VHE”)  Wyoming, USA   Dissolved   100%
Verses Global BV (“VBV”)  Netherlands   100%   100%
Verses Solutions Inc (“VSI”)  Wyoming, USA   100%   100%

 

c)Significant accounting estimates and judgments

 

The preparation of these condensed consolidated interim financial statements requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. These consolidated financial statements include estimates that, by their nature, are uncertain. The impacts of such estimates are pervasive throughout the consolidated financial statements, and may require accounting adjustments based on future occurrences. Revisions to accounting estimates are recognized in the period in which the estimate is revised and future periods if the revision affects both current and future periods. These estimates are based on historical experience, current and future economic conditions, and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Actual outcomes could differ from these estimates.

 

The significant judgements made by management in the Company’s accounting policies and key sources of estimation uncertainty were the same as those applied in the annual audited consolidated financial statements for the year ended March 31, 2025.

 

-10-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

3.DEFERRED GRANT

 

The Company’s subsidiary, VBV, entered into a grant agreement (along with other beneficiaries) with the Horizon Europe, which is a program delegated under the European Commission, to provide technical expertise on artificial intelligence.

 

Under the grant agreement, VBV received $226,877 (€209,056) on July 24, 2024, upon the execution of the agreement. The funds under this agreement are to reimburse the Company for amounts spent on the project. The Company is required to submit their costs incurred related to the project and only approved expenses under the project are reimbursed.

 

Of the expenses incurred in connection with the grant agreement, $24,013 (March 31, 2025 - $17,944) are included in accounts payable, with $1,613 (March 31, 2025 - $67,732) remaining in restricted cash as of September 30, 2025. Grant income of $81,909 (September 30, 2024 - $56,034) was recognized during the six months ended September 30, 2025.

 

   September 30, 2025   March 31, 2025 
Balance, beginning of the year  $67,732   $- 
Grant received   -    226,877 
Expenses on the project   (71,530)   (156,885)
Exchange difference   3,798    (2,260)
Balance, end of the period  $-   $67,732 

 

4.REVENUE

 

The Company recognized revenues from contracts with customers in accordance with the following timing under ASC 606 Revenue from Contracts with Customers.

 

   2025   2024   2025   2024 
  

Three months ended

September 30,

  

Six months ended

September 30,

 
   2025   2024   2025   2024 
Recognized at a point in time (1)  $-   $155,000   $300,000   $155,000 
Recognized over the duration of contracts (2)   100,700    -    100,700    - 
Total  $100,700   $155,000   $400,700   $155,000 

 

  (1) Includes revenues from completed Proof of Concept contracts (“POCs”) and software implementation services.
  (2) Includes revenue from Software as a Service (“SaaS”).

 

On August 14, 2024, the Company announced the existing SaaS contract with its customer was terminated by both parties. As a result, the Company has recorded a provision for the contract settlement for $1,252,076 on June 30, 2024.

 

5.COST OF REVENUE

 

The Company’s cost of revenue is summarized as follows:

 

   2025   2024   2025   2024 
   Three months ended   Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Cost of Revenue from POCs and software implementation  $-   $145,000   $184,061   $145,000 
Cost of Revenue from SaaS   70,490    -    70,490    - 
Total  $70,490   $145,000   $254,551   $145,000 

 

-11-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

6.LOANS PAYABLE

 

Loan activity consisted of the following:

 

For the period ended  September 30, 2025   March 31, 2025 
Balance, beginning of the year  $139,039   $140,904 
Repayment   (1,938)   (7,106)
Interest expense   2,621    5,241 
Balance, end of the period  $139,722   $139,039 

 

On June 5, 2020, the Company received a $142,400 loan from the U.S. Small Business Administration. The loan is secured by all tangible and intangible personal property of VTU, and bears interest of 3.75% per annum and requires monthly payments of $646 starting in June 2021 with a maturity of 30 years.

 

7.SHARE BASED PAYMENTS

 

a)Stock Options

 

The Company has an Omnibus Equity Incentive Plan (the “Plan”) available to employees, directors, officers, and consultants with grants under the Plan approved from time to time by the Board of Directors. Under the Plan, the Company is authorized to issue options (“Options”) to purchase an aggregate of up to 25% of the Company’s issued and outstanding Subordinate Voting Shares. Each option can be exercised to acquire one Subordinate Voting Share of the Company (“Share”). The exercise price for an option granted under the Plan may not be less than the prevailing market price at the date of grant.

 

Options to purchase Subordinate Voting Shares have been granted to directors, employees, and consultants as follows:

 

Expiry date  Average Remaining Contractual Life in Years   Exercise Price (CAD$)  

Exercise Price

(USD$ equivalent) (1)

   Outstanding 
June 16, 2027   1.71    21.60    15.52    103,703 
September 4, 2027   1.93    7.44    5.34    125,000 
September 16, 2027   1.96    27.00    19.39    19,072 
April 28, 2028   2.58    44.55    32.00    3,703 
December 15, 2028   3.21    32.85    23.60    345,204 
December 23, 2028   3.23    30.51    21.92    136,290 
April 15, 2029   3.54    30.78    22.11    8,794 
July 3, 2029   3.76    29.01    20.84    142,808 
May 26, 2030   4.65    12.57    9.03    33,334 
September 19, 2030   4.97    6.90    4.96    261,726 
    3.42    22.03    15.82    1,179,634 

 

(1)Converted at balance sheet rate.

 

-12-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

7. SHARE BASED PAYMENTS (continued)

 

a)Stock Options (continued)

 

A summary of the Company’s Options as of June 30, 2025, and changes for previous financial year end is as follows:

 

  

Number of

stock options

  

Weighted Average

Exercise Price

(CAD$)

  

Weighted Average

Exercise Price

(USD$ equivalent) (1)

 
Outstanding, March 31, 2024   542,334   $32.09   $23.05 
Granted   364,099    27.39    19.67 
Exercised   (51,235)   23.22    16.68 
Cancelled   (84,314)   35.37    25.41 
Outstanding, March 31, 2025   770,884    30.10    21.62 
Granted   670,060    7.94    5.70 
Exercised   (250,000)   8.66    6.22 
Expired   (11,310)   33.89    24.34 
Outstanding, September 30, 2025   1,179,634    22.03    15.82 
Exercisable, September 30, 2025   834,135   $23.64   $16.98 

 

(1)Converted at balance sheet rate.

 

During the six month period ended September 30, 2025:

 

-11,310 Options at an average exercise price of CAD$33.89 ($24.84 at balance sheet rate) belonging to inactive employees expired according to the Plan.
-250,000 Options, which were granted on July 24, 2025 to Consultant “B”, were exercised at an exercise price of CAD$8.66 for the net proceeds of $1,572,440. The original fair value of these Options of $1,327,787 was reclassified from additional paid-in capital to share capital upon exercise.

 

On September 19, 2025, the Company granted 261,726 Options to employees and independent contractors of the Company with an exercise price of CAD$6.90 ($4.96 at balance sheet rate), expiring in 5 years, of which 218,247 will vest 25% every quarter subsequent to the vesting start date, and 43,479 with vest 25% on the date that is one (1) year from the vesting start date and 6.25% every subsequent quarter.

 

These Options were fair valued at $1,092,915 using the Black-Scholes option pricing model with the following assumptions:

 

   CAD$   $ 
Share price at grant date  $6.90   $5.00 
Risk-free interest rate   2.74%   2.74%
Expected life   5 years    5 years 
Expected volatility   120.6%   120.6%
Expected forfeitures   0%   0%
Expected dividends   Nil    Nil 
Grant date fair value per option  $5.76   $4.18 

 

During the six month period ended September 30, 2025, the Company recognized $376,295 as share-based payment for these Options using the graded vesting method over the vesting period.

 

-13-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

7. SHARE BASED PAYMENTS (continued)

 

a)Stock Options (continued)

 

On September 4, 2025, the Company granted 125,000 Options to the consultant “B” with an exercise price of CAD$7.44 ($5.34 at balance sheet rate), expiring in 2 years, and vesting on the grant date. These Options were fair valued at $414,244 using the Black-Scholes option pricing model with the following assumptions:

 

   CAD$   $ 
Share price at grant date  $7.44   $5.45 
Risk-free interest rate   2.47%   2.47%
Expected life   5 years    5 years 
Expected volatility   120.6%   120.6%
Expected forfeitures   0%   0%
Expected dividends   Nil    Nil 
Grant date fair value per option  $4.58   $3.31 

 

On July 24, 2025, the Company granted 250,000 Options to the consultant “B” with an exercise price of CAD$8.66 ($6.22 at balance sheet rate), expiring in 5 years, and vesting on the grant date. These Options were fair valued at $1,327,787 using the Black-Scholes option pricing model with the following assumptions:

 

   CAD$   $ 
Share price at grant date  $8.66   $6.35 
Risk-free interest rate   3.10%   3.10%
Expected life   5 years    5 years 
Expected volatility   120.6%   120.6%
Expected forfeitures   0%   0%
Expected dividends   Nil    Nil 
Grant date fair value per option  $7.24   $5.31 

 

On May 26, 2025, the Company granted 16,667 Options to the consultant “E” and 16,667 Options to the consultant “F” with an exercise price of CAD$12.57 ($9.21 at balance sheet rate), expiring in 5 years, and vesting on the grant date. These Options were fair valued at $258,056 using the Black-Scholes option pricing model with the following assumptions:

 

   CAD$   $ 
Share price at grant date  $12.57   $9.21 
Risk-free interest rate   2.92%   2.92%
Expected life   5 years    5 years 
Expected volatility   123.9%   123.9%
Expected forfeitures   0%   0%
Expected dividends   Nil    Nil 
Grant date fair value per option  $10.63   $7.74 

 

-14-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

7. SHARE BASED PAYMENTS (continued)

 

a)Stock Options (continued)

 

On December 23, 2024, the Company granted 49,444 Options to employees and independent contractors of the Company with an exercise price of CAD$30.51($21.92 at balance sheet rate), expiring in 5 years, with 25% vesting on the date that is one (1) year from the vesting start date and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $134,400 as share-based payment for these Options using the graded vesting method over the vesting period.

 

On December 23, 2024, the Company granted 86,852 Options to consultants of the Company with an exercise price of CAD$30.51 ($21.92 at balance sheet rate), expiring in 5 years, where 33.33% of these Options vested on the grant date and 33.33% will vest every 6 months after the grant date.

 

During the six month period ended September 30, 2025, the Company recognized $318,445 as share-based payment for these Options using the graded vesting method over the vesting period.

 

On July 3, 2024, the Company granted 85,682 Options to employees and independent contractors of the Company with a weighted average exercise price of CAD$29.10 ($20.90 at balance sheet rate), expiring in 5 years, with 25% vesting on the date that is one (1) year from the vesting start date and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $158,174 as share-based payment for these Options using the graded vesting method over the vesting period.

 

On April 15, 2024, the Company granted 4,260 Options to employees and independent contractors of the Company with a weighted average exercise price of CAD$33.86 ($24.32 at balance sheet rate), expiring in 5 years, with 25% vesting on the date that is one (1) year from the vesting start date and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $7,111 as share-based payment for these Options using the graded vesting method over the vesting period.

 

On December 15, 2023, the Company granted 347,952 Options to employees and independent contractors of the Company with an exercise price of CAD$36.45 ($26.18 at balance sheet rate), expiring in 5 years, where 173,186 of these Options vest on the grant date, based on previous commitments, and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $93,580 as share-based payment for these Options using the graded vesting method over the vesting period.

 

-15-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

7. SHARE BASED PAYMENTS (continued)

 

a)Stock Options (continued)

 

The table below consolidates the position of the Options granted related to consultants of the Company:

 

Consultant  Total granted amount   Exercised - Inception to March 31, 2025   Outstanding March 31, 2025   Granted Q2-2026 (ytd)   Exercised Q2-2026 (ytd)   Cancelled Q2-2026 (ytd)   Outstanding September 30, 2025   % of the total 
A   64,815          (55,556)   9,259    -    -    -    9,259    2.5%
B   64,814    (9,259)   55,555    375,000    (250,000)   -    180,555    47.8%
C   55,555    (44,444)   11,111    -    -    -    11,111    2.9%
D   44,444    -    44,444    -    -    -    44,444    11.8%
E   23,889    -    23,889    16,667    -    -    40,556    10.7%
F   3,704    -    3,704    16,667    -    -    20,371    5.4%
G   14,815    (14,815)   -    -    -    -    -    0.0%
H   14,815    -    14,815    -    -    -    14,815    3.9%
I   12,963    -    12,963    -    -    -    12,963    3.4%
J   12,963    (10,556)   2,407    -    -    -    2,407    0.6%
K   9,259    (9,259)   -    -    -    -    -    0.0%
L   7,407    -    7,407    -    -    -    7,407    2.0%
M   6,481    -    6,481    -    -    -    6,481    1.7%
N   6,481    -    6,481    -    -    -    6,481    1.7%
O   4,457    -    4,457    -    -    -    4,457    1.2%
P   3,704    -    3,704    -    -    -    3,704    1.0%
Q   3,704    -    3,704    -    -    -    3,704    1.0%
Others   10,577    (1,235)   9,342    -    -    (617)   8,725    2.3%
Total   364,847    (145,124)   219,723    408,334    (250,000)   (617)   377,440    100.0%

 

-16-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

7. SHARE BASED PAYMENTS (continued)

 

b)Restricted Shares Units

 

Pursuant to the Plan, the Company may grant RSUs to employees, directors, officers, and consultants. The RSUs can be settled at the election of the holder for Subordinate Voting Shares (“Shares”), cash, or a combination of Shares and cash. The RSUs are determined to be a liability instrument, and the fair value will be recognized as an expense using the graded vesting method over the vesting period.

 

On September 19, 2025, the Company granted 30,000 RSUs to independent contractors of the Company, expiring in 5 years, which vest 25% every quarter after the grant date. These RSUs were fair valued based on the prevailing market price of one Share on the balance sheet date. The Company recognized $8,616 as share-based payment during the six month period ended September 30, 2025.

 

On July 28, 2025, the Company converted 40,742 RSUs, of which 18,519 RSUs to consultant “E” and 18,519 RSUs to consultant “F” based on the completion of the milestones of funding the company in aggregate greater than CAD50 million. The Company also converted 3,704 to other consultants. These RSUs were valued based on the prevailing market price of one Share on the completion date, and the Company recognized an expense of $230,491 during the six month period ended September 30, 2025.

 

On July 3, 2025, the Company granted converted a total of 92,944 RSUs, of which 42,592 RSUs to consultant “B”, 18,519 RSUs to consultant “E”, 18,519 RSUs to consultant “F”, 351 to other consultants, and 12,963 to directors and officers of the Company. These RSUs were valued based on the prevailing market price of one Share on the conversion date, and the Company recognized $253,541 as share capital.

 

On May 26, 2025, the Company granted 33,333 RSUs to consultant “B”, expiring in 5 years, and vest on July 1, 2025. These RSUs were fair valued based on the market price of one Share on the balance sheet date. The Company recognized $344,431 as share-based payment during the six month period ended September 30, 2025.

 

The table below consolidates the position of the RSUs granted related to consultants of the Company:

 

Consultant  Total granted amount   Converted - Inception to March 31, 2025   Outstanding March 31, 2025   Granted Q2-2026 (ydt)   Converted Q2-2026 (ytd)   Outstanding September 30, 2025   % of the total 
A   7,407    (2,469)   4,938    -    -    4,938    4.1%
B   46,296    (9,259)   37,037    33,333    (42,592)   27,778    22.9%
E   111,111    (37,037)   74,074    -    (37,038)   37,036    30.5%
F   111,111    (37,037)   74,074    -    (37,038)   37,036    30.5%
L   1,852    -    1,852    -    -    1,852    1.5%
Others   20,371    (3,704)   16,667    -    (4,055)   12,612    10.4%
Total   298,148    (89,506)   208,642    33,333    (120,723)   121,252    100.0%

 

On September 30, 2025, the balance of 585,020 RSUs granted in the previous periods, were revalued based on the prevailing market price of one Share on the revaluation date, and the Company derecognized $1,581,375 as share-based payment for RSUs during the six month period ended September 30, 2025.

 

-17-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

7. SHARE BASED PAYMENTS (continued)

 

b)Restricted Shares Units

 

A summary of the Company’s restricted shares units as at September 30, 2025, and changes for the years then ended is as follows:

 

   Number of RSUs 
Balance, March 31, 2024   24,075 
Issued, April 15, 2024   1,852 
Issued, June 20, 2024   37,037 
Issued, July 3, 2024   359,817 
Issued, September 13, 2024   74,074 
Issued, December 23, 2024   296,296 
Cancelled   (5,926)
Converted   (101,852)
Balance, March 31, 2025   685,373 
Issued, May 26, 2025   33,333 
Issued, September 19, 2025   30,000 
Converted   (133,686)
Balance, September 30, 2025   615,020 
Exercisable, September 30, 2025   145,853 

 

A reconciliation of share based payments is as follows:

 

Share based payments  Stock Options   RSUs   Total 
Previous years graded vesting   402,225    -    402,225 
Previous years RSUs revaluation   -    (251,392)   (251,392)
New grants Q1 2025   76,787    26,668    103,455 
New grants Q2 2025   1,027,452    805,605    1,833,057 
Cancelled options   (125,621)   -    (125,621)
Balance, September 30, 2024  $1,380,843   $580,881   $1,961,724 
                
Previous years graded vesting   711,710    -    711,710 
Previous years RSUs revaluation   -    (1,581,375)   (1,581,375)
New grants Q1 2026   258,056    344,431    602,487 
New grants Q2 2026   2,118,326    8,616    2,126,942 
RSU milestone conversion   -    230,491    230,491 
Balance, September 30, 2025  $3,088,092   $(997,837)  $2,090,255 

 

As of September 30, 2025, the fair value of RSUs was $1,776,600 (March 31, 2025 - $3,911,823).

 

-18-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

8.RELATED PARTY TRANSACTIONS AND BALANCES

 

The Company’s related parties consist of the directors, executive officers and key management personnel, who have authority and responsibility for planning, directing, and controlling the Company’s activity and companies controlled by them. Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control or common significant influence. Related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources, services, or obligations between related parties.

 

Transactions are measured at the exchange amount, which is the amount agreed to by the parties.

 

Key management personnel include those with authority and responsibility for planning, directing, and controlling the company’s activities. The Company has determined that key management personnel consist of executive and non-executive members of its Board of Directors and senior officers.

 

During the three and six month periods ended September 30, 2025 and 2024, related party transactions were as follows:

 

   2025   2024   2025   2024 
   Three months ended   Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Management fees  $60,000   $59,455   $120,000   $84,581 
Management salaries and benefits included in personnel expenses   463,104    464,884    900,870    770,635 
Share-based payments   (159,394)   34,914    (194,919)   (67,827)
Related party transactions  $363,710   $559,253   $825,951   $787,389 

 

Included in accounts payable as due from related parties at September 30, 2025, were amounts totaling $20,000 due to Michael Blum, the Chairman (March 31, 2025 – $20,000), $nil due to James Hendrickson, the Chief Operating Officer (March 31, 2025 - $83,500), and $nil due to Kevin Wilson, the Chief Accounting Officer (March 31, 2025 - $2,299).

 

Also included as due from related parties at September 30, 2025, is an unsecured loan made on April 28, 2023 of $69,657 (March 31, 2025 - $68,080) to Michael Wadden, the Chief Commercial Officer of the Company. The loan has an annual interest rate of 5% and requires principal and interest to be paid in full by May 1, 2033. No repayments were made during the six month period ended September 30, 2025.

 

On December 23, 2024, the Company granted 7,407 Options to James Hendrickson, the Chief Operating Officer, with an exercise price of CAD$30.51 ($21.92 at balance sheet rate), expiring in 5 years, where 25% will vest within one year of the grant date, and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $1,587 as share-based payment for stock these Options using the graded vesting method over the vesting period.

 

On December 23, 2024, the Company granted 7,408 RSUs to two independent directors of the Company, 3,704 to Gordon Scott Paterson and 3,704 to Jonathan de Vos. These RSUs have no exercise price and expire in 5 years. They vest 33.33% within one year of the grant date and 33.33% yearly thereafter. The Company revalued the RSUs based on the prevailing market price of one Share on the revaluation date. The Company derecognized $857 as share-based payment for these RSUs during the six month period ended September 30, 2025.

 

-19-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

8. RELATED PARTY TRANSACTIONS AND BALANCES (continued)

 

On September 13, 2024, the Company granted 74,074 RSUs to Michael Blum, the Chairman, with no exercise price and expire in 10 years. 24,691 RSUs vest 12 months after the grant date and 8.33% every three months afterwards. During the period ended September 30, 2025, the Company revalued these RSUs based on the prevailing market price of one Share on the revaluation date. The Company derecognized $170,708 as share-based payment for RSUs during the six month period ended September 30, 2025.

 

On July 3, 2024, the Company granted 3,704 Options to James Hendrickson, the Chief Operating Officer and 1,852 to Kevin Wilson, its Chief Financial Officer. The Options have an exercise price of CAD$28.89 ($20.75 at balance sheet rate) and expire in 5 years. 25% of the options will vest 12 months after the grant date and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $12,834 as share-based payment for these stock options using the graded vesting method over the vesting period.

 

On July 3, 2024, the Company granted 1,852 RSUs to Kevin Wilson, its Chief Financial Officer and 16,665 to the three independent directors of the Company, 5,555 to Gordon Scott Paterson, 5,555 to Jonathan de Vos, and 5,555 to Jay Samit. The RSUs have no exercise price and expire in 10 years. 33.33% vest every 12 months after the grant date. The Company revalued the RSUs based on the prevailing market price of one Share on the revaluation date. The Company derecognized $31,703 as share-based payment for during the six month period ended September 30, 2025.

 

On December 23, 2023, the Company granted 16,278 stock options to Kevin Wilson, its Chief Financial Officer and 1,852 stock options to James Hendrickson, its Chief Operating Officer with an exercise price of CAD$36.45 ($26.18 at balance sheet rate), expiring in 5 years, where 16,278 vested on the grant date, and 1,852 will vest 25% within one year of the grant date, and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $20,134 as share-based payment for these Options using the graded vesting method over the vesting period.

 

On September 30, 2025, the remaining unvested 6,172 RSUs granted to Gordon Scott Paterson, a director of the Company, in the year ended March 31, 2023, were valued based on the market price of one Subordinate Voting Share on the revaluation date, of which $26,206 is derecognized in the six month period ended September 30, 2025.

 

-20-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

9.COMMITMENTS

 

The Company has an obligation to pay royalties to Cyberlab, LLC (“Cyberlab”) (a company controlled by Dan Mapes, a director and officer). Cyberlab shall be entitled to receive a share of the gross revenue derived from the sales, licensing, and other commercial activities involving Spatial Domain Names, pursuant to the following schedule:

 

-Years 1 through 10 of the Spatial Domain Program: Cyberlab shall be entitled to retain Five Percent (5%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Five Percent (95%) to allocate between itself and other Spatial Domain Program stakeholders (e.g., registries, registrars, etc.) as it sees fit.
-Years 11 through 14 of the Spatial Domain Program: Cyberlab shall be entitled to retain Four Percent (4%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Six Percent (96%).
-Years 15 through 17 of the Spatial Domain Program: Cyberlab shall be entitled to retain Three Percent (3%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Seven Percent (97%).
-Years 18 and 19 of the Spatial Domain Program: Cyberlab shall be entitled to retain Two Percent (2%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Eight Percent (98%).
-Years 20 to 25 of the Spatial Domain Program: Cyberlab shall be entitled to retain One Percent (1%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Nine Percent (99%).

 

As of September 30, 2025, no amounts are payable under the royalty agreement.

 

The Company may grant stock options (“Options”), deferred share units (“DSU”), or restricted stock units (“RSU”) to qualifying consultants and employees based on their respective contracts, to be determined at the grant date based on the prevailing market price of the Company’s shares. As of September 30, 2025, the outstanding commitment balance is 77,510 (March 31, 2025 – nil) to be granted as Options, RSUs or DSUs, of which 37,510 stock options is for the new Board of Directors member, David Scott, and 30,000 RSUs to Expansion Project Technologies Holding 9 SPV RSC Ltd in connection with CAD$400,000 in revenues derived by Verses from the commercial agreements it enters into with affiliates of G42.

 

The Company has entered into severance agreements with Gabriel Rene (Chief Executive Officer and Director), Dan Mapes (President Emeritus and Global Ambassador and Director), James Christodoulou (Chief Financial Officer), Kevin Wilson (Chief Accounting Officer), Donald Moody (General Counsel and Chief Legal Officer), Capm Petersen (Chief Innovation Officer), Steven Swanson (Chief Experience Officer), and Michael Wadden (Chief Commercial Officer). In the case of involuntary termination or a change in control, the executives are entitled to a monetary payment of base salary, continuation of medical and dental insurance, and immediate, accelerated vesting of all stock options, equity, and related compensation.

 

10.SHARE CAPITAL

 

a)Authorized shares

 

Effective July 20, 2021, the Company amended its Articles to create an unlimited number of Class A Subordinate Voting Shares and unlimited number of Class B Proportionate Voting Shares. Each Subordinate Voting Share shall entitle the holder thereof to one vote. Each Class B share shall entitle the holder thereof to 6.25 votes and such proportionate dividends and liquidation rights. Each Class B share is convertible, at the holder’s option, into 6.25 Subordinate Voting Shares.

 

On May 30, 2024, all 370,370 Class B Proportionate Voting Shares were converted to 2,314,815 Class A Subordinate Voting Shares.

 

On September 26, 2025, 1,240,741 Class A Subordinate Voting Shares were converted to 198,517 Class B Proportionate Voting Shares.

 

-21-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

10.SHARE CAPITAL (continued)

 

b)Issued

 

On July 29 and August 13, 2025, a total of 250,000 options were exercised.

 

On July 28, 2025, 40,742 RSUs were settled into Shares with a value of $253,541 based on the prevailing share price and exchange rate on the settlement date.

 

On July 11, 2025, the Company closed an offering by way of prospectus supplement. Pursuant to the Offering, the Company raised gross proceeds of approximately CAD$9,573,758 (US$7,000,331) by issuing 1,007,764 units of the Company (the “Units”) at a price of CAD$9.50 (US$6.946) per Unit.

 

Each Unit is comprised of one Class A Subordinate Voting Share of the Company (a “Share”) and one-half of one Share purchase warrant (each whole Share purchase warrant, a “Warrant”). Each Warrant entitles the holder to purchase one Share of the Company (a “Warrant Share”) at an exercise price of CAD$11.50 ($8.26 at balance sheet rate) per Warrant Share at any time until the date that is 36-month from the date of issuance, subject to adjustment in certain events.

 

The Offering was completed pursuant to an agency agreement dated July 9, 2025 between the Company, A.G.P. Canada Investments ULC and A.G.P./Alliance Global Partners. Each of A.G.P. Canada Investments ULC and A.G.P./Alliance Global Partners acted as co-lead agents, on behalf of a syndicate of agents including Imperial Capital, LLC and Haywood Securities Inc.

 

In connection with the Offering, the Company agreed to pay the agents a cash commission of CAD$400,000 ($292,480), and further agreed to issue to the agents 35,271 of compensation warrants (the “Compensation Warrants”). Each Compensation Warrant is exercisable into a Share at an exercise price of CAD$11.50 (US$8.409) per Share until the date that is 36 months after the date of issuance. In addition, the Company paid a cash fee of US$250,000 and issued 75,000 corporate finance fee warrants to TriView Capital Ltd., a financial advisor of the Company, with such corporate finance fee warrants having identical terms to the Compensation Warrants.

 

On July 3, 2025, 92,944 RSUs were settled into Shares with a value of $883,851 based on the prevailing share price and exchange rate on the settlement date.

 

On May 9, 2025, in connection with the conversion of the convertible debentures, the Company issued 4,253 Shares as an interest remainder.

 

On April 28, 2025, the Company closed an offering by way of prospectus supplement (the “Offering”). Pursuant to the Offering, the Company raised gross proceeds of $7,929,900 (CAD$11,000,000) by issuing 916,666 Units of the Company (the “Units”) at a price of US$8.64 (CAD$12.00) per Unit.

 

Each Unit is comprised of one Class A Subordinate Voting Share of the Company (a “Share”) and one-half of one Share purchase warrant (each whole Share purchase warrant, a “Warrant”). Each Warrant entitles the holder to purchase one Share of the Company (a “Warrant Share”) at an exercise price of CAD$15.00 ($11.00 at balance sheet rate) per Warrant Share at any time until the date that is 36-month from the date of issuance, subject to adjustment in certain events.

 

The Offering was completed pursuant to an agency agreement dated April 23, 2025 between the Company, A.G.P. Canada Investments ULC, Clear Street LLC and A.G.P./Alliance Global Partners.

 

-22-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

10.SHARE CAPITAL (continued)

 

b)Issued

 

In connection with the Offering, the Company agreed to pay the agents a cash commission equal to $575,655, incurred in legal fees of $242,418, and agreed to issue 70,334 compensation warrants (the “Compensation Warrants”) valued at $495,635 (Note 11). Each Compensation Warrant is exercisable into a Share at an exercise price of CAD$12.00 ($8.80 at balance sheet rate) per Share until the date that is 36 months after the date of issuance. The cash commission and the number of Compensation Warrants was reduced from 7% to 2.0% in respect to the portion of aggregate gross proceeds of the Offering attributable to subscribers identified by the Company.

 

The Offering was completed in Canada pursuant to a prospectus supplement dated April 25, 2025 (the “Supplement”) to the Company’s base shelf prospectus receipted on September 26, 2024 (the “Base Shelf Prospectus”).

 

11.WARRANTS

 

On July 11, 2025, in connection with the Prospectus Supplement offering closed, the Company issued 503,882 warrants and 110,271 Compensation Warrants (Note 10). Each Warrant entitles the holder to purchase one Share of the Company (a “Warrant Share”) at an exercise price of CAD$11.50 ($8.26 at balance sheet rate) per Warrant Share at any time until the date that is 36-month from the date of issuance, subject to adjustment in certain events.

 

The total fair value of these Compensation Warrants was $660,900, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

   CAD$   $ 
Share price at grant date  $11.46   $8.38 
Risk-free interest rate   2.72%   2.72%
Expected life   3 years    3 years 
Expected volatility   120.6%   120.6%
Expected dividends   Nil    Nil 
Grant date fair value per warrant  $8.20   $5.99 

 

On May 9, 2025, in connection with the Prospectus Supplement offering closed, the Company issued 458,333 warrants and 70,334 Compensation Warrants (Note 10).

 

The total fair value of these Compensation Warrants was $495,635, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

   CAD$   $ 
Share price at grant date  $13.20   $9.52 
Risk-free interest rate   2.61%   2.61%
Expected life   3 years    3 years 
Expected volatility   123.9%   123.9%
Expected dividends   Nil    Nil 
Grant date fair value per warrant  $9.78   $7.05 

 

Warrants outstanding as at September 30, 2025 are summarized below:

 

   Number of warrants   Weighted Average Exercise Price (CAD$)  

Exercise Price

(USD$ equivalent) (1)

 
Balance, March 31, 2024   878,061   $41.10   $29.52 
Issued   1,340,158    40.16    28.85 
Exercised   (122,993)   24.09    17.30 
Expired   (2)   21.60    15.52 
Balance, March 31, 2025   2,095,224   $41.50   $29.81 
Issued   1,142,820    12.93    9.29 
Expired   (368,303)   26.54    19.06 
Balance, September 30, 2025   2,869,741   $32.04   $23.02 

 

(1)Converted at balance sheet rate.

 

-23-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

11. WARRANTS (continued)

 

As of September 30, 2025, the Company’s outstanding share purchase warrants expire as follows:

 

Expiry date  Weighted Average Remaining Contractual Life in Years   Exercise Price (CAD$)  

Exercise Price (USD$ equivalent) (1)

   Outstanding 
April 15, 2026   0.54    10.80    7.76    46,296 
April 17, 2026   0.55    27.00    19.39    3,348 
April 29, 2026   0.58    27.00    19.39    6,618 
May 16, 2026   0.62    27.00    19.39    1,702 
July 6, 2026   0.76    55.35    39.76    29,227 
July 6, 2026   0.76    68.85    49.45    294,694 
August 15, 2026   0.87    27.00    19.39    45,496 
August 17, 2026   0.88    40.50    29.09    126,853 
August 30, 2026   0.92    40.50    29.09    43,062 
September 17, 2026   0.96    40.50    29.09    12,494 
December 22, 2026   1.23    32.40    23.27    809 
January 8, 2027   1.27    40.50    29.09    28 
June 20, 2027   1.72    40.50    29.09    255,185 
September 26, 2027   1.99    21.60    15.52    10,562 
September 26, 2027   1.99    32.40    23.27    114,354 
November 8, 2027   2.11    13.50    9.70    14,444 
November 8, 2027   2.11    18.90    13.58    85,699 
November 15, 2027   2.13    13.50    9.70    2,229 
November 15, 2027   2.13    18.90    13.58    15,290 
December 9, 2027   2.19    13.50    9.70    3,707 
December 9, 2027   2.19    18.90    13.58    28,519 
January 9, 2028   2.28    52.92    38.01    235,906 
January 9, 2028   2.28    42.39    30.45    26,420 
February 25, 2028   2.41    52.92    38.01    257,312 
March 9, 2028   2.44    18.90    13.58    66,667 
April 28, 2028   2.58    15.00    10.77    458,333 
April 28, 2028   2.58    12.00    8.62    70,334 
July 11, 2028   2.78    11.50    8.26    614,153 
    2.07   $32.04   $23.02    2,869,741 

 

Notes:

 

(1)Converted at balance sheet rate.

sheet rate) = 1 New Class A Subordinate Voting share.

 

(2)Warrants expiring July 6, 2026

 

Pre-Consolidation Exercise Terms: 1 Warrant + CAD$2.55 ($1.83 at balance sheet rate) = 1 Class A Subordinate Voting share.

 

Post-Consolidation Exercise Terms: 27 Warrants + CAD$68.85 ($49.46 at balance sheet rate) = 1 New Class A Subordinate Voting share.

 

For presentation purposes, the Company divided the total outstanding warrants by 27 to reflect 1 warrant + CAD$68.85 ($49.46 at balance sheet rate) = 1 New Class A Subordinate Voting share.

 

-24-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

12.PREPAID EXPENSES

 

Prepaid expenses consisted of the following:

 

   September 30, 2025   March 31, 2025 
Deposit  $34,929   $10,000 
Retainer   269,311    251,983 
Prepaid insurance   540,495    106,084 
Subscriptions   371,040    267,997 
Balance, end of the period  $1,215,775   $636,064 

 

13.EQUIPMENT

   

Cost  Equipment 
Balance, March 31, 2025  $580,751 
Additions   40,489 
Balance, September 30, 2025  $621,240 
      
Accumulated depreciation   Equipment 
Balance, March 31, 2025  $455,338 
Additions   45,894 
Balance, September 30, 2025  $501,232 
      
Net book value, March 31, 2025  $125,413 
Net book value, September 30, 2025  $120,008 

 

14.FINANCIAL INSTRUMENTS

 

As of September 30, 2025, the Company’s financial instruments consist of cash and restricted cash, accounts receivable, accounts payable and accrued liabilities, restricted share unit liability, provision for legal claim, convertible debenture, and loans payable.

 

In accordance with ASC 820, Fair Value Measurement, the Company categorizes financial assets and liabilities measured at fair value into a three-level hierarchy based on the inputs used in the valuation techniques. The hierarchy gives the highest priority to quoted prices in active markets (Level 1) and the lowest priority to unobservable inputs (Level 3).

 

The levels of the fair value hierarchy are defined as follows:

 

Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date.

 

Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, such as quoted prices for similar assets or liabilities in active or inactive markets.

 

-25-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

14. FINANCIAL INSTRUMENTS (continued)

 

Level 3 – Unobservable inputs for the asset or liability, which are used to measure fair value to the extent that observable inputs are not available, and which are significant to the overall fair value measurement.

   

As of September 30, 2025  Level 1 ($)   Level 2 ($)   Level 3 ($)   Total ($) 
Assets:                    
Cash and restricted cash   1,209,908    -    -    1,209,908 
Accounts receivable   296,700    -    -    296,700 
Due from related parties   69,657    -    -    69,657 
Liabilities:                    
Accounts payable   1,508,247    -    -    1,508,247 
Accrued liabilities   132,665    -    -    132,665 
Provision for legal claim   9,402,338    -    -    9,402,338 
Restricted share unit liability   -    1,776,600    -    1,776,600 
Loans payable   139,722    -    -    139,722 

 

As of March 31, 2025   Level 1    Level 2    Level 3    Total 
Assets:                    
Cash and restricted cash   4,816,906    -    -    4,816,906 
Due from related parties   68,080    -    -    68,080 
Liabilities:                    
Accounts payable   2,036,916    -    -    2,036,916 
Accrued liabilities   41,736    -    -    41,736 
Provision for legal claim   8,948,085    -    -    8,948,085 
Restricted share unit liability   -    3,911,823    -    3,911,823 
Loans payable   139,039    -    -    139,039 

 

Credit risk

 

Credit risk is the risk of loss associated with a counterparty’s inability to fulfill its payment obligations. The financial instrument that potentially subjects the Company to concentrations of credit risk consists principally of cash, accounts receivable, and due from related parties. To minimize the credit risk, the Company places its cash with large financial institutions.

 

Amounts due from related parties of $69,657 as of September 30, 2025 (March 31, 2025 - $68,080) represent receivables from an unsecured loan to a key member of the management team. The loan has an annual interest rate of 5% and requires principal and interest to be paid in full by May 1, 2033 (Note 8).

 

As of September 30, 2025, management assessed that there is no need to provide a credit loss allowance.

 

Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company’s operations on an ongoing basis. The Company strives to ensure that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations, cash holdings, and anticipated future financing transactions.

 

-26-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

14. FINANCIAL INSTRUMENTS (continued)

 

Liquidity risk (continued)

 

The Company has historically raised capital to fund operations, primarily through debt and equity investors, although there is no assurance that it will be able to raise funds in the future. The Company will continue to rely on such financings to generate sufficient amounts of cash and cash equivalents to cover its operating costs, satisfy short and long term capital requirements, and meet growth objectives.

 

Contractual cash flow requirements as of September 30, 2025, were as follows:

  

    Less than 1 year    1 to 2 years    2 to 5 years    After 5 years    Total 
  

<1 year

$

  

1-2 years

$

  

2-5 years

$

  

>5 years

$

  

Total

$

 
Accounts payable   1,508,247    -    -    -    1,508,247 
Accrued liabilities   132,665    -    -    -    132,665 
Loans payable   7,752    7,752    23,256    100,962    139,722 
Total   1,648,664    7,752    23,256    100,962    1,780,634 

 

As of September 30, 2025, the Company had a working capital deficit of $9,205,281 (March 31, 2025 - $8,923,210).

 

Foreign exchange risk

 

Foreign exchange risk is the risk that the fair value or future cash flows will fluctuate due to changes in foreign exchange rates. The Company has financial assets denominated in Euros and Canadian dollars and is therefore exposed to exchange rate fluctuations. As of September 30, 2025, the Company had the equivalent of $96,283 (March 31, 2025 - $223,534) net financial liabilities denominated in Canadian dollars and $14,864 (March 31, 2025 net financial assets - $104,416) in net financial liabilities denominated in Euros.

 

The foreign exchange risk exposure of the Company financial instruments as at September 30, 2025 is as below:

  

            
           +/- 10% fluctuation 
   Currency   Increase/(decrease) 
Financial Instrument Type  CAD$   $   $ impact 
Cash   987,753    709,503    70,950    (70,950)
Tax receivable   1,003,283    720,659    72,066    (72,066)
Prepaid expenses   1,172,734    842,375    84,237    (84,237)
Accounts payable   (774,473)   (556,304)   (55,630)   55,630 
Accrued liabilities   (50,000)   (35,915)   (3,592)   3,592 
Restricted share unit liability   (2,473,384)   (1,776,600)   (177,660)   177,660 
Foreign currency future instrument    (134,087)   (96,283)   (9,629)   9,629 

 

            
           +/- 10% fluctuation 
   Currency       Increase/(decrease) 
Financial Instrument Type  EURO   $   $ impact 
Restricted cash   1,375    1,613    161    (161)
Tax receivable   6,423    7,535    753    (753)
Accounts payable   (20,468)   (24,011)   (2,401)   2,401 
Foreign currency future instrument    (12,670)   (14,864)   (1,486)   1,486 

 

-27-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

14. FINANCIAL INSTRUMENTS (continued)

 

Interest rate risk

 

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate due to changes in market interest rates. The interest earned on cash balances approximate fair value rates, and the Company is not subject to significant risk due to fluctuating interest rates. As of September 30, 2025, the Company does not hold any liabilities that are subject to fluctuations in market interest rates.

 

Price risk

 

Price risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate due to changes in market prices, other than those arising from interest rate risk or currency risk. The Company is not exposed to other price risk.

 

15.MANAGEMENT OF CAPITAL

 

The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to pursue the development of their technology. The Company considers the items in shareholders’ equity as capital. There has been no change to what the Company considers capital from the prior year. The Company does not have any externally imposed capital requirements to which it is subject to.

 

The Company manages the capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust the capital structure, the Company may issue Subordinate Voting Shares, dispose of assets or adjust the amount of cash. There has been no change to how capital is managed from the prior year.

 

16.SUPPLEMENTAL CASH FLOW INFORMATION

 

The supplemental cash paid and received by the Company as of September 30, 2025 is as below:

  

             
   For three months ended   For Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Cash paid for interest  $1,313   $5,524   $2,621   $6,843 
Cash received for interest  $37,609   $35,147   $85,053   $49,970 

 

17.SEGMENT REPORTING

 

Operating segments comprised of the components of an entity in which separate information is available for evaluation by the Company’s Chief Operating Decision Maker (“CODM”), the Company’s Chief Executive Officer, or group of decision makers, in determining how to allocate resources in evaluating performance.

 

The CODM has determined that the Company consists of a single reporting segment providing Software as a Service, which includes proof of concept and software implementation services.

 

The accounting policies of the services segment are as described in the summary of significant accounting policies. The CODM evaluates the performance of the services segment based on the Company’s net income (loss) as reported in the Statements of Operations.

 

The CODM reviews performance based on gross profit, operating profit, and net earnings. Operating profit is reviewed to monitor the operating and administrative expenses of the Company. The Company does not have any operations or sources of revenue outside of the United States. Accordingly, the CODM considers the revenue, operating expenses, and other income (expenses) of our single operating segment as reported on the statement of operations and considers our current and total assets as recorded on the balance sheet. There are no additional expense or asset information that are supplemental to those disclosed in these consolidated financial statements that are regularly provided to the CODM.

 

-28-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

18.OTHER INCOME

 

Other income consisted of the following:

  

             
   For three months ended   For Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Accretion expense  $-   $(411,813)  $-   $(453,839)
Grant Income   17,720    56,034    81,909    56,034 
Interest earned   37,609    35,147    85,053    49,970 
Gain on derivative liability   -    2,464,873    -    2,464,873 
Interest expense   (7,278)   (221,720)   (12,254)   (293,038)
Legal claim expense   (359,164)   -    (582,253)   - 
Provision for losses on related party transactions   -    (235,413)   -    (396,524)
R&D tax credits   65,679    -    416,208    - 
Other income  $(245,434)  $1,687,108   $(11,337)  $1,427,476 

 

 

19.PROVISION FOR LEGAL CLAIM

 

On July 13, 2022, David Thomson, a former independent contractor, filed a lawsuit against VTU, Cyberlab LLC, and two directors/officers of the Company in Los Angeles Superior Court. The claim alleged violations of various sections of the California Corporations code, breach of contract, breach of the implied covenant of good faith and fair dealing, and unjust enrichment. Plaintiff claimed as much as $5,000,000 in damages, subject to proof.

 

On September 1, 2022, the Company filed an answer denying any wrongdoing, and also made its own counterclaim against Mr. Thomson. The cross-claims against David Thomson included: (i) misappropriation of trade secrets; (ii) breach of contract; (iii) violation of the California Computer Data Access and Fraud Act

 

(“CDAFA”); and (iv) violation of the Economic Espionage Act, along with three additional cross-claims (alleging violation of the Computer Fraud and Abuse Act, conversion, violation of the Stored Communications Act, respectively) that were subsequently dismissed by the Court. The Company, for its part, sought to recover both compensatory and punitive damages from Mr. Thomson, as well as restitution of any ill-gotten gains and an award of reasonable attorneys’ fees.

 

The arbitration was conducted for a total of 13 days over a period from February 5 through April 3, 2024, via a single arbitrator at the American Arbitration Association. The CDAFA claim was dismissed by the Arbitrator, but the claims for trade secret misappropriation, breach of contract and unjust enrichment were allowed to move forward.

 

A final arbitration award was issued on May 17, 2024. It imposed liability against: (i) Verses Technologies USA, Inc. (VTU), a subsidiary of the Company, jointly and severally with Cyberlab, LLC (a company owned by the Company’s president, Dan Mapes), in the amount of $6,307,258, inclusive of interest; and (ii) Cyberlab, VTU and its principals, Gabriel René and Daniel Mapes, jointly and severally, for damages in the amount of $1,900,000, interest of $709,973, costs of $64,303 and the fees of plaintiff’s counsel totaling $920,231. To resolve their part of joint and several liability, Mr. René and Mr. Mapes are working toward satisfying the portion of the award that applies to them as individuals, including $1,666,000 proceeds from insurance. The remaining liability belongs to VTU, a subsidiary of the Company. Initial good faith payments of $1,791,000 have been made to the claimant. However, the likelihood of a favourable or unfavourable outcome, or an estimate of the amount or range of potential loss, which is isolated to VTU and Cyberlab, is not reasonably foreseeable at this time.

 

On January 24, 2025, Mr. Thompson filed a Petition to Confirm the Arbitration Award with the Los Angeles Superior Court. This is a necessary “first step” that must be undertaken before an arbitration award can be converted into an enforceable judgment. A hearing on the Petition was set for April 29, 2025. On May 8, 2025, the Petition was confirmed for the amounts listed below, including interest from the date of the Arbitration Award.

 

On or about August 12, 2025, attorneys for Mr. Thomson served VTU with several collections-related discovery requests asking, inter alia, the company to identify assets and property that it holds. The company responded to these requests within the allotted time-frame. 

 

A reconciliation of the legal claim provision is provided in the table below:

  

   September 30, 2025   March 31, 2025 
Beginning of the year   8,948,085    9,921,298 
Payments in the year   -    (1,791,000)
Interest   454,253    817,787 
Balance, end of the period   9,402,338    8,948,085 

 

-29-

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

20.SUBSEQUENT EVENTS

 

On October 1, 2025, the Company granted 20,000 RSUs to consultant “P” vesting on the grant date and 105,000 Option to the consultants listed bellow at an exercise price of CAD$7.55 ($5.42 at balance sheet rate), vesting on the grant date, that expire 5 years after the date of grant.

 

Consultant “E” 37,500
Consultant “F” 37,500
Consultant “P” 20,000
Consultant “I” 10,000

 

On October 1, 2025, what remains subject to shareholder approval, the Company repriced 849,263 outstanding Options to acquire Class A Common shares of the Company to an exercise price of CAD$7.55 ($5.42 at balance sheet rate).

 

Original vesting terms and expiry date of the repriced stock options were maintained according to the original certificate agreement.

 

On October 1, 2025, the Company cancelled of an aggregate 90,313 Options and 46,296 RSUs in accordance with the rescission agreements as these Options and RSUs we initially granted to entities and not individuals as required by the Plan.

 

A total of 90,313 Options (the “Replacement Options”) and 46,296 RSUs (the “Replacement RSUs”) were granted on the same date to individuals related to the original entities. Original vesting terms and exercise price Replacement Options and Replacement RSUs where maintained according to the original certificate agreement. The Replacement Options have a 5 year expiry.

 

On October 20, 2025, the Company learned that Philip Plough had filed a claim against XYZ Global Technologies Inc. (“XYZ”) for an alleged breach of a promissory note (“Note”) related to a $35,000 loan made in 2018, which also named VAI, one of its wholly-owned U.S. subsidiaries (VTU) and two directors/officers of the Company, as well as a law firm, Gresham International America LLC, as co-defendants with XYZ Global Technologies Inc. The claim alleges, inter alia, breach of contract, fraudulent inducement, conversion, successor liability and unjust enrichment. The Plaintiff is seeking, subject to proof, $1,856,000 in compensatory damages for breach of contract, and any other punitive, exemplary, treble damages and attorneys’ fees, as the Court deems just and proper.

 

The Company, for its part, disputes any liability for a loan made to a separate company (XYZ) and if the action continues to be pursued, the Company will vigorously contest Mr. Plough’s claims, including seeking to dismiss VAI, VTU and the individual directors / officers.

 

As litigation is subject to many uncertainties, it is not possible to predict the ultimate outcome of this claim or to estimate the loss, if any, which may result. Accordingly, the outcome of the claim is not yet determinable, and the extent to which an outflow of funds may be required to settle this possible obligation cannot be reliably determined.

 

On October 31, 2025, the Company initiated a workforce reduction program designed to streamline operations, reduce costs, and strengthen the Company’s liquidity position. The program is a combination of targeted workforce reductions, furloughs, and executive salary deferrals.

 

On November 10, 2025, the Company closed a financing agreement with Sorbie Bornholm LP with a notional value of CAD$14,000,000 in exchange for the issuance of an aggregate of 2,660,000 Units, including finder’s fees. Each Unit consists of one Class A subordinated voting share (a “Common Share”) of the Company and one half warrant (each whole warrant, a “Warrant”), where each Warrant will entitle the holder to acquire one additional Common Share at an exercise price of CAD$7.00 for a period of 36 months from the closing of the Offering.

 

Upon closing, the Company received CAD$700,000 representing the first tranche of the Offering, and expects to receive eleven additional tranches expected to be paid monthly subject to the terms of the Sharing Agreement. The Sharing Agreement calculates each additional tranche, as CAD$1,209,091 times the percent increase or decrease between the benchmark price of CAD$7.75 and the trailing 20-day Value Weighted Average Price. The Company anticipates that the additional tranches will begin 30 days after closing and is responsible to pay 8% brokerage fee with each tranche.

 

The securities issued under the Offering are subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation in Canada.

 

-30-

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, this discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those discussed below. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, and those discussed in the section titled “Risk Factors” included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025 as may be amended, supplemented or superseded from time to time by other reports we file with the SEC. Unless stated otherwise or the context otherwise requires, in this Quarterly Report on Form 10-Q, references to “CAD$” are to Canadian dollars and references to “$” are to United States dollars. On September 30, 2025, the noon buying rates in New York City for cable transfers in foreign currencies as certified for customs purposes by the Federal Reserve Bank of New York, referred to as the “Noon Buying Rate”, for the conversion of Canadian dollars into United States dollars was CAD$1.00 equals $0.7183.

 

Unless the context otherwise requires, references to “we”, “our”, “us”, the “Company” or “VERSES” mean Verses AI Inc. and its subsidiaries.

 

Overview

 

VERSES is a cognitive computing company specializing in next generation intelligence software systems. We are primarily focused on developing an intelligence-as-a-service smart software platform. Our business is based on the vision of the “Spatial Web” - an open, hyper-connected, context-aware, governance-based network of humans, machines and intelligent agents. We also intend to build tools that enable the Spatial Web and to become a leader in the transition from the information age to the intelligence age.

 

In early 2024, we launched a private beta program of our software platform with a few select users with whom we had existing business relationships. During the second half of 2024, we launched a public beta program for a broader number of developers.

 

On April 30, 2025, we announced the commercial launch of our flagship software platform, called Genius, which is designed to enable agentic intelligence for enterprises. Genius is designed to provide the tools necessary to build domain-specific models that are intended to improve decision-making (inference as a service) for third-party agents through our software development kits/application programming interfaces and model editor. We are implementing a “Lighthouse” go to market strategy that will focus on working with a small number of high-value, high-impact clients in sectors where success will have broad applicability, such as financial services, robotics, and smart cities. Each client will allow us to continue to develop and validate our Genius model that can then be applied to other clients in the same sector. During the coming quarters, we plan to expand from these initial sectors into others, such logistics, and infrastructure management.

 

Genius includes:

 

  Intelligent, autonomous software agents
  A visual model editor for building and testing AI models
  APIs to integrate with existing enterprise systems
  A full-featured developer portal for rapid deployment

 

Recent Developments

 

On July 11, 2025, the Company closed of a public offering of 1,007,764 units at $6.946 (CAD$9.50) per unit for gross proceeds of approximately $7,000,331 (CAD$9,573,758), before deducting commissions and expenses incurred in connection with the offering. Proceeds to the company after deducting commissions and expenses was $6,058,610. Each unit consists of one Class A Subordinate Voting Share (“Share”) of the Company and one-half of one Class A Subordinate Voting Share purchase warrant. Each whole warrant is exercisable to acquire one Class A Subordinate Voting Share at a price of $8.41 (CAD$11.50) per share for a period of 36 months from the date of issuance.

 

-31-

 

 

SELECTED FINANCIAL INFORMATION

 

FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025, COMPARED TO THE QUARTER ENDED SEPTEMBER 30, 2024

 

   Quarter ended September 30,         
   2025   2024   $ Change   % Change 
REVENUE  $100,700   $155,000   $(54,300)   -35%
COST OF REVENUE   (70,490)   (145,000)   74,510    -51%
NET REVENUE   30,210    10,000    20,210    202%
OPERATING EXPENSES                    
Cash expenses                    
Accounting fees   (229,873)   (200,526)   (29,347)   15%
Consulting fees   (777,873)   (630,846)   (147,027)   23%
Investor relations and marketing   (561,458)   (1,401,530)   840,072    -60%
Legal fees   (663,861)   (426,198)   (237,663)   56%
Board fees   (60,556)   (59,455)   (1,101)   2%
Office and general   (636,611)   (508,714)   (127,897)   25%
Personnel expenses   (908,651)   (908,304)   (347)   0%
Rent   (5,849)   (24,741)   18,892    -76%
Research and development   (4,242,443)   (4,166,763)   (75,680)   2%
Travel and meals   (122,542)   (150,672)   28,130    -19%
    (8,209,717)   (8,477,749)   268,032    -3%
Non-cash expenses                    
Depreciation   (22,503)   (47,857)   25,354    -53%
Provision for contract settlement   -    -    -    N/A 
Share based payments   (1,419,614)   (1,740,224)   320,610    -18%
    (1,442,117)   (1,788,081)   345,964    -19%
TOTAL EXPENSES   (9,651,834)   (10,265,830)   613,996    -6%
OTHER ITEMS:                    
Grant income   17,720    56,034    (38,314)   -68%
Other income   103,288    35,147    68,141    194%
Gain on derivative liability   -    2,464,873    (2,464,873)   -100%
Accretion expense   -    (411,813)   411,813    -100%
Interest expense   (7,278)   (221,720)   214,442    -97%
Legal claim expense   (359,164)   -    (359,164)   N/A 
Provision for losses on related party transactions   -    (235,413)   235,413    -100%
NET LOSS   (9,867,058)   (8,568,722)   (1,298,336)   15%
Loss Per Class A Subordinate Voting Shares - Basic and Diluted  $(1.00)  $(1.48)  $0.49    -33%
Loss Per Class B Proportionate Voting Shares - Basic and Diluted  $(6.22)  $-   $(6.22)   N/A 
Class A Subordinate Voting Shares Shares used in computing earnings per share - Basic and Diluted   9,861,001    5,780,312    4,080,689    71%
Class B Proportionate Voting Shares Shares used in computing earnings per share - Basic and Diluted   8,726    -    8,726    N/A 

 

   September 30, 2025   % of Revenue   September 30, 2024   % of Revenue   $ Change   % Change 
REVENUE  $100,700        $155,000        $(54,300)   -35%
COST OF REVENUE   (70,490)   70%   (145,000)   94%   74,510    -51%
NET REVENUE   30,210    30%   10,000    6%   20,210    202%

 

-32-

 

 

QUARTER ENDED SEPTEMBER 30, 2025, COMPARED TO THE QUARTER ENDED SEPTEMBER 30, 2024

 

Revenue was $100,700 for the quarter ended September 30, 2025, which consisted of revenue from our first Genius Platform customers. Revenue for the quarter ended September 30, 2024 was $155,000, which is related to the conclusion of a proof-of-concept project.

 

Cost of revenue consists of personnel and contractors’ costs directly related to the delivery of services to the customers. Cost of Revenue was $70,490 for the quarter ended September 30, 2025, which related to services provided to the customers referenced above. Cost of revenue for the quarter ended September 30, 2024 was $145,000, which is related to the conclusion of a proof-of-concept project. Costs of revenue as a percentage of revenue was 70% for the quarter ending September 30, 2025, compared to 94% for the quarter ending September 30, 2024, which reflects the economics associated with our core Genius Platform.

 

Net revenue represents the revenue minus the cost of revenue. Net revenue was $30,210 for the quarter ended September 30, 2025, compared to $10,000 reported in the quarter ended September 30, 2024. Net revenue as a percentage of revenue was 30% for the quarter ending September 30, 2025, compared to 6% for the quarter ending September 20, 2024, which reflects the economics associated with our core Genius Platform.

 

Operating expenses are allocated between cash and non-cash expenses. We allocated expenses on this basis to calculate and understand the Company’s cash flow from operations and liquidity, which we believe are important financial and operating metrics.

 

Cash expenses consist of the items below. Total Cash Expenses (“TCE”) decreased by $268,032, or 3%, to $8.21 million for the quarter ended September 30, 2025, compared to $8.48 million for the quarter ended September 30, 2024.

 

   September 30, 2025   % of TCE   September 30, 2024   % of TCE   $ Change   % Change 
Cash expenses                              
Accounting fees   (229,873)   3%   (200,526)   2%   (29,347)   15%
Consulting fees   (777,873)   9%   (630,846)   7%   (147,027)   23%
Investor relations and marketing   (561,458)   7%   (1,401,530)   17%   840,072    -60%
Legal fees   (663,861)   8%   (426,198)   5%   (237,663)   56%
Board fees   (60,556)   1%   (59,455)   1%   (1,101)   2%
Office and general   (636,611)   8%   (508,714)   6%   (127,897)   25%
Personnel expenses   (908,651)   11%   (908,304)   11%   (347)   0%
Rent   (5,849)   0%   (24,741)   0%   18,892    -76%
Research and development   (4,242,443)   52%   (4,166,763)   49%   (75,680)   2%
Travel and meals   (122,542)   1%   (150,672)   2%   28,130    -19%
Total Cash Expenses (TCE)   (8,209,717)   100%   (8,477,749)   100%   268,032    -3%

 

Accounting Fees are related to accounting staff and external audit fees. Accounting fees increased by $29,347, or 15%, to $229,873 for the quarter ended September 30, 2025, compared to $200,529 for the quarter ended September 30, 2024. Accounting Fees were 3% of TCE for the quarter ended September 30, 2025, compared to 2% for the quarter ended September 30, 2024. The increase of $29,347 is primarily due to additional costs associated with translating our financial statements to USGAAP and complying with new SEC reporting requirements.

 

-33-

 

 

Consulting Fees are related to financial advisory and general consulting services. Consulting Fees increased by $147,027, or 23%, to $777,873 for the quarter ended September 30, 2025, compared to $630,846 for the quarter ended September 30, 2024. Consulting Fees were 9% of TCE for the quarter ended September 30, 2025, compared to 7% for the quarter ended September 30, 2024.

 

Financial advisory services was $559,682 for the quarter ended September 30, 2025, compared to $543,966 for the quarter ended September 30, 2024. The increase of $15,716 is primarily due to less fees paid to financial advisors in connection with funds raised by the Company: The Company raised $6.06 million in net proceeds during the quarter ended September 30, 2025, compared to $3.37 million during the quarter ended September 30, 2024.
General consulting services was $218,191 for the quarter ended September 30, 2025, compared to $86,880 for the quarter ended September 30, 2024. The increase of $131,311 is due to a new consulting agreement for market intelligence services ($53,780), a new administrative agreement to support operations in Europe ($38,012), and other general consulting services ($39,519).

 

Investor Relations and Marketing are related to messaging, marketing, and advertising of the Company and its products to potential users, to develop general Company and brand awareness as well as investor relations initiatives in media, roadshows, and on social media. Investor Relations and Marketing decreased by $840,072 or 60% to $561,458 for the quarter ended September 30, 2025, compared to $1.40 million for the quarter ended September 30, 2024. Investor Relations and Marketing was approximately 7% of TCE for the quarter ended September 30, 2025, compared to 17% for the quarter ended September 30, 2024.

 

These expenses are currently combined, as the initiatives to market the product and services of the Company and investment in the Company are intertwined and indistinguishable. As the Company begins to market its core products and services, marketing and investor relations expenses will be separated. The decrease in Investor Relations and Marketing is due to:

 

  Marketing and investor awareness decreased by $726,223 or 60% to $481,846 for the quarter ended September 30, 2025, compared to $1.21 million for the quarter ended September 30, 2024. The decrease is a result of fewer consultants engaged to perform marketing and investor awareness activities during the quarter ended September 30, 2025 compared to the quarter ended September 20, 2024.
  Business development decreased by $123,499 or 61% to $79,613 for the quarter ended September 30, 2025, compared to $203,112 for the quarter ended September 30, 2024. The decrease is a result of fewer consultants engaged to perform business development activities during the quarter ended September 30, 2025 compared to the quarter ended September 20, 2024.

 

Legal Fees are related to fees paid to external counsel in the US and Canada.

 

-34-

 

 

Legal fees increased by $237,663, or 56%, to $663,861 for the quarter ended September 30, 2025, compared to $426,198 for the quarter ended September 30, 2024. Legal fees represented 8% of TCE for the quarter ended September 30, 2025, compared to 5% for the quarter ended September 30, 2024. The increase of $237,663 is primarily due to increased legal costs associated with the Company becoming a U.S. SEC reporting on April 1, 2025, which requires additional disclosure and reporting.

 

Board Fees are related to costs associated with Board members. Board Fees increased by $1,101, or 2%, to $60,556 during the quarter ended September 30, 2025, compared to $59,455 for the quarter ended September 30, 2024. Board Fees were 1% of TCE for both quarters ended September 30, 2025 and September 30, 2024.The increase of $60,556 is due to increased fees paid to board members for the quarter ended September 30, 2025, compared to the quarter ended September 30, 2024.

 

Office and General Expenses are related to subscriptions, insurance, transaction fees, and general expenses of the Company. Office and general expenses increased by $127,897, or 25%, to $636,611 for the quarter ended September 30, 2025, compared to $508,714 for the quarter ended September 30, 2024. Office and General Expenses was 8% of TCE for the quarter ended September 30, 2025, compared to 6% for the quarter ended September 30, 2024. The increase of $127,898 is primarily due to higher Directors and Officers (“D&O”) insurance premium costs of $124,904 resulting from increased coverage as the Company became a U.S. SEC reporting on April 1, 2025, which requires additional disclosure and reporting.

 

Personnel expenses are related to general and administrative payroll costs. Personnel expenses increased by $347, to $908,651 for the quarter ended September 30, 2025, compared to $908,304 for the quarter ended September 30, 2024. Personnel expenses were 11% of TCE for both quarters ended September 30, 2025 and September 30, 2024.

 

Rent is related to payments for office and other spaces utilized by the Company. Rent decreased by $18,892, totaling $5,849 for the quarter ended September 30, 2025, compared to $24,741 for the quarter ended September 30, 2024. Rent expense accounted for less than 1% of TCE for both quarters ended September 30, 2025 and September 30, 2024.

 

Research and Development (R&D) is related to payroll and contractor costs associated with developing the Company’s product. R&D increased by $75,680, or 2%, to $4.24 million for the quarter ended September 30, 2025, compared to $4.17 million for the quarter ended September 30, 2024. R&D was 52% of TCE for the quarter ended September 30, 2025, compared to 49% for the quarter ended September 30, 2024. The increase of $75,680 is primarily due to the higher salaries and fees paid to personnel for the quarter ended September 30, 2025, compared to the salaries and fees paid to personnel for the quarter ended September 30, 2024.

 

Travel and Meals are related to expenses related to meals, airfare, transportation, and other related expenses. Travel and Meals decreased by $28,132, or 19%, to $122,542 for the quarter ended September 30, 2025, compared to $150,672 for the quarter ended September 30, 2024. Travel and Meals remained consistent at approximately 1.5-2% of cash expenses for both periods.

NON-CASH EXPENSES – Consisted of the items below. Non-Cash Expenses decreased by $345,964, or 19%, to $1,44 million for the quarter ended September 30, 2025, compared to $1.79 million for the quarter ended September 30, 2024.

 

   September 30, 2025   % of TNCE   September 30, 2024   % of TNCE   $ Change   % Change 
Non-cash expenses                              
Depreciation   (22,503)   2%   (47,857)   3%   25,354    -53%
Share based payments   (1,419,614)   98%   (1,740,224)   97%   320,610    -18%
Total Non Cash Expenses (TNCE)   (1,442,117)   100%   (1,788,081)   100%   345,964    -19%

 

-35-

 

 

Depreciation is related to the decrease in the useful life of computer and other equipment. Depreciation decreased by $25,354, or 53%, to $22,503 for the quarter ended September 30, 2025, compared to $47,857 for the quarter ended September 30, 2024. The decrease for the quarter ended September 30, 2025 is due to certain assets reaching the end of their three-year useful life.

 

Share based payments are related to the Black-Scholes valuation and vesting of stock options (“Options”) and Restricted Share Units (RSUs) granted to the Company’s employees, contractors, and consultants. Share-based payments decreased by $320,610, or 18%, to $1.42 million for the quarter ended September 30, 2025, compared to $1.74 million for the quarter ended September 30, 2024. This decrease is primarily due to the decline in the fair value of RSUs, which are tied to the Class A Subordinate Voting Share price as of the balance sheet date for the quarter ended September 30, 2025, compared to the quarters ended September 30, 2024. The decrease during the quarter ended September 30, 2025 was partially offset by a higher number of Options granted during the quarter ended September 30, 2025. For a detailed breakdown of the changes, please refer to the table below.

Share based payments  Stock Options   RSUs   Total 
Previous years graded vesting   139,476    -    139,476 
Previous years RSUs revaluation   -    (99,082)   (99,082)
New grants Q1 2025   2,491    (10,227)   (7,736)
New grants Q2 2025   1,027,452    805,735    1,833,187 
Cancelled options   (125,621)   -    (125,621)
Balance, September 30, 2024  $1,043,798   $696,426   $1,740,224 
                
Previous years graded vesting   289,706    -    289,706 
Previous years RSUs revaluation   -    (1,350,582)   (1,350,582)
New grants Q2 2026   2,118,326    8,616    2,126,942 
Cancelled options   123,057    -    123,057 
RSU milestone conversion   -    230,491    230,491 
Balance, September 30, 2025  $2,531,089   $(1,111,475)  $1,419,614 

 

Total Operating expenses decreased by $613,995, or 6%, to $9.65 million for the quarter ended September 30, 2025, compared to $10.27 million for the quarter ended September 30, 2024. The decrease during the quarter ended September 30, 2025 is primarily due to $320,610 in non-cash expenses associated with share based payments during the quarter ended September 30, 2025, as well as a decrease in expenses associated with investor relations and marketing, which decreased by $840,072. The decrease during the quarter ended September 30, 2025 was partially offset by increases in legal fees ($237,663), consulting fees ($147,027), and Office and General expenses ($127,898) during the quarter ended September 30, 2025.

Other Items consisted of the items below. Other Items resulted in a loss of $245,434 for the quarter ended September 30, 2025, compared to a gain of $1.68 million for the quarter ended September 30, 2024.

   September 30, 2025   % TOI   September 30, 2024   % TOI   $ Change   % Change 
OTHER ITEMS:                              
Grant income   17,720    -7%   56,034    3%   (38,314)   -68%
Other income   103,288    -42%   35,147    2%   68,141    194%
Gain on derivative liability   -    0%   2,464,873    146%   (2,464,873)   -100%
Accretion expense   -    0%   (411,813)   -24%   411,813    -100%
Interest expense   (7,278)   3%   (221,720)   -13%   214,442    -97%
Legal claim expense   (359,164)   146%   -    0%   (359,164)   N/A 
Provision for losses on related party transactions   -    0%   (235,413)   -14%   235,413    -100%
Total Other Items (TOI)   (245,434)   100%   1,687,108    100%   (1,932,542)   -115%

 

Grant Income is related to reimbursing expenses for amounts spent on project activities related to the grant agreement with Horizon Europe, which is a program delegated by the European Commission. Grant income was $17,720 for the quarter ended September 30, 2025, compared to $56,034 for the quarter ended September 30, 2024. This project is expected to end in August 2026.

 

-36-

 

 

Other Income is related to R&D tax credits and interest received from interest-bearing bank accounts. Other income increased $68,141 to $103,288 for the quarter ended September 30, 2025, compared to $35,147 for the quarter ended September 30, 2024. This increase is primarily due to $65,679 of R&D tax credits received during the quarter ended September 30, 2025.

 

Gain on derivative liability is the result of measuring the derivative liability embedded in the convertible debenture using the Monte-Carlo binomial. Changes in the estimates for the quarter ended September 30, 2024, resulted in a gain on the fair value of derivative liability of the convertible debenture of $2,464,873. There was no such expense during the quarter ended September 30, 2025.

 

Accretion Expense is related to the increase in the carrying value of the discounted value of the convertible debenture converted in 2025. There was no accretion expense for the quarter ended September 30, 2025, compared to an expense of $411,813 for the quarter ended September 30, 2024.

 

Interest Expense is related to interest incurred in the conversion of the convertible debenture converted in 2025, interest incurred in the loan payable, and the interest related to the financing of the director’s and officer’s insurance. Interest expense decreased $214,442, or 97%, to $7,278 for the quarter ended September 30, 2025, compared to an expense of $221,720 for the quarter ended September 30, 2024. This decrease is primarily due to the conversion of the convertible debenture during the quarter ended September 30, 2024.

 

Legal Claim Expense was $359,164 for the quarter ended September 30, 2025, compared to nil for the quarter ended September 30, 2024. This amount is interest accrued in connection with the David Thomson arbitration award, which was confirmed by the Los Angeles Superior Court in the quarter ended June 30, 2025. There was no such expense in the quarter ended September 30, 2024.

 

Provision for Loss on Related Party Transactions was $235,413 for the quarter ended September 30, 2024. There was no provision for the quarter ended September 30, 2025.

 

The provision for loss on related party transactions includes amounts due from Cyberlab LLC (“Cyberlab”) and the Spatial Web Foundation (“SWF”), entities controlled or associated with the Company’s founders, Dan Mapes and Gabriel Rene.

 

The related expenses arose primarily from payments made by the Company on behalf of these related parties to third-party vendors.
Although these amounts are expected to be settled through future service agreements, management performed a credit assessment in accordance with the current expected credit loss (“CECL”) model under ASC 326. Based on this assessment, management determined that there is significant uncertainty regarding the timing and collectability of these receivables. As of September 30, 2025, management concluded that full repayment is not probable within a reasonable timeframe.

 

Net Loss increased by $1.30 million, or 15%, to $9.87 million for the quarter ended September 30, 2025, compared to a net loss of $8.57 million for the quarter ended September 30, 2024.

 

-37-

 

 

FINANCIAL RESULTS FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2025, COMPARED TO THE SIX MONTHS ENDED SEPTEMBER 30, 2024

 

SELECTED FINANCIAL INFORMATION

 

   Six months ended September 30,         
   2025   2024   $ Change   % Change 
REVENUE  $400,700   $155,000   $245,700    159%
COST OF REVENUE   (254,551)   (145,000)   (109,551)   76%
NET REVENUE   146,149    10,000    136,149    1361%
OPERATING EXPENSES                    
Cash expenses                    
Accounting fees   (392,360)   (350,407)   (41,953)   12%
Consulting fees   (1,494,960)   (1,793,016)   298,056    -17%
Investor relations and marketing   (2,191,491)   (2,867,059)   675,568    -24%
Legal fees   (1,479,224)   (864,112)   (615,112)   71%
Board fees   (119,342)   (84,581)   (34,761)   41%
Office and general   (1,097,098)   (940,979)   (156,119)   17%
Personnel expenses   (1,877,672)   (1,762,012)   (115,660)   7%
Rent   (37,374)   (60,079)   22,705    -38%
Research and development   (8,543,836)   (8,261,915)   (281,921)   3%
Travel and meals   (271,207)   (275,036)   3,829    -1%
    (17,504,564)   (17,259,196)   (245,368)   1%
Non-cash expenses                    
Depreciation   (45,894)   (93,907)   48,013    -51%
Provision for contract settlement   -    (1,252,076)   1,252,076    -100%
Share based payments   (2,090,255)   (1,961,724)   (128,531)   7%
    (2,136,149)   (3,307,707)   1,171,558    -35%
TOTAL EXPENSES   (19,640,713)   (20,566,903)   926,190    -5%
OTHER ITEMS:                    
Grant income   81,909    56,034    25,875    46%
Other income   501,261    49,970    451,291    903%
Gain on derivative liability   -    2,464,873    (2,464,873)   -100%
Accretion expense   -    (453,839)   453,839    -100%
Interest expense   (12,254)   (293,038)   280,784    -96%
Legal claim expense   (582,253)   -    (582,253)   N/A 
Provision for losses on related party transactions   -    (396,524)   396,524    -100%
NET LOSS   (19,505,901)   (19,129,427)   (376,474)   2%
Loss Per Class A Subordinate Voting Shares - Basic and Diluted  $(2.12)  $(3.90)  $1.78    -46%
Loss Per Class B Proportionate Voting Shares - Basic and Diluted  $(13.26)  $-   $(13.26)   N/A 
Class A Subordinate Voting Shares Shares used in computing earnings per share - Basic and Diluted   9,166,869    4,905,748    4,261,121    87%
Class B Proportionate Voting Shares Shares used in computing earnings per share - Basic and Diluted   4,363    -    4,363    N/A 

 

   September 30, 2025   % of Revenue   September 30, 2024   % of Revenue   $ Change   % Change 
REVENUE  $400,700        $155,000        $245,700    159%
COST OF REVENUE   (254,551)   64%   (145,000)   94%   (109,551)   76%
NET REVENUE   146,149    36%   10,000    6%   136,149    1361%

 

-38-

 

 

SIX MONTHS ENDED SEPTEMBER 30, 2025, COMPARED TO THE SIX MONTHS ENDED SEPTEMBER 30, 2024

 

Revenue was $400,700 for the six months ended September 30, 2025, which consisted of revenue from our first Genius Platform customers. Revenue for the six months ended September 30, 2024 was $155,000, which is related to the conclusion of a proof-of-concept project.

 

Cost of revenue consists of personnel and contractors’ costs directly related to the delivery of services to the customers. Cost of Revenue was $254,551 for the six months ended September 30, 2025, which related to services provided to the customers referenced above. Cost of revenue for the six months ended September 30, 2024 was $145,000, which is related to the conclusion of a proof-of-concept project. Costs of revenue as a percentage of revenue was 64% for the quarter ending September 30, 2025, compared to 94% for the quarter ending September 30, 2024, which reflects the economics associated with our core Genius Platform.

 

Net revenue represents the revenue minus the cost of revenue. Net revenue was $146,149 for the six months ended September 30, 2025, compared to $10,000 reported for the six months ended September 30, 2024. Net revenue as a percentage of revenue was 36% for the quarter ending September 30, 2025, compared to 6% for the quarter ending September 20, 2024, which reflects the economics associated with our core Genius Platform.

 

Operating expenses are allocated between cash and non-cash expenses. We allocated expenses on this basis to calculate and understand the Company’s cash flow from operations and liquidity, which we believe are important financial and operating metrics.

 

Cash expenses consist of the items below. Total Cash Expenses (“TCE”) increased by $245,368, or 1%, to $17.50 million for the six months ended September 30, 2025, compared to $17.26 million for the six months ended September 30, 2024.

 

-39-

 

 

   September 30, 2025   % of TCE   September 30, 2024   % of TCE   $ Change   % Change 
Cash expenses                              
Accounting fees   (392,360)   2%   (350,407)   2%   (41,953)   12%
Consulting fees   (1,494,960)   9%   (1,793,016)   10%   298,056    -17%
Investor relations and marketing   (2,191,491)   13%   (2,867,059)   17%   675,568    -24%
Legal fees   (1,479,224)   8%   (864,112)   5%   (615,112)   71%
Board fees   (119,342)   1%   (84,581)   0%   (34,761)   41%
Office and general   (1,097,098)   6%   (940,979)   5%   (156,119)   17%
Personnel expenses   (1,877,672)   11%   (1,762,012)   10%   (115,660)   7%
Rent   (37,374)   0%   (60,079)   0%   22,705    -38%
Research and development   (8,543,836)   49%   (8,261,915)   48%   (281,921)   3%
Travel and meals   (271,207)   2%   (275,036)   2%   3,829    -1%
Total Cash Expenses (TCE)   (17,504,564)   100%   (17,259,196)   100%   (245,368)   1%

 

Accounting Fees are related to accounting staff and external audit fees. Accounting fees increased by $41,953, or 12%, to $392,360 for the six months ended September 30, 2025, compared to $350,407 for the six months ended September 30, 2024. Accounting Fees were 2% of TCE for both six month periods ended September 30, 2025 and September 30, 2024. The increase of $41,953 is primarily due to additional costs associated with translating our financial statements to USGAAP and complying with new SEC reporting requirements.

 

Consulting Fees are related to financial advisory and general consulting services. Consulting Fees decreased by $298,056, or 17%, to $1,49 million for the six months ended September 30, 2025, compared to $1.79 million for the six months ended September 30, 2024. Consulting Fees were 9% of TCE for the six months ended September 30, 2025, compared to 10% for the six months ended September 30, 2024.

 

Financial advisory services was $1.10 million for the six months ended September 30, 2025, compared to $1.49 million for the six months ended September 30, 2024. The decrease of $384,144 is primarily due to less fees paid to financial advisors in connection with funds raised by the Company: The Company raised $13.17 million in net proceeds during the six months ended September 30, 2025, compared to $10.31 million during the six months ended September 30, 2024.
General consulting services was $391,552 for the six months ended September 30, 2025, compared to $305,465 for the six months ended September 30, 2024. The increase of $86,087 is primarily due to a consulting firm hired to provide business and technology insights ($94,449) during the six months ended September 30, 2025.

 

Investor Relations and Marketing are related to messaging, marketing, and advertising of the Company and its products to potential users, and to develop general Company and brand awareness as well as investor relations initiatives in media, roadshows, and on social media. Investor Relations and Marketing decreased by $675,568 or 24% to $2.19 million for the six months ended September 30, 2025, compared to $2.87 million for the six months ended September 30, 2024. Investor Relations and Marketing was 13% of TCE for the six months ended September 30, 2025, compared to 17% for the six months ended September 30, 2024. These expenses are currently combined, as the initiatives to market the product and services of the Company and investment in the Company are intertwined and indistinguishable. As the Company begins to market its core products and services, marketing and investor relations expenses will be separated. The decrease in Investor Relations and Marketing is due to:

 

  Marketing and investor awareness decreased by $388,265 or 19% to $1.61 million for the six months ended September 30, 2025, compared to $2.00 million for the six months ended September 30, 2024. The decrease is a result of fewer consultants engaged to perform marketing and investor awareness activities during the six months ended September 30, 2025 compared to the six months ended September 20, 2024.
  Business development decreased by $287,303 or 33% to $582,298 for the six months ended September 30, 2025, compared to $869,601 for the six months ended September 30, 2024. The decrease is a result of fewer consultants engaged to perform business development activities during the six months ended September 30, 2025 compared to the six months ended September 20, 2024.

 

-40-

 

 

Legal Fees are related to fees paid to external counsel in the US and Canada. Legal fees increased by $615,112, or 71%, to $1.48 million for the six months ended September 30, 2025, compared to $864,112 for the six months ended September 30, 2024. Legal fees were 8% of TCE for the six months ended September 30, 2025, compared to 5% for the six months ended September 30, 2024. The increase of $615,112 for the six months ended September 30, 2025 was primarily due to increased legal costs associated with the Company becoming a U.S. SEC reporting on April 1, 2025, which requires additional disclosure and reporting.

 

Board Fees are related to costs associated with Board members. Board Fees increased by $34,761, or 41%, to $119,342 for the six months ended September 30, 2025, compared to $84,581 for the six months ended September 30, 2024. Board Fees were 1% of TCE for the six months ended September 30, 2025, compared to less than 1% for the six months ended September 30, 2024. The increase of $34,761 is due to increased fees paid to board members during the six months ended September 30, 2025, compared to the six months ended September 30, 2024.

 

Office and General Expenses are related to subscriptions, insurance, transaction fees, and general expenses of the Company. Office and general expenses increased by $156,119, or 17%, to $1.10 million for the six months ended September 30, 2025, compared to $940,979 for the six months ended September 30, 2024. Office and General Expenses was 6% of TCE for the six months ended September 30, 2025, compared to 5% for the six months ended September 30, 2024. The increase of $156,119 for the six months ended September 30, 2025 is primarily due to higher Directors and Officers (“D&O”) insurance premium cost of $124,904 resulting from increased coverage as the Company became a U.S. SEC reporting on April 1, 2025, which requires additional disclosure and reporting.

 

Personnel expenses are related to general and administrative payroll costs. Personnel expenses increased by $115,660, or 7%, to $1.88 million for the six months ended September 30, 2025, compared to $1.76 million for the six months ended September 30, 2024. Personnel expenses were 11% of TCE for the six months ended September 30, 2025, compared to 10% for the six months ended September 30, 2024. The increase of $115,660 in personnel expenses is primarily due to the higher salaries paid to personnel during the six months ended September 30, 2025, compared to the salaries and fees paid to personnel during the six months ended September 30, 2024.

 

Rent is related to payments for office and other spaces utilized by the Company. Rent decreased by $22,705, totaling $37,374 for the six months ended September 30, 2025, compared to $60,079 for the six months ended September 30, 2024. Rent expense accounted for less than 1% of TCE for both six month periods ended September 30, 2025 and September 30, 2024.

 

Research and Development (R&D) is related to payroll and contractor costs associated with developing the Company’s product. R&D increased by $281,921, or 3%, to $8.54 million for the six months ended September 30, 2025, compared to $8.26 million for the six months ended September 30, 2024. R&D was approximately 48-49% of TCE for both six month periods ended September 30, 2025 and September 30, 2024. The increase of $281,921 is primarily due to the higher salaries and fees paid to personnel during the six months ended September 30, 2025, compared to the salaries and fees paid to personnel during the six months ended September 30, 2024.

 

-41-

 

 

Travel and Meals are related to expenses related to meals, airfare, transportation, and other related expenses. Travel and Meals decreased by $3,829, or 1%, to $271,207 for the six months ending September 30, 2025, compared to $275,036 for the six months ended September 30, 2024. Travel and Meals remained consistent at 2% of TCE for both six month periods ended September 30, 2025 and September 30, 2024.

 

NON-CASH EXPENSES – Consisted of the items below. Non-Cash Expenses decreased by $1.17 million, or 35%, to $2.14 million for the six months ended September 30, 2025, compared to $3.31 million for the six months ended September 30, 2024.

 

   September 30, 2025   % of TNCE   September 30, 2024   % of TNCE   $ Change   % Change 
Non-cash expenses                              
Depreciation   (45,894)   2%   (93,907)   3%   48,013    -51%
Provision for contract settlement   -    0%   (1,252,076)   38%   1,252,076    -100%
Share based payments   (2,090,255)   98%   (1,961,724)   59%   (128,531)   7%
Total Non Cash Expenses (TNCE)   (2,136,149)   100%   (3,307,707)   100%   1,171,558    -35%

 

Depreciation is related to the decrease in the useful life of computer and other equipment. Depreciation decreased by $48,013, or 51%, to $45,894 for the six months ended September 30, 2025, compared to $93,907 for the six months ended September 30, 2024. The decrease for the six months ended September 30, 2025 is due to certain assets reaching the end of their three-year useful life.

 

Provision for contract settlement is related to the unbilled balance of the SaaS project terminated in August 2024. Provision for contract settlement was $1.25 million for the six months ended September 30, 2024. There was no comparable expense for the six months ended September 30, 2025.

 

Share based payments are related to the Black-Scholes valuation and vesting of stock options and Restricted Share Units (RSUs) granted to the Company’s employees, contractors, and consultants. Share-based payments increased by $128,531, or 7%, to $2.09 million for the six months ended September 30, 2025, compared to $1.96 million for the six months ended September 30, 2024. This increase is primarily due to a higher amount of equity grants issued for the six months ended September 30, 2025, compared to the six months ended September 30, 2024. The increase during the six months ended September 30, 2025 was partially offset by a decline in the fair value of RSUs, which are tied to the Class A Subordinate Voting Share price as of the balance sheet date. For a detailed breakdown of the changes, please refer to the table below.

 

Share based payments  Stock Options   RSUs   Total 
Previous years graded vesting   402,225    -    402,225 
Previous years RSUs revaluation   -    (251,392)   (251,392)
New grants Q1 2025   76,787    26,668    103,455 
New grants Q2 2025   1,027,452    805,605    1,833,057 
Cancelled options   (125,621)   -    (125,621)
Balance, September 30, 2024  $1,380,843   $580,881   $1,961,724 
                
Previous years graded vesting   711,710    -    711,710 
Previous years RSUs revaluation   -    (1,581,375)   (1,581,375)
New grants Q1 2026   258,056    344,431    602,487 
New grants Q2 2026   2,118,326    8,616    2,126,942 
RSU milestone conversion   -    230,491    230,491 
Balance, September 30, 2025  $3,088,092   $(997,837)  $2,090,255 

 

-42-

 

 

Total Operating expenses decreased by $926,190, or 5%, to $19.64 million for the six months ended September 30, 2025, compared to $19.13 million for the six months ended September 30, 2024. The decrease for the six months ended September 30, 2025 is primarily due to $1.25 million in non-cash expenses associated with the provision for contract settlement during the six months ended September 30, 2024 that was not present during the six months ended September 30, 2025, as well as a decrease in expenses associated with investor relations and marketing, which decreased by $675,568. The decrease during the six months ended September 30, 2025 was partially offset by increases in legal fees ($615,112) during the six months ended September 30, 2025.

 

Other Items consisted of the items below. Other Items resulted in a loss of $11,337 for the six months ended September 30, 2025, compared to a gain of $1.43 million for the six months ended September 30, 2024.

 

   September 30, 2025   % TOI   September 30, 2024   % TOI   $ Change   % Change 
OTHER ITEMS:                              
Grant income   81,909    -722%   56,034    4%   25,875    46%
Other income   501,261    -4421%   49,970    4%   451,291    903%
Gain on derivative liability   -    0%   2,464,873    173%   (2,464,873)   -100%
Accretion expense   -    0%   (453,839)   -32%   453,839    -100%
Interest expense   (12,254)   108%   (293,038)   -21%   280,784    -96%
Legal claim expense   (582,253)   5136%   -    0%   (582,253)   N/A 
Provision for losses on related party transactions   -    0%   (396,524)   -28%   396,524    -100%
Total Other Items (TOI)   (11,337)   100%   1,427,476    100%   (1,438,813)   -101%

 

Grant Income is related to the reimbursement of expenses for amounts spent on project activities related to the grant agreement with Horizon Europe, which is a program delegated by the European Commission. Grant income was $81,909 for the six months ended September 30, 2025, compared to $56,034 for the six months ended September 30, 2024. This project is expected to end in August 2026.

 

Other Income is related to R&D tax credits and interest received from interest-bearing bank accounts. Other income increased $451,291 to $501,261 for the six months ended September 30, 2025, compared to $49,970 for the six months ended September 30, 2024. This increase is primarily due to $416,208 of R&D tax credits received during the six months ended September 30, 2025.

 

-43-

 

 

Gain on derivative liability is the result of measuring the derivative liability embedded in the convertible debenture using the Monte-Carlo binomial. Changes in the estimates during the six months ended September 30, 2024, resulted in a gain on the fair value of derivative liability of the convertible debenture of $2,464,873. There was no such expense during the six months ended September 30, 2025.

 

Accretion Expense is related to the increase in the carrying value of the discounted value of the convertible debenture converted in 2025. There was no accretion expense during the six months ended September 30, 2025, compared to an expense of $453,839 during the six months ended September 30, 2024.

 

Interest Expense is related to interest incurred in the conversion of the convertible debenture converted in 2025, interest incurred in the loan payable, and the interest related to the financing of the director’s and officer’s insurance. Interest expense decreased $280,784, or 96%, to $12,254 for the six months ended September 30, 2025, compared to an expense of $293,038 for the six months ended September 30, 2024. This decrease is primarily due to the conversion of the convertible debenture during the six months ended September 30, 2024.

 

Legal Claim Expense was $582,253 for the six months ended September 30, 2025, compared to nil for the six months ended September 30, 2024. This amount is interest accrued in connection with the David Thomson arbitration award, which was confirmed by the Los Angeles Superior Court during the six months ended September 30, 2025. There was not such expense during the six months ended September 30, 2024.

 

Provision for Loss on Related Party Transactions was $396,524 for the six months ended September 30, 2024. There was no provision for the six months ended September 30, 2025.

 

The provision for loss on related party transactions includes amounts due from Cyberlab LLC (“Cyberlab”) and the Spatial Web Foundation (“SWF”), entities controlled or associated with the Company’s founders, Dan Mapes and Gabriel Rene.

 

The related expenses arose primarily from payments made by the Company on behalf of these related parties to third-party vendors.
Although these amounts are expected to be settled through future service agreements, management performed a credit assessment in accordance with the current expected credit loss (“CECL”) model under ASC 326. Based on this assessment, management determined that there is significant uncertainty regarding the timing and collectability of these receivables. As of September 30, 2025, management concluded that full repayment is not probable within a reasonable timeframe.

 

Net Loss increased $376,474, or 2%, to $19.51 million for the six months ended September 30, 2025, compared to a net loss of $19.13 million for the six months ended September 30, 2024.

 

-44-

 

 

LIQUIDITY AND CAPITAL RESOURCES

 

Verses is a development-stage technology cognitive computing company specializing in researching, developing, and selling next generation intelligence software systems. We are primarily focused on developing an intelligence-as-a-service smart software platform called Genius. As described above, for the six month period ended September 30, 2025, we reported Total Cash Expense (“TCE”) of $17.50 million, and for the six month period ended September 30, 2024, we reported TCE of $17.26 million. Our largest cash expense is associated with research and development, comprising $8.54 million or 49% of TCE for the six months ended September 30, 2025; $8.26 million or 48% of TCE for the six month period ended September 30, 2024. We anticipate that research and development will continue to be our largest expense, and that we will continue to have negative operating cash flow for the foreseeable future as we continue to invest in research and product development, as well as commercialization, marketing and sales of our systems and cannot accurately project when we will generate positive operating cash flow. Our average monthly cash used by operating activities, as described below, was $2.69 million per month for the past 24 months and $2.73 million for the past 3 months, which reflects an increase in research and development. We anticipate that our average monthly cash used in operations activity will increase as we commercialize, market, and sell our systems and that over time, the revenue generated from product sales will offset the increased costs commercialization, marketing, and sales and will position the company to generate positive operating cash flow. Our approach to managing liquidity is to ensure, to the extent possible, that we always have sufficient liquidity to meet our obligations as they become due, and we do so by monitoring cash flow and performing budget-to-actual analysis on a regular basis.

 

The Company has historically raised capital to fund operations, primarily through debt and equity investors, although there is no assurance that it will be able to raise funds in the future. The Company will continue to rely on such financings to generate sufficient amounts of cash and cash equivalents to cover its operating costs, satisfy short and long term capital requirements, and meet growth objectives. The ability of the Company to arrange additional financing in the future will also depend, in part, on prevailing capital market conditions. Any quoted market for the Company’s shares may be subject to market trends generally, notwithstanding any potential success of the Company in creating new revenues, cash flows or earnings.

 

The Company’s ability to continue its operations and to realize its assets at their carrying values is dependent upon obtaining additional financing and generating revenues sufficient to cover its operating costs. The ability of the Company to raise sufficient capital to fund operations are conditional primarily through the continuation of its agreements and investor support. The material uncertainty associated with these events and conditions may cast substantial doubt about the Company’s ability to continue as a going concern. The Company’s financial statements do not give effect to any adjustments, which would be necessary should the Company be unable to continue as a going concern. In such circumstances, the Company would be required to realize its assets and discharge its liabilities outside of the normal course of business, and the amounts realized could differ materially from those reflected in the accompanying condensed consolidated interim financial statements.

 

The Company’s consolidated financial statements have been prepared as a going concern, which assumes that the Company will continue to operate for the foreseeable future and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company has incurred losses since inception and has not yet achieved profitable operations. The Company has been relying on debt and equity financing to fund its operations in the past. While the Company has been successful in securing financing to date, there can be no assurances that it will be able to do so in the future. As noted in the report of our independent public accountants for our financial statements for the year ended March 31, 2025, the aforementioned factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that such audited annual financial statements were issued.

 

Historically, the Company has used net proceeds from issuances of debt and equity to provide sufficient funds to meet its near-term operating expenses and other contractual obligations when due. Management plans to fund operations of the Company with its current working capital and through additional equity and/or debt financings.

 

In view of these matters, continuing as a going concern is dependent upon continued operations of the Company, which in turn is dependent upon the Company’s ability to, meets its financial requirements, raise additional capital, and the success of its future operations.

 

-45-

 

 

The Company’s long-term capital requirements may vary materially from those currently planned and will depend on many factors, including net sales, the timing and extent of spending on research and development efforts and other initiatives, sales and marketing activities, the timing of new products, and overall economic conditions. Any quoted market for the Subordinate Voting Shares may be subject to market trends generally, notwithstanding any potential success of the Company in creating new revenues, cash flows or earnings. The sale of additional equity would result in additional dilution to the Company’s shareholders. The incurrence of debt financing would result in debt service obligations and the instruments governing such debt could provide for operating and financing covenants that may restrict our operations. There can be no assurances that we will be able to raise additional capital on terms that are attractive to us or at all. The inability to raise capital would adversely affect our ability to achieve our business objectives.

 

   September 30, 2025   March 31, 2025 
Cash   1,209,908    4,816,906 
Current assets, including cash   3,450,576    6,183,082 
Total Assets  $3,640,241   $6,376,575 
           
Current liabilities   12,819,850    15,106,292 
Other liabilities   139,722    139,039 
Shareholder’s deficiency   (9,319,331)   (8,868,756)
Total liabilities and shareholder’s deficiency  $3,640,241   $6,376,575 

 

Cash decreased to $1.21 million as of September 30, 2025, compared to $4.82 million as of March 31, 2025. Working capital is current assets minus current liabilities, including the current portion of long-term debt. The Company had a working capital deficit of $9.37 million as of September 30, 2025, compared to a working capital deficit of $8.92 million as of the year ended March 31, 2025.

 

For the six months ended  September 30, 2025   September 30, 2024   Change 
Cash provided by (used) in operating activities  $(18,323,019)  $(16,168,175)  $(2,154,844)
Cash provided by (used) in investing activities   (40,489)   (428,678)   388,189 
Cash provided by (used) in financing activities   14,673,207    18,162,469    (3,489,262)
Foreign exchange effect on cash   83,303    (221,845)   305,148 
Net change in cash during the period  $(3,606,998)  $1,343,771   $(4,950,769)

 

Cash used in operating activities is comprised of net loss, add-back of non-cash expenses, and net change in non-cash working capital items. Cash used in operating activities increased by $2.15 million to $18.32 million during the six months ended September 30, 2025, compared to $16.17 million during the six months ended September 30, 2024. The increase is primarily due to a higher variation of cash used to settle accounts payable ($1.56 million), prepaids ($324,422), and the cash allocated to accounts receivable ($241,700).

 

Cash used in investing activities primarily reflects payments related to Spatial Web Foundation (“SWF”) and Cyberlab LLC (“Cyberlab”), entities controlled or associated with the Company’s founders, Dan Mapes and Gabriel Rene, as well as purchases of computer equipment. During the six months ended September 30, 2025, the Company did not report payments related to SWF and Cyberlab, compared to payments of $398,099 during the six months ended September 30, 2024. Capital expenditures associated with computers and other equipment increased by $9,910 to $40,489 during the six months ended September 30, 2025, compared to $30,579 during the six months ended September 30, 2024.

 

-46-

 

 

Cash provided by financing activities relates to the instruments used by the Company to fund its working capital needs. Cash provided by financing activities was $14.67 million during the six months ended September 30, 2025 compared to $18.16 million during the six months ended September 30, 2024.

 

During the six months ended September 30, 2025 the Company received (used)

 

-Received $13.17 million net proceeds from the issuance of Units.
-Received $1.57 million net proceeds from the issuance of equity instruments.
-Used $(67,732) as expenses related to the European Grant (Horizon Europe, which is a program delegated under the European Commission).
-Used $(1.94) million on the repayment of loans.

 

During the six months ended September 30, 2024 the Company received (used)

 

-Received $10.00 million for the issuance of convertible debentures.
-Received $6.94 million net proceeds from the issuance of special warrants.
-Received $1.32 million net proceeds from the issuance of Units.
-Received $1.73 million from the issuance of equity instruments.
-Used $(2.00) million on the repayment of promissory notes.

 

CRITICAL ACCOUNTING ESTIMATES

 

Equipment

 

The Company reviews its estimate of the useful lives of depreciable assets at each reporting date, based on the expected remaining useful life of the assets. Uncertainties in these estimates relate to technical obsolescence that may change the utilization of equipment.

 

Recoverability of accounts receivable, contracts assets, and unbilled revenues, and allowance for credit loss

 

The Company provides an allowance for expected credit losses based on an assessment of the recoverability of accounts receivable. Allowances are applied to accounts receivable at initial recognition based on the probability of default. Management analyzes its debts, customer concentrations, customer creditworthiness, current economic trends, and changes in customer payment terms when making a judgment to evaluate the adequacy of the allowance for expected credit losses. Where the expectation is different from the original estimate, such difference will impact the carrying value of accounts receivable.

 

Functional currency

 

The determination of the functional currency of each entity within the Company requires management judgment in determining the currency that mainly influences the sale price of services and costs of providing services.

 

Revenue recognition

 

When the Company enters into an agreement for software development which is longer in nature (longer than 1 year), the Company records a contract asset which is representative of receivables from the agreements not yet billed to the customer. Significant judgment is made to determine the performance obligations and whether each performance obligation is satisfied at a point in time or over the term of the contracts.

 

Going concern

 

The assessment of the Company’s ability to continue as a going concern. The determination that the Company will be able to continue as a going concern is subject to critical judgments of management with respect to assumptions surrounding the short and long-term operating budget and financing activities. Should these judgments prove to be inaccurate, management’s continued use of the going concern assumption may be inappropriate.

 

JOBS Act

 

On April 5, 2012, the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) was enacted. Section 107 of the JOBS Act provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.

 

We have chosen to take advantage of the extended transition periods available to emerging growth companies under the JOBS Act for complying with new or revised accounting standards until those standards would otherwise apply to private companies provided under the JOBS Act. As a result, our financial statements may not be comparable to those of companies that comply with public company effective dates for complying with new or revised accounting standards.

 

Subject to certain conditions set forth in the JOBS Act, as an “emerging growth company,” we intend to rely on certain of these exemptions, including, without limitation, (i) providing an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002, as amended, and (ii) complying with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements, known as the auditor discussion and analysis. We will remain an “emerging growth company” until the earliest of (i) the last day of the fiscal year in which we have total annual gross revenues of $1.235 billion or more; (ii) the last day of our fiscal year following the fifth anniversary of the date of our initial public offering; (iii) the date on which we have issued more than $1 billion in nonconvertible debt during the previous three years; or (iv) the date on which we are deemed to be a large accelerated filer under the rules of the SEC.

 

-47-

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company is not required to provide the information required by this Item as it is a “smaller reporting company,” as defined in Rule 12b-2 of the Exchange Act.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Principal Executive Officer and Principal Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2025, the end of the period covered by this Quarterly Report on Form 10-Q. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures. Based on such evaluation, our Principal Executive Officer and Principal Financial Officer have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were not effective  to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.

 

Identified Material Weakness

 

In connection with the audit of our financial statements as of March 31, 2025, we identified material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

 

The material weaknesses that we have identified relate to:

 

1. Insufficient written policies and procedures to ensure the correct application of accounting and financial reporting with respect to the current requirements of GAAP and SEC disclosure requirements.

 

2. Due to the Company’s size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible.

 

3. Although the Company does have a written procedure for the approval, identification and reporting of related-party transactions may be limited.

 

Remediation Plan

 

We are taking actions to remediate the material weakness described above by reviewing and updating our internal policies and human resources allocations.

 

Changes in Internal Control Over Financial Reporting

 

Other than as described above, there have been no changes in our internal control over financial reporting that occurred during our last fiscal quarter ended September 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.  

 

-48-

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. Other than as set forth below, we are currently not aware of any such legal proceedings or claims that will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

 

On July 13, 2022, David Thomson, a former independent contractor, filed a claim against one of the Company’s U.S. subsidiaries, Verses Technologies USA Inc. (“VTU”), Cyberlab LLC (“Cyberlab”), and two directors/officers of the Company in Los Angeles Superior Court. The claim alleged violations of various sections of the California Corporations Code, breach of contract, breach of the implied covenant of good faith and fair dealing, and unjust enrichment. Plaintiff claimed as much as $5,000,000 in damages, subject to proof. On September 1, 2022, VTU filed an answer denying any wrongdoing, and also made its own counterclaim against Mr. Thomson. The cross-claims against David Thomson included: (i) misappropriation of trade secrets; (ii) breach of contract; (iii) violation of the California Computer Data Access and Fraud Act (“CDAFA”); and (iv) violation of the Economic Espionage Act along with three additional cross-claims (alleging violation of the Computer Fraud and Abuse Act, conversion, violation of the Stored Communications Act, respectively) that were subsequently dismissed by the Court. VTU, for its part, sought to recover both compensatory and punitive damages from Mr. Thomson, as well as restitution of any ill-gotten gains and an award of reasonable attorneys’ fees. The arbitration was conducted for a total of 13 days over a period from February 5 through April 3, 2024, via a single arbitrator at the American Arbitration Association. The CDAFA claim was dismissed by the Arbitrator, but the claims for trade secret misappropriation, breach of contract and unjust enrichment were allowed to move forward. A final arbitration award was issued on May 17, 2024. The final award imposed liability against: (i) VTU, jointly and severally with Cyberlab, LLC, a company owned by the Company’s former president and current President Emeritus, Director of Global Development and a director of the Company, Dan Mapes, in the amount of $6,307,258, inclusive of interest; and (ii) Cyberlab, LLC, VTU and its principals, Gabriel René and Dan Mapes, jointly and severally, for damages in the amount of $1,900,000, interest of $709,973 costs of $64,303 and the fees of plaintiff’s counsel totaling $920,231. To resolve their part of joint and several liability, Mr. René and Mr. Mapes are working toward satisfying the portion of the award that applies to them as individuals, including $1,666,000 proceeds from insurance. The remaining liability belongs to VTU. Initial good faith payments of $1,791,000 have been made to the claimant. On January 24, 2025, Mr. Thomson filed a Petition to Confirm the Arbitration Award with the Los Angeles Superior Court. A hearing on the Petition was held and on May 8, 2025, the Petition was confirmed for approximately $9,900,000 million together with interest accrued thereon. We recorded the total amount of this award as an expense incurred during our fiscal year ended March 31, 2024, while in the following fiscal year we recorded as income the $1,666,000 insurance payment received by Mr. Mapes and Mr. Rene, which was partially offset by an aggregate of $817,787 of interest that accrued on the total award during the most recently completed fiscal year ended.

 

On August 10, 2024, the Company learned that a complaint (the “Complaint”) had been filed in the Los Angeles Superior Court on June 21, 2024 by a former employee (the “Complainant”) against one of the Company’s US subsidiaries (VERSES, Inc. or “VINC”) and one of its employees in their individual capacity. The Complainant worked for VINC but had been terminated several weeks prior by VINC for poor work performance. The Complaint alleges, inter alia, gender harassment; gender discrimination; race discrimination; race harassment; retaliation; and wrongful termination, while seeking to recover as much as US$3,500,000 in general and special compensatory damages, subject to proof. The Company (and VINC) for its part, disputes the allegations, and considers the Complainant’s termination to have been completely proper and justified under applicable law. VINC was properly served with a copy of the Complaint (and associated summons) and it filed an Answer to the allegations raised therein on September 24, 2024. The employment contract with the Complainant contained an arbitration clause, and VINC’s counsel timely moved to compel arbitration (the “VINC Motion”) and a hearing was held on April 1, 2025. The tentative ruling from the Los Angeles Superior Court (the “Court”) denied the VINC Motion, finding that the Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021 (“EFAA”) was applicable to the Complainant’s “gender harassment” claim and that the Complainant had the option to bring her claims to the Court instead of arbitration. The Court allowed for limited oral advocacy during which VINC’s counsel argued that the arbitration clause should be enforced. The Court took the matter under submission but, after due deliberation, reaffirmed its original conclusions. The Complainant served VINC with discovery requests, and responses were sent on May 8, 2025. The Court assigned a trial date of July 10, 2026, and also asked the parties to engage in informal mediation via a court sponsored alternative dispute resolution program. A post-mediation status conference is scheduled for Sept. 15, 2025 where the parties have been instructed to summarize the outcome of the mediation process.

 

-49-

 

 

On August 11, 2025, David Thomson (“Complainant”) made a motion with the Court seeking from VTU, Cyberlab and two directors/officers of the Company, an aggregate of $495,543 for attorney’s fees and related costs incurred by the Complainant after the May 17, 2024, final arbitration award. This motion is based on the Court’s judgment on May 28, 2025, which gave the Court discretion to award the Complainant attorney’s fees and expenses incurred by the Complainant after May 17, 2024. A hearing date has been set for April 21, 2026. We are currently evaluating this motion and intend to respond to it in due course.  

Other than the above, we are not currently involved in any material legal proceedings. We may be involved from time to time in various claims and legal actions arising in the ordinary course of business, including proceedings involving employee claims, contract disputes, and other general liability claims, as well as trademark, copyright, and related claims and legal actions. In the opinion of our management, the ultimate disposition of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.

 

ITEM 1A. RISK FACTORS

 

Risk factors that affect our business and financial results are discussed in Part I, Item 1A “Risk Factors,” in our Annual Report on Form 10-K for the year ended March 31, 2025 as filed with the SEC on July 14, 2025 (“Annual Report”). There have been no material changes in our risk factors from those previously disclosed in our Annual Report. You should carefully consider the risks in our Annual Report which could materially affect our business, financial condition or future results. The risks in our Annual Report are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, and/or operating results. If any of the risks actually occur, our business, financial condition, and/or results of operations could be negatively affected.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 5. OTHER INFORMATION

 

Rule 10b5-1 Trading Plans

 

During the fiscal quarter ended September 30, 2025, none of the Company’s directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

 

-50-

 

 

ITEM 6. EXHIBITS

 

Exhibit No.   Description
31.1*   Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of the Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*   Cover Page Interactive Data File - the cover page from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 is formatted in Inline XBRL

 

* Filed herewith.
   
** Furnished herewith.

 

-51-

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  VERSES AI INC.
   
Date: November 13, 2025 By: /s/ Gabriel René
    Gabriel René
    Chief Executive Officer
    (Principal Executive Officer)
     
Date: November 13, 2025 By: /s/ James Christodoulou
    James Christodoulou
    Chief Financial Officer
    (Principal Financial Officer)

 

-52-

 

 

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF VERSES AI INC.

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Gabriel René, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Verses AI Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 13, 2025 /s/ Gabriel René
  Gabriel René
  Chief Executive Officer
  (Principal Executive Officer)

 

 

 

 

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER OF VERSES AI INC.

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, James Christodoulou, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Verses AI Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 13, 2025 /s/ James Christodoulou
  James Christodoulou
  Chief Financial Officer
  (Principal Financial Officer)

 

 

 

 

Exhibit 32.1

 

STATEMENT OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 1350 OF TITLE 18 OF THE UNITED STATES CODE

 

Pursuant to Section 1350 of Title 18 of the United States Code as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Gabriel René and James Christodoulou, the, Chief Executive Officer and Chief Financial Officer, respectively, of Verses AI Inc. (the “Company”), hereby certifies that based on the undersigned’s knowledge:

 

  1. The Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 13, 2025 /s/ Gabriel René
  Gabriel René
  Chief Executive Officer
  (Principal Executive Officer)
   
Date: November 13, 2025 /s/ James Christodoulou
  James Christodoulou
  Chief Financial Officer
  (Principal Financial Officer)

 

 

 

v3.25.3
Cover - shares
6 Months Ended
Sep. 30, 2025
Nov. 14, 2025
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2025  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2026  
Current Fiscal Year End Date --03-31  
Entity File Number 000-56692  
Entity Registrant Name VERSES AI INC.  
Entity Central Index Key 0001879001  
Entity Tax Identification Number 88-2921736  
Entity Incorporation, State or Country Code A1  
Entity Address, Address Line One 2121 Avenue of the Stars  
Entity Address, Address Line Two 8th Floor  
Entity Address, City or Town Los Angeles  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 90067  
City Area Code (310)  
Local Phone Number 988-1944  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   12,611,275

v3.25.3
Condensed Consolidated Interim Balance Sheet - USD ($)
Sep. 30, 2025
Mar. 31, 2025
CURRENT    
Cash and restricted cash $ 1,209,908 $ 4,816,906
Accounts receivable 296,700
Deferred financing costs 118,546
Work in progress 6,654
Tax receivable 728,193 604,912
Prepaid expenses 1,215,775 636,064
Total current assets 3,450,576 6,183,082
Due from related parties 69,657 68,080
Equipment 120,008 125,413
TOTAL ASSETS 3,640,241 6,376,575
CURRENT    
Accounts payable 1,508,247 2,036,916
Accrued liabilities 132,665 41,736
Deferred grant 67,732
Deferred revenue 100,000
Provision for legal claim 9,402,338 8,948,085
Restricted share unit liability 1,776,600 3,911,823
Total current liabilities 12,819,850 15,106,292
Loans payable 139,722 139,039
TOTAL LIABILITIES 12,959,572 15,245,331
SHAREHOLDERS’ DEFICIENCY    
Additional paid-in capital 18,808,571 15,891,737
Accumulated other comprehensive loss (591,715) (675,018)
Deficit (149,068,526) (129,562,625)
TOTAL SHAREHOLDERS’ DEFICIENCY (9,319,331) (8,868,756)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIENCY 3,640,241 6,376,575
Class A Subordinate Voting Shares [Member]    
SHAREHOLDERS’ DEFICIENCY    
Voting shares, value 121,532,339 105,477,150
Class B Proportionate Voting Stock [Member]    
SHAREHOLDERS’ DEFICIENCY    
Voting shares, value

v3.25.3
Condensed Consolidated Interim Balance Sheet (Parenthetical) - $ / shares
6 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Class A Subordinate Voting Shares [Member]    
Voting shares, no par value
Voting shares, shares authorized Unlimited Unlimited
Voting shares, shares issued 8,897,200 7,825,571
Voting shares, shares outstanding 8,897,200 7,825,571
Class B Proportionate Voting Stock [Member]    
Voting shares, no par value
Voting shares, shares authorized Unlimited Unlimited
Voting shares, shares issued 198,517
Voting shares, shares outstanding 198,517

v3.25.3
Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
REVENUE $ 100,700 $ 155,000 $ 400,700 $ 155,000
COST OF REVENUE (70,490) (145,000) (254,551) (145,000)
NET REVENUE 30,210 10,000 146,149 10,000
Operating expenses:        
Selling, general and administrative expenses (9,651,834) (10,265,830) (19,640,713) (20,566,903)
OPERATING INCOME (EXPENSE) (9,621,624) (10,255,830) (19,494,564) (20,556,903)
Other income/(expense), net (245,434) 1,687,108 (11,337) 1,427,476
NET LOSS $ (9,867,058) $ (8,568,722) $ (19,505,901) $ (19,129,427)
Class A Subordinate Voting Shares [Member]        
Operating expenses:        
Loss Per Voting Shares - Basic $ (1.00) $ (1.48) $ (2.12) $ (3.90)
Loss Per Voting Shares - Diluted $ (1.00) $ (1.48) $ (2.12) $ (3.90)
Voting Shares Shares used in computing earnings per share - Basic 9,861,001 5,780,312 9,166,869 4,905,748
Voting Shares Shares used in computing earnings per share - Diluted 9,861,001 5,780,312 9,166,869 4,905,748
Class B Proportionate Voting Stock [Member]        
Operating expenses:        
Loss Per Voting Shares - Basic $ (6.22) $ (13.26)
Loss Per Voting Shares - Diluted $ (6.22) $ (13.26)
Voting Shares Shares used in computing earnings per share - Basic 8,726 4,363
Voting Shares Shares used in computing earnings per share - Diluted 8,726 4,363

v3.25.3
Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net Loss $ (9,867,058) $ (8,568,722) $ (19,505,901) $ (19,129,427)
Change in foreign currency translation (87,018) (134,465) 83,303 (221,974)
NET COMPREHENSIVE LOSS $ (9,954,076) $ (8,703,187) $ (19,422,598) $ (19,351,401)

v3.25.3
Condensed Consolidated Interim Statements of Shareholders' Deficiency (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Balance $ (10,664,780) $ (8,868,756) $ (13,825,210) $ (11,676,112) $ (8,868,756) $ (11,676,112)
Exercise of options and warrants 1,572,440   554,294 1,171,989    
Stock options granted 2,531,083 557,003 1,043,798 337,045    
Conversion of Class B Proportionate Voting shares into Class A Subordinate Voting shares          
Shares issued for services       49,714    
Special warrants converted to shares     6,940,368    
Foreign exchange difference (87,018) 170,321 (134,465) (87,509) 83,303 (221,974)
Net loss (9,867,058) (9,638,843) (8,568,722) (10,560,705) (19,505,901) (19,129,427)
Additional interest convertible debenture   3,668   3,668    
RSUs converted 1,137,392     1,137,392    
Conversion of Class A Subordinate Voting shares into Class B Proportionate Voting shares        
Issuance of Units for cash (net) 6,058,610 7,111,827 3,365,971      
Balance $ (9,319,331) $ (10,664,780) $ (17,564,334) $ (13,825,210) $ (9,319,331) $ (17,564,334)
Class A Subordinate Voting Shares [Member]            
Balance, shares 8,746,491 7,825,571 5,596,129 3,205,319 7,825,571 3,205,319
Exercise of options and warrants, shares 250,000   28,240 74,143    
Conversion of Class B Proportionate Voting shares into Class A Subordinate Voting shares, shares       2,314,815    
Shares issued for services, shares       1,852    
Special warrants converted to shares, shares     370,370    
Additional interest convertible debenture, shares   4,254      
RSUs converted, shares 133,686        
Conversion of Class A Subordinate Voting shares into Class B Proportionate Voting shares, shares (1,240,741)        
Issuance of units for cash (net), shares 1,007,764 916,666 231,481      
Balance, shares 8,897,200 8,746,491 6,226,220 5,596,129 8,897,200 6,226,220
Class B Proportionate Voting Stock [Member]            
Balance, shares 370,370 370,370
Conversion of Class B Proportionate Voting shares into Class A Subordinate Voting shares, shares       (370,370)    
Conversion of Class A Subordinate Voting shares into Class B Proportionate Voting shares, shares 198,517          
Balance, shares 198,517 198,517
Common Stock [Member] | Class A Subordinate Voting Shares [Member]            
Balance $ 112,097,010 $ 105,477,150 $ 64,578,758 $ 62,472,187 $ 105,477,150 $ 62,472,187
Exercise of options and warrants 2,900,227   656,969 2,056,857    
Stock options granted    
Conversion of Class B Proportionate Voting shares into Class A Subordinate Voting shares          
Shares issued for services       49,714    
Special warrants converted to shares     6,758,974    
Foreign exchange difference    
Net loss    
Additional interest convertible debenture   3,668   3,668    
RSUs converted 1,137,392     1,137,392    
Conversion of Class A Subordinate Voting shares into Class B Proportionate Voting shares        
Issuance of Units for cash (net) 5,397,710 6,616,192 3,231,158      
Balance 121,532,339 112,097,010 75,225,859 64,578,758 121,532,339 75,225,859
Additional Paid-in Capital [Member]            
Balance 16,944,375 15,891,737 12,976,131 13,342,560 15,891,737 13,342,560
Exercise of options and warrants (1,327,787)   (102,675) (884,868)    
Stock options granted 2,531,083 557,003 1,043,798 337,045    
Conversion of Class B Proportionate Voting shares into Class A Subordinate Voting shares          
Shares issued for services          
Special warrants converted to shares     181,394    
Foreign exchange difference    
Net loss    
Additional interest convertible debenture        
RSUs converted        
Conversion of Class A Subordinate Voting shares into Class B Proportionate Voting shares        
Issuance of Units for cash (net) 660,900 495,635 134,813      
Balance 18,808,571 16,944,375 14,052,067 12,976,131 18,808,571 14,052,067
Obligation to Issue Shares [Member]            
Balance 6,758,974
Exercise of options and warrants      
Stock options granted    
Conversion of Class B Proportionate Voting shares into Class A Subordinate Voting shares          
Shares issued for services          
Special warrants converted to shares     (6,758,974) 6,758,974    
Foreign exchange difference    
Net loss    
Additional interest convertible debenture        
RSUs converted        
Conversion of Class A Subordinate Voting shares into Class B Proportionate Voting shares        
Issuance of Units for cash (net)      
Balance 6,758,974
AOCI Attributable to Parent [Member]            
Balance (504,697) (675,018) (1,008,467) (920,958) (675,018) (920,958)
Exercise of options and warrants      
Stock options granted    
Conversion of Class B Proportionate Voting shares into Class A Subordinate Voting shares          
Shares issued for services          
Special warrants converted to shares        
Foreign exchange difference (87,018) 170,321 (134,465) (87,509)    
Net loss    
Additional interest convertible debenture        
RSUs converted        
Conversion of Class A Subordinate Voting shares into Class B Proportionate Voting shares        
Issuance of Units for cash (net)      
Balance (591,715) (504,697) (1,142,932) (1,008,467) (591,715) (1,142,932)
Retained Earnings [Member]            
Balance (139,201,468) (129,562,625) (97,130,606) (86,569,901) (129,562,625) (86,569,901)
Exercise of options and warrants      
Stock options granted    
Conversion of Class B Proportionate Voting shares into Class A Subordinate Voting shares          
Shares issued for services          
Special warrants converted to shares        
Foreign exchange difference    
Net loss (9,867,058) (9,638,843) (8,568,722) (10,560,705)    
Additional interest convertible debenture        
RSUs converted        
Conversion of Class A Subordinate Voting shares into Class B Proportionate Voting shares        
Issuance of Units for cash (net)      
Balance $ (149,068,526) $ (139,201,468) $ (105,699,328) $ (97,130,606) $ (149,068,526) $ (105,699,328)

v3.25.3
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash provided by (used in): OPERATING ACTIVITIES    
Net loss $ (19,505,901) $ (19,129,427)
Adjustments to reconcile net losses to net cash used in operating activities:    
Depreciation 45,894 93,907
Interest due from related parties loan (1,577)
Fair value gain on derivative liability (2,464,873)
Foreign exchange effect on convertible debenture 216,334
Provision for legal claim 454,253
Provision for contract settlement 1,252,076
Provision for losses on related party transactions 396,524
Accretion expense 453,839
Interest expense 12,254 293,038
Issuance of shares for services 49,714
Restricted shares units (2,135,223) 581,010
Share based payments 4,225,478 1,380,714
Changes in operating assets and liabilities:    
Accounts receivable (296,700) (55,000)
Contract assets and unbilled revenue 6,654
Tax receivable (123,281) (173,932)
Prepaid expenses (579,711) (255,289)
Deferred financing costs 118,546 80,993
Accounts payable and accrued liabilities (443,705) 1,112,197
Deferred revenue (100,000)
Net cash used in operating activities (18,323,019) (16,168,175)
INVESTING ACTIVITIES    
Due from related parties (398,099)
Investment in equipment (40,489) (30,579)
Net cash used in investing activities (40,489) (428,678)
FINANCING ACTIVITIES    
Deferred grant (67,732) 176,030
Repayments of loans (1,938) (2,003,876)
Proceeds from issuance of special warrants 7,306,000
Special warrant issuance costs (365,632)
Proceeds from issuance of equity instruments 1,572,440 1,726,283
Proceeds from issuance of Units 14,930,232 1,643,693
Private placement issuance costs (1,759,795) (320,029)
Proceeds from issuance of convertible debentures 10,000,000
Net cash provided by financing activities 14,673,207 18,162,469
Foreign exchange effect on cash 83,303 (221,845)
Net change in cash during the period (3,606,998) 1,343,771
Cash, beginning of the period 4,816,906 892,727
Cash, end of the period $ 1,209,908 $ 2,236,498

v3.25.3
Pay vs Performance Disclosure - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Pay vs Performance Disclosure [Table]            
Net Income (Loss) $ (9,867,058) $ (9,638,843) $ (8,568,722) $ (10,560,705) $ (19,505,901) $ (19,129,427)

v3.25.3
Insider Trading Arrangements
3 Months Ended
Sep. 30, 2025
Insider Trading Arrangements [Line Items]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false

v3.25.3
NATURE OF BUSINESS AND GOING CONCERN
6 Months Ended
Sep. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
NATURE OF BUSINESS AND GOING CONCERN

 

1.NATURE OF BUSINESS AND GOING CONCERN

 

VERSES is a cognitive computing company specializing in next generation intelligence software systems. We are primarily focused on developing an intelligence-as-a-service smart software platform. Our business is based on the vision of the “Spatial Web” - an open, hyper-connected, context-aware, governance-based network of humans, machines and intelligent agents. We also intend to build tools that enable the Spatial Web and to become a leader in the transition from the information age to the intelligence age.

 

In early 2024, we launched a private beta program of our software platform with a few select users with whom we had existing business relationships. During the second half of 2024, we launched a public beta program for a broader number of developers.

 

On April 30, 2025, we announced the commercial launch of our flagship software platform, called Genius, which is designed to enable agentic intelligence for enterprises. Genius is designed to provide the tools necessary to build domain-specific models that are intended to improve decision-making (inference as a service) for third-party agents through our software development kits/application programming interfaces and model editor. We are implementing a “Lighthouse” go to market strategy that will focus on working with a small number of high-value, high-impact clients in sectors where success will have broad applicability, such as financial services, robotics, and smart cities. Each client will allow us to continue to develop and validate our Genius model that can then be applied to other clients in the same sector. During the coming quarters, we plan to expand from these initial sectors into others, such as logistics and infrastructure management.

 

On June 28, 2022, the Subordinate Class A shares of the Company were listed and started trading on the NEO Exchange in Canada (“NEO”) (“Listing”) under the symbol “VERS”.

 

On October 4, 2022, the Company announced that the Company’s Class A shares have commenced trading on the OTCQX® Best Market, an over-the-counter public market in the United States, under the ticker symbol “VRSSF”. VERSES will continue to trade on the NEO Exchange in Canada, as its primary listing.

 

On July 20, 2023, the Company was downgraded from the OTCQX and started trading on OTCQB® Venture Market under the same ticker symbol “VRSSF”.

 

The Company’s head office and registered and records office is located at 1111 West Hastings Street, 15th Floor, Vancouver, British Columbia, V6E 2J3, Canada.

 

For the six-month period ending September 30, 2025, the Company incurred a net loss of $19,505,901 (September 30, 2025 - $19,129,427), which was primarily funded by the issuance of Units and exercise of equity instruments (Note 10). As of September 30, 2025, the Company has an accumulated deficit of $149,068,526 (March 31, 2025 - $129,562,625). The Company’s ability to continue its operations and to realize its assets at their carrying values is dependent upon obtaining additional financing and generating revenues sufficient to cover its operating costs and working capital deficit.

 

The ability of the Company to raise additional capital sufficient to continue operations is dependant, in part, on the progress of its technology development and continued investor support. The material uncertainty of these items raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not give effect to any adjustments, which would be necessary should the Company be unable to raise additional capital to continue as a going concern. In such circumstances, the Company would be required to realize its assets and discharge its liabilities outside of the normal course of business, and the amounts realized could differ materially from those reflected in these consolidated financial statements.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

v3.25.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

a)Basis of presentation

 

The condensed consolidated interim financial statements include the accounts of VERSES AI Inc. and its wholly owned subsidiaries (“Subsidiaries”) (collectively “VERSES” or the “Company”) have been prepared in accordance with U.S generally accepted accounting principles (“GAAP”) as defined by the Financial Accounting Standards Board (FASB).

 

b)Consolidation

 

These consolidated financial statements include the accounts of the Company and its wholly owned Subsidiaries. The results of the Subsidiaries will continue to be included in the consolidated financial statements of the Company until the date that the Company’s control over the Subsidiaries ceases. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. All intercompany transactions are eliminated on these consolidated financial statements.

 

Details of the Company’s Subsidiaries at September 30, 2025 and March 31, 2025 are as follows:

 

Name 

Place of

 Incorporation

 

September 30, 2025

Interest

 

March 31, 2025

Interest

Verses Technologies USA, Inc.

(formerly Verses Labs Inc.) (“VTU”)

  Wyoming, USA   100%   100%
Verses Operations Canada Inc. (“VOC”)  British Columbia, CA   100%   100%
Verses Logistics Inc. (“VLOG”)  Wyoming, USA   100%   100%
Verses Realities Inc. (“VRI”)  Wyoming, USA   Dissolved   100%
Verses Inc. (“VINC”)  Wyoming, USA   100%   100%
Verses Health Inc. (“VHE”)  Wyoming, USA   Dissolved   100%
Verses Global BV (“VBV”)  Netherlands   100%   100%
Verses Solutions Inc (“VSI”)  Wyoming, USA   100%   100%

 

c)Significant accounting estimates and judgments

 

The preparation of these condensed consolidated interim financial statements requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. These consolidated financial statements include estimates that, by their nature, are uncertain. The impacts of such estimates are pervasive throughout the consolidated financial statements, and may require accounting adjustments based on future occurrences. Revisions to accounting estimates are recognized in the period in which the estimate is revised and future periods if the revision affects both current and future periods. These estimates are based on historical experience, current and future economic conditions, and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Actual outcomes could differ from these estimates.

 

The significant judgements made by management in the Company’s accounting policies and key sources of estimation uncertainty were the same as those applied in the annual audited consolidated financial statements for the year ended March 31, 2025.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

v3.25.3
DEFERRED GRANT
6 Months Ended
Sep. 30, 2025
Deferred Grant  
DEFERRED GRANT

 

3.DEFERRED GRANT

 

The Company’s subsidiary, VBV, entered into a grant agreement (along with other beneficiaries) with the Horizon Europe, which is a program delegated under the European Commission, to provide technical expertise on artificial intelligence.

 

Under the grant agreement, VBV received $226,877 (€209,056) on July 24, 2024, upon the execution of the agreement. The funds under this agreement are to reimburse the Company for amounts spent on the project. The Company is required to submit their costs incurred related to the project and only approved expenses under the project are reimbursed.

 

Of the expenses incurred in connection with the grant agreement, $24,013 (March 31, 2025 - $17,944) are included in accounts payable, with $1,613 (March 31, 2025 - $67,732) remaining in restricted cash as of September 30, 2025. Grant income of $81,909 (September 30, 2024 - $56,034) was recognized during the six months ended September 30, 2025.

 

   September 30, 2025   March 31, 2025 
Balance, beginning of the year  $67,732   $- 
Grant received   -    226,877 
Expenses on the project   (71,530)   (156,885)
Exchange difference   3,798    (2,260)
Balance, end of the period  $-   $67,732 

 

v3.25.3
REVENUE
6 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
REVENUE
4.REVENUE

 

The Company recognized revenues from contracts with customers in accordance with the following timing under ASC 606 Revenue from Contracts with Customers.

 

   2025   2024   2025   2024 
  

Three months ended

September 30,

  

Six months ended

September 30,

 
   2025   2024   2025   2024 
Recognized at a point in time (1)  $-   $155,000   $300,000   $155,000 
Recognized over the duration of contracts (2)   100,700    -    100,700    - 
Total  $100,700   $155,000   $400,700   $155,000 

 

  (1) Includes revenues from completed Proof of Concept contracts (“POCs”) and software implementation services.
  (2) Includes revenue from Software as a Service (“SaaS”).

 

On August 14, 2024, the Company announced the existing SaaS contract with its customer was terminated by both parties. As a result, the Company has recorded a provision for the contract settlement for $1,252,076 on June 30, 2024.

v3.25.3
COST OF REVENUE
6 Months Ended
Sep. 30, 2025
Cost Of Revenue  
COST OF REVENUE

 

5.COST OF REVENUE

 

The Company’s cost of revenue is summarized as follows:

 

   2025   2024   2025   2024 
   Three months ended   Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Cost of Revenue from POCs and software implementation  $-   $145,000   $184,061   $145,000 
Cost of Revenue from SaaS   70,490    -    70,490    - 
Total  $70,490   $145,000   $254,551   $145,000 

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

v3.25.3
LOANS PAYABLE
6 Months Ended
Sep. 30, 2025
Debt Disclosure [Abstract]  
LOANS PAYABLE

 

6.LOANS PAYABLE

 

Loan activity consisted of the following:

 

For the period ended  September 30, 2025   March 31, 2025 
Balance, beginning of the year  $139,039   $140,904 
Repayment   (1,938)   (7,106)
Interest expense   2,621    5,241 
Balance, end of the period  $139,722   $139,039 

 

On June 5, 2020, the Company received a $142,400 loan from the U.S. Small Business Administration. The loan is secured by all tangible and intangible personal property of VTU, and bears interest of 3.75% per annum and requires monthly payments of $646 starting in June 2021 with a maturity of 30 years.

v3.25.3
SHARE BASED PAYMENTS
6 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
SHARE BASED PAYMENTS

 

7.SHARE BASED PAYMENTS

 

a)Stock Options

 

The Company has an Omnibus Equity Incentive Plan (the “Plan”) available to employees, directors, officers, and consultants with grants under the Plan approved from time to time by the Board of Directors. Under the Plan, the Company is authorized to issue options (“Options”) to purchase an aggregate of up to 25% of the Company’s issued and outstanding Subordinate Voting Shares. Each option can be exercised to acquire one Subordinate Voting Share of the Company (“Share”). The exercise price for an option granted under the Plan may not be less than the prevailing market price at the date of grant.

 

Options to purchase Subordinate Voting Shares have been granted to directors, employees, and consultants as follows:

 

Expiry date  Average Remaining Contractual Life in Years   Exercise Price (CAD$)  

Exercise Price

(USD$ equivalent) (1)

   Outstanding 
June 16, 2027   1.71    21.60    15.52    103,703 
September 4, 2027   1.93    7.44    5.34    125,000 
September 16, 2027   1.96    27.00    19.39    19,072 
April 28, 2028   2.58    44.55    32.00    3,703 
December 15, 2028   3.21    32.85    23.60    345,204 
December 23, 2028   3.23    30.51    21.92    136,290 
April 15, 2029   3.54    30.78    22.11    8,794 
July 3, 2029   3.76    29.01    20.84    142,808 
May 26, 2030   4.65    12.57    9.03    33,334 
September 19, 2030   4.97    6.90    4.96    261,726 
    3.42    22.03    15.82    1,179,634 

 

(1)Converted at balance sheet rate.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

7. SHARE BASED PAYMENTS (continued)

 

a)Stock Options (continued)

 

A summary of the Company’s Options as of June 30, 2025, and changes for previous financial year end is as follows:

 

  

Number of

stock options

  

Weighted Average

Exercise Price

(CAD$)

  

Weighted Average

Exercise Price

(USD$ equivalent) (1)

 
Outstanding, March 31, 2024   542,334   $32.09   $23.05 
Granted   364,099    27.39    19.67 
Exercised   (51,235)   23.22    16.68 
Cancelled   (84,314)   35.37    25.41 
Outstanding, March 31, 2025   770,884    30.10    21.62 
Granted   670,060    7.94    5.70 
Exercised   (250,000)   8.66    6.22 
Expired   (11,310)   33.89    24.34 
Outstanding, September 30, 2025   1,179,634    22.03    15.82 
Exercisable, September 30, 2025   834,135   $23.64   $16.98 

 

(1)Converted at balance sheet rate.

 

During the six month period ended September 30, 2025:

 

-11,310 Options at an average exercise price of CAD$33.89 ($24.84 at balance sheet rate) belonging to inactive employees expired according to the Plan.
-250,000 Options, which were granted on July 24, 2025 to Consultant “B”, were exercised at an exercise price of CAD$8.66 for the net proceeds of $1,572,440. The original fair value of these Options of $1,327,787 was reclassified from additional paid-in capital to share capital upon exercise.

 

On September 19, 2025, the Company granted 261,726 Options to employees and independent contractors of the Company with an exercise price of CAD$6.90 ($4.96 at balance sheet rate), expiring in 5 years, of which 218,247 will vest 25% every quarter subsequent to the vesting start date, and 43,479 with vest 25% on the date that is one (1) year from the vesting start date and 6.25% every subsequent quarter.

 

These Options were fair valued at $1,092,915 using the Black-Scholes option pricing model with the following assumptions:

 

   CAD$   $ 
Share price at grant date  $6.90   $5.00 
Risk-free interest rate   2.74%   2.74%
Expected life   5 years    5 years 
Expected volatility   120.6%   120.6%
Expected forfeitures   0%   0%
Expected dividends   Nil    Nil 
Grant date fair value per option  $5.76   $4.18 

 

During the six month period ended September 30, 2025, the Company recognized $376,295 as share-based payment for these Options using the graded vesting method over the vesting period.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

7. SHARE BASED PAYMENTS (continued)

 

a)Stock Options (continued)

 

On September 4, 2025, the Company granted 125,000 Options to the consultant “B” with an exercise price of CAD$7.44 ($5.34 at balance sheet rate), expiring in 2 years, and vesting on the grant date. These Options were fair valued at $414,244 using the Black-Scholes option pricing model with the following assumptions:

 

   CAD$   $ 
Share price at grant date  $7.44   $5.45 
Risk-free interest rate   2.47%   2.47%
Expected life   5 years    5 years 
Expected volatility   120.6%   120.6%
Expected forfeitures   0%   0%
Expected dividends   Nil    Nil 
Grant date fair value per option  $4.58   $3.31 

 

On July 24, 2025, the Company granted 250,000 Options to the consultant “B” with an exercise price of CAD$8.66 ($6.22 at balance sheet rate), expiring in 5 years, and vesting on the grant date. These Options were fair valued at $1,327,787 using the Black-Scholes option pricing model with the following assumptions:

 

   CAD$   $ 
Share price at grant date  $8.66   $6.35 
Risk-free interest rate   3.10%   3.10%
Expected life   5 years    5 years 
Expected volatility   120.6%   120.6%
Expected forfeitures   0%   0%
Expected dividends   Nil    Nil 
Grant date fair value per option  $7.24   $5.31 

 

On May 26, 2025, the Company granted 16,667 Options to the consultant “E” and 16,667 Options to the consultant “F” with an exercise price of CAD$12.57 ($9.21 at balance sheet rate), expiring in 5 years, and vesting on the grant date. These Options were fair valued at $258,056 using the Black-Scholes option pricing model with the following assumptions:

 

   CAD$   $ 
Share price at grant date  $12.57   $9.21 
Risk-free interest rate   2.92%   2.92%
Expected life   5 years    5 years 
Expected volatility   123.9%   123.9%
Expected forfeitures   0%   0%
Expected dividends   Nil    Nil 
Grant date fair value per option  $10.63   $7.74 

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

7. SHARE BASED PAYMENTS (continued)

 

a)Stock Options (continued)

 

On December 23, 2024, the Company granted 49,444 Options to employees and independent contractors of the Company with an exercise price of CAD$30.51($21.92 at balance sheet rate), expiring in 5 years, with 25% vesting on the date that is one (1) year from the vesting start date and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $134,400 as share-based payment for these Options using the graded vesting method over the vesting period.

 

On December 23, 2024, the Company granted 86,852 Options to consultants of the Company with an exercise price of CAD$30.51 ($21.92 at balance sheet rate), expiring in 5 years, where 33.33% of these Options vested on the grant date and 33.33% will vest every 6 months after the grant date.

 

During the six month period ended September 30, 2025, the Company recognized $318,445 as share-based payment for these Options using the graded vesting method over the vesting period.

 

On July 3, 2024, the Company granted 85,682 Options to employees and independent contractors of the Company with a weighted average exercise price of CAD$29.10 ($20.90 at balance sheet rate), expiring in 5 years, with 25% vesting on the date that is one (1) year from the vesting start date and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $158,174 as share-based payment for these Options using the graded vesting method over the vesting period.

 

On April 15, 2024, the Company granted 4,260 Options to employees and independent contractors of the Company with a weighted average exercise price of CAD$33.86 ($24.32 at balance sheet rate), expiring in 5 years, with 25% vesting on the date that is one (1) year from the vesting start date and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $7,111 as share-based payment for these Options using the graded vesting method over the vesting period.

 

On December 15, 2023, the Company granted 347,952 Options to employees and independent contractors of the Company with an exercise price of CAD$36.45 ($26.18 at balance sheet rate), expiring in 5 years, where 173,186 of these Options vest on the grant date, based on previous commitments, and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $93,580 as share-based payment for these Options using the graded vesting method over the vesting period.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

7. SHARE BASED PAYMENTS (continued)

 

a)Stock Options (continued)

 

The table below consolidates the position of the Options granted related to consultants of the Company:

 

Consultant  Total granted amount   Exercised - Inception to March 31, 2025   Outstanding March 31, 2025   Granted Q2-2026 (ytd)   Exercised Q2-2026 (ytd)   Cancelled Q2-2026 (ytd)   Outstanding September 30, 2025   % of the total 
A   64,815          (55,556)   9,259    -    -    -    9,259    2.5%
B   64,814    (9,259)   55,555    375,000    (250,000)   -    180,555    47.8%
C   55,555    (44,444)   11,111    -    -    -    11,111    2.9%
D   44,444    -    44,444    -    -    -    44,444    11.8%
E   23,889    -    23,889    16,667    -    -    40,556    10.7%
F   3,704    -    3,704    16,667    -    -    20,371    5.4%
G   14,815    (14,815)   -    -    -    -    -    0.0%
H   14,815    -    14,815    -    -    -    14,815    3.9%
I   12,963    -    12,963    -    -    -    12,963    3.4%
J   12,963    (10,556)   2,407    -    -    -    2,407    0.6%
K   9,259    (9,259)   -    -    -    -    -    0.0%
L   7,407    -    7,407    -    -    -    7,407    2.0%
M   6,481    -    6,481    -    -    -    6,481    1.7%
N   6,481    -    6,481    -    -    -    6,481    1.7%
O   4,457    -    4,457    -    -    -    4,457    1.2%
P   3,704    -    3,704    -    -    -    3,704    1.0%
Q   3,704    -    3,704    -    -    -    3,704    1.0%
Others   10,577    (1,235)   9,342    -    -    (617)   8,725    2.3%
Total   364,847    (145,124)   219,723    408,334    (250,000)   (617)   377,440    100.0%

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

7. SHARE BASED PAYMENTS (continued)

 

b)Restricted Shares Units

 

Pursuant to the Plan, the Company may grant RSUs to employees, directors, officers, and consultants. The RSUs can be settled at the election of the holder for Subordinate Voting Shares (“Shares”), cash, or a combination of Shares and cash. The RSUs are determined to be a liability instrument, and the fair value will be recognized as an expense using the graded vesting method over the vesting period.

 

On September 19, 2025, the Company granted 30,000 RSUs to independent contractors of the Company, expiring in 5 years, which vest 25% every quarter after the grant date. These RSUs were fair valued based on the prevailing market price of one Share on the balance sheet date. The Company recognized $8,616 as share-based payment during the six month period ended September 30, 2025.

 

On July 28, 2025, the Company converted 40,742 RSUs, of which 18,519 RSUs to consultant “E” and 18,519 RSUs to consultant “F” based on the completion of the milestones of funding the company in aggregate greater than CAD50 million. The Company also converted 3,704 to other consultants. These RSUs were valued based on the prevailing market price of one Share on the completion date, and the Company recognized an expense of $230,491 during the six month period ended September 30, 2025.

 

On July 3, 2025, the Company granted converted a total of 92,944 RSUs, of which 42,592 RSUs to consultant “B”, 18,519 RSUs to consultant “E”, 18,519 RSUs to consultant “F”, 351 to other consultants, and 12,963 to directors and officers of the Company. These RSUs were valued based on the prevailing market price of one Share on the conversion date, and the Company recognized $253,541 as share capital.

 

On May 26, 2025, the Company granted 33,333 RSUs to consultant “B”, expiring in 5 years, and vest on July 1, 2025. These RSUs were fair valued based on the market price of one Share on the balance sheet date. The Company recognized $344,431 as share-based payment during the six month period ended September 30, 2025.

 

The table below consolidates the position of the RSUs granted related to consultants of the Company:

 

Consultant  Total granted amount   Converted - Inception to March 31, 2025   Outstanding March 31, 2025   Granted Q2-2026 (ydt)   Converted Q2-2026 (ytd)   Outstanding September 30, 2025   % of the total 
A   7,407    (2,469)   4,938    -    -    4,938    4.1%
B   46,296    (9,259)   37,037    33,333    (42,592)   27,778    22.9%
E   111,111    (37,037)   74,074    -    (37,038)   37,036    30.5%
F   111,111    (37,037)   74,074    -    (37,038)   37,036    30.5%
L   1,852    -    1,852    -    -    1,852    1.5%
Others   20,371    (3,704)   16,667    -    (4,055)   12,612    10.4%
Total   298,148    (89,506)   208,642    33,333    (120,723)   121,252    100.0%

 

On September 30, 2025, the balance of 585,020 RSUs granted in the previous periods, were revalued based on the prevailing market price of one Share on the revaluation date, and the Company derecognized $1,581,375 as share-based payment for RSUs during the six month period ended September 30, 2025.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

7. SHARE BASED PAYMENTS (continued)

 

b)Restricted Shares Units

 

A summary of the Company’s restricted shares units as at September 30, 2025, and changes for the years then ended is as follows:

 

   Number of RSUs 
Balance, March 31, 2024   24,075 
Issued, April 15, 2024   1,852 
Issued, June 20, 2024   37,037 
Issued, July 3, 2024   359,817 
Issued, September 13, 2024   74,074 
Issued, December 23, 2024   296,296 
Cancelled   (5,926)
Converted   (101,852)
Balance, March 31, 2025   685,373 
Issued, May 26, 2025   33,333 
Issued, September 19, 2025   30,000 
Converted   (133,686)
Balance, September 30, 2025   615,020 
Exercisable, September 30, 2025   145,853 

 

A reconciliation of share based payments is as follows:

 

Share based payments  Stock Options   RSUs   Total 
Previous years graded vesting   402,225    -    402,225 
Previous years RSUs revaluation   -    (251,392)   (251,392)
New grants Q1 2025   76,787    26,668    103,455 
New grants Q2 2025   1,027,452    805,605    1,833,057 
Cancelled options   (125,621)   -    (125,621)
Balance, September 30, 2024  $1,380,843   $580,881   $1,961,724 
                
Previous years graded vesting   711,710    -    711,710 
Previous years RSUs revaluation   -    (1,581,375)   (1,581,375)
New grants Q1 2026   258,056    344,431    602,487 
New grants Q2 2026   2,118,326    8,616    2,126,942 
RSU milestone conversion   -    230,491    230,491 
Balance, September 30, 2025  $3,088,092   $(997,837)  $2,090,255 

 

As of September 30, 2025, the fair value of RSUs was $1,776,600 (March 31, 2025 - $3,911,823).

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

v3.25.3
RELATED PARTY TRANSACTIONS AND BALANCES
6 Months Ended
Sep. 30, 2025
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS AND BALANCES

 

8.RELATED PARTY TRANSACTIONS AND BALANCES

 

The Company’s related parties consist of the directors, executive officers and key management personnel, who have authority and responsibility for planning, directing, and controlling the Company’s activity and companies controlled by them. Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control or common significant influence. Related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources, services, or obligations between related parties.

 

Transactions are measured at the exchange amount, which is the amount agreed to by the parties.

 

Key management personnel include those with authority and responsibility for planning, directing, and controlling the company’s activities. The Company has determined that key management personnel consist of executive and non-executive members of its Board of Directors and senior officers.

 

During the three and six month periods ended September 30, 2025 and 2024, related party transactions were as follows:

 

   2025   2024   2025   2024 
   Three months ended   Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Management fees  $60,000   $59,455   $120,000   $84,581 
Management salaries and benefits included in personnel expenses   463,104    464,884    900,870    770,635 
Share-based payments   (159,394)   34,914    (194,919)   (67,827)
Related party transactions  $363,710   $559,253   $825,951   $787,389 

 

Included in accounts payable as due from related parties at September 30, 2025, were amounts totaling $20,000 due to Michael Blum, the Chairman (March 31, 2025 – $20,000), $nil due to James Hendrickson, the Chief Operating Officer (March 31, 2025 - $83,500), and $nil due to Kevin Wilson, the Chief Accounting Officer (March 31, 2025 - $2,299).

 

Also included as due from related parties at September 30, 2025, is an unsecured loan made on April 28, 2023 of $69,657 (March 31, 2025 - $68,080) to Michael Wadden, the Chief Commercial Officer of the Company. The loan has an annual interest rate of 5% and requires principal and interest to be paid in full by May 1, 2033. No repayments were made during the six month period ended September 30, 2025.

 

On December 23, 2024, the Company granted 7,407 Options to James Hendrickson, the Chief Operating Officer, with an exercise price of CAD$30.51 ($21.92 at balance sheet rate), expiring in 5 years, where 25% will vest within one year of the grant date, and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $1,587 as share-based payment for stock these Options using the graded vesting method over the vesting period.

 

On December 23, 2024, the Company granted 7,408 RSUs to two independent directors of the Company, 3,704 to Gordon Scott Paterson and 3,704 to Jonathan de Vos. These RSUs have no exercise price and expire in 5 years. They vest 33.33% within one year of the grant date and 33.33% yearly thereafter. The Company revalued the RSUs based on the prevailing market price of one Share on the revaluation date. The Company derecognized $857 as share-based payment for these RSUs during the six month period ended September 30, 2025.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

8. RELATED PARTY TRANSACTIONS AND BALANCES (continued)

 

On September 13, 2024, the Company granted 74,074 RSUs to Michael Blum, the Chairman, with no exercise price and expire in 10 years. 24,691 RSUs vest 12 months after the grant date and 8.33% every three months afterwards. During the period ended September 30, 2025, the Company revalued these RSUs based on the prevailing market price of one Share on the revaluation date. The Company derecognized $170,708 as share-based payment for RSUs during the six month period ended September 30, 2025.

 

On July 3, 2024, the Company granted 3,704 Options to James Hendrickson, the Chief Operating Officer and 1,852 to Kevin Wilson, its Chief Financial Officer. The Options have an exercise price of CAD$28.89 ($20.75 at balance sheet rate) and expire in 5 years. 25% of the options will vest 12 months after the grant date and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $12,834 as share-based payment for these stock options using the graded vesting method over the vesting period.

 

On July 3, 2024, the Company granted 1,852 RSUs to Kevin Wilson, its Chief Financial Officer and 16,665 to the three independent directors of the Company, 5,555 to Gordon Scott Paterson, 5,555 to Jonathan de Vos, and 5,555 to Jay Samit. The RSUs have no exercise price and expire in 10 years. 33.33% vest every 12 months after the grant date. The Company revalued the RSUs based on the prevailing market price of one Share on the revaluation date. The Company derecognized $31,703 as share-based payment for during the six month period ended September 30, 2025.

 

On December 23, 2023, the Company granted 16,278 stock options to Kevin Wilson, its Chief Financial Officer and 1,852 stock options to James Hendrickson, its Chief Operating Officer with an exercise price of CAD$36.45 ($26.18 at balance sheet rate), expiring in 5 years, where 16,278 vested on the grant date, and 1,852 will vest 25% within one year of the grant date, and 6.25% every subsequent quarter.

 

During the six month period ended September 30, 2025, the Company recognized $20,134 as share-based payment for these Options using the graded vesting method over the vesting period.

 

On September 30, 2025, the remaining unvested 6,172 RSUs granted to Gordon Scott Paterson, a director of the Company, in the year ended March 31, 2023, were valued based on the market price of one Subordinate Voting Share on the revaluation date, of which $26,206 is derecognized in the six month period ended September 30, 2025.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

v3.25.3
COMMITMENTS
6 Months Ended
Sep. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS

 

9.COMMITMENTS

 

The Company has an obligation to pay royalties to Cyberlab, LLC (“Cyberlab”) (a company controlled by Dan Mapes, a director and officer). Cyberlab shall be entitled to receive a share of the gross revenue derived from the sales, licensing, and other commercial activities involving Spatial Domain Names, pursuant to the following schedule:

 

-Years 1 through 10 of the Spatial Domain Program: Cyberlab shall be entitled to retain Five Percent (5%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Five Percent (95%) to allocate between itself and other Spatial Domain Program stakeholders (e.g., registries, registrars, etc.) as it sees fit.
-Years 11 through 14 of the Spatial Domain Program: Cyberlab shall be entitled to retain Four Percent (4%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Six Percent (96%).
-Years 15 through 17 of the Spatial Domain Program: Cyberlab shall be entitled to retain Three Percent (3%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Seven Percent (97%).
-Years 18 and 19 of the Spatial Domain Program: Cyberlab shall be entitled to retain Two Percent (2%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Eight Percent (98%).
-Years 20 to 25 of the Spatial Domain Program: Cyberlab shall be entitled to retain One Percent (1%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Nine Percent (99%).

 

As of September 30, 2025, no amounts are payable under the royalty agreement.

 

The Company may grant stock options (“Options”), deferred share units (“DSU”), or restricted stock units (“RSU”) to qualifying consultants and employees based on their respective contracts, to be determined at the grant date based on the prevailing market price of the Company’s shares. As of September 30, 2025, the outstanding commitment balance is 77,510 (March 31, 2025 – nil) to be granted as Options, RSUs or DSUs, of which 37,510 stock options is for the new Board of Directors member, David Scott, and 30,000 RSUs to Expansion Project Technologies Holding 9 SPV RSC Ltd in connection with CAD$400,000 in revenues derived by Verses from the commercial agreements it enters into with affiliates of G42.

 

The Company has entered into severance agreements with Gabriel Rene (Chief Executive Officer and Director), Dan Mapes (President Emeritus and Global Ambassador and Director), James Christodoulou (Chief Financial Officer), Kevin Wilson (Chief Accounting Officer), Donald Moody (General Counsel and Chief Legal Officer), Capm Petersen (Chief Innovation Officer), Steven Swanson (Chief Experience Officer), and Michael Wadden (Chief Commercial Officer). In the case of involuntary termination or a change in control, the executives are entitled to a monetary payment of base salary, continuation of medical and dental insurance, and immediate, accelerated vesting of all stock options, equity, and related compensation.

v3.25.3
SHARE CAPITAL
6 Months Ended
Sep. 30, 2025
Equity [Abstract]  
SHARE CAPITAL

 

10.SHARE CAPITAL

 

a)Authorized shares

 

Effective July 20, 2021, the Company amended its Articles to create an unlimited number of Class A Subordinate Voting Shares and unlimited number of Class B Proportionate Voting Shares. Each Subordinate Voting Share shall entitle the holder thereof to one vote. Each Class B share shall entitle the holder thereof to 6.25 votes and such proportionate dividends and liquidation rights. Each Class B share is convertible, at the holder’s option, into 6.25 Subordinate Voting Shares.

 

On May 30, 2024, all 370,370 Class B Proportionate Voting Shares were converted to 2,314,815 Class A Subordinate Voting Shares.

 

On September 26, 2025, 1,240,741 Class A Subordinate Voting Shares were converted to 198,517 Class B Proportionate Voting Shares.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

10.SHARE CAPITAL (continued)

 

b)Issued

 

On July 29 and August 13, 2025, a total of 250,000 options were exercised.

 

On July 28, 2025, 40,742 RSUs were settled into Shares with a value of $253,541 based on the prevailing share price and exchange rate on the settlement date.

 

On July 11, 2025, the Company closed an offering by way of prospectus supplement. Pursuant to the Offering, the Company raised gross proceeds of approximately CAD$9,573,758 (US$7,000,331) by issuing 1,007,764 units of the Company (the “Units”) at a price of CAD$9.50 (US$6.946) per Unit.

 

Each Unit is comprised of one Class A Subordinate Voting Share of the Company (a “Share”) and one-half of one Share purchase warrant (each whole Share purchase warrant, a “Warrant”). Each Warrant entitles the holder to purchase one Share of the Company (a “Warrant Share”) at an exercise price of CAD$11.50 ($8.26 at balance sheet rate) per Warrant Share at any time until the date that is 36-month from the date of issuance, subject to adjustment in certain events.

 

The Offering was completed pursuant to an agency agreement dated July 9, 2025 between the Company, A.G.P. Canada Investments ULC and A.G.P./Alliance Global Partners. Each of A.G.P. Canada Investments ULC and A.G.P./Alliance Global Partners acted as co-lead agents, on behalf of a syndicate of agents including Imperial Capital, LLC and Haywood Securities Inc.

 

In connection with the Offering, the Company agreed to pay the agents a cash commission of CAD$400,000 ($292,480), and further agreed to issue to the agents 35,271 of compensation warrants (the “Compensation Warrants”). Each Compensation Warrant is exercisable into a Share at an exercise price of CAD$11.50 (US$8.409) per Share until the date that is 36 months after the date of issuance. In addition, the Company paid a cash fee of US$250,000 and issued 75,000 corporate finance fee warrants to TriView Capital Ltd., a financial advisor of the Company, with such corporate finance fee warrants having identical terms to the Compensation Warrants.

 

On July 3, 2025, 92,944 RSUs were settled into Shares with a value of $883,851 based on the prevailing share price and exchange rate on the settlement date.

 

On May 9, 2025, in connection with the conversion of the convertible debentures, the Company issued 4,253 Shares as an interest remainder.

 

On April 28, 2025, the Company closed an offering by way of prospectus supplement (the “Offering”). Pursuant to the Offering, the Company raised gross proceeds of $7,929,900 (CAD$11,000,000) by issuing 916,666 Units of the Company (the “Units”) at a price of US$8.64 (CAD$12.00) per Unit.

 

Each Unit is comprised of one Class A Subordinate Voting Share of the Company (a “Share”) and one-half of one Share purchase warrant (each whole Share purchase warrant, a “Warrant”). Each Warrant entitles the holder to purchase one Share of the Company (a “Warrant Share”) at an exercise price of CAD$15.00 ($11.00 at balance sheet rate) per Warrant Share at any time until the date that is 36-month from the date of issuance, subject to adjustment in certain events.

 

The Offering was completed pursuant to an agency agreement dated April 23, 2025 between the Company, A.G.P. Canada Investments ULC, Clear Street LLC and A.G.P./Alliance Global Partners.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

10.SHARE CAPITAL (continued)

 

b)Issued

 

In connection with the Offering, the Company agreed to pay the agents a cash commission equal to $575,655, incurred in legal fees of $242,418, and agreed to issue 70,334 compensation warrants (the “Compensation Warrants”) valued at $495,635 (Note 11). Each Compensation Warrant is exercisable into a Share at an exercise price of CAD$12.00 ($8.80 at balance sheet rate) per Share until the date that is 36 months after the date of issuance. The cash commission and the number of Compensation Warrants was reduced from 7% to 2.0% in respect to the portion of aggregate gross proceeds of the Offering attributable to subscribers identified by the Company.

 

The Offering was completed in Canada pursuant to a prospectus supplement dated April 25, 2025 (the “Supplement”) to the Company’s base shelf prospectus receipted on September 26, 2024 (the “Base Shelf Prospectus”).

v3.25.3
WARRANTS
6 Months Ended
Sep. 30, 2025
Warrants  
WARRANTS

 

11.WARRANTS

 

On July 11, 2025, in connection with the Prospectus Supplement offering closed, the Company issued 503,882 warrants and 110,271 Compensation Warrants (Note 10). Each Warrant entitles the holder to purchase one Share of the Company (a “Warrant Share”) at an exercise price of CAD$11.50 ($8.26 at balance sheet rate) per Warrant Share at any time until the date that is 36-month from the date of issuance, subject to adjustment in certain events.

 

The total fair value of these Compensation Warrants was $660,900, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

   CAD$   $ 
Share price at grant date  $11.46   $8.38 
Risk-free interest rate   2.72%   2.72%
Expected life   3 years    3 years 
Expected volatility   120.6%   120.6%
Expected dividends   Nil    Nil 
Grant date fair value per warrant  $8.20   $5.99 

 

On May 9, 2025, in connection with the Prospectus Supplement offering closed, the Company issued 458,333 warrants and 70,334 Compensation Warrants (Note 10).

 

The total fair value of these Compensation Warrants was $495,635, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

   CAD$   $ 
Share price at grant date  $13.20   $9.52 
Risk-free interest rate   2.61%   2.61%
Expected life   3 years    3 years 
Expected volatility   123.9%   123.9%
Expected dividends   Nil    Nil 
Grant date fair value per warrant  $9.78   $7.05 

 

Warrants outstanding as at September 30, 2025 are summarized below:

 

   Number of warrants   Weighted Average Exercise Price (CAD$)  

Exercise Price

(USD$ equivalent) (1)

 
Balance, March 31, 2024   878,061   $41.10   $29.52 
Issued   1,340,158    40.16    28.85 
Exercised   (122,993)   24.09    17.30 
Expired   (2)   21.60    15.52 
Balance, March 31, 2025   2,095,224   $41.50   $29.81 
Issued   1,142,820    12.93    9.29 
Expired   (368,303)   26.54    19.06 
Balance, September 30, 2025   2,869,741   $32.04   $23.02 

 

(1)Converted at balance sheet rate.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

11. WARRANTS (continued)

 

As of September 30, 2025, the Company’s outstanding share purchase warrants expire as follows:

 

Expiry date  Weighted Average Remaining Contractual Life in Years   Exercise Price (CAD$)  

Exercise Price (USD$ equivalent) (1)

   Outstanding 
April 15, 2026   0.54    10.80    7.76    46,296 
April 17, 2026   0.55    27.00    19.39    3,348 
April 29, 2026   0.58    27.00    19.39    6,618 
May 16, 2026   0.62    27.00    19.39    1,702 
July 6, 2026   0.76    55.35    39.76    29,227 
July 6, 2026   0.76    68.85    49.45    294,694 
August 15, 2026   0.87    27.00    19.39    45,496 
August 17, 2026   0.88    40.50    29.09    126,853 
August 30, 2026   0.92    40.50    29.09    43,062 
September 17, 2026   0.96    40.50    29.09    12,494 
December 22, 2026   1.23    32.40    23.27    809 
January 8, 2027   1.27    40.50    29.09    28 
June 20, 2027   1.72    40.50    29.09    255,185 
September 26, 2027   1.99    21.60    15.52    10,562 
September 26, 2027   1.99    32.40    23.27    114,354 
November 8, 2027   2.11    13.50    9.70    14,444 
November 8, 2027   2.11    18.90    13.58    85,699 
November 15, 2027   2.13    13.50    9.70    2,229 
November 15, 2027   2.13    18.90    13.58    15,290 
December 9, 2027   2.19    13.50    9.70    3,707 
December 9, 2027   2.19    18.90    13.58    28,519 
January 9, 2028   2.28    52.92    38.01    235,906 
January 9, 2028   2.28    42.39    30.45    26,420 
February 25, 2028   2.41    52.92    38.01    257,312 
March 9, 2028   2.44    18.90    13.58    66,667 
April 28, 2028   2.58    15.00    10.77    458,333 
April 28, 2028   2.58    12.00    8.62    70,334 
July 11, 2028   2.78    11.50    8.26    614,153 
    2.07   $32.04   $23.02    2,869,741 

 

Notes:

 

(1)Converted at balance sheet rate.

sheet rate) = 1 New Class A Subordinate Voting share.

 

(2)Warrants expiring July 6, 2026

 

Pre-Consolidation Exercise Terms: 1 Warrant + CAD$2.55 ($1.83 at balance sheet rate) = 1 Class A Subordinate Voting share.

 

Post-Consolidation Exercise Terms: 27 Warrants + CAD$68.85 ($49.46 at balance sheet rate) = 1 New Class A Subordinate Voting share.

 

For presentation purposes, the Company divided the total outstanding warrants by 27 to reflect 1 warrant + CAD$68.85 ($49.46 at balance sheet rate) = 1 New Class A Subordinate Voting share.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

v3.25.3
PREPAID EXPENSES
6 Months Ended
Sep. 30, 2025
Prepaid Expenses  
PREPAID EXPENSES

 

12.PREPAID EXPENSES

 

Prepaid expenses consisted of the following:

 

   September 30, 2025   March 31, 2025 
Deposit  $34,929   $10,000 
Retainer   269,311    251,983 
Prepaid insurance   540,495    106,084 
Subscriptions   371,040    267,997 
Balance, end of the period  $1,215,775   $636,064 

 

v3.25.3
EQUIPMENT
6 Months Ended
Sep. 30, 2025
Property, Plant and Equipment [Abstract]  
EQUIPMENT
13.EQUIPMENT

   

Cost  Equipment 
Balance, March 31, 2025  $580,751 
Additions   40,489 
Balance, September 30, 2025  $621,240 
      
Accumulated depreciation   Equipment 
Balance, March 31, 2025  $455,338 
Additions   45,894 
Balance, September 30, 2025  $501,232 
      
Net book value, March 31, 2025  $125,413 
Net book value, September 30, 2025  $120,008 

 

v3.25.3
FINANCIAL INSTRUMENTS
6 Months Ended
Sep. 30, 2025
Investments, All Other Investments [Abstract]  
FINANCIAL INSTRUMENTS
14.FINANCIAL INSTRUMENTS

 

As of September 30, 2025, the Company’s financial instruments consist of cash and restricted cash, accounts receivable, accounts payable and accrued liabilities, restricted share unit liability, provision for legal claim, convertible debenture, and loans payable.

 

In accordance with ASC 820, Fair Value Measurement, the Company categorizes financial assets and liabilities measured at fair value into a three-level hierarchy based on the inputs used in the valuation techniques. The hierarchy gives the highest priority to quoted prices in active markets (Level 1) and the lowest priority to unobservable inputs (Level 3).

 

The levels of the fair value hierarchy are defined as follows:

 

Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date.

 

Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, such as quoted prices for similar assets or liabilities in active or inactive markets.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

14. FINANCIAL INSTRUMENTS (continued)

 

Level 3 – Unobservable inputs for the asset or liability, which are used to measure fair value to the extent that observable inputs are not available, and which are significant to the overall fair value measurement.

   

As of September 30, 2025  Level 1 ($)   Level 2 ($)   Level 3 ($)   Total ($) 
Assets:                    
Cash and restricted cash   1,209,908    -    -    1,209,908 
Accounts receivable   296,700    -    -    296,700 
Due from related parties   69,657    -    -    69,657 
Liabilities:                    
Accounts payable   1,508,247    -    -    1,508,247 
Accrued liabilities   132,665    -    -    132,665 
Provision for legal claim   9,402,338    -    -    9,402,338 
Restricted share unit liability   -    1,776,600    -    1,776,600 
Loans payable   139,722    -    -    139,722 

 

As of March 31, 2025   Level 1    Level 2    Level 3    Total 
Assets:                    
Cash and restricted cash   4,816,906    -    -    4,816,906 
Due from related parties   68,080    -    -    68,080 
Liabilities:                    
Accounts payable   2,036,916    -    -    2,036,916 
Accrued liabilities   41,736    -    -    41,736 
Provision for legal claim   8,948,085    -    -    8,948,085 
Restricted share unit liability   -    3,911,823    -    3,911,823 
Loans payable   139,039    -    -    139,039 

 

Credit risk

 

Credit risk is the risk of loss associated with a counterparty’s inability to fulfill its payment obligations. The financial instrument that potentially subjects the Company to concentrations of credit risk consists principally of cash, accounts receivable, and due from related parties. To minimize the credit risk, the Company places its cash with large financial institutions.

 

Amounts due from related parties of $69,657 as of September 30, 2025 (March 31, 2025 - $68,080) represent receivables from an unsecured loan to a key member of the management team. The loan has an annual interest rate of 5% and requires principal and interest to be paid in full by May 1, 2033 (Note 8).

 

As of September 30, 2025, management assessed that there is no need to provide a credit loss allowance.

 

Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company’s operations on an ongoing basis. The Company strives to ensure that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations, cash holdings, and anticipated future financing transactions.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

14. FINANCIAL INSTRUMENTS (continued)

 

Liquidity risk (continued)

 

The Company has historically raised capital to fund operations, primarily through debt and equity investors, although there is no assurance that it will be able to raise funds in the future. The Company will continue to rely on such financings to generate sufficient amounts of cash and cash equivalents to cover its operating costs, satisfy short and long term capital requirements, and meet growth objectives.

 

Contractual cash flow requirements as of September 30, 2025, were as follows:

  

    Less than 1 year    1 to 2 years    2 to 5 years    After 5 years    Total 
  

<1 year

$

  

1-2 years

$

  

2-5 years

$

  

>5 years

$

  

Total

$

 
Accounts payable   1,508,247    -    -    -    1,508,247 
Accrued liabilities   132,665    -    -    -    132,665 
Loans payable   7,752    7,752    23,256    100,962    139,722 
Total   1,648,664    7,752    23,256    100,962    1,780,634 

 

As of September 30, 2025, the Company had a working capital deficit of $9,205,281 (March 31, 2025 - $8,923,210).

 

Foreign exchange risk

 

Foreign exchange risk is the risk that the fair value or future cash flows will fluctuate due to changes in foreign exchange rates. The Company has financial assets denominated in Euros and Canadian dollars and is therefore exposed to exchange rate fluctuations. As of September 30, 2025, the Company had the equivalent of $96,283 (March 31, 2025 - $223,534) net financial liabilities denominated in Canadian dollars and $14,864 (March 31, 2025 net financial assets - $104,416) in net financial liabilities denominated in Euros.

 

The foreign exchange risk exposure of the Company financial instruments as at September 30, 2025 is as below:

  

            
           +/- 10% fluctuation 
   Currency   Increase/(decrease) 
Financial Instrument Type  CAD$   $   $ impact 
Cash   987,753    709,503    70,950    (70,950)
Tax receivable   1,003,283    720,659    72,066    (72,066)
Prepaid expenses   1,172,734    842,375    84,237    (84,237)
Accounts payable   (774,473)   (556,304)   (55,630)   55,630 
Accrued liabilities   (50,000)   (35,915)   (3,592)   3,592 
Restricted share unit liability   (2,473,384)   (1,776,600)   (177,660)   177,660 
Foreign currency future instrument    (134,087)   (96,283)   (9,629)   9,629 

 

            
           +/- 10% fluctuation 
   Currency       Increase/(decrease) 
Financial Instrument Type  EURO   $   $ impact 
Restricted cash   1,375    1,613    161    (161)
Tax receivable   6,423    7,535    753    (753)
Accounts payable   (20,468)   (24,011)   (2,401)   2,401 
Foreign currency future instrument    (12,670)   (14,864)   (1,486)   1,486 

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

 

14. FINANCIAL INSTRUMENTS (continued)

 

Interest rate risk

 

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate due to changes in market interest rates. The interest earned on cash balances approximate fair value rates, and the Company is not subject to significant risk due to fluctuating interest rates. As of September 30, 2025, the Company does not hold any liabilities that are subject to fluctuations in market interest rates.

 

Price risk

 

Price risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate due to changes in market prices, other than those arising from interest rate risk or currency risk. The Company is not exposed to other price risk.

v3.25.3
MANAGEMENT OF CAPITAL
6 Months Ended
Sep. 30, 2025
Management Of Capital  
MANAGEMENT OF CAPITAL

 

15.MANAGEMENT OF CAPITAL

 

The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to pursue the development of their technology. The Company considers the items in shareholders’ equity as capital. There has been no change to what the Company considers capital from the prior year. The Company does not have any externally imposed capital requirements to which it is subject to.

 

The Company manages the capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust the capital structure, the Company may issue Subordinate Voting Shares, dispose of assets or adjust the amount of cash. There has been no change to how capital is managed from the prior year.

v3.25.3
SUPPLEMENTAL CASH FLOW INFORMATION
6 Months Ended
Sep. 30, 2025
Supplemental Cash Flow Elements [Abstract]  
SUPPLEMENTAL CASH FLOW INFORMATION

 

16.SUPPLEMENTAL CASH FLOW INFORMATION

 

The supplemental cash paid and received by the Company as of September 30, 2025 is as below:

  

             
   For three months ended   For Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Cash paid for interest  $1,313   $5,524   $2,621   $6,843 
Cash received for interest  $37,609   $35,147   $85,053   $49,970 

 

v3.25.3
SEGMENT REPORTING
6 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
SEGMENT REPORTING
17.SEGMENT REPORTING

 

Operating segments comprised of the components of an entity in which separate information is available for evaluation by the Company’s Chief Operating Decision Maker (“CODM”), the Company’s Chief Executive Officer, or group of decision makers, in determining how to allocate resources in evaluating performance.

 

The CODM has determined that the Company consists of a single reporting segment providing Software as a Service, which includes proof of concept and software implementation services.

 

The accounting policies of the services segment are as described in the summary of significant accounting policies. The CODM evaluates the performance of the services segment based on the Company’s net income (loss) as reported in the Statements of Operations.

 

The CODM reviews performance based on gross profit, operating profit, and net earnings. Operating profit is reviewed to monitor the operating and administrative expenses of the Company. The Company does not have any operations or sources of revenue outside of the United States. Accordingly, the CODM considers the revenue, operating expenses, and other income (expenses) of our single operating segment as reported on the statement of operations and considers our current and total assets as recorded on the balance sheet. There are no additional expense or asset information that are supplemental to those disclosed in these consolidated financial statements that are regularly provided to the CODM.

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

v3.25.3
OTHER INCOME
6 Months Ended
Sep. 30, 2025
Other Income and Expenses [Abstract]  
OTHER INCOME

 

18.OTHER INCOME

 

Other income consisted of the following:

  

             
   For three months ended   For Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Accretion expense  $-   $(411,813)  $-   $(453,839)
Grant Income   17,720    56,034    81,909    56,034 
Interest earned   37,609    35,147    85,053    49,970 
Gain on derivative liability   -    2,464,873    -    2,464,873 
Interest expense   (7,278)   (221,720)   (12,254)   (293,038)
Legal claim expense   (359,164)   -    (582,253)   - 
Provision for losses on related party transactions   -    (235,413)   -    (396,524)
R&D tax credits   65,679    -    416,208    - 
Other income  $(245,434)  $1,687,108   $(11,337)  $1,427,476 

 

v3.25.3
PROVISION FOR LEGAL CLAIM
6 Months Ended
Sep. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
PROVISION FOR LEGAL CLAIM

 

19.PROVISION FOR LEGAL CLAIM

 

On July 13, 2022, David Thomson, a former independent contractor, filed a lawsuit against VTU, Cyberlab LLC, and two directors/officers of the Company in Los Angeles Superior Court. The claim alleged violations of various sections of the California Corporations code, breach of contract, breach of the implied covenant of good faith and fair dealing, and unjust enrichment. Plaintiff claimed as much as $5,000,000 in damages, subject to proof.

 

On September 1, 2022, the Company filed an answer denying any wrongdoing, and also made its own counterclaim against Mr. Thomson. The cross-claims against David Thomson included: (i) misappropriation of trade secrets; (ii) breach of contract; (iii) violation of the California Computer Data Access and Fraud Act

 

(“CDAFA”); and (iv) violation of the Economic Espionage Act, along with three additional cross-claims (alleging violation of the Computer Fraud and Abuse Act, conversion, violation of the Stored Communications Act, respectively) that were subsequently dismissed by the Court. The Company, for its part, sought to recover both compensatory and punitive damages from Mr. Thomson, as well as restitution of any ill-gotten gains and an award of reasonable attorneys’ fees.

 

The arbitration was conducted for a total of 13 days over a period from February 5 through April 3, 2024, via a single arbitrator at the American Arbitration Association. The CDAFA claim was dismissed by the Arbitrator, but the claims for trade secret misappropriation, breach of contract and unjust enrichment were allowed to move forward.

 

A final arbitration award was issued on May 17, 2024. It imposed liability against: (i) Verses Technologies USA, Inc. (VTU), a subsidiary of the Company, jointly and severally with Cyberlab, LLC (a company owned by the Company’s president, Dan Mapes), in the amount of $6,307,258, inclusive of interest; and (ii) Cyberlab, VTU and its principals, Gabriel René and Daniel Mapes, jointly and severally, for damages in the amount of $1,900,000, interest of $709,973, costs of $64,303 and the fees of plaintiff’s counsel totaling $920,231. To resolve their part of joint and several liability, Mr. René and Mr. Mapes are working toward satisfying the portion of the award that applies to them as individuals, including $1,666,000 proceeds from insurance. The remaining liability belongs to VTU, a subsidiary of the Company. Initial good faith payments of $1,791,000 have been made to the claimant. However, the likelihood of a favourable or unfavourable outcome, or an estimate of the amount or range of potential loss, which is isolated to VTU and Cyberlab, is not reasonably foreseeable at this time.

 

On January 24, 2025, Mr. Thompson filed a Petition to Confirm the Arbitration Award with the Los Angeles Superior Court. This is a necessary “first step” that must be undertaken before an arbitration award can be converted into an enforceable judgment. A hearing on the Petition was set for April 29, 2025. On May 8, 2025, the Petition was confirmed for the amounts listed below, including interest from the date of the Arbitration Award.

 

On or about August 12, 2025, attorneys for Mr. Thomson served VTU with several collections-related discovery requests asking, inter alia, the company to identify assets and property that it holds. The company responded to these requests within the allotted time-frame. 

 

A reconciliation of the legal claim provision is provided in the table below:

  

   September 30, 2025   March 31, 2025 
Beginning of the year   8,948,085    9,921,298 
Payments in the year   -    (1,791,000)
Interest   454,253    817,787 
Balance, end of the period   9,402,338    8,948,085 

 

 

VERSES AI INC.

Unaudited Condensed Consolidated Interim Statements of Shareholders’ Deficiency

For the three and six months ended September 30, 2025 and 2024

(Expressed in United States dollars)

v3.25.3
SUBSEQUENT EVENTS
6 Months Ended
Sep. 30, 2025
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

 

20.SUBSEQUENT EVENTS

 

On October 1, 2025, the Company granted 20,000 RSUs to consultant “P” vesting on the grant date and 105,000 Option to the consultants listed bellow at an exercise price of CAD$7.55 ($5.42 at balance sheet rate), vesting on the grant date, that expire 5 years after the date of grant.

 

Consultant “E” 37,500
Consultant “F” 37,500
Consultant “P” 20,000
Consultant “I” 10,000

 

On October 1, 2025, what remains subject to shareholder approval, the Company repriced 849,263 outstanding Options to acquire Class A Common shares of the Company to an exercise price of CAD$7.55 ($5.42 at balance sheet rate).

 

Original vesting terms and expiry date of the repriced stock options were maintained according to the original certificate agreement.

 

On October 1, 2025, the Company cancelled of an aggregate 90,313 Options and 46,296 RSUs in accordance with the rescission agreements as these Options and RSUs we initially granted to entities and not individuals as required by the Plan.

 

A total of 90,313 Options (the “Replacement Options”) and 46,296 RSUs (the “Replacement RSUs”) were granted on the same date to individuals related to the original entities. Original vesting terms and exercise price Replacement Options and Replacement RSUs where maintained according to the original certificate agreement. The Replacement Options have a 5 year expiry.

 

On October 20, 2025, the Company learned that Philip Plough had filed a claim against XYZ Global Technologies Inc. (“XYZ”) for an alleged breach of a promissory note (“Note”) related to a $35,000 loan made in 2018, which also named VAI, one of its wholly-owned U.S. subsidiaries (VTU) and two directors/officers of the Company, as well as a law firm, Gresham International America LLC, as co-defendants with XYZ Global Technologies Inc. The claim alleges, inter alia, breach of contract, fraudulent inducement, conversion, successor liability and unjust enrichment. The Plaintiff is seeking, subject to proof, $1,856,000 in compensatory damages for breach of contract, and any other punitive, exemplary, treble damages and attorneys’ fees, as the Court deems just and proper.

 

The Company, for its part, disputes any liability for a loan made to a separate company (XYZ) and if the action continues to be pursued, the Company will vigorously contest Mr. Plough’s claims, including seeking to dismiss VAI, VTU and the individual directors / officers.

 

As litigation is subject to many uncertainties, it is not possible to predict the ultimate outcome of this claim or to estimate the loss, if any, which may result. Accordingly, the outcome of the claim is not yet determinable, and the extent to which an outflow of funds may be required to settle this possible obligation cannot be reliably determined.

 

On October 31, 2025, the Company initiated a workforce reduction program designed to streamline operations, reduce costs, and strengthen the Company’s liquidity position. The program is a combination of targeted workforce reductions, furloughs, and executive salary deferrals.

 

On November 10, 2025, the Company closed a financing agreement with Sorbie Bornholm LP with a notional value of CAD$14,000,000 in exchange for the issuance of an aggregate of 2,660,000 Units, including finder’s fees. Each Unit consists of one Class A subordinated voting share (a “Common Share”) of the Company and one half warrant (each whole warrant, a “Warrant”), where each Warrant will entitle the holder to acquire one additional Common Share at an exercise price of CAD$7.00 for a period of 36 months from the closing of the Offering.

 

Upon closing, the Company received CAD$700,000 representing the first tranche of the Offering, and expects to receive eleven additional tranches expected to be paid monthly subject to the terms of the Sharing Agreement. The Sharing Agreement calculates each additional tranche, as CAD$1,209,091 times the percent increase or decrease between the benchmark price of CAD$7.75 and the trailing 20-day Value Weighted Average Price. The Company anticipates that the additional tranches will begin 30 days after closing and is responsible to pay 8% brokerage fee with each tranche.

 

The securities issued under the Offering are subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation in Canada.

v3.25.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Basis of presentation

 

a)Basis of presentation

 

The condensed consolidated interim financial statements include the accounts of VERSES AI Inc. and its wholly owned subsidiaries (“Subsidiaries”) (collectively “VERSES” or the “Company”) have been prepared in accordance with U.S generally accepted accounting principles (“GAAP”) as defined by the Financial Accounting Standards Board (FASB).

Consolidation

 

b)Consolidation

 

These consolidated financial statements include the accounts of the Company and its wholly owned Subsidiaries. The results of the Subsidiaries will continue to be included in the consolidated financial statements of the Company until the date that the Company’s control over the Subsidiaries ceases. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. All intercompany transactions are eliminated on these consolidated financial statements.

 

Details of the Company’s Subsidiaries at September 30, 2025 and March 31, 2025 are as follows:

 

Name 

Place of

 Incorporation

 

September 30, 2025

Interest

 

March 31, 2025

Interest

Verses Technologies USA, Inc.

(formerly Verses Labs Inc.) (“VTU”)

  Wyoming, USA   100%   100%
Verses Operations Canada Inc. (“VOC”)  British Columbia, CA   100%   100%
Verses Logistics Inc. (“VLOG”)  Wyoming, USA   100%   100%
Verses Realities Inc. (“VRI”)  Wyoming, USA   Dissolved   100%
Verses Inc. (“VINC”)  Wyoming, USA   100%   100%
Verses Health Inc. (“VHE”)  Wyoming, USA   Dissolved   100%
Verses Global BV (“VBV”)  Netherlands   100%   100%
Verses Solutions Inc (“VSI”)  Wyoming, USA   100%   100%

 

Use of Estimates, Policy [Policy Text Block]
c)Significant accounting estimates and judgments

 

The preparation of these condensed consolidated interim financial statements requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. These consolidated financial statements include estimates that, by their nature, are uncertain. The impacts of such estimates are pervasive throughout the consolidated financial statements, and may require accounting adjustments based on future occurrences. Revisions to accounting estimates are recognized in the period in which the estimate is revised and future periods if the revision affects both current and future periods. These estimates are based on historical experience, current and future economic conditions, and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Actual outcomes could differ from these estimates.

 

The significant judgements made by management in the Company’s accounting policies and key sources of estimation uncertainty were the same as those applied in the annual audited consolidated financial statements for the year ended March 31, 2025.

v3.25.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
SCHEDULE OF SUBSIDIARIES

Details of the Company’s Subsidiaries at September 30, 2025 and March 31, 2025 are as follows:

 

Name 

Place of

 Incorporation

 

September 30, 2025

Interest

 

March 31, 2025

Interest

Verses Technologies USA, Inc.

(formerly Verses Labs Inc.) (“VTU”)

  Wyoming, USA   100%   100%
Verses Operations Canada Inc. (“VOC”)  British Columbia, CA   100%   100%
Verses Logistics Inc. (“VLOG”)  Wyoming, USA   100%   100%
Verses Realities Inc. (“VRI”)  Wyoming, USA   Dissolved   100%
Verses Inc. (“VINC”)  Wyoming, USA   100%   100%
Verses Health Inc. (“VHE”)  Wyoming, USA   Dissolved   100%
Verses Global BV (“VBV”)  Netherlands   100%   100%
Verses Solutions Inc (“VSI”)  Wyoming, USA   100%   100%

v3.25.3
DEFERRED GRANT (Tables)
6 Months Ended
Sep. 30, 2025
Deferred Grant  
SCHEDULE OF DEFERRED GRANT

 

   September 30, 2025   March 31, 2025 
Balance, beginning of the year  $67,732   $- 
Grant received   -    226,877 
Expenses on the project   (71,530)   (156,885)
Exchange difference   3,798    (2,260)
Balance, end of the period  $-   $67,732 

v3.25.3
REVENUE (Tables)
6 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
SCHEDULE OF REVENUE FROM CONTACT WITH CUSTOMERS

 

   2025   2024   2025   2024 
  

Three months ended

September 30,

  

Six months ended

September 30,

 
   2025   2024   2025   2024 
Recognized at a point in time (1)  $-   $155,000   $300,000   $155,000 
Recognized over the duration of contracts (2)   100,700    -    100,700    - 
Total  $100,700   $155,000   $400,700   $155,000 

 

  (1) Includes revenues from completed Proof of Concept contracts (“POCs”) and software implementation services.
  (2) Includes revenue from Software as a Service (“SaaS”).

v3.25.3
COST OF REVENUE (Tables)
6 Months Ended
Sep. 30, 2025
Cost Of Revenue  
SCHEDULE OF COST OF REVENUE

The Company’s cost of revenue is summarized as follows:

 

   2025   2024   2025   2024 
   Three months ended   Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Cost of Revenue from POCs and software implementation  $-   $145,000   $184,061   $145,000 
Cost of Revenue from SaaS   70,490    -    70,490    - 
Total  $70,490   $145,000   $254,551   $145,000 

v3.25.3
LOANS PAYABLE (Tables)
6 Months Ended
Sep. 30, 2025
Debt Disclosure [Abstract]  
SCHEDULE OF LOANS PAYABLE

Loan activity consisted of the following:

 

For the period ended  September 30, 2025   March 31, 2025 
Balance, beginning of the year  $139,039   $140,904 
Repayment   (1,938)   (7,106)
Interest expense   2,621    5,241 
Balance, end of the period  $139,722   $139,039 

v3.25.3
SHARE BASED PAYMENTS (Tables)
6 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF OPTIONS TO PURCHASE SUBORDINATE VOTING SHARES

Options to purchase Subordinate Voting Shares have been granted to directors, employees, and consultants as follows:

 

Expiry date  Average Remaining Contractual Life in Years   Exercise Price (CAD$)  

Exercise Price

(USD$ equivalent) (1)

   Outstanding 
June 16, 2027   1.71    21.60    15.52    103,703 
September 4, 2027   1.93    7.44    5.34    125,000 
September 16, 2027   1.96    27.00    19.39    19,072 
April 28, 2028   2.58    44.55    32.00    3,703 
December 15, 2028   3.21    32.85    23.60    345,204 
December 23, 2028   3.23    30.51    21.92    136,290 
April 15, 2029   3.54    30.78    22.11    8,794 
July 3, 2029   3.76    29.01    20.84    142,808 
May 26, 2030   4.65    12.57    9.03    33,334 
September 19, 2030   4.97    6.90    4.96    261,726 
    3.42    22.03    15.82    1,179,634 

 

(1)Converted at balance sheet rate.
SUMMARY OF OPTIONS

A summary of the Company’s Options as of June 30, 2025, and changes for previous financial year end is as follows:

 

  

Number of

stock options

  

Weighted Average

Exercise Price

(CAD$)

  

Weighted Average

Exercise Price

(USD$ equivalent) (1)

 
Outstanding, March 31, 2024   542,334   $32.09   $23.05 
Granted   364,099    27.39    19.67 
Exercised   (51,235)   23.22    16.68 
Cancelled   (84,314)   35.37    25.41 
Outstanding, March 31, 2025   770,884    30.10    21.62 
Granted   670,060    7.94    5.70 
Exercised   (250,000)   8.66    6.22 
Expired   (11,310)   33.89    24.34 
Outstanding, September 30, 2025   1,179,634    22.03    15.82 
Exercisable, September 30, 2025   834,135   $23.64   $16.98 

 

(1)Converted at balance sheet rate.
SCHEDULE OF THE BLACK-SCHOLES OPTION PRICING MODEL WITH THE FOLLOWING WEIGHTED AVERAGE ASSUMPTIONS

 

   CAD$   $ 
Share price at grant date  $6.90   $5.00 
Risk-free interest rate   2.74%   2.74%
Expected life   5 years    5 years 
Expected volatility   120.6%   120.6%
Expected forfeitures   0%   0%
Expected dividends   Nil    Nil 
Grant date fair value per option  $5.76   $4.18 
 
   CAD$   $ 
Share price at grant date  $7.44   $5.45 
Risk-free interest rate   2.47%   2.47%
Expected life   5 years    5 years 
Expected volatility   120.6%   120.6%
Expected forfeitures   0%   0%
Expected dividends   Nil    Nil 
Grant date fair value per option  $4.58   $3.31 
 
   CAD$   $ 
Share price at grant date  $8.66   $6.35 
Risk-free interest rate   3.10%   3.10%
Expected life   5 years    5 years 
Expected volatility   120.6%   120.6%
Expected forfeitures   0%   0%
Expected dividends   Nil    Nil 
Grant date fair value per option  $7.24   $5.31 
  
   CAD$   $ 
Share price at grant date  $12.57   $9.21 
Risk-free interest rate   2.92%   2.92%
Expected life   5 years    5 years 
Expected volatility   123.9%   123.9%
Expected forfeitures   0%   0%
Expected dividends   Nil    Nil 
Grant date fair value per option  $10.63   $7.74 
 
SCHEDULE OF CONSOLIDATES THE POSITION OF OPTIONS GRANTED RELATED TO STRATEGIC CONSULTANTS

The table below consolidates the position of the Options granted related to consultants of the Company:

 

Consultant  Total granted amount   Exercised - Inception to March 31, 2025   Outstanding March 31, 2025   Granted Q2-2026 (ytd)   Exercised Q2-2026 (ytd)   Cancelled Q2-2026 (ytd)   Outstanding September 30, 2025   % of the total 
A   64,815          (55,556)   9,259    -    -    -    9,259    2.5%
B   64,814    (9,259)   55,555    375,000    (250,000)   -    180,555    47.8%
C   55,555    (44,444)   11,111    -    -    -    11,111    2.9%
D   44,444    -    44,444    -    -    -    44,444    11.8%
E   23,889    -    23,889    16,667    -    -    40,556    10.7%
F   3,704    -    3,704    16,667    -    -    20,371    5.4%
G   14,815    (14,815)   -    -    -    -    -    0.0%
H   14,815    -    14,815    -    -    -    14,815    3.9%
I   12,963    -    12,963    -    -    -    12,963    3.4%
J   12,963    (10,556)   2,407    -    -    -    2,407    0.6%
K   9,259    (9,259)   -    -    -    -    -    0.0%
L   7,407    -    7,407    -    -    -    7,407    2.0%
M   6,481    -    6,481    -    -    -    6,481    1.7%
N   6,481    -    6,481    -    -    -    6,481    1.7%
O   4,457    -    4,457    -    -    -    4,457    1.2%
P   3,704    -    3,704    -    -    -    3,704    1.0%
Q   3,704    -    3,704    -    -    -    3,704    1.0%
Others   10,577    (1,235)   9,342    -    -    (617)   8,725    2.3%
Total   364,847    (145,124)   219,723    408,334    (250,000)   (617)   377,440    100.0%
SCHEDULE OF POSITION OF THE RSUS GRANTED RELATED TO STRATEGIC CONSULTANTS

The table below consolidates the position of the RSUs granted related to consultants of the Company:

 

Consultant  Total granted amount   Converted - Inception to March 31, 2025   Outstanding March 31, 2025   Granted Q2-2026 (ydt)   Converted Q2-2026 (ytd)   Outstanding September 30, 2025   % of the total 
A   7,407    (2,469)   4,938    -    -    4,938    4.1%
B   46,296    (9,259)   37,037    33,333    (42,592)   27,778    22.9%
E   111,111    (37,037)   74,074    -    (37,038)   37,036    30.5%
F   111,111    (37,037)   74,074    -    (37,038)   37,036    30.5%
L   1,852    -    1,852    -    -    1,852    1.5%
Others   20,371    (3,704)   16,667    -    (4,055)   12,612    10.4%
Total   298,148    (89,506)   208,642    33,333    (120,723)   121,252    100.0%
SCHEDULE OF RESTRICTED SHARES

A summary of the Company’s restricted shares units as at September 30, 2025, and changes for the years then ended is as follows:

 

   Number of RSUs 
Balance, March 31, 2024   24,075 
Issued, April 15, 2024   1,852 
Issued, June 20, 2024   37,037 
Issued, July 3, 2024   359,817 
Issued, September 13, 2024   74,074 
Issued, December 23, 2024   296,296 
Cancelled   (5,926)
Converted   (101,852)
Balance, March 31, 2025   685,373 
Issued, May 26, 2025   33,333 
Issued, September 19, 2025   30,000 
Converted   (133,686)
Balance, September 30, 2025   615,020 
Exercisable, September 30, 2025   145,853 
SCHEDULE OF RECONCILIATION SHARE BASED PAYMENTS

A reconciliation of share based payments is as follows:

 

Share based payments  Stock Options   RSUs   Total 
Previous years graded vesting   402,225    -    402,225 
Previous years RSUs revaluation   -    (251,392)   (251,392)
New grants Q1 2025   76,787    26,668    103,455 
New grants Q2 2025   1,027,452    805,605    1,833,057 
Cancelled options   (125,621)   -    (125,621)
Balance, September 30, 2024  $1,380,843   $580,881   $1,961,724 
                
Previous years graded vesting   711,710    -    711,710 
Previous years RSUs revaluation   -    (1,581,375)   (1,581,375)
New grants Q1 2026   258,056    344,431    602,487 
New grants Q2 2026   2,118,326    8,616    2,126,942 
RSU milestone conversion   -    230,491    230,491 
Balance, September 30, 2025  $3,088,092   $(997,837)  $2,090,255 

v3.25.3
RELATED PARTY TRANSACTIONS AND BALANCES (Tables)
6 Months Ended
Sep. 30, 2025
Related Party Transactions [Abstract]  
SCHEDULE OF RELATED PARTY TRANSACTIONS

During the three and six month periods ended September 30, 2025 and 2024, related party transactions were as follows:

 

   2025   2024   2025   2024 
   Three months ended   Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Management fees  $60,000   $59,455   $120,000   $84,581 
Management salaries and benefits included in personnel expenses   463,104    464,884    900,870    770,635 
Share-based payments   (159,394)   34,914    (194,919)   (67,827)
Related party transactions  $363,710   $559,253   $825,951   $787,389 

v3.25.3
WARRANTS (Tables)
6 Months Ended
Sep. 30, 2025
Warrants  
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS

The total fair value of these Compensation Warrants was $660,900, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

   CAD$   $ 
Share price at grant date  $11.46   $8.38 
Risk-free interest rate   2.72%   2.72%
Expected life   3 years    3 years 
Expected volatility   120.6%   120.6%
Expected dividends   Nil    Nil 
Grant date fair value per warrant  $8.20   $5.99 
 

The total fair value of these Compensation Warrants was $495,635, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

   CAD$   $ 
Share price at grant date  $13.20   $9.52 
Risk-free interest rate   2.61%   2.61%
Expected life   3 years    3 years 
Expected volatility   123.9%   123.9%
Expected dividends   Nil    Nil 
Grant date fair value per warrant  $9.78   $7.05 
 
SCHEDULE OF WARRANTS OUTSTANDING

Warrants outstanding as at September 30, 2025 are summarized below:

 

   Number of warrants   Weighted Average Exercise Price (CAD$)  

Exercise Price

(USD$ equivalent) (1)

 
Balance, March 31, 2024   878,061   $41.10   $29.52 
Issued   1,340,158    40.16    28.85 
Exercised   (122,993)   24.09    17.30 
Expired   (2)   21.60    15.52 
Balance, March 31, 2025   2,095,224   $41.50   $29.81 
Issued   1,142,820    12.93    9.29 
Expired   (368,303)   26.54    19.06 
Balance, September 30, 2025   2,869,741   $32.04   $23.02 

 

(1)Converted at balance sheet rate.
SCHEDULE OF OUTSTANDING SHARE PURCHASE WARRANTS EXPIRE

As of September 30, 2025, the Company’s outstanding share purchase warrants expire as follows:

 

Expiry date  Weighted Average Remaining Contractual Life in Years   Exercise Price (CAD$)  

Exercise Price (USD$ equivalent) (1)

   Outstanding 
April 15, 2026   0.54    10.80    7.76    46,296 
April 17, 2026   0.55    27.00    19.39    3,348 
April 29, 2026   0.58    27.00    19.39    6,618 
May 16, 2026   0.62    27.00    19.39    1,702 
July 6, 2026   0.76    55.35    39.76    29,227 
July 6, 2026   0.76    68.85    49.45    294,694 
August 15, 2026   0.87    27.00    19.39    45,496 
August 17, 2026   0.88    40.50    29.09    126,853 
August 30, 2026   0.92    40.50    29.09    43,062 
September 17, 2026   0.96    40.50    29.09    12,494 
December 22, 2026   1.23    32.40    23.27    809 
January 8, 2027   1.27    40.50    29.09    28 
June 20, 2027   1.72    40.50    29.09    255,185 
September 26, 2027   1.99    21.60    15.52    10,562 
September 26, 2027   1.99    32.40    23.27    114,354 
November 8, 2027   2.11    13.50    9.70    14,444 
November 8, 2027   2.11    18.90    13.58    85,699 
November 15, 2027   2.13    13.50    9.70    2,229 
November 15, 2027   2.13    18.90    13.58    15,290 
December 9, 2027   2.19    13.50    9.70    3,707 
December 9, 2027   2.19    18.90    13.58    28,519 
January 9, 2028   2.28    52.92    38.01    235,906 
January 9, 2028   2.28    42.39    30.45    26,420 
February 25, 2028   2.41    52.92    38.01    257,312 
March 9, 2028   2.44    18.90    13.58    66,667 
April 28, 2028   2.58    15.00    10.77    458,333 
April 28, 2028   2.58    12.00    8.62    70,334 
July 11, 2028   2.78    11.50    8.26    614,153 
    2.07   $32.04   $23.02    2,869,741 

 

Notes:

 

(1)Converted at balance sheet rate.

sheet rate) = 1 New Class A Subordinate Voting share.

 

(2)Warrants expiring July 6, 2026

 

Pre-Consolidation Exercise Terms: 1 Warrant + CAD$2.55 ($1.83 at balance sheet rate) = 1 Class A Subordinate Voting share.

 

Post-Consolidation Exercise Terms: 27 Warrants + CAD$68.85 ($49.46 at balance sheet rate) = 1 New Class A Subordinate Voting share.

 

For presentation purposes, the Company divided the total outstanding warrants by 27 to reflect 1 warrant + CAD$68.85 ($49.46 at balance sheet rate) = 1 New Class A Subordinate Voting share.

v3.25.3
PREPAID EXPENSES (Tables)
6 Months Ended
Sep. 30, 2025
Prepaid Expenses  
SCHEDULE OF PREPAID EXPENSES

Prepaid expenses consisted of the following:

 

   September 30, 2025   March 31, 2025 
Deposit  $34,929   $10,000 
Retainer   269,311    251,983 
Prepaid insurance   540,495    106,084 
Subscriptions   371,040    267,997 
Balance, end of the period  $1,215,775   $636,064 

v3.25.3
EQUIPMENT (Tables)
6 Months Ended
Sep. 30, 2025
Property, Plant and Equipment [Abstract]  
SCHEDULE OF EQUIPMENT

   

Cost  Equipment 
Balance, March 31, 2025  $580,751 
Additions   40,489 
Balance, September 30, 2025  $621,240 
      
Accumulated depreciation   Equipment 
Balance, March 31, 2025  $455,338 
Additions   45,894 
Balance, September 30, 2025  $501,232 
      
Net book value, March 31, 2025  $125,413 
Net book value, September 30, 2025  $120,008 

v3.25.3
FINANCIAL INSTRUMENTS (Tables)
6 Months Ended
Sep. 30, 2025
Investments, All Other Investments [Abstract]  
SCHEDULE OF FAIR VALUE HIERARCHY

   

As of September 30, 2025  Level 1 ($)   Level 2 ($)   Level 3 ($)   Total ($) 
Assets:                    
Cash and restricted cash   1,209,908    -    -    1,209,908 
Accounts receivable   296,700    -    -    296,700 
Due from related parties   69,657    -    -    69,657 
Liabilities:                    
Accounts payable   1,508,247    -    -    1,508,247 
Accrued liabilities   132,665    -    -    132,665 
Provision for legal claim   9,402,338    -    -    9,402,338 
Restricted share unit liability   -    1,776,600    -    1,776,600 
Loans payable   139,722    -    -    139,722 

 

As of March 31, 2025   Level 1    Level 2    Level 3    Total 
Assets:                    
Cash and restricted cash   4,816,906    -    -    4,816,906 
Due from related parties   68,080    -    -    68,080 
Liabilities:                    
Accounts payable   2,036,916    -    -    2,036,916 
Accrued liabilities   41,736    -    -    41,736 
Provision for legal claim   8,948,085    -    -    8,948,085 
Restricted share unit liability   -    3,911,823    -    3,911,823 
Loans payable   139,039    -    -    139,039 
SCHEDULE OF CONTRACTUAL CASH FLOW REQUIREMENT

Contractual cash flow requirements as of September 30, 2025, were as follows:

  

    Less than 1 year    1 to 2 years    2 to 5 years    After 5 years    Total 
  

<1 year

$

  

1-2 years

$

  

2-5 years

$

  

>5 years

$

  

Total

$

 
Accounts payable   1,508,247    -    -    -    1,508,247 
Accrued liabilities   132,665    -    -    -    132,665 
Loans payable   7,752    7,752    23,256    100,962    139,722 
Total   1,648,664    7,752    23,256    100,962    1,780,634 
SCHEDULE OF FOREIGN EXCHANGE RISK EXPOSURE OF FINANCIAL INSTRUMENTS

The foreign exchange risk exposure of the Company financial instruments as at September 30, 2025 is as below:

  

            
           +/- 10% fluctuation 
   Currency   Increase/(decrease) 
Financial Instrument Type  CAD$   $   $ impact 
Cash   987,753    709,503    70,950    (70,950)
Tax receivable   1,003,283    720,659    72,066    (72,066)
Prepaid expenses   1,172,734    842,375    84,237    (84,237)
Accounts payable   (774,473)   (556,304)   (55,630)   55,630 
Accrued liabilities   (50,000)   (35,915)   (3,592)   3,592 
Restricted share unit liability   (2,473,384)   (1,776,600)   (177,660)   177,660 
Foreign currency future instrument    (134,087)   (96,283)   (9,629)   9,629 

 

            
           +/- 10% fluctuation 
   Currency       Increase/(decrease) 
Financial Instrument Type  EURO   $   $ impact 
Restricted cash   1,375    1,613    161    (161)
Tax receivable   6,423    7,535    753    (753)
Accounts payable   (20,468)   (24,011)   (2,401)   2,401 
Foreign currency future instrument    (12,670)   (14,864)   (1,486)   1,486 

v3.25.3
SUPPLEMENTAL CASH FLOW INFORMATION (Tables)
6 Months Ended
Sep. 30, 2025
Supplemental Cash Flow Elements [Abstract]  
SCHEDULE OF SUPPLEMENTAL CASH PAID AND RECEIVED BY THE COMPANY

The supplemental cash paid and received by the Company as of September 30, 2025 is as below:

  

             
   For three months ended   For Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Cash paid for interest  $1,313   $5,524   $2,621   $6,843 
Cash received for interest  $37,609   $35,147   $85,053   $49,970 

v3.25.3
OTHER INCOME (Tables)
6 Months Ended
Sep. 30, 2025
Other Income and Expenses [Abstract]  
SCHEDULE OF OTHER INCOME

Other income consisted of the following:

  

             
   For three months ended   For Six months ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Accretion expense  $-   $(411,813)  $-   $(453,839)
Grant Income   17,720    56,034    81,909    56,034 
Interest earned   37,609    35,147    85,053    49,970 
Gain on derivative liability   -    2,464,873    -    2,464,873 
Interest expense   (7,278)   (221,720)   (12,254)   (293,038)
Legal claim expense   (359,164)   -    (582,253)   - 
Provision for losses on related party transactions   -    (235,413)   -    (396,524)
R&D tax credits   65,679    -    416,208    - 
Other income  $(245,434)  $1,687,108   $(11,337)  $1,427,476 

v3.25.3
PROVISION FOR LEGAL CLAIM (Tables)
6 Months Ended
Sep. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
SCHEDULE OF SETTLEMENT DISCUSSIONS ARE ONGOING

A reconciliation of the legal claim provision is provided in the table below:

  

   September 30, 2025   March 31, 2025 
Beginning of the year   8,948,085    9,921,298 
Payments in the year   -    (1,791,000)
Interest   454,253    817,787 
Balance, end of the period   9,402,338    8,948,085 

v3.25.3
NATURE OF BUSINESS AND GOING CONCERN (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]              
Net loss $ 9,867,058 $ 9,638,843 $ 8,568,722 $ 10,560,705 $ 19,505,901 $ 19,129,427  
Accumulated deficit $ 149,068,526       $ 149,068,526   $ 129,562,625

v3.25.3
SCHEDULE OF SUBSIDIARIES (Details)
6 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Verses Technologies USA, Inc. (“VTU”) [Member]    
ScheduleOfSubsidiariesLineItems [Line Items]    
Place of Incorporation Wyoming, USA  
Interest, percentage 100.00% 100.00%
Verses Operations Canada Inc. (“VOC”) [Member]    
ScheduleOfSubsidiariesLineItems [Line Items]    
Place of Incorporation British Columbia, CA  
Interest, percentage 100.00% 100.00%
Verses Logistics Inc. (“VLOG”) [Member]    
ScheduleOfSubsidiariesLineItems [Line Items]    
Place of Incorporation Wyoming, USA  
Interest, percentage 100.00% 100.00%
Verses Realities Inc. (“VRI”) [Member]    
ScheduleOfSubsidiariesLineItems [Line Items]    
Place of Incorporation Wyoming, USA  
Interest, percentage   100.00%
Interest description Dissolved  
Verses Inc. (“VINC”) [Member]    
ScheduleOfSubsidiariesLineItems [Line Items]    
Place of Incorporation Wyoming, USA  
Interest, percentage 100.00% 100.00%
Verses Health Inc. (“VHE”) [Member]    
ScheduleOfSubsidiariesLineItems [Line Items]    
Place of Incorporation Wyoming, USA  
Interest, percentage   100.00%
Interest description Dissolved  
Verses Global BV (“VBV”) [Member]    
ScheduleOfSubsidiariesLineItems [Line Items]    
Place of Incorporation Netherlands  
Interest, percentage 100.00% 100.00%
Verses Solutions Inc (“VSI”) [Member]    
ScheduleOfSubsidiariesLineItems [Line Items]    
Place of Incorporation Wyoming, USA  
Interest, percentage 100.00% 100.00%

v3.25.3
SCHEDULE OF DEFERRED GRANT (Details) - USD ($)
6 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Deferred Grant    
Balance, beginning of the year $ 67,732
Grant received 226,877
Expenses on the project (71,530) (156,885)
Exchange difference 3,798 (2,260)
Balance, end of the period $ 67,732

v3.25.3
DEFERRED GRANT (Details Narrative)
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 24, 2024
USD ($)
Jul. 24, 2024
EUR (€)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Mar. 31, 2025
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Grant received           $ 226,877
Grant Income     $ 17,720 $ 56,034 81,909 $ 56,034  
Grant Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Grant received $ 226,877 € 209,056          
Outstanding expense in accounts payable and accrued liabilities     24,013   24,013   17,944
Restricted Cash     $ 1,613   1,613   $ 67,732
Grant Income         $ 81,909 $ 56,034  

v3.25.3
SCHEDULE OF REVENUE FROM CONTACT WITH CUSTOMERS (Details) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Disaggregation of Revenue [Line Items]        
Total $ 100,700 $ 155,000 $ 400,700 $ 155,000
Transferred at Point in Time [Member]        
Disaggregation of Revenue [Line Items]        
Total [1] 155,000 300,000 155,000
Transferred over Time [Member]        
Disaggregation of Revenue [Line Items]        
Total [2] $ 100,700 $ 100,700
[1] Includes revenues from completed Proof of Concept contracts (“POCs”) and software implementation services.
[2] Includes revenue from Software as a Service (“SaaS”).

v3.25.3
REVENUE (Details Narrative)
Jun. 30, 2024
USD ($)
Revenue from Contract with Customer [Abstract]  
Provision for contract settlement $ 1,252,076

v3.25.3
SCHEDULE OF COST OF REVENUE (Details) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Cost Of Revenue        
Cost of Revenue from POCs and software implementation $ 145,000 $ 184,061 $ 145,000
Cost of Revenue from SaaS 70,490 70,490
Total $ 70,490 $ 145,000 $ 254,551 $ 145,000

v3.25.3
SCHEDULE OF LOANS PAYABLE (Details) - USD ($)
6 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Debt Disclosure [Abstract]    
Balance, beginning of the year $ 139,039 $ 140,904
Repayment (1,938) (7,106)
Interest expense 2,621 5,241
Balance, end of the period $ 139,722 $ 139,039

v3.25.3
LOANS PAYABLE (Details Narrative) - USD ($)
Jun. 05, 2020
Sep. 30, 2025
Debt Disclosure [Abstract]    
Loans recieved $ 142,400  
Debt interest per annum 3.75% 5.00%
Monthly payment $ 646  
Debt instrument, maturity date, description June 2021 with a maturity of 30 years  

v3.25.3
SCHEDULE OF OPTIONS TO PURCHASE SUBORDINATE VOTING SHARES (Details)
6 Months Ended
Sep. 30, 2025
$ / shares
shares
Sep. 30, 2025
$ / shares
shares
Mar. 31, 2025
shares
Mar. 31, 2024
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Average Remaining Contractual Life in Years 3 years 5 months 1 day      
Exercise Price | (per share) $ 15.82 [1] $ 22.03    
Outstanding 1,179,634 1,179,634 770,884 542,334
June 16, 2027 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Average Remaining Contractual Life in Years 1 year 8 months 15 days      
Exercise Price | (per share) $ 15.52 [1] $ 21.60    
Outstanding 103,703 103,703    
September 4, 2027 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Average Remaining Contractual Life in Years 1 year 11 months 4 days      
Exercise Price | (per share) $ 5.34 [1] $ 7.44    
Outstanding 125,000 125,000    
September 16, 2027 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Average Remaining Contractual Life in Years 1 year 11 months 15 days      
Exercise Price | (per share) $ 19.39 [1] $ 27.00    
Outstanding 19,072 19,072    
April 28, 2028 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Average Remaining Contractual Life in Years 2 years 6 months 29 days      
Exercise Price | (per share) $ 32.00 [1] $ 44.55    
Outstanding 3,703 3,703    
December 15, 2028 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Average Remaining Contractual Life in Years 3 years 2 months 15 days      
Exercise Price | (per share) $ 23.60 [1] $ 32.85    
Outstanding 345,204 345,204    
December 23, 2028 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Average Remaining Contractual Life in Years 3 years 2 months 23 days      
Exercise Price | (per share) $ 21.92 [1] $ 30.51    
Outstanding 136,290 136,290    
April 15, 2029 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Average Remaining Contractual Life in Years 3 years 6 months 14 days      
Exercise Price | (per share) $ 22.11 [1] $ 30.78    
Outstanding 8,794 8,794    
July 3, 2029 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Average Remaining Contractual Life in Years 3 years 9 months 3 days      
Exercise Price | (per share) $ 20.84 [1] $ 29.01    
Outstanding 142,808 142,808    
May 26, 2023 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Average Remaining Contractual Life in Years 4 years 7 months 24 days      
Exercise Price | (per share) $ 9.03 [1] $ 12.57    
Outstanding 33,334 33,334    
September 19, 2030 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Average Remaining Contractual Life in Years 4 years 11 months 19 days      
Exercise Price | (per share) $ 4.96 [1] $ 6.90    
Outstanding 261,726 261,726    
[1] Converted at balance sheet rate.

v3.25.3
SUMMARY OF OPTIONS (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2025
$ / shares
shares
Sep. 30, 2025
$ / shares
shares
Jun. 30, 2025
$ / shares
shares
Sep. 30, 2024
shares
Jun. 30, 2024
$ / shares
shares
Jun. 30, 2024
$ / shares
shares
Sep. 30, 2025
$ / shares
shares
Sep. 30, 2025
$ / shares
shares
Mar. 31, 2025
$ / shares
shares
Mar. 31, 2025
$ / shares
shares
Share-Based Payment Arrangement [Abstract]                    
Number of stock options, Outstanding beginning balance     770,884   542,334 542,334 770,884 770,884 542,334 542,334
Weighted- Average Exercise Price, Outstanding beginning balance | (per share)     $ 30.10   $ 23.05 [1] $ 32.09 $ 21.62 [1] $ 30.10 $ 23.05 [1] $ 32.09
Number of stock options, Granted 2,126,942 2,126,942   1,833,057 103,455 103,455 670,060 670,060 364,099 364,099
Weighted- Average Exercise Price, Granted | (per share)     $ 7.94       $ 5.70 [1]   $ 19.67 [1] $ 27.39
Number of stock options, Exercised             (250,000) (250,000) (51,235) (51,235)
Weighted- Average Exercise Price, Exercised | (per share)             $ 6.22 [1] $ 8.66 $ 16.68 [1] $ 23.22
Number of stock options, Cancelled                 (84,314) (84,314)
Weighted- Average Exercise Price, Cancelled | (per share)                 $ 25.41 [1] $ 35.37
Number of stock options, Expired             (11,310) (11,310)    
Weighted- Average Exercise Price, Expired | (per share)             $ 24.34 $ 33.89    
Number of stock options, Outstanding ending balance 1,179,634 1,179,634         1,179,634 1,179,634 770,884 770,884
Weighted- Average Exercise Price, Outstanding ending balance | (per share) $ 15.82 [1] $ 22.03         $ 15.82 [1] $ 22.03 $ 21.62 [1] $ 30.10
Number of stock options, Exercisable ending balance 834,135 834,135         834,135 834,135    
Weighted- Average Exercise Price, Exercisable ending balance | (per share) $ 16.98 [1] $ 23.64         $ 16.98 [1] $ 23.64    
[1] Converted at balance sheet rate.

v3.25.3
SCHEDULE OF THE BLACK-SCHOLES OPTION PRICING MODEL WITH THE FOLLOWING WEIGHTED AVERAGE ASSUMPTIONS (Details)
May 26, 2025
$ / shares
May 26, 2025
$ / shares
$ / shares
Jul. 11, 2025
$ / shares
Jul. 11, 2025
$ / shares
May 26, 2025
$ / shares
Apr. 28, 2025
$ / shares
Apr. 28, 2025
$ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Share price at grant date | (per share)     $ 6.946 $ 9.50   $ 8.64 $ 12.00
Employees and Independent Contractors [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Share price at grant date | (per share) $ 5.00 $ 5.00     $ 6.90    
Risk-free interest rate 2.74% 2.74%          
Expected life 5 years 5 years          
Expected volatility 120.60% 120.60%          
Expected forfeitures 0.00% 0.00%          
Expected dividends          
Grant date fair value per option | (per share) $ 4.18 $ 5.76          
Employees and Independent Contractors [Member] | Canadian Dollar [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Risk-free interest rate 2.74% 2.74%          
Expected life 5 years 5 years          
Expected volatility 120.60% 120.60%          
Expected forfeitures 0.00% 0.00%          
Expected dividends          

v3.25.3
SCHEDULE OF CONSOLIDATES THE POSITION OF OPTIONS GRANTED RELATED TO STRATEGIC CONSULTANTS (Details) - shares
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 04, 2025
Jul. 24, 2025
May 26, 2025
Sep. 30, 2025
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2025
Mar. 31, 2025
Defined Benefit Plan Disclosure [Line Items]                
Number of stock options, Outstanding beginning balance           542,334 770,884 542,334
Number of stock options, Granted       2,126,942 1,833,057 103,455 670,060 364,099
Number of stock options, Exercised             (250,000) (51,235)
Number of stock options, Cancelled               (84,314)
Number of stock options, Outstanding ending balance       1,179,634     1,179,634 770,884
Consultant A [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             64,815  
Number of stock options, Exercised             (55,556)  
Number of stock options, Outstanding beginning balance             9,259  
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       9,259     9,259 9,259
Percentage of the total             2.50%  
Consultant B [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             64,814  
Number of stock options, Exercised             (9,259)  
Number of stock options, Outstanding beginning balance             55,555  
Number of stock options, Granted 125,000 250,000         375,000  
Number of stock options, Exercised             (250,000)  
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       180,555     180,555 55,555
Percentage of the total             47.80%  
Consultant C [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             55,555  
Number of stock options, Exercised             (44,444)  
Number of stock options, Outstanding beginning balance             11,111  
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       11,111     11,111 11,111
Percentage of the total             2.90%  
Consultant D [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             44,444  
Number of stock options, Exercised              
Number of stock options, Outstanding beginning balance             44,444  
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       44,444     44,444 44,444
Percentage of the total             11.80%  
Consultant E [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             23,889  
Number of stock options, Exercised              
Number of stock options, Outstanding beginning balance             23,889  
Number of stock options, Granted     16,667       16,667  
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       40,556     40,556 23,889
Percentage of the total             10.70%  
Consultant F [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             3,704  
Number of stock options, Exercised              
Number of stock options, Outstanding beginning balance             3,704  
Number of stock options, Granted     16,667       16,667  
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       20,371     20,371 3,704
Percentage of the total             5.40%  
Consultant G [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             14,815  
Number of stock options, Exercised             (14,815)  
Number of stock options, Outstanding beginning balance              
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance          
Percentage of the total             0.00%  
Consultant H [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             14,815  
Number of stock options, Exercised              
Number of stock options, Outstanding beginning balance             14,815  
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       14,815     14,815 14,815
Percentage of the total             3.90%  
Consultant I [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             12,963  
Number of stock options, Exercised              
Number of stock options, Outstanding beginning balance             12,963  
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       12,963     12,963 12,963
Percentage of the total             3.40%  
Consultant J [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             12,963  
Number of stock options, Exercised             (10,556)  
Number of stock options, Outstanding beginning balance             2,407  
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       2,407     2,407 2,407
Percentage of the total             0.60%  
Consultant K [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             9,259  
Number of stock options, Exercised             (9,259)  
Number of stock options, Outstanding beginning balance              
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance          
Percentage of the total             0.00%  
Consultant L [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             7,407  
Number of stock options, Exercised              
Number of stock options, Outstanding beginning balance             7,407  
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       7,407     7,407 7,407
Percentage of the total             2.00%  
Consultant M [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             6,481  
Number of stock options, Exercised              
Number of stock options, Outstanding beginning balance             6,481  
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       6,481     6,481 6,481
Percentage of the total             1.70%  
Consultant N [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             6,481  
Number of stock options, Exercised              
Number of stock options, Outstanding beginning balance             6,481  
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       6,481     6,481 6,481
Percentage of the total             1.70%  
Consultant O [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             4,457  
Number of stock options, Exercised              
Number of stock options, Outstanding beginning balance             4,457  
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       4,457     4,457 4,457
Percentage of the total             1.20%  
Consultant P [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             3,704  
Number of stock options, Exercised              
Number of stock options, Outstanding beginning balance             3,704  
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       3,704     3,704 3,704
Percentage of the total             1.00%  
Consultant Q [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             3,704  
Number of stock options, Exercised              
Number of stock options, Outstanding beginning balance             3,704  
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled              
Number of stock options, Outstanding ending balance       3,704     3,704 3,704
Percentage of the total             1.00%  
Other Consultant [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             10,577  
Number of stock options, Exercised             (1,235)  
Number of stock options, Outstanding beginning balance             9,342  
Number of stock options, Granted              
Number of stock options, Exercised              
Number of stock options, Cancelled             (617)  
Number of stock options, Outstanding ending balance       8,725     8,725 9,342
Percentage of the total             2.30%  
Strategic Consultants [Member]                
Defined Benefit Plan Disclosure [Line Items]                
Total granted amount             364,847  
Number of stock options, Exercised             (145,124)  
Number of stock options, Outstanding beginning balance             219,723  
Number of stock options, Granted             408,334  
Number of stock options, Exercised             (250,000)  
Number of stock options, Cancelled             (617)  
Number of stock options, Outstanding ending balance       377,440     377,440 219,723
Percentage of the total             100.00%  

v3.25.3
SCHEDULE OF POSITION OF THE RSUS GRANTED RELATED TO STRATEGIC CONSULTANTS (Details) - Restricted Stock Units (RSUs) [Member] - shares
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 28, 2025
Jul. 03, 2025
Jun. 30, 2025
Sep. 30, 2025
Mar. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Outstanding, beginning balance     685,373 685,373 24,075
Granted 40,742 92,944   585,020  
Outstanding, ending balance       615,020 685,373
Consultant A [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Total granted amount       7,407  
Converted Inception       (2,469)  
Outstanding, beginning balance     4,938 4,938  
Granted        
Converted Inception        
Outstanding, ending balance       4,938 4,938
Percentage of the total       4.10%  
Consultant B [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Total granted amount       46,296  
Converted Inception       (9,259)  
Outstanding, beginning balance     37,037 37,037  
Granted       33,333  
Converted Inception       (42,592)  
Outstanding, ending balance       27,778 37,037
Percentage of the total       22.90%  
Consultant E [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Total granted amount       111,111  
Converted Inception       (37,037)  
Outstanding, beginning balance     74,074 74,074  
Granted        
Converted Inception       (37,038)  
Outstanding, ending balance       37,036 74,074
Percentage of the total       30.50%  
Consultant F [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Total granted amount       111,111  
Converted Inception       (37,037)  
Outstanding, beginning balance     74,074 74,074  
Granted        
Converted Inception       (37,038)  
Outstanding, ending balance       37,036 74,074
Percentage of the total       30.50%  
Consultant L [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Total granted amount       1,852  
Converted Inception        
Outstanding, beginning balance     1,852 1,852  
Granted        
Converted Inception        
Outstanding, ending balance       1,852 1,852
Percentage of the total       1.50%  
Other Consultant [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Total granted amount       20,371  
Converted Inception       (3,704)  
Outstanding, beginning balance     16,667 16,667  
Granted        
Converted Inception       (4,055)  
Outstanding, ending balance       12,612 16,667
Percentage of the total       10.40%  
Strategic Consultants [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Total granted amount       298,148  
Converted Inception     (89,506)    
Outstanding, beginning balance     208,642 208,642  
Granted       33,333  
Converted Inception       (120,723)  
Outstanding, ending balance       121,252 208,642
Percentage of the total       100.00%  

v3.25.3
SCHEDULE OF RESTRICTED SHARES (Details) - Restricted Stock Units (RSUs) [Member] - shares
6 Months Ended 12 Months Ended
Jul. 28, 2025
Jul. 03, 2025
Sep. 30, 2025
Mar. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Outstanding, beginning balance     685,373 24,075
Issued 40,742 92,944 585,020  
Cancelled       (5,926)
Converted     (133,686) (101,852)
Outstanding, ending balance     615,020 685,373
Exercisable, September 30, 2025     145,853  
April 15, 2024 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Issued       1,852
June 20, 2024 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Issued       37,037
July 3, 2024 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Issued       359,817
September 13, 2024 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Issued       74,074
December 23, 2024 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Issued       296,296
May 26, 2025 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Issued     33,333  
September 19, 2025 [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Issued     30,000  

v3.25.3
SCHEDULE OF RECONCILIATION SHARE BASED PAYMENTS (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 19, 2025
Sep. 30, 2025
Jun. 30, 2025
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2025
Mar. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Previous years graded vesting         402,225    
Previous years RSUs revaluation     (1,581,375)   (251,392)    
New grants Q2 2026   2,126,942   1,833,057 103,455 670,060 364,099
Cancelled options       (125,621)      
Balance, September 30, 2025   $ 2,090,255   $ 1,961,724      
Previous years graded vesting     711,710        
New grants Q1 2026     602,487        
RSU milestone conversion   230,491          
Stock Optios [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Previous years graded vesting         402,225    
Previous years RSUs revaluation          
New grants Q2 2026   2,118,326   1,027,452 76,787    
Cancelled options       (125,621)      
Balance, September 30, 2025   $ 3,088,092   $ 1,380,843      
Previous years graded vesting     711,710        
New grants Q1 2026     258,056        
RSU milestone conversion            
Restricted Stock Units (RSUs) [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Previous years graded vesting 30,000          
Previous years RSUs revaluation     (1,581,375)   (251,392)    
New grants Q2 2026   8,616   805,605 26,668    
Cancelled options            
Balance, September 30, 2025   $ (997,837)   $ 580,881      
Previous years graded vesting            
New grants Q1 2026     344,431        
RSU milestone conversion   230,491          

v3.25.3
SHARE BASED PAYMENTS (Details Narrative)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 19, 2025
USD ($)
$ / shares
shares
Sep. 04, 2025
USD ($)
$ / shares
shares
Sep. 04, 2025
$ / shares
$ / shares
Jul. 28, 2025
CAD ($)
shares
Jul. 24, 2025
USD ($)
$ / shares
shares
Jul. 24, 2025
$ / shares
$ / shares
Jul. 03, 2025
USD ($)
shares
May 26, 2025
USD ($)
$ / shares
shares
May 26, 2025
$ / shares
$ / shares
May 06, 2025
shares
Apr. 28, 2025
USD ($)
$ / shares
Apr. 28, 2025
CAD ($)
Dec. 23, 2024
$ / shares
shares
Jul. 03, 2024
$ / shares
shares
Apr. 15, 2024
$ / shares
shares
Dec. 15, 2023
$ / shares
shares
Sep. 30, 2025
$ / shares
shares
Sep. 30, 2024
shares
Jun. 30, 2024
shares
Sep. 30, 2025
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
$ / shares
shares
Sep. 30, 2025
$ / shares
shares
Sep. 19, 2025
$ / shares
shares
Sep. 04, 2025
$ / shares
Jul. 24, 2025
$ / shares
Jul. 11, 2025
$ / shares
Jul. 11, 2025
$ / shares
May 26, 2025
$ / shares
Apr. 28, 2025
$ / shares
Mar. 31, 2025
$ / shares
shares
Dec. 23, 2024
$ / shares
Jul. 03, 2024
$ / shares
Apr. 15, 2024
$ / shares
Mar. 31, 2024
$ / shares
shares
Mar. 31, 2024
$ / shares
shares
Dec. 15, 2023
$ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Subordinate voting shares percentage                                       25.00%                                
Stock option, shares                                 1,179,634     1,179,634 770,884 1,179,634               770,884       542,334 542,334  
Exercise price | (per share)                                 $ 15.82 [1]     $ 15.82 [1] $ 21.62 [1] $ 22.03               $ 30.10       $ 23.05 [1] $ 32.09  
Number of stock options, granted                                 2,126,942 1,833,057 103,455 670,060 364,099                              
Proceeds from issuance of common stock                     $ 7,929,900 $ 11,000,000                                                
Stock option fair value | $ $ 1,092,915                                                                      
Share price at grant date | (per share)                     $ 8.64                             $ 6.946 $ 9.50   $ 12.00              
Issuance of shares granted                                     402,225                                  
Restricted Stock Units (RSUs) [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Number of stock options, granted                                 8,616 805,605 26,668                                  
Share-based payment award, award expiration year 5 years                                                                      
Issuance of shares granted 30,000                                                                    
Recognized share-based payments for stock options granted | $                                       $ 8,616                                
Issuance of shares granted       40,742     92,944                         585,020                                
Milestones | $       $ 50,000,000                                                                
Conversion shares       3,704                                                                
Shares expenses | $             $ 253,541                         $ 230,491                                
Derecognized share-based payments for stock options granted | $                                       1,581,375                                
Restricted share unit fair value | $                                       $ 1,776,600 $ 3,911,823                              
Restricted Stock Units (RSUs) [Member] | Director [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Conversion shares             12,963                                                          
Consultants F [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Conversion shares             351                                                          
Consultant B [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Stock option, shares                                 180,555     180,555 55,555 180,555               55,555            
Exercise price | (per share)         $ 6.22 $ 6.22             $ 5.34                 $ 8.66     $ 8.66           $ 7.44          
Number of stock options, granted   125,000     250,000                             375,000                                
Proceeds from issuance of common stock | $                                       $ 1,572,440                                
Stock option fair value | $   $ 414,244     $ 1,327,787                             $ 1,327,787                                
Share-based payment award, award expiration year   2 years     5 years                                                              
Share price at grant date | (per share)   $ 5.45 $ 5.45   $ 6.35 $ 6.35                                   $ 7.44 $ 8.66                      
Risk-free interest rate   2.47%     3.10%                                                              
Expected life   5 years     5 years                                                              
Expected volatility   120.60%     120.60%                                                              
Expected forfeitures   0.00%     0.00%                                                              
Expected dividends                                                                    
Grant date fair value per option | (per share)   $ 3.31 $ 4.58   $ 5.31 $ 7.24                                                            
Consultant B [Member] | Canadian Dollar [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Risk-free interest rate   2.47%     3.10%                                                              
Expected life   5 years     5 years                                                              
Expected volatility   120.60%     120.60%                                                              
Expected forfeitures   0.00%     0.00%                                                              
Expected dividends                                                                    
Consultant B [Member] | Restricted Stock Units (RSUs) [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Issuance of shares granted                                       33,333                                
Employees and Independent Contractors [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Exercise price | (per share) $ 4.96                       $ 21.92   $ 24.32 $ 26.18             $ 6.90               30.51   $ 33.86     $ 36.45
Number of stock options, granted 261,726                       49,444   4,260 347,952                                        
Share-based payment award, award expiration year 5 years                       5 years   5 years 5 years                                        
Vesting shares 218,247                                           218,247                          
Share-based payment award, award vesting rights description 25% every quarter subsequent                       25% vesting on the date that is one (1) year from the vesting start date and 6.25% every subsequent quarter 25% vesting on the date that is one (1) year from the vesting start date and 6.25% every subsequent quarter   based on previous commitments, and 6.25% every subsequent quarter                                        
Share-based payments for stock options granted | $                                       $ 134,400                                
Share price at grant date | (per share)               $ 5.00 $ 5.00                                     $ 6.90                
Risk-free interest rate               2.74%                                                        
Expected life               5 years                                                        
Expected volatility               120.60%                                                        
Expected forfeitures               0.00%                                                        
Expected dividends                                                                      
Grant date fair value per option | (per share)               $ 4.18 $ 5.76                                                      
Stock options are vested on the grant date                               173,186                                        
Employees and Independent Contractors [Member] | July 2024 [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Share-based payments for stock options granted | $                                       158,174                                
Employees and Independent Contractors [Member] | April 2024 [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Share-based payments for stock options granted | $                                       7,111                                
Employees and Independent Contractors [Member] | December 2023 [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Share-based payments for stock options granted | $                                       $ 93,580                                
Employees and Independent Contractors [Member] | Canadian Dollar [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Risk-free interest rate               2.74%                                                        
Expected life               5 years                                                        
Expected volatility               120.60%                                                        
Expected forfeitures               0.00%                                                        
Expected dividends                                                                      
Employees and Independent Contractors [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Vesting shares 43,479                                           43,479                          
Share-based payment award, award vesting rights description 25% on the date that is one (1) year from the vesting start date and 6.25% every subsequent quarter                                                                      
Strategic Consultants [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Stock option, shares                                 377,440     377,440 219,723 377,440               219,723            
Number of stock options, granted                                       408,334                                
Share-based payments for stock options granted | $                                       $ 376,295                                
Strategic Consultants [Member] | Restricted Stock Units (RSUs) [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Issuance of shares granted                                       33,333                                
Consultant E [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Stock option, shares                                 40,556     40,556 23,889 40,556               23,889            
Number of stock options, granted               16,667                       16,667                                
Consultant E [Member] | Restricted Stock Units (RSUs) [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Issuance of shares granted                                                                      
Consultant F [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Stock option, shares                                 20,371     20,371 3,704 20,371               3,704            
Number of stock options, granted               16,667                       16,667                                
Consultant F [Member] | Restricted Stock Units (RSUs) [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Issuance of shares granted                                                                      
Financial Consultan E Andt F [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Exercise price | (per share)               $ 9.21 $ 9.21                                     12.57                
Stock option fair value | $               $ 258,056                                                        
Share-based payment award, award expiration year               5 years                                                        
Share price at grant date | (per share)               $ 9.21 $ 9.21                                     $ 12.57                
Risk-free interest rate               2.92%                                                        
Expected life               5 years                                                        
Expected volatility               123.90%                                                        
Expected forfeitures               0.00%                                                        
Expected dividends                                                                      
Grant date fair value per option | (per share)               $ 7.74 $ 10.63                                                      
Financial Consultan E Andt F [Member] | Canadian Dollar [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Risk-free interest rate               2.92%                                                        
Expected life               5 years                                                        
Expected volatility               123.90%                                                        
Expected forfeitures               0.00%                                                        
Expected dividends                                                                      
Consultants [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Exercise price | (per share)                         $ 21.92 $ 20.90                                 $ 30.51 $ 29.10        
Number of stock options, granted                         86,852 85,682                                            
Share-based payment award, award expiration year                         5 years 5 years                                            
Share-based payment award, award vesting rights description                         33.33% of these Options vested on the grant date and 33.33% will vest every 6 months after the grant date                                              
Consultants [Member] | December 2024 [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Share-based payments for stock options granted | $                                       $ 318,445                                
Consultants E [Member] | Restricted Stock Units (RSUs) [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Issuance of shares granted       18,519                                                                
Consultants F [Member] | Restricted Stock Units (RSUs) [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Issuance of shares granted       18,519                                                                
Consultants B [Member] | Restricted Stock Units (RSUs) [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Share-based payment award, award expiration year               5 years                                                        
Issuance of shares granted                   33,333                                                    
Recognized share-based payments for stock options granted | $                                       $ 344,431                                
Issuance of shares granted       18,519     42,592                                                          
Inactive Employee [Member]                                                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                                        
Stock option, shares                                 11,310     11,310   11,310                            
Exercise price | (per share)                                 $ 24.84     $ 24.84   $ 33.89                            
[1] Converted at balance sheet rate.

v3.25.3
SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Related Party Transactions [Abstract]        
Management fees $ 60,000 $ 59,455 $ 120,000 $ 84,581
Management salaries and benefits included in personnel expenses 463,104 464,884 900,870 770,635
Share-based payments (159,394) 34,914 (194,919) (67,827)
Related party transactions $ 363,710 $ 559,253 $ 825,951 $ 787,389

v3.25.3
RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2025
USD ($)
$ / shares
shares
Jul. 28, 2025
shares
Jul. 03, 2025
shares
Apr. 28, 2025
USD ($)
Dec. 23, 2024
$ / shares
shares
Sep. 13, 2024
$ / shares
shares
Jul. 03, 2024
$ / shares
shares
Dec. 23, 2023
$ / shares
shares
Sep. 30, 2025
USD ($)
$ / shares
shares
Sep. 30, 2024
shares
Jun. 30, 2024
shares
Sep. 30, 2025
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
$ / shares
shares
Sep. 30, 2025
$ / shares
Mar. 31, 2025
$ / shares
Dec. 23, 2024
$ / shares
Jul. 03, 2024
$ / shares
Mar. 31, 2024
$ / shares
[1]
Mar. 31, 2024
$ / shares
Dec. 23, 2023
$ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Unsecured loan | $ $ 69,657               $ 69,657     $ 69,657 $ 68,080              
Interest rate 5.00%               5.00%     5.00%                
Repayments of related party debt | $                       $ 0                
Number of stock options, Granted                 2,126,942 1,833,057 103,455 670,060 364,099              
Exercise price | (per share) $ 15.82 [1]               $ 15.82 [1]     $ 15.82 [1] $ 21.62 [1] $ 22.03 $ 30.10     $ 23.05 $ 32.09  
Shares granted | $       $ 495,635                                
Restricted Stock Units (RSUs) [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Number of stock options, Granted                 8,616 805,605 26,668                  
Granted   40,742 92,944                 585,020                
December 2024 [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Shares granted | $                       $ 1,587                
July 2024 [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Shares granted | $                       12,834                
December 2023 [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Shares granted | $                       20,134                
Michael Blum [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Other liabilities | $ $ 20,000               $ 20,000     20,000 $ 20,000              
Michael Blum [Member] | Restricted Stock Units (RSUs) [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Expiration term           10 years                            
Share-based payment award, award rights description           8.33                            
Restricted stock exercise price | $ / shares           $ 0                            
Share-based payment | $                       170,708                
Granted           74,074                            
Expected to vesting shares           24,691                            
James Hendrickson [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Other liabilities | $                   83,500              
Number of stock options, Granted         7,407   3,704 1,852                        
Exercise price | (per share)         $ 21.92     $ 26.18               $ 30.51       $ 36.45
Expiration term         5 years   5 years 5 years                        
Share-based payment award, award rights description         25% will vest within one year of the grant date, and 6.25% every subsequent quarter   25% of the options will vest 12 months after the grant date and 6.25% every subsequent quarter 25% within one year of the grant date, and 6.25% every subsequent quarter                        
Shares vested               1,852                        
Kevin Wilson [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Other liabilities | $                   $ 2,299              
Number of stock options, Granted             1,852 16,278                        
Exercise price | (per share)             $ 20.75                   $ 28.89      
Expiration term             5 years 5 years                        
Share-based payment award, award rights description             25% of the options will vest 12 months after the grant date and 6.25% every subsequent quarter 25% within one year of the grant date, and 6.25% every subsequent quarter                        
Shares vested               16,278                        
Kevin Wilson [Member] | Restricted Stock Units (RSUs) [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Granted             1,852                          
Two Independent Directors [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Number of stock options, Granted         7,408                              
Two Independent Directors [Member] | Restricted Stock Units (RSUs) [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Share-based payment | $                       857                
Gordon Scott Paterson [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Number of stock options, Granted         3,704                              
Expiration term         5 years                              
Gordon Scott Paterson [Member] | Restricted Stock Units (RSUs) [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Shares granted | $                       26,206                
Restricted stock exercise price | $ / shares         $ 0                              
Granted 6,172           5,555                          
Jonathan de Vos [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Number of stock options, Granted         3,704                              
Expiration term         5 years                              
Share-based payment award, award rights description         They vest 33.33% within one year of the grant date and 33.33% yearly thereafter                              
Jonathan de Vos [Member] | Restricted Stock Units (RSUs) [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Restricted stock exercise price | $ / shares         $ 0                              
Three Independent Directors [Member] | Restricted Stock Units (RSUs) [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Share-based payment award, award rights description             33.33% vest every 12 months after the grant date.                          
Restricted stock exercise price | $ / shares             $ 0                          
Granted             16,665                          
Contractual terms             10 years                          
Jonhatande Vos [Member] | Restricted Stock Units (RSUs) [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Granted             5,555                          
Jay Samit [Member] | Restricted Stock Units (RSUs) [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Granted             5,555                          
Kelvin Wilson [Member] | Restricted Stock Units (RSUs) [Member]                                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                        
Share-based payment | $                       $ 31,703                
[1] Converted at balance sheet rate.

v3.25.3
COMMITMENTS (Details Narrative) - USD ($)
6 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Commitment balance
Years 1 Through 10 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Revenue description Years 1 through 10 of the Spatial Domain Program: Cyberlab shall be entitled to retain Five Percent (5%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Five Percent (95%) to allocate between itself and other Spatial Domain Program stakeholders (e.g., registries, registrars, etc.) as it sees fit  
Years 11 Through 14 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Revenue description Years 11 through 14 of the Spatial Domain Program: Cyberlab shall be entitled to retain Four Percent (4%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Six Percent (96%)  
Years 15 Through 17 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Revenue description Years 15 through 17 of the Spatial Domain Program: Cyberlab shall be entitled to retain Three Percent (3%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Seven Percent (97%)  
Years 18 and 19 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Revenue description Years 18 and 19 of the Spatial Domain Program: Cyberlab shall be entitled to retain Two Percent (2%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Eight Percent (98%)  
Years 20 to 25 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Revenue description Years 20 to 25 of the Spatial Domain Program: Cyberlab shall be entitled to retain One Percent (1%) of all gross revenue from the Spatial Domain Program, while VERSES shall retain the remaining Ninety-Nine Percent (99%)  
Restricted Stock Units (RSUs) [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Revenue description RSUs or DSUs, of which 37,510 stock options is for the new Board of Directors member, David Scott, and 30,000 RSUs to Expansion Project Technologies Holding 9 SPV RSC Ltd in connection with CAD$400,000 in revenues derived by Verses from the commercial agreements it enters into with affiliates of G42  

v3.25.3
SHARE CAPITAL (Details Narrative)
3 Months Ended
Sep. 26, 2025
shares
Jul. 28, 2025
USD ($)
shares
Jul. 11, 2025
USD ($)
$ / shares
shares
Jul. 11, 2025
CAD ($)
shares
Jul. 09, 2025
shares
Jul. 03, 2025
USD ($)
May 09, 2025
shares
Apr. 28, 2025
USD ($)
$ / shares
shares
Apr. 28, 2025
CAD ($)
shares
May 30, 2024
shares
Jul. 20, 2021
Sep. 30, 2025
USD ($)
$ / shares
Jun. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
$ / shares
Jul. 11, 2025
CAD ($)
$ / shares
Apr. 28, 2025
$ / shares
Class of Stock [Line Items]                                  
Voting description                     the Company amended its Articles to create an unlimited number of Class A Subordinate Voting Shares and unlimited number of Class B Proportionate Voting Shares. Each Subordinate Voting Share shall entitle the holder thereof to one vote. Each Class B share shall entitle the holder thereof to 6.25 votes and such proportionate dividends and liquidation rights. Each Class B share is convertible, at the holder’s option, into 6.25 Subordinate Voting Shares            
Conversion of convertible securities, shares         250,000   4,253                    
Issuance of shares               916,666 916,666                
Subordinate voting shares, value | $   $ 253,541 $ 1,007,764     $ 883,851           $ 6,058,610 $ 7,111,827 $ 3,365,971      
Proceeds from issuance of debt     $ 7,000,331 $ 9,573,758                          
Share price | (per share)     $ 6.946         $ 8.64               $ 9.50 $ 12.00
Cash commission     $ 292,480         $ 575,655               $ 400,000  
Compensation warrants     35,271 35,271       70,334 70,334                
Warrant exercise price | (per share)     $ 8.409         $ 8.80       $ 23.02 [1]     $ 32.04 $ 11.50 12.00
Proceeds from issuance of common stock               $ 7,929,900 $ 11,000,000                
Legal fees | $               242,418                  
Compensation warrants | $               $ 495,635                  
Maximum [Member]                                  
Class of Stock [Line Items]                                  
Compensation warrants reduced percentage               7.00%                  
Minimum [Member]                                  
Class of Stock [Line Items]                                  
Compensation warrants reduced percentage               2.00%                  
Warrant Share [Member]                                  
Class of Stock [Line Items]                                  
Warrant exercise price | (per share)               $ 11.00                 $ 15.00
Financial Advisor [Member]                                  
Class of Stock [Line Items]                                  
Payments for cash fee | $     $ 250,000                            
Stock issued to finance fee shares     75,000 75,000                          
Warrant [Member]                                  
Class of Stock [Line Items]                                  
Share price | (per share)     $ 8.26                         $ 11.50  
Restricted Stock Units (RSUs) [Member]                                  
Class of Stock [Line Items]                                  
Issuance of shares   40,742                              
Subordinate voting shares, value | $           $ 92,944                      
Common Class B [Member]                                  
Class of Stock [Line Items]                                  
Conversion of convertible securities, shares 198,517                 370,370              
Common Class A [Member]                                  
Class of Stock [Line Items]                                  
Conversion of convertible securities, shares 1,240,741                 2,314,815              
[1] Converted at balance sheet rate.

v3.25.3
WARRANTS (Details Narrative)
Jul. 11, 2025
USD ($)
$ / shares
shares
May 09, 2025
USD ($)
shares
Jul. 11, 2025
$ / shares
shares
Apr. 28, 2025
$ / shares
Apr. 28, 2025
$ / shares
WarrantsLineItems [Line Items]          
Exercise price, per share | (per share) $ 6.946   $ 9.50 $ 8.64 $ 12.00
Fair value of compensation warrants | $ $ 660,900 $ 495,635      
Compensation Warrants [Member]          
WarrantsLineItems [Line Items]          
Issuance of warrants 110,271 70,334 110,271    
Warrant [Member]          
WarrantsLineItems [Line Items]          
Issuance of warrants   458,333      
Warrant [Member]          
WarrantsLineItems [Line Items]          
Issuance of warrants 503,882   503,882    
Exercise price, per share | (per share) $ 8.26   $ 11.50    

v3.25.3
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) - Compensation Warrants [Member]
Jul. 11, 2025
Jul. 11, 2025
$ / shares
Jul. 11, 2025
Jul. 11, 2025
$ / shares
May 09, 2025
May 09, 2025
$ / shares
May 09, 2025
May 09, 2025
$ / shares
Measurement Input, Share Price [Member]                
Class of Warrant or Right [Line Items]                
Grant date fair value per warrant   8.38   11.46   9.52   13.20
Measurement Input, Risk Free Interest Rate [Member]                
Class of Warrant or Right [Line Items]                
Grant date fair value per warrant     2.72       2.61  
Measurement Input, Risk Free Interest Rate [Member] | Canadian Dollar [Member]                
Class of Warrant or Right [Line Items]                
Grant date fair value per warrant     2.72       2.61  
Measurement Input, Expected Term [Member]                
Class of Warrant or Right [Line Items]                
Expected life 3 years       3 years      
Measurement Input, Expected Term [Member] | Canadian Dollar [Member]                
Class of Warrant or Right [Line Items]                
Expected life 3 years       3 years      
Measurement Input, Option Volatility [Member]                
Class of Warrant or Right [Line Items]                
Grant date fair value per warrant     120.6       123.9  
Measurement Input, Option Volatility [Member] | Canadian Dollar [Member]                
Class of Warrant or Right [Line Items]                
Grant date fair value per warrant     120.6       123.9  
Measurement Input Grant Date Fair Value [Member]                
Class of Warrant or Right [Line Items]                
Grant date fair value per warrant   5.99   8.20   7.05   9.78

v3.25.3
SCHEDULE OF WARRANTS OUTSTANDING (Details) - Warrant [Member]
6 Months Ended 12 Months Ended
Sep. 30, 2025
$ / shares
shares
Sep. 30, 2025
$ / shares
shares
Mar. 31, 2025
$ / shares
shares
Mar. 31, 2025
$ / shares
shares
ScheduleOfWarrantsOutstandingLineItems [Line Items]        
Number of warrants outstanding, Balance beginning 2,095,224 2,095,224 878,061 878,061
Weighted average exercise price, Balance beginning | (per share) $ 29.81 [1] $ 41.50 $ 29.52 [1] $ 41.10
Number of warrants, issued 1,142,820 1,142,820 1,340,158 1,340,158
Weighted average exercise price, warrants issued | (per share) $ 9.29 [1] $ 12.93 $ 28.85 [1] $ 40.16
Number of warrants, Exercised     (122,993) (122,993)
Weighted average exercise price, warrants exercised | (per share)     $ 17.30 [1] $ 24.09
Number of warrants, Expired (368,303) (368,303) (2) (2)
Weighted average exercise price, warrants expired | $ / shares   $ 26.54   $ 21.60
Weighted average exercise price, warrants expired | $ / shares $ 19.06 [1]   $ 15.52 [1]  
Number of warrants outstanding, Balance ending 2,869,741 2,869,741 2,095,224 2,095,224
Weighted average exercise price, Balance ending | (per share) $ 23.02 [1] $ 32.04 $ 29.81 [1] $ 41.50
[1] Converted at balance sheet rate.

v3.25.3
SCHEDULE OF OUTSTANDING SHARE PURCHASE WARRANTS EXPIRE (Details)
6 Months Ended
Sep. 30, 2025
$ / shares
shares
Sep. 30, 2025
$ / shares
shares
Jul. 11, 2025
$ / shares
Jul. 11, 2025
$ / shares
Apr. 28, 2025
$ / shares
Apr. 28, 2025
$ / shares
Class of Warrant or Right [Line Items]            
Weighted Average Remaining Contractual Life in Years 2 years 25 days          
Exercise Price | (per share) $ 23.02 [1] $ 32.04 $ 8.409 $ 11.50 $ 8.80 $ 12.00
Number of warrants outstanding 2,869,741 2,869,741        
Warrants Expire One [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Apr. 15, 2026 Apr. 15, 2026        
Weighted Average Remaining Contractual Life in Years 6 months 14 days          
Exercise Price | (per share) $ 7.76 [1] $ 10.80        
Number of warrants outstanding 46,296 46,296        
Warrants Expire Two [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Apr. 17, 2026 Apr. 17, 2026        
Weighted Average Remaining Contractual Life in Years 6 months 18 days          
Exercise Price | (per share) $ 19.39 [1] $ 27.00        
Number of warrants outstanding 3,348 3,348        
Warrants Expire Three [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Apr. 29, 2026 Apr. 29, 2026        
Weighted Average Remaining Contractual Life in Years 6 months 29 days          
Exercise Price | (per share) $ 19.39 [1] $ 27.00        
Number of warrants outstanding 6,618 6,618        
Warrants Expire Four [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date [2] May 16, 2026 May 16, 2026        
Weighted Average Remaining Contractual Life in Years 7 months 13 days          
Exercise Price | (per share) $ 19.39 [1],[2] $ 27.00        
Number of warrants outstanding 1,702 1,702        
Warrants Expire Five [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Jul. 06, 2026 Jul. 06, 2026        
Weighted Average Remaining Contractual Life in Years 9 months 3 days          
Exercise Price | (per share) $ 39.76 [1] $ 55.35        
Number of warrants outstanding 29,227 29,227        
Warrants Expire Six [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Jul. 06, 2026 Jul. 06, 2026        
Weighted Average Remaining Contractual Life in Years 9 months 3 days          
Exercise Price | (per share) $ 49.45 [1] $ 68.85        
Number of warrants outstanding 294,694 294,694        
Warrants Expire Seven [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Aug. 15, 2026 Aug. 15, 2026        
Weighted Average Remaining Contractual Life in Years 10 months 13 days          
Exercise Price | (per share) $ 19.39 [1] $ 27.00        
Number of warrants outstanding 45,496 45,496        
Warrants Expire Eight [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Aug. 17, 2026 Aug. 17, 2026        
Weighted Average Remaining Contractual Life in Years 10 months 17 days          
Exercise Price | (per share) $ 29.09 [1] $ 40.50        
Number of warrants outstanding 126,853 126,853        
Warrants Expire Nine [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Aug. 30, 2026 Aug. 30, 2026        
Weighted Average Remaining Contractual Life in Years 11 months 1 day          
Exercise Price | (per share) $ 29.09 [1] $ 40.50        
Number of warrants outstanding 43,062 43,062        
Warrants Expire Ten [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Sep. 17, 2026 Sep. 17, 2026        
Weighted Average Remaining Contractual Life in Years 11 months 15 days          
Exercise Price | (per share) $ 29.09 [1] $ 40.50        
Number of warrants outstanding 12,494 12,494        
Warrants Expire Eleven [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Dec. 22, 2026 Dec. 22, 2026        
Weighted Average Remaining Contractual Life in Years 1 year 2 months 23 days          
Exercise Price | (per share) $ 23.27 [1] $ 32.40        
Number of warrants outstanding 809 809        
Warrants Expire Twelve [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Jan. 08, 2027 Jan. 08, 2027        
Weighted Average Remaining Contractual Life in Years 1 year 3 months 7 days          
Exercise Price | (per share) $ 29.09 [1] $ 40.50        
Number of warrants outstanding 28 28        
Warrants Expire Thirteen [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Jun. 20, 2027 Jun. 20, 2027        
Weighted Average Remaining Contractual Life in Years 1 year 8 months 19 days          
Exercise Price | (per share) $ 29.09 [1] $ 40.50        
Number of warrants outstanding 255,185 255,185        
Warrants Expire Fourteen [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Sep. 26, 2027 Sep. 26, 2027        
Weighted Average Remaining Contractual Life in Years 1 year 11 months 26 days          
Exercise Price | (per share) $ 15.52 [1] $ 21.60        
Number of warrants outstanding 10,562 10,562        
Warrants Expire Fifteen [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Sep. 26, 2027 Sep. 26, 2027        
Weighted Average Remaining Contractual Life in Years 1 year 11 months 26 days          
Exercise Price | (per share) $ 23.27 [1] $ 32.40        
Number of warrants outstanding 114,354 114,354        
Warrants Expire Sixteen [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Nov. 08, 2027 Nov. 08, 2027        
Weighted Average Remaining Contractual Life in Years 2 years 1 month 9 days          
Exercise Price | (per share) $ 9.70 [1] $ 13.50        
Number of warrants outstanding 14,444 14,444        
Warrants Expire Seventeen [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Nov. 08, 2027 Nov. 08, 2027        
Weighted Average Remaining Contractual Life in Years 2 years 1 month 9 days          
Exercise Price | (per share) $ 13.58 [1] $ 18.90        
Number of warrants outstanding 85,699 85,699        
Warrants Expire Eighteen [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Nov. 15, 2027 Nov. 15, 2027        
Weighted Average Remaining Contractual Life in Years 2 years 1 month 17 days          
Exercise Price | (per share) $ 9.70 [1] $ 13.50        
Number of warrants outstanding 2,229 2,229        
Warrants Expire Nineteen [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Nov. 15, 2027 Nov. 15, 2027        
Weighted Average Remaining Contractual Life in Years 2 years 1 month 17 days          
Exercise Price | (per share) $ 13.58 [1] $ 18.90        
Number of warrants outstanding 15,290 15,290        
Warrants Expire Twenty [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Dec. 09, 2027 Dec. 09, 2027        
Weighted Average Remaining Contractual Life in Years 2 years 2 months 8 days          
Exercise Price | (per share) $ 9.70 [1] $ 13.50        
Number of warrants outstanding 3,707 3,707        
Warrants Expire Twenty One [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Dec. 09, 2027 Dec. 09, 2027        
Weighted Average Remaining Contractual Life in Years 2 years 2 months 8 days          
Exercise Price | (per share) $ 13.58 [1] $ 18.90        
Number of warrants outstanding 28,519 28,519        
Warrants Expire Twenty Two [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Jan. 09, 2028 Jan. 09, 2028        
Weighted Average Remaining Contractual Life in Years 2 years 3 months 10 days          
Exercise Price | (per share) $ 38.01 [1] $ 52.92        
Number of warrants outstanding 235,906 235,906        
Warrants Expire Twenty Three [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Jan. 09, 2028 Jan. 09, 2028        
Weighted Average Remaining Contractual Life in Years 2 years 3 months 10 days          
Exercise Price | (per share) $ 30.45 [1] $ 42.39        
Number of warrants outstanding 26,420 26,420        
Warrants Expire Twenty Four [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Feb. 25, 2028 Feb. 25, 2028        
Weighted Average Remaining Contractual Life in Years 2 years 4 months 28 days          
Exercise Price | (per share) $ 38.01 [1] $ 52.92        
Number of warrants outstanding 257,312 257,312        
Warrants Expire Twenty Five [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Mar. 09, 2028 Mar. 09, 2028        
Weighted Average Remaining Contractual Life in Years 2 years 5 months 8 days          
Exercise Price | (per share) $ 13.58 [1] $ 18.90        
Number of warrants outstanding 66,667 66,667        
Warrants Expire Twenty Six [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Apr. 28, 2028 Apr. 28, 2028        
Weighted Average Remaining Contractual Life in Years 2 years 6 months 29 days          
Exercise Price | (per share) $ 10.77 [1] $ 15.00        
Number of warrants outstanding 458,333 458,333        
Warrants Expire Twenty Seven [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Apr. 28, 2028 Apr. 28, 2028        
Weighted Average Remaining Contractual Life in Years 2 years 6 months 29 days          
Exercise Price | (per share) $ 8.62 [1] $ 12.00        
Number of warrants outstanding 70,334 70,334        
Warrants Expire Twenty Eight [Member]            
Class of Warrant or Right [Line Items]            
Warrants expire date Jul. 11, 2028 Jul. 11, 2028        
Weighted Average Remaining Contractual Life in Years 2 years 9 months 10 days          
Exercise Price | (per share) $ 8.26 [1] $ 11.50        
Number of warrants outstanding 614,153 614,153        
[1] Converted at balance sheet rate.
[2] Warrants expiring July 6, 2026

v3.25.3
SCHEDULE OF OUTSTANDING SHARE PURCHASE WARRANTS EXPIRE (Details) (Parenthetical) - Forecast [Member]
Jul. 06, 2026
Pre-Consolidation Exercise Terms [Member]  
Class of Warrant or Right [Line Items]  
Warrants description Pre-Consolidation Exercise Terms: 1 Warrant + CAD$2.55 ($1.83 at balance sheet rate) = 1 Class A Subordinate Voting share
Post-Consolidation Exercise Terms [Member]  
Class of Warrant or Right [Line Items]  
Warrants description Post-Consolidation Exercise Terms: 27 Warrants + CAD$68.85 ($49.46 at balance sheet rate) = 1 New Class A Subordinate Voting share

v3.25.3
SCHEDULE OF PREPAID EXPENSES (Details) - USD ($)
Sep. 30, 2025
Mar. 31, 2025
Prepaid Expenses    
Deposit $ 34,929 $ 10,000
Retainer 269,311 251,983
Prepaid insurance 540,495 106,084
Subscriptions 371,040 267,997
Prepaid expenses $ 1,215,775 $ 636,064

v3.25.3
SCHEDULE OF EQUIPMENT (Details) - USD ($)
6 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Property, Plant and Equipment [Abstract]    
Cost, Equipment, Balance $ 580,751  
Cost, Equipment, Additions 40,489  
Cost, Equipment, Balance 621,240  
Accumulated depreciation, Equipment, Balance 455,338  
Accumulated depreciation, Equipment, Additions 45,894  
Accumulated depreciation, Equipment, Balance 501,232  
Net book value $ 120,008 $ 125,413

v3.25.3
SCHEDULE OF FAIR VALUE HIERARCHY (Details) - USD ($)
Sep. 30, 2025
Mar. 31, 2025
Mar. 31, 2024
Assets:      
Cash and restricted cash $ 1,209,908 $ 4,816,906  
Accounts receivable 296,700    
Due from related parties 69,657 68,080  
Liabilities:      
Accounts payable 1,508,247 2,036,916  
Accrued liabilities 132,665 41,736  
Provision for legal claim 9,402,338 8,948,085  
Restricted share unit liability 1,776,600 3,911,823  
Loans payable 139,722 139,039 $ 140,904
Related Party [Member]      
Assets:      
Due from related parties 69,657 68,080  
Fair Value, Inputs, Level 1 [Member]      
Assets:      
Cash and restricted cash 1,209,908 4,816,906  
Accounts receivable 296,700    
Liabilities:      
Accounts payable 1,508,247 2,036,916  
Accrued liabilities 132,665 41,736  
Provision for legal claim 9,402,338 8,948,085  
Restricted share unit liability  
Loans payable 139,722 139,039  
Fair Value, Inputs, Level 1 [Member] | Related Party [Member]      
Assets:      
Due from related parties 69,657 68,080  
Fair Value, Inputs, Level 2 [Member]      
Assets:      
Cash and restricted cash  
Accounts receivable    
Liabilities:      
Accounts payable  
Accrued liabilities  
Provision for legal claim  
Restricted share unit liability 1,776,600 3,911,823  
Loans payable  
Fair Value, Inputs, Level 2 [Member] | Related Party [Member]      
Assets:      
Due from related parties  
Fair Value, Inputs, Level 3 [Member]      
Assets:      
Cash and restricted cash  
Accounts receivable    
Liabilities:      
Accounts payable  
Accrued liabilities  
Provision for legal claim  
Restricted share unit liability  
Loans payable  
Fair Value, Inputs, Level 3 [Member] | Related Party [Member]      
Assets:      
Due from related parties  

v3.25.3
SCHEDULE OF CONTRACTUAL CASH FLOW REQUIREMENT (Details)
Sep. 30, 2025
USD ($)
Accounts Payable [Member]  
ScheduleOfContractualCashFlowRequirementLineItems [Line Items]  
Less than 1 year $ 1,508,247
1 to 2 years
2 to 5 years
After 5 years
Total 1,508,247
Accrued Liabilities [Member]  
ScheduleOfContractualCashFlowRequirementLineItems [Line Items]  
Less than 1 year 132,665
1 to 2 years
2 to 5 years
After 5 years
Total 132,665
Loans Payable [Member]  
ScheduleOfContractualCashFlowRequirementLineItems [Line Items]  
Less than 1 year 7,752
1 to 2 years 7,752
2 to 5 years 23,256
After 5 years 100,962
Total 139,722
Other Current Liabilities [Member]  
ScheduleOfContractualCashFlowRequirementLineItems [Line Items]  
Less than 1 year 1,648,664
1 to 2 years 7,752
2 to 5 years 23,256
After 5 years 100,962
Total $ 1,780,634

v3.25.3
SCHEDULE OF FOREIGN EXCHANGE RISK EXPOSURE OF FINANCIAL INSTRUMENTS (Details)
6 Months Ended
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
CAD ($)
Sep. 30, 2025
EUR (€)
Jul. 11, 2025
USD ($)
Jul. 11, 2025
CAD ($)
Apr. 28, 2025
USD ($)
Mar. 31, 2025
USD ($)
Trading Activity, Gains and Losses, Net [Line Items]                
Cash         $ 292,480 $ 400,000 $ 575,655  
Tax receivable $ 728,193             $ 604,912
Increase/decrease in prepaid expenses 579,711 $ 255,289            
Restricted share unit liability 1,776,600             $ 3,911,823
Fair Value Concentration of Risk All Financial Instrument [Member]                
Trading Activity, Gains and Losses, Net [Line Items]                
Tax receivable 7,535              
Accounts payable (24,011)              
Foreign currency future instrument 14,864              
Restricted cash 1,613              
Plus 10 Percentage Fluctuation [Member] | Fair Value Concentration of Risk All Financial Instrument [Member]                
Trading Activity, Gains and Losses, Net [Line Items]                
Increase/decrease in tax receivable 753              
Increase/decrease in accounts payable 2,401              
Increase/decrease in foreign currency future instrument 1,486              
Increase/decrease in restricted cash 161              
Minus 10 Percentage Fluctuation [Member] | Fair Value Concentration of Risk All Financial Instrument [Member]                
Trading Activity, Gains and Losses, Net [Line Items]                
Increase/decrease in tax receivable (753)              
Increase/decrease in accounts payable (2,401)              
Increase/decrease in foreign currency future instrument (1,486)              
Increase/decrease in restricted cash (161)              
Foreign Exchange [Member]                
Trading Activity, Gains and Losses, Net [Line Items]                
Cash 709,503   $ 987,753          
Tax receivable 720,659   1,003,283          
Prepaid expenses 842,375   1,172,734          
Accounts payable (556,304)   (774,473)          
Accrued liabilities (35,915)   (50,000)          
Restricted share unit liability (1,776,600)   (2,473,384)          
Foreign currency future instrument 96,283   $ 134,087          
Foreign Exchange [Member] | Plus 10 Percentage Fluctuation [Member]                
Trading Activity, Gains and Losses, Net [Line Items]                
Increase/decrease in cash 70,950              
Increase/decrease in tax receivable 72,066              
Increase/decrease in prepaid expenses 84,237              
Increase/decrease in accounts payable 55,630              
Increase/decrease in accrued liabilities 3,592              
Increase/decrease in restricted share unit liability 177,660              
Increase/decrease in foreign currency future instrument 9,629              
Foreign Exchange [Member] | Minus 10 Percentage Fluctuation [Member]                
Trading Activity, Gains and Losses, Net [Line Items]                
Increase/decrease in cash (70,950)              
Increase/decrease in tax receivable (72,066)              
Increase/decrease in prepaid expenses (84,237)              
Increase/decrease in accounts payable (55,630)              
Increase/decrease in accrued liabilities (3,592)              
Increase/decrease in restricted share unit liability (177,660)              
Increase/decrease in foreign currency future instrument $ (9,629)              
Fair Value Concentration of Risk All Financial Instrument [Member]                
Trading Activity, Gains and Losses, Net [Line Items]                
Tax receivable | €       € 6,423        
Accounts payable | €       (20,468)        
Foreign currency future instrument | €       12,670        
Restricted cash | €       € 1,375        

v3.25.3
FINANCIAL INSTRUMENTS (Details Narrative)
6 Months Ended 12 Months Ended
Sep. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Sep. 30, 2025
CAD ($)
Mar. 31, 2025
CAD ($)
Jun. 05, 2020
Defined Benefit Plan Disclosure [Line Items]          
Due from related parties $ 69,657 $ 68,080      
Interest rate 5.00%   5.00%   3.75%
Working capital deficit $ 9,205,281 8,923,210      
Financial liabilities 96,283 223,534 $ 14,864 $ 104,416  
Related Party [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Due from related parties 69,657 68,080      
Related Party [Member] | Unsecured Loan [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Due from related parties $ 69,657 $ 68,080      

v3.25.3
SCHEDULE OF SUPPLEMENTAL CASH PAID AND RECEIVED BY THE COMPANY (Details) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Supplemental Cash Flow Elements [Abstract]        
Cash paid for interest $ 1,313 $ 5,524 $ 2,621 $ 6,843
Cash received for interest $ 37,609 $ 35,147 $ 85,053 $ 49,970

v3.25.3
SCHEDULE OF OTHER INCOME (Details) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Other Income and Expenses [Abstract]        
Accretion expense $ (411,813) $ (453,839)
Grant Income 17,720 56,034 81,909 56,034
Interest earned 37,609 35,147 85,053 49,970
Gain on derivative liability 2,464,873 2,464,873
Interest expense (7,278) (221,720) (12,254) (293,038)
Legal claim expense (359,164) (582,253)
Provision for losses on related party transactions (235,413) (396,524)
R&D tax credits 65,679 416,208
Other income $ (245,434) $ 1,687,108 $ (11,337) $ 1,427,476

v3.25.3
PROVISION FOR LEGAL CLAIM (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
May 17, 2024
Jul. 13, 2022
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Mar. 31, 2025
ProvisionForLegalClaimLineItems [Line Items]              
Damage value   $ 5,000,000          
Litigation interest         $ 454,253   $ 817,787
Plaintiff total     $ (359,164) (582,253)  
Proceeds from insurance         $ 1,252,076  
Initial good faith payments           $ 1,791,000
Cyberlab [Member]              
ProvisionForLegalClaimLineItems [Line Items]              
Litigation interest $ 6,307,258            
Cyberlab VTU [Member]              
ProvisionForLegalClaimLineItems [Line Items]              
Damage value 1,900,000            
Litigation interest 709,973            
Damage cost 64,303            
Plaintiff total 920,231            
Initial good faith payments 1,791,000            
Cyberlab VTU [Member] | Gabriel Rene and Daniel Mapes [Member]              
ProvisionForLegalClaimLineItems [Line Items]              
Proceeds from insurance $ 1,666,000            

v3.25.3
SCHEDULE OF SETTLEMENT DISCUSSIONS ARE ONGOING (Details) - USD ($)
6 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Commitments and Contingencies Disclosure [Abstract]    
Provision for legal claim $ 8,948,085 $ 9,921,298
Payments in the year (1,791,000)
Interest 454,253 817,787
Provision for legal claim $ 9,402,338 $ 8,948,085

v3.25.3
SUBSEQUENT EVENTS (Details Narrative)
3 Months Ended 6 Months Ended 12 Months Ended
Nov. 10, 2025
USD ($)
shares
Nov. 10, 2025
$ / shares
Oct. 20, 2025
USD ($)
Oct. 01, 2025
USD ($)
$ / shares
shares
Oct. 01, 2025
$ / shares
shares
Apr. 28, 2025
USD ($)
Sep. 30, 2025
shares
Sep. 30, 2024
shares
Jun. 30, 2024
shares
Sep. 30, 2025
$ / shares
shares
Sep. 30, 2025
$ / shares
shares
Mar. 31, 2025
$ / shares
shares
Mar. 31, 2025
$ / shares
shares
Mar. 31, 2024
shares
Subsequent Event [Line Items]                            
Stock option, excercise                   250,000 250,000 51,235 51,235  
Exercise price, per share | (per share)                   $ 6.22 [1] $ 8.66 $ 16.68 [1] $ 23.22  
Stock options outstanding             1,179,634     1,179,634 1,179,634 770,884 770,884 542,334
Stock options cancelled                       84,314 84,314  
Number of stock options, Granted             2,126,942 1,833,057 103,455 670,060 670,060 364,099 364,099  
Legal fees | $           $ 242,418                
Restricted Stock Units (RSUs) [Member]                            
Subsequent Event [Line Items]                            
Number of stock options, Granted             8,616 805,605 26,668          
Subsequent Event [Member]                            
Subsequent Event [Line Items]                            
Options expiration period       5 years                    
Stock options cancelled       90,313                    
Number of stock options, Granted       90,313                    
Subsequent Event [Member] | Class A Common Shares [Member]                            
Subsequent Event [Line Items]                            
Exercise price, per share | (per share)       $ 5.42 $ 7.55                  
Stock options outstanding       849,263 849,263                  
Subsequent Event [Member] | Restricted Stock Units (RSUs) [Member]                            
Subsequent Event [Line Items]                            
Restricted stock cancelled | $       $ 46,296                    
Restricted stock granted       46,296                    
Subsequent Event [Member] | Consultant P [Member]                            
Subsequent Event [Line Items]                            
Stock option, excercise       105,000                    
Exercise price, per share | (per share)       $ 5.42 $ 7.55                  
Options expiration period       5 years                    
Stock option splits       20,000                    
Subsequent Event [Member] | Consultant P [Member] | Restricted Stock Units (RSUs) [Member]                            
Subsequent Event [Line Items]                            
Stock option, excercise       20,000                    
Subsequent Event [Member] | Consultant E [Member]                            
Subsequent Event [Line Items]                            
Stock option splits       37,500                    
Subsequent Event [Member] | Consultant F [Member]                            
Subsequent Event [Line Items]                            
Stock option splits       37,500                    
Subsequent Event [Member] | Consultant I [Member]                            
Subsequent Event [Line Items]                            
Stock option splits       10,000                    
Subsequent Event [Member] | XYZ Global Technologies Inc [Member]                            
Subsequent Event [Line Items]                            
Long term loan | $     $ 35,000                      
Legal fees | $     $ 1,856,000                      
Subsequent Event [Member] | Sorbie Bornholm LP [Member]                            
Subsequent Event [Line Items]                            
Exercise price, per share | $ / shares   $ 7.00                        
Notional value | $ $ 14,000,000                          
Exchange of notional value, shares 2,660,000                          
Percentage of brokerage fees 8.00%                          
Subsequent Event [Member] | Sorbie Bornholm LP [Member] | Share-Based Payment Arrangement, Tranche One [Member]                            
Subsequent Event [Line Items]                            
Sale of stock | $ $ 700,000                          
Subsequent Event [Member] | Sorbie Bornholm LP [Member] | Share Based Compensation Award Tranche [Member]                            
Subsequent Event [Line Items]                            
Exercise price, per share | $ / shares   $ 7.75                        
Sale of stock | $ $ 1,209,091                          
[1] Converted at balance sheet rate.

{
 "version": "2.2",
 "instance": {
  "form10-q.htm": {
   "nsprefix": "VRSSF",
   "nsuri": "http://verses.ai/20250930",
   "dts": {
    "inline": {
     "local": [
      "form10-q.htm"
     ]
    },
    "schema": {
     "local": [
      "vrssf-20250930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "vrssf-20250930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "vrssf-20250930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "vrssf-20250930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vrssf-20250930_pre.xml"
     ]
    }
   },
   "keyStandard": 262,
   "keyCustom": 73,
   "axisStandard": 22,
   "axisCustom": 0,
   "memberStandard": 29,
   "memberCustom": 125,
   "hidden": {
    "total": 319,
    "http://fasb.org/us-gaap/2025": 246,
    "http://verses.ai/20250930": 68,
    "http://xbrl.sec.gov/dei/2025": 5
   },
   "contextCount": 480,
   "entityCount": 1,
   "segmentCount": 162,
   "elementCount": 714,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 1315,
    "http://xbrl.sec.gov/dei/2025": 28,
    "http://xbrl.sec.gov/ecd/2025": 4
   },
   "report": {
    "R1": {
     "role": "http://verses.ai/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://verses.ai/role/InterimBalanceSheet",
     "longName": "00000002 - Statement - Condensed Consolidated Interim Balance Sheet",
     "shortName": "Condensed Consolidated Interim Balance Sheet",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://verses.ai/role/InterimBalanceSheetParenthetical",
     "longName": "00000003 - Statement - Condensed Consolidated Interim Balance Sheet (Parenthetical)",
     "shortName": "Condensed Consolidated Interim Balance Sheet (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-30_custom_ClassASubordinateVotingStockMember",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-30_custom_ClassASubordinateVotingStockMember",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://verses.ai/role/InterimStatementsOfOperations",
     "longName": "00000004 - Statement - Condensed Consolidated Interim Statements of Operations (Unaudited)",
     "shortName": "Condensed Consolidated Interim Statements of Operations (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "us-gaap:GrossProfit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://verses.ai/role/InterimStatementsOfComprehensiveLoss",
     "longName": "00000005 - Statement - Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)",
     "shortName": "Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "us-gaap:ComprehensiveIncomeNetOfTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency",
     "longName": "00000006 - Statement - Condensed Consolidated Interim Statements of Shareholders' Deficiency (Unaudited)",
     "shortName": "Condensed Consolidated Interim Statements of Shareholders' Deficiency (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "VRSSF:StockIssuedDuringPeriodValueExerciseOfOptionsAndWarrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://verses.ai/role/InterimStatementsOfCashFlows",
     "longName": "00000007 - Statement - Condensed Consolidated Interim Statements of Cash Flows (Unaudited)",
     "shortName": "Condensed Consolidated Interim Statements of Cash Flows (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R9": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://verses.ai/role/NatureOfBusinessAndGoingConcern",
     "longName": "999013 - Disclosure - NATURE OF BUSINESS AND GOING CONCERN",
     "shortName": "NATURE OF BUSINESS AND GOING CONCERN",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://verses.ai/role/SummaryOfSignificantAccountingPolicies",
     "longName": "999014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://verses.ai/role/DeferredGrant",
     "longName": "999015 - Disclosure - DEFERRED GRANT",
     "shortName": "DEFERRED GRANT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:DeferredGrantDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:DeferredGrantDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://verses.ai/role/Revenue",
     "longName": "999016 - Disclosure - REVENUE",
     "shortName": "REVENUE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://verses.ai/role/CostOfRevenue",
     "longName": "999017 - Disclosure - COST OF REVENUE",
     "shortName": "COST OF REVENUE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:CostOfRevenueDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:CostOfRevenueDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://verses.ai/role/LoansPayable",
     "longName": "999018 - Disclosure - LOANS PAYABLE",
     "shortName": "LOANS PAYABLE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://verses.ai/role/ShareBasedPayments",
     "longName": "999019 - Disclosure - SHARE BASED PAYMENTS",
     "shortName": "SHARE BASED PAYMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://verses.ai/role/RelatedPartyTransactionsAndBalances",
     "longName": "999020 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES",
     "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://verses.ai/role/Commitments",
     "longName": "999021 - Disclosure - COMMITMENTS",
     "shortName": "COMMITMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://verses.ai/role/ShareCapital",
     "longName": "999022 - Disclosure - SHARE CAPITAL",
     "shortName": "SHARE CAPITAL",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://verses.ai/role/Warrants",
     "longName": "999023 - Disclosure - WARRANTS",
     "shortName": "WARRANTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://verses.ai/role/PrepaidExpenses",
     "longName": "999024 - Disclosure - PREPAID EXPENSES",
     "shortName": "PREPAID EXPENSES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:PrepaidExpensesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:PrepaidExpensesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://verses.ai/role/Equipment",
     "longName": "999025 - Disclosure - EQUIPMENT",
     "shortName": "EQUIPMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://verses.ai/role/FinancialInstruments",
     "longName": "999026 - Disclosure - FINANCIAL INSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://verses.ai/role/ManagementOfCapital",
     "longName": "999027 - Disclosure - MANAGEMENT OF CAPITAL",
     "shortName": "MANAGEMENT OF CAPITAL",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:ManagementOfCapitalTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:ManagementOfCapitalTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://verses.ai/role/SupplementalCashFlowInformation",
     "longName": "999028 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://verses.ai/role/SegmentReporting",
     "longName": "999029 - Disclosure - SEGMENT REPORTING",
     "shortName": "SEGMENT REPORTING",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://verses.ai/role/OtherIncome",
     "longName": "999030 - Disclosure - OTHER INCOME",
     "shortName": "OTHER INCOME",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:InterestAndOtherIncomeTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:InterestAndOtherIncomeTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://verses.ai/role/ProvisionForLegalClaim",
     "longName": "999031 - Disclosure - PROVISION FOR LEGAL CLAIM",
     "shortName": "PROVISION FOR LEGAL CLAIM",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://verses.ai/role/SubsequentEvents",
     "longName": "999032 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://verses.ai/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "999033 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://verses.ai/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "999034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:ScheduleOfSubsidiariesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ConsolidationPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:ScheduleOfSubsidiariesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ConsolidationPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://verses.ai/role/DeferredGrantTables",
     "longName": "999035 - Disclosure - DEFERRED GRANT (Tables)",
     "shortName": "DEFERRED GRANT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:DeferredGrantTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "VRSSF:DeferredGrantDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:DeferredGrantTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "VRSSF:DeferredGrantDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://verses.ai/role/RevenueTables",
     "longName": "999036 - Disclosure - REVENUE (Tables)",
     "shortName": "REVENUE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://verses.ai/role/CostOfRevenueTables",
     "longName": "999037 - Disclosure - COST OF REVENUE (Tables)",
     "shortName": "COST OF REVENUE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:ScheduleOfCostOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "VRSSF:CostOfRevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:ScheduleOfCostOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "VRSSF:CostOfRevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://verses.ai/role/LoansPayableTables",
     "longName": "999038 - Disclosure - LOANS PAYABLE (Tables)",
     "shortName": "LOANS PAYABLE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://verses.ai/role/ShareBasedPaymentsTables",
     "longName": "999039 - Disclosure - SHARE BASED PAYMENTS (Tables)",
     "shortName": "SHARE BASED PAYMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://verses.ai/role/RelatedPartyTransactionsAndBalancesTables",
     "longName": "999040 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Tables)",
     "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://verses.ai/role/WarrantsTables",
     "longName": "999041 - Disclosure - WARRANTS (Tables)",
     "shortName": "WARRANTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "VRSSF:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "VRSSF:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://verses.ai/role/PrepaidExpensesTables",
     "longName": "999042 - Disclosure - PREPAID EXPENSES (Tables)",
     "shortName": "PREPAID EXPENSES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:ScheduleOfPrepaidExpensesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "VRSSF:PrepaidExpensesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:ScheduleOfPrepaidExpensesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "VRSSF:PrepaidExpensesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://verses.ai/role/EquipmentTables",
     "longName": "999043 - Disclosure - EQUIPMENT (Tables)",
     "shortName": "EQUIPMENT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://verses.ai/role/FinancialInstrumentsTables",
     "longName": "999044 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://verses.ai/role/SupplementalCashFlowInformationTables",
     "longName": "999045 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables)",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://verses.ai/role/OtherIncomeTables",
     "longName": "999046 - Disclosure - OTHER INCOME (Tables)",
     "shortName": "OTHER INCOME (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:InterestAndOtherIncomeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InterestAndOtherIncomeTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:InterestAndOtherIncomeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InterestAndOtherIncomeTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://verses.ai/role/ProvisionForLegalClaimTables",
     "longName": "999047 - Disclosure - PROVISION FOR LEGAL CLAIM (Tables)",
     "shortName": "PROVISION FOR LEGAL CLAIM (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:ScheduleOfSettlementDiscussionsAreOngoingTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LegalMattersAndContingenciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:ScheduleOfSettlementDiscussionsAreOngoingTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LegalMattersAndContingenciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://verses.ai/role/NatureOfBusinessAndGoingConcernDetailsNarrative",
     "longName": "999048 - Disclosure - NATURE OF BUSINESS AND GOING CONCERN (Details Narrative)",
     "shortName": "NATURE OF BUSINESS AND GOING CONCERN (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R46": {
     "role": "http://verses.ai/role/ScheduleOfSubsidiariesDetails",
     "longName": "999049 - Disclosure - SCHEDULE OF SUBSIDIARIES (Details)",
     "shortName": "SCHEDULE OF SUBSIDIARIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2025-04-012025-09-30_custom_VersesTechnologiesUSAIncMember",
      "name": "VRSSF:PlaceOfIncorporation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "VRSSF:ScheduleOfSubsidiariesTableTextBlock",
       "us-gaap:ConsolidationPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-012025-09-30_custom_VersesTechnologiesUSAIncMember",
      "name": "VRSSF:PlaceOfIncorporation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "VRSSF:ScheduleOfSubsidiariesTableTextBlock",
       "us-gaap:ConsolidationPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://verses.ai/role/ScheduleOfDeferredGrantDetails",
     "longName": "999050 - Disclosure - SCHEDULE OF DEFERRED GRANT (Details)",
     "shortName": "SCHEDULE OF DEFERRED GRANT (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:DeferredGrantTableTextBlock",
       "VRSSF:DeferredGrantDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:GrantExpensesOnProject",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:DeferredGrantTableTextBlock",
       "VRSSF:DeferredGrantDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://verses.ai/role/DeferredGrantDetailsNarrative",
     "longName": "999051 - Disclosure - DEFERRED GRANT (Details Narrative)",
     "shortName": "DEFERRED GRANT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "From2024-04-012025-03-31",
      "name": "VRSSF:ProceedsFromGrantReceived",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:DeferredGrantTableTextBlock",
       "VRSSF:DeferredGrantDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-242024-07-24_custom_GrantAgreementMember",
      "name": "VRSSF:ProceedsFromGrantReceived",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "VRSSF:DeferredGrantDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://verses.ai/role/ScheduleOfRevenueFromContactWithCustomersDetails",
     "longName": "999052 - Disclosure - SCHEDULE OF REVENUE FROM CONTACT WITH CUSTOMERS (Details)",
     "shortName": "SCHEDULE OF REVENUE FROM CONTACT WITH CUSTOMERS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30_us-gaap_TransferredAtPointInTimeMember",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://verses.ai/role/RevenueDetailsNarrative",
     "longName": "999053 - Disclosure - REVENUE (Details Narrative)",
     "shortName": "REVENUE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "VRSSF:ProvisionForContractSettlement",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "VRSSF:ProvisionForContractSettlement",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://verses.ai/role/ScheduleOfCostOfRevenueDetails",
     "longName": "999054 - Disclosure - SCHEDULE OF COST OF REVENUE (Details)",
     "shortName": "SCHEDULE OF COST OF REVENUE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:CostDirectMaterial",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:ScheduleOfCostOfRevenueTableTextBlock",
       "VRSSF:CostOfRevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:CostDirectMaterial",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:ScheduleOfCostOfRevenueTableTextBlock",
       "VRSSF:CostOfRevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://verses.ai/role/ScheduleOfLoansPayableDetails",
     "longName": "999055 - Disclosure - SCHEDULE OF LOANS PAYABLE (Details)",
     "shortName": "SCHEDULE OF LOANS PAYABLE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:LongTermLoansPayable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:RepaymentsOfLongTermDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://verses.ai/role/LoansPayableDetailsNarrative",
     "longName": "999056 - Disclosure - LOANS PAYABLE (Details Narrative)",
     "shortName": "LOANS PAYABLE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "From2020-06-052020-06-05",
      "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2020-06-052020-06-05",
      "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails",
     "longName": "999057 - Disclosure - SCHEDULE OF OPTIONS TO PURCHASE SUBORDINATE VOTING SHARES (Details)",
     "shortName": "SCHEDULE OF OPTIONS TO PURCHASE SUBORDINATE VOTING SHARES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://verses.ai/role/SummaryOfOptionsDetails",
     "longName": "999058 - Disclosure - SUMMARY OF OPTIONS (Details)",
     "shortName": "SUMMARY OF OPTIONS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-012025-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
      "unitRef": "CADShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
     "longName": "999059 - Disclosure - SCHEDULE OF THE BLACK-SCHOLES OPTION PRICING MODEL WITH THE FOLLOWING WEIGHTED AVERAGE ASSUMPTIONS (Details)",
     "shortName": "SCHEDULE OF THE BLACK-SCHOLES OPTION PRICING MODEL WITH THE FOLLOWING WEIGHTED AVERAGE ASSUMPTIONS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "AsOf2025-07-11",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R57": {
     "role": "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
     "longName": "999060 - Disclosure - SCHEDULE OF CONSOLIDATES THE POSITION OF OPTIONS GRANTED RELATED TO STRATEGIC CONSULTANTS (Details)",
     "shortName": "SCHEDULE OF CONSOLIDATES THE POSITION OF OPTIONS GRANTED RELATED TO STRATEGIC CONSULTANTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "AsOf2024-03-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-012025-09-30_custom_ConsultantAMember",
      "name": "VRSSF:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalGrossAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
     "longName": "999061 - Disclosure - SCHEDULE OF POSITION OF THE RSUS GRANTED RELATED TO STRATEGIC CONSULTANTS (Details)",
     "shortName": "SCHEDULE OF POSITION OF THE RSUS GRANTED RELATED TO STRATEGIC CONSULTANTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31_us-gaap_RestrictedStockUnitsRSUMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-012025-09-30_custom_ConsultantAMember_us-gaap_RestrictedStockUnitsRSUMember",
      "name": "VRSSF:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodTotalGrossAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://verses.ai/role/ScheduleOfRestrictedSharesDetails",
     "longName": "999062 - Disclosure - SCHEDULE OF RESTRICTED SHARES (Details)",
     "shortName": "SCHEDULE OF RESTRICTED SHARES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31_us-gaap_RestrictedStockUnitsRSUMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-04-012025-03-31_us-gaap_RestrictedStockUnitsRSUMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails",
     "longName": "999063 - Disclosure - SCHEDULE OF RECONCILIATION SHARE BASED PAYMENTS (Details)",
     "shortName": "SCHEDULE OF RECONCILIATION SHARE BASED PAYMENTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "From2024-04-012024-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-012025-06-30",
      "name": "VRSSF:StockIssuedDuringPeriodSharesStockOptionsRevaluationRSUs",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative",
     "longName": "999064 - Disclosure - SHARE BASED PAYMENTS (Details Narrative)",
     "shortName": "SHARE BASED PAYMENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://verses.ai/role/ScheduleOfRelatedPartyTransactionsDetails",
     "longName": "999065 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)",
     "shortName": "SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "VRSSF:ManagementFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "VRSSF:ManagementFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
     "longName": "999066 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)",
     "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "us-gaap:UnsecuredDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:UnsecuredDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://verses.ai/role/CommitmentsDetailsNarrative",
     "longName": "999067 - Disclosure - COMMITMENTS (Details Narrative)",
     "shortName": "COMMITMENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "From2025-04-012025-09-30_custom_YearsOneThroughTenMember",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-012025-09-30_custom_YearsOneThroughTenMember",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://verses.ai/role/ShareCapitalDetailsNarrative",
     "longName": "999068 - Disclosure - SHARE CAPITAL (Details Narrative)",
     "shortName": "SHARE CAPITAL (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "From2021-07-202021-07-20",
      "name": "us-gaap:CommonStockVotingRights",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2021-07-202021-07-20",
      "name": "us-gaap:CommonStockVotingRights",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://verses.ai/role/WarrantsDetailsNarrative",
     "longName": "999069 - Disclosure - WARRANTS (Details Narrative)",
     "shortName": "WARRANTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "AsOf2025-07-11",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-07-112025-07-11",
      "name": "VRSSF:FairValueAdjustmentOfWarrantsCompensationWarrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "VRSSF:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails",
     "longName": "999070 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details)",
     "shortName": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "AsOf2025-07-11_custom_CompensationWarrantsMember_us-gaap_MeasurementInputSharePriceMember",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "VRSSF:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-07-11_custom_CompensationWarrantsMember_us-gaap_MeasurementInputSharePriceMember",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "VRSSF:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails",
     "longName": "999071 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details)",
     "shortName": "SCHEDULE OF WARRANTS OUTSTANDING (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31_us-gaap_WarrantMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "VRSSF:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-31_us-gaap_WarrantMember",
      "name": "VRSSF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageGrantDateFairValue",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "VRSSF:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails",
     "longName": "999072 - Disclosure - SCHEDULE OF OUTSTANDING SHARE PURCHASE WARRANTS EXPIRE (Details)",
     "shortName": "SCHEDULE OF OUTSTANDING SHARE PURCHASE WARRANTS EXPIRE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:ScheduleOfWarrantsOutstandingSharePurchaseWarrantsExpireTableTextBlock",
       "VRSSF:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:ScheduleOfWarrantsOutstandingSharePurchaseWarrantsExpireTableTextBlock",
       "VRSSF:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetailsParenthetical",
     "longName": "999073 - Disclosure - SCHEDULE OF OUTSTANDING SHARE PURCHASE WARRANTS EXPIRE (Details) (Parenthetical)",
     "shortName": "SCHEDULE OF OUTSTANDING SHARE PURCHASE WARRANTS EXPIRE (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "From2026-07-062026-07-06_custom_PreConsolidationExerciseTermsMember_srt_ScenarioForecastMember",
      "name": "us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "VRSSF:ScheduleOfWarrantsOutstandingSharePurchaseWarrantsExpireTableTextBlock",
       "VRSSF:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2026-07-062026-07-06_custom_PreConsolidationExerciseTermsMember_srt_ScenarioForecastMember",
      "name": "us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "VRSSF:ScheduleOfWarrantsOutstandingSharePurchaseWarrantsExpireTableTextBlock",
       "VRSSF:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://verses.ai/role/ScheduleOfPrepaidExpensesDetails",
     "longName": "999074 - Disclosure - SCHEDULE OF PREPAID EXPENSES (Details)",
     "shortName": "SCHEDULE OF PREPAID EXPENSES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "VRSSF:PrepaidDeposit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:ScheduleOfPrepaidExpensesTextBlock",
       "VRSSF:PrepaidExpensesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "VRSSF:PrepaidDeposit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:ScheduleOfPrepaidExpensesTextBlock",
       "VRSSF:PrepaidExpensesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://verses.ai/role/ScheduleOfEquipmentDetails",
     "longName": "999075 - Disclosure - SCHEDULE OF EQUIPMENT (Details)",
     "shortName": "SCHEDULE OF EQUIPMENT (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails",
     "longName": "999076 - Disclosure - SCHEDULE OF FAIR VALUE HIERARCHY (Details)",
     "shortName": "SCHEDULE OF FAIR VALUE HIERARCHY (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "us-gaap:OtherRestrictedAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails",
     "longName": "999077 - Disclosure - SCHEDULE OF CONTRACTUAL CASH FLOW REQUIREMENT (Details)",
     "shortName": "SCHEDULE OF CONTRACTUAL CASH FLOW REQUIREMENT (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-30_us-gaap_AccountsPayableMember",
      "name": "VRSSF:ContractualObligationToBePaidLessThanOneYear",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:ScheduleOfContractualCashFlowRequirementsTableTextBlock",
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-30_us-gaap_AccountsPayableMember",
      "name": "VRSSF:ContractualObligationToBePaidLessThanOneYear",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:ScheduleOfContractualCashFlowRequirementsTableTextBlock",
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails",
     "longName": "999078 - Disclosure - SCHEDULE OF FOREIGN EXCHANGE RISK EXPOSURE OF FINANCIAL INSTRUMENTS (Details)",
     "shortName": "SCHEDULE OF FOREIGN EXCHANGE RISK EXPOSURE OF FINANCIAL INSTRUMENTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "AsOf2025-07-11",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-30_custom_FairValueConcentrationOfRiskAllFinancialInstrumentMember34073375",
      "name": "us-gaap:IncomeTaxReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://verses.ai/role/FinancialInstrumentsDetailsNarrative",
     "longName": "999079 - Disclosure - FINANCIAL INSTRUMENTS (Details Narrative)",
     "shortName": "FINANCIAL INSTRUMENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-30",
      "name": "us-gaap:OtherReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "VRSSF:WorkingCapitalDeficit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://verses.ai/role/ScheduleOfSupplementalCashPaidAndReceivedByCompanyDetails",
     "longName": "999080 - Disclosure - SCHEDULE OF SUPPLEMENTAL CASH PAID AND RECEIVED BY THE COMPANY (Details)",
     "shortName": "SCHEDULE OF SUPPLEMENTAL CASH PAID AND RECEIVED BY THE COMPANY (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://verses.ai/role/ScheduleOfOtherIncomeDetails",
     "longName": "999081 - Disclosure - SCHEDULE OF OTHER INCOME (Details)",
     "shortName": "SCHEDULE OF OTHER INCOME (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:AccretionExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InterestAndOtherIncomeTableTextBlock",
       "us-gaap:InterestAndOtherIncomeTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-07-012025-09-30",
      "name": "us-gaap:InterestCostsIncurred",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InterestAndOtherIncomeTableTextBlock",
       "us-gaap:InterestAndOtherIncomeTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative",
     "longName": "999082 - Disclosure - PROVISION FOR LEGAL CLAIM (Details Narrative)",
     "shortName": "PROVISION FOR LEGAL CLAIM (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "From2022-07-132022-07-13",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LegalMattersAndContingenciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-132022-07-13",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LegalMattersAndContingenciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://verses.ai/role/ScheduleOfSettlementDiscussionsAreOngoingDetails",
     "longName": "999083 - Disclosure - SCHEDULE OF SETTLEMENT DISCUSSIONS ARE ONGOING (Details)",
     "shortName": "SCHEDULE OF SETTLEMENT DISCUSSIONS ARE ONGOING (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:ScheduleOfSettlementDiscussionsAreOngoingTableTextBlock",
       "us-gaap:LegalMattersAndContingenciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-31",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "VRSSF:ScheduleOfSettlementDiscussionsAreOngoingTableTextBlock",
       "us-gaap:LegalMattersAndContingenciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://verses.ai/role/SubsequentEventsDetailsNarrative",
     "longName": "999084 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "From2025-04-01to2025-09-30",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-10-012025-10-01_us-gaap_SubsequentEventMember",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-q.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/DeferredGrantDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding expense in accounts payable and accrued liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r97"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r680"
     ]
    },
    "us-gaap_AccountsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts payable",
        "label": "Accounts Payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r913"
     ]
    },
    "us-gaap_AccountsPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable [Member]",
        "documentation": "Obligations incurred and payable to vendors for goods and services received."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "us-gaap_AccretionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccretionExpense",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows",
      "http://verses.ai/role/ScheduleOfOtherIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion expense",
        "negatedLabel": "Accretion expense",
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations."
       }
      }
     },
     "auth_ref": [
      "r640",
      "r836"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued liabilities",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accrued liabilities",
        "label": "Accrued Liabilities",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Member]",
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Accumulated depreciation, Equipment, Balance",
        "periodEndLabel": "Accumulated depreciation, Equipment, Balance",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r127",
      "r495"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive loss",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r59",
      "r133",
      "r491",
      "r508",
      "r509",
      "r881"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r9",
      "r17",
      "r420",
      "r423",
      "r460",
      "r504",
      "r505",
      "r799",
      "r800",
      "r801",
      "r818",
      "r819",
      "r820",
      "r821"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r742"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r680",
      "r921"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r520",
      "r818",
      "r819",
      "r820",
      "r821",
      "r882",
      "r926"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net losses to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options granted",
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC)."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r713",
      "r724",
      "r734",
      "r760"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r716",
      "r727",
      "r737",
      "r763"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r749"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r756"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r717",
      "r728",
      "r738",
      "r756",
      "r764",
      "r768",
      "r776"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "VRSSF_AprilFifteenTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "AprilFifteenTwoThousandTwentyFourMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "April 15, 2024 [Member]",
        "documentation": "April 15, 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_AprilFifteenTwoThousandTwentyNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "AprilFifteenTwoThousandTwentyNineMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "April 15, 2029 [Member]",
        "documentation": "April 15, 2029 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_AprilTwentyEightTwoThousandTwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "AprilTwentyEightTwoThousandTwentyEightMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "April 28, 2028 [Member]",
        "documentation": "April 28, 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_AprilTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "AprilTwoThousandTwentyFourMember",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "April 2024 [Member]",
        "documentation": "April 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://verses.ai/role/DeferredGrantDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r394"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r106",
      "r128",
      "r155",
      "r158",
      "r159",
      "r190",
      "r203",
      "r211",
      "r214",
      "r222",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r395",
      "r397",
      "r445",
      "r481",
      "r482",
      "r486",
      "r558",
      "r632",
      "r633",
      "r646",
      "r680",
      "r682",
      "r683",
      "r694",
      "r840",
      "r841",
      "r901"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS",
        "verboseLabel": "Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r135",
      "r155",
      "r158",
      "r159",
      "r222",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r395",
      "r397",
      "r445",
      "r680",
      "r840",
      "r841",
      "r901"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "us-gaap_AwardDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardDateAxis",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails",
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Date [Axis]",
        "documentation": "Information by date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873"
     ]
    },
    "us-gaap_AwardDateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardDateDomain",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails",
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r767"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://verses.ai/role/CommitmentsDetailsNarrative",
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails",
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails",
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative",
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance is reported."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r444",
      "r670",
      "r671",
      "r789",
      "r918"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of financial position where disaggregated cumulative balance is reported."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r444",
      "r670",
      "r671",
      "r789",
      "r918"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://verses.ai/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "VRSSF_CanadianDollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "CanadianDollarMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canadian Dollar [Member]",
        "documentation": "Canadian Dollar [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails",
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash commission",
        "verboseLabel": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r489",
      "r532",
      "r551",
      "r680",
      "r682",
      "r683",
      "r694",
      "r792"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, beginning of the period",
        "periodEndLabel": "Cash, end of the period",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r71",
      "r152"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in cash during the period",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r71"
     ]
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "presentation": [
      "http://verses.ai/role/SupplementalCashFlowInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL CASH FLOW INFORMATION",
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ClassACommonSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ClassACommonSharesMember",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Common Shares [Member]",
        "documentation": "Class A Common Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ClassASubordinateVotingStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ClassASubordinateVotingStockMember",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/InterimBalanceSheetParenthetical",
      "http://verses.ai/role/InterimStatementsOfOperations",
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Subordinate Voting Shares [Member]",
        "documentation": "Class A Subordinate Voting Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ClassBProportionateVotingStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ClassBProportionateVotingStockMember",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/InterimBalanceSheetParenthetical",
      "http://verses.ai/role/InterimStatementsOfOperations",
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Proportionate Voting Stock [Member]",
        "documentation": "Class B Proportionate Voting Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/InterimBalanceSheetParenthetical",
      "http://verses.ai/role/InterimStatementsOfOperations",
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency",
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails",
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r129",
      "r130",
      "r131",
      "r155",
      "r159",
      "r183",
      "r184",
      "r186",
      "r188",
      "r192",
      "r193",
      "r222",
      "r242",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250",
      "r282",
      "r283",
      "r285",
      "r286",
      "r288",
      "r290",
      "r292",
      "r293",
      "r295",
      "r296",
      "r298",
      "r445",
      "r512",
      "r513",
      "r514",
      "r515",
      "r520",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r533",
      "r543",
      "r566",
      "r586",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r785",
      "r813",
      "r815",
      "r822"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r192",
      "r285",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r418",
      "r512",
      "r513",
      "r514",
      "r515",
      "r647",
      "r785",
      "r811",
      "r813"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails",
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetailsParenthetical",
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails",
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetailsParenthetical",
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails",
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant exercise price",
        "verboseLabel": "Exercise Price",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r160",
      "r299"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails",
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetailsParenthetical",
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://verses.ai/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of warrants",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of warrants outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightReasonForIssuingToNonemployees",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants description",
        "documentation": "Description of reason for issuing warrant or right."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails",
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetailsParenthetical",
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://verses.ai/role/DeferredGrantDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r394"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsDisclosureTextBlock",
     "presentation": [
      "http://verses.ai/role/Commitments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS",
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r684",
      "r685",
      "r686",
      "r688",
      "r689",
      "r690",
      "r691",
      "r818",
      "r819",
      "r821",
      "r882",
      "r919",
      "r926"
     ]
    },
    "us-gaap_CommonStockNoParValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockNoParValue",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheetParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Voting shares, no par value",
        "documentation": "Face amount per share of no-par value common stock."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_CommonStockSharesAuthorizedUnlimited": {
     "xbrltype": "authorizedUnlimitedItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorizedUnlimited",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheetParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Voting shares, shares authorized",
        "documentation": "Indicates whether number of common shares permitted to be issued is unlimited. Acceptable value is \"Unlimited\"."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheetParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Voting shares, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheetParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Voting shares, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r53",
      "r543",
      "r564",
      "r926",
      "r927"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Voting shares, value",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r283",
      "r289",
      "r490",
      "r680"
     ]
    },
    "us-gaap_CommonStockVotingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockVotingRights",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Voting description",
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r753"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r751"
     ]
    },
    "us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CompensationExpenseExcludingCostOfGoodAndServiceSold",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management salaries and benefits included in personnel expenses",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold."
       }
      }
     },
     "auth_ref": [
      "r632",
      "r803"
     ]
    },
    "VRSSF_CompensationWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "CompensationWarrantsMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Warrants [Member]",
        "documentation": "Compensation Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_CompensationWarrantsReducedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "CompensationWarrantsReducedPercentage",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation warrants reduced percentage",
        "documentation": "Compensation warrants reduced percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET COMPREHENSIVE LOSS",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r137",
      "r139",
      "r144",
      "r479",
      "r499",
      "r500"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://verses.ai/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r622"
     ]
    },
    "VRSSF_ConsultantAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantAMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant A [Member]",
        "documentation": "Consultant A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantBMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant B [Member]",
        "documentation": "Consultant B [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantCMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant C [Member]",
        "documentation": "Consultant C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantDMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant D [Member]",
        "documentation": "Consultant D [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantEMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant E [Member]",
        "documentation": "Consultant E [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantFMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantFMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant F [Member]",
        "documentation": "Consultant F [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantGMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant G [Member]",
        "documentation": "Consultant G [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantHMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantHMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant H [Member]",
        "documentation": "Consultant H [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantIMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant I [Member]",
        "documentation": "Consultant I [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantJMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantJMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant J [Member]",
        "documentation": "Consultant J [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantKMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantKMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant K [Member]",
        "documentation": "Consultant K [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantLMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant L [Member]",
        "documentation": "Consultant L [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantMMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantMMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant M [Member]",
        "documentation": "Consultant M [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantNMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantNMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant N [Member]",
        "documentation": "Consultant N [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantOMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant O [Member]",
        "documentation": "Consultant O [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantPMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant P [Member]",
        "documentation": "Consultant P [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantQMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantQMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant Q [Member]",
        "documentation": "Consultant Q [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantsBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantsBMember",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultants B [Member]",
        "documentation": "Consultants B [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantsEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantsEMember",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultants E [Member]",
        "documentation": "Consultants E [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantsFMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantsFMember",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultants F [Member]",
        "documentation": "Consultants F [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ConsultantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ConsultantsMember",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultants [Member]",
        "documentation": "Consultants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfDeferredGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of the year",
        "periodEndLabel": "Balance, end of the period",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r302",
      "r304",
      "r314"
     ]
    },
    "us-gaap_ContractualObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractualObligation",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total",
        "documentation": "Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments."
       }
      }
     },
     "auth_ref": [
      "r812",
      "r817",
      "r911"
     ]
    },
    "us-gaap_ContractualObligationDueAfterFifthYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractualObligationDueAfterFifthYear",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "After 5 years",
        "documentation": "Amount of contractual obligation to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r812",
      "r817",
      "r911"
     ]
    },
    "VRSSF_ContractualObligationToBePaidFromYearOneToYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ContractualObligationToBePaidFromYearOneToYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "1 to 2 years",
        "documentation": "Contractual obligation to be paid from year one to year two."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ContractualObligationToBePaidFromYearTwoToYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ContractualObligationToBePaidFromYearTwoToYearFive",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2 to 5 years",
        "documentation": "Contractual obligation to be paid from year two to year five."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ContractualObligationToBePaidLessThanOneYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ContractualObligationToBePaidLessThanOneYear",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less than 1 year",
        "documentation": "Contractual obligation to be paid less than one year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostDirectMaterial": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostDirectMaterial",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/ScheduleOfCostOfRevenueDetails": {
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/ScheduleOfCostOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue from POCs and software implementation",
        "documentation": "Cost of material used for good produced and service rendered."
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "us-gaap_CostMaintenance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostMaintenance",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/ScheduleOfCostOfRevenueDetails": {
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/ScheduleOfCostOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue from SaaS",
        "documentation": "Cost of maintenance incurred and directly related to good produced and service rendered."
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      },
      "http://verses.ai/role/ScheduleOfCostOfRevenueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfOperations",
      "http://verses.ai/role/ScheduleOfCostOfRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "COST OF REVENUE",
        "totalLabel": "Total",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r155",
      "r158",
      "r159",
      "r222",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r445",
      "r632",
      "r840"
     ]
    },
    "VRSSF_CostOfRevenueDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "CostOfRevenueDisclosureTextBlock",
     "presentation": [
      "http://verses.ai/role/CostOfRevenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COST OF REVENUE",
        "documentation": "Cost of Revenue Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_CyberlabLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "CyberlabLLCMember",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cyberlab [Member]",
        "documentation": "Cyberlab LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_CyberlabVTUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "CyberlabVTUMember",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cyberlab VTU [Member]",
        "documentation": "Cyberlab VTU [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion shares",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://verses.ai/role/LoansPayable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LOANS PAYABLE",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r155",
      "r157",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r240",
      "r241",
      "r251",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r267",
      "r274",
      "r275",
      "r276",
      "r418",
      "r455"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r43",
      "r44",
      "r95",
      "r99",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r679",
      "r811",
      "r812",
      "r814",
      "r817",
      "r832",
      "r833",
      "r834",
      "r895",
      "r896",
      "r911"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r278",
      "r455",
      "r456",
      "r679"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsDetailsNarrative",
      "http://verses.ai/role/LoansPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt interest per annum",
        "verboseLabel": "Interest rate",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r253"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDateDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentMaturityDateDescription",
     "presentation": [
      "http://verses.ai/role/LoansPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument, maturity date, description",
        "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r679",
      "r811",
      "r812",
      "r814",
      "r817",
      "r832",
      "r833",
      "r834",
      "r895",
      "r896",
      "r911"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/LoansPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Monthly payment",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r41"
     ]
    },
    "VRSSF_December2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "December2023Member",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "December 2023 [Member]",
        "documentation": "December 2023 [Member]",
        "label": "December 2023 [Member] [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_December2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "December2024Member",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "December 2024 [Member]",
        "documentation": "December 2024 [Member]",
        "label": "December 2024 [Member] [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_DecemberFifteenTwoThousandTwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "DecemberFifteenTwoThousandTwentyEightMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "December 15, 2028 [Member]",
        "documentation": "December 15, 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_DecemberTwentyThreeTwoThousandTwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "DecemberTwentyThreeTwoThousandTwentyEightMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "December 23, 2028 [Member]",
        "documentation": "December 23, 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_DecemberTwentyThreeTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "DecemberTwentyThreeTwoThousandTwentyFourMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "December 23, 2024 [Member]",
        "documentation": "December 23, 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_DecemberTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "DecemberTwoThousandTwentyFourMember",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "December 2024 [Member]",
        "documentation": "December 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_DecemberTwoThousandTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "DecemberTwoThousandTwentyThreeMember",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "December 2023 [Member]",
        "documentation": "December 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCompensationLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredCompensationLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred grant",
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r84"
     ]
    },
    "us-gaap_DeferredCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredCostsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred financing costs",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "VRSSF_DeferredGrantDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "DeferredGrantDisclosureTextBlock",
     "presentation": [
      "http://verses.ai/role/DeferredGrant"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DEFERRED GRANT",
        "documentation": "Deferred grant disclosure text block."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_DeferredGrantTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "DeferredGrantTableTextBlock",
     "presentation": [
      "http://verses.ai/role/DeferredGrantTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF DEFERRED GRANT",
        "documentation": "Deferred Grant [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsDetailsNarrative",
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r23",
      "r146",
      "r615",
      "r616",
      "r618",
      "r620"
     ]
    },
    "us-gaap_DerivativeGainOnDerivative": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeGainOnDerivative",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows",
      "http://verses.ai/role/ScheduleOfOtherIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Fair value gain on derivative liability",
        "label": "Gain on derivative liability",
        "documentation": "Amount of increase in the fair value of derivatives recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "DirectorMember",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r920"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRevenueFromContactWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r313",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRevenueFromContactWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r313",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://verses.ai/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF REVENUE FROM CONTACT WITH CUSTOMERS",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "VRSSF_DisclosureCostOfRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "DisclosureCostOfRevenueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost Of Revenue",
        "verboseLabel": "Schedule Of Cost Of Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_DisclosureDeferredGrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "DisclosureDeferredGrantAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Grant",
        "verboseLabel": "Schedule Of Deferred Grant"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_DisclosureManagementOfCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "DisclosureManagementOfCapitalAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Of Capital"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://verses.ai/role/ShareBasedPayments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHARE BASED PAYMENTS",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r348",
      "r351",
      "r380",
      "r381",
      "r382",
      "r663"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_DisclosurePrepaidExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "DisclosurePrepaidExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expenses",
        "verboseLabel": "Schedule Of Prepaid Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_DisclosureWarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "DisclosureWarrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r706",
      "r708",
      "r720"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r695"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r698"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Per Voting Shares - Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r145",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r181",
      "r183",
      "r186",
      "r187",
      "r188",
      "r189",
      "r281",
      "r383",
      "r390",
      "r393",
      "r430",
      "r431",
      "r480",
      "r501",
      "r623"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Per Voting Shares - Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r145",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r183",
      "r186",
      "r187",
      "r188",
      "r189",
      "r281",
      "r383",
      "r390",
      "r393",
      "r430",
      "r431",
      "r480",
      "r501",
      "r623"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign exchange effect on cash",
        "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "us-gaap_EmployeeBenefitsAndShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeBenefitsAndShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance, September 30, 2025",
        "documentation": "Amount of expense for employee benefit and equity-based compensation."
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "us-gaap_EmployeeBenefitsAndShareBasedCompensationNoncash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeBenefitsAndShareBasedCompensationNoncash",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payments",
        "documentation": "Amount of noncash expense (reversal of expense) for employee benefits and share-based payment arrangement. Includes, but is not limited to, pension, other postretirement, postemployment and termination benefits."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares expenses",
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "VRSSF_EmployeesAndIndependentContractorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "EmployeesAndIndependentContractorsMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees and Independent Contractors [Member]",
        "documentation": "Employees and Independent Contractors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_EmployeesAndIndependentContractorsOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "EmployeesAndIndependentContractorsOneMember",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Employees and Independent Contractors [Member]",
        "documentation": "Employees and Independent Contractors [Member]",
        "label": "Employees and Independent Contractors [Member] [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r701"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r697"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r697"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r784"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r697"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r697"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r697"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r697"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r697"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r782"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency",
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r117",
      "r118",
      "r119",
      "r140",
      "r141",
      "r142",
      "r164",
      "r165",
      "r166",
      "r168",
      "r175",
      "r177",
      "r179",
      "r191",
      "r223",
      "r224",
      "r227",
      "r280",
      "r300",
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r457",
      "r458",
      "r460",
      "r498",
      "r504",
      "r505",
      "r506",
      "r520",
      "r586"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r713",
      "r724",
      "r734",
      "r760"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r710",
      "r721",
      "r731",
      "r757"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r756"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_FairValueAdjustmentOfWarrantsCompensationWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "FairValueAdjustmentOfWarrantsCompensationWarrants",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of compensation warrants",
        "documentation": "Fair value adjustment of warrants compensation warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://verses.ai/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r435",
      "r674"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r328",
      "r329",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r472",
      "r473",
      "r474",
      "r611",
      "r642",
      "r643",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r673",
      "r674",
      "r678"
     ]
    },
    "VRSSF_FairValueConcentrationOfRiskAllFinancialInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "FairValueConcentrationOfRiskAllFinancialInstrumentMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Concentration of Risk All Financial Instrument [Member]",
        "documentation": "Fair Value Concentration of Risk All Financial Instrument [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueConcentrationOfRiskDisclosureItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueConcentrationOfRiskDisclosureItemsAxis",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit or Market Risk [Axis]",
        "documentation": "Information by type of credit or market risk."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r787"
     ]
    },
    "us-gaap_FairValueConcentrationOfRiskDisclosureItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueConcentrationOfRiskDisclosureItemsDomain",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provides the general information items required or determined to be disclosed with respect to all significant concentrations of risk, including credit risk and market risk, arising from all financial instruments (as defined), whether from an individual counterparty or groups of counterparties."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r787"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r317",
      "r322",
      "r328",
      "r433",
      "r438",
      "r441",
      "r472",
      "r611",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r673",
      "r678"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r317",
      "r322",
      "r328",
      "r330",
      "r433",
      "r434",
      "r438",
      "r441",
      "r473",
      "r611",
      "r642",
      "r643",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r673",
      "r678"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r328",
      "r329",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r441",
      "r474",
      "r611",
      "r642",
      "r643",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r673",
      "r674",
      "r678"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r328",
      "r329",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r472",
      "r473",
      "r474",
      "r611",
      "r642",
      "r643",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r673",
      "r674",
      "r678"
     ]
    },
    "VRSSF_FinancialAdvisorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "FinancialAdvisorMember",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Advisor [Member]",
        "documentation": "Financial Advisor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_FinancialConsultantEAndFMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "FinancialConsultantEAndFMember",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Consultan E Andt F [Member]",
        "documentation": "Financial Consultan E Andt F [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "presentation": [
      "http://verses.ai/role/FinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCIAL INSTRUMENTS",
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "us-gaap_FinancialInstrumentsOwnedAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialInstrumentsOwnedAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign currency future instrument",
        "documentation": "The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings."
       }
      }
     },
     "auth_ref": [
      "r909"
     ]
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities",
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities."
       }
      }
     },
     "auth_ref": [
      "r883",
      "r884",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892"
     ]
    },
    "VRSSF_ForeignExchangeEffectOnConvertibleDebenture": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ForeignExchangeEffectOnConvertibleDebenture",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign exchange effect on convertible debenture",
        "documentation": "Foreign exchange effect on convertible debenture."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignExchangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignExchangeMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Exchange [Member]",
        "documentation": "Trading of derivative or nonderivative instruments whose primary underlying risk is tied to foreign exchange rates."
       }
      }
     },
     "auth_ref": [
      "r669",
      "r672"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r717",
      "r728",
      "r738",
      "r764"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r717",
      "r728",
      "r738",
      "r764"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r717",
      "r728",
      "r738",
      "r764"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r717",
      "r728",
      "r738",
      "r764"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r717",
      "r728",
      "r738",
      "r764"
     ]
    },
    "VRSSF_GabrielReneAndDanielMapesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "GabrielReneAndDanielMapesMember",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gabriel Rene and Daniel Mapes [Member]",
        "documentation": "Gabriel Rene and Daniel Mapes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_GordonScottPatersonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "GordonScottPatersonMember",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gordon Scott Paterson [Member]",
        "documentation": "Gordon Scott Paterson [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_GrantAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "GrantAgreementMember",
     "presentation": [
      "http://verses.ai/role/DeferredGrantDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grant Agreement [Member]",
        "documentation": "Grant Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_GrantExchangeDifference": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "GrantExchangeDifference",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfDeferredGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange difference",
        "documentation": "Grant exchange difference."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_GrantExpensesOnProject": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "GrantExpensesOnProject",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfDeferredGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses on the project",
        "documentation": "Grant expenses on project."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_GrantIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "GrantIncome",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/DeferredGrantDetailsNarrative",
      "http://verses.ai/role/ScheduleOfOtherIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grant Income",
        "documentation": "Grant income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET REVENUE",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r105",
      "r155",
      "r158",
      "r159",
      "r222",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r445",
      "r628",
      "r632",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r840"
     ]
    },
    "VRSSF_InactiveEmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "InactiveEmployeeMember",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inactive Employee [Member]",
        "documentation": "Inactive Employee [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReceivable",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax receivable",
        "documentation": "Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase/decrease in accounts payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase/decrease in accrued liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInCashCollateralForBorrowedSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInCashCollateralForBorrowedSecurities",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase/decrease in cash",
        "documentation": "The increase (decrease) during the reporting period in the amount of cash that is pledged as security when borrowing securities."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Contract assets and unbilled revenue",
        "label": "Increase (Decrease) in Contract with Customer, Asset",
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r808"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInDeferredCharges",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred financing costs",
        "label": "Increase (Decrease) in Deferred Charges",
        "documentation": "The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "VRSSF_IncreaseDecreaseInForeignCurrency": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "IncreaseDecreaseInForeignCurrency",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase/decrease in foreign currency future instrument",
        "documentation": "Increase decrease in foreign currency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase/decrease in tax receivable",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets."
       }
      }
     },
     "auth_ref": [
      "r808"
     ]
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax receivable",
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows",
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "Increase/decrease in prepaid expenses",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "VRSSF_IncreaseDecreaseInRestrictedShareUnitLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "IncreaseDecreaseInRestrictedShareUnitLiability",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase/decrease in restricted share unit liability",
        "documentation": "Increase decrease in restricted share unit liability."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_IncreasedDecreasedInRestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "IncreasedDecreasedInRestrictedCash",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase/decrease in restricted cash",
        "documentation": "Increased decreased in restricted cash."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r717",
      "r728",
      "r738",
      "r756",
      "r764",
      "r768",
      "r776"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r774"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r709",
      "r780"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r709",
      "r780"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r709",
      "r780"
     ]
    },
    "us-gaap_InterestAndOtherIncomeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestAndOtherIncomeTableTextBlock",
     "presentation": [
      "http://verses.ai/role/OtherIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF OTHER INCOME",
        "documentation": "Tabular disclosure of interest income and income classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestAndOtherIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestAndOtherIncomeTextBlock",
     "presentation": [
      "http://verses.ai/role/OtherIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER INCOME",
        "documentation": "The entire disclosure for interest and other income."
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "us-gaap_InterestCostsIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestCostsIncurred",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOtherIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest earned",
        "documentation": "Total interest costs incurred during the period and either capitalized or charged against earnings."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r454"
     ]
    },
    "VRSSF_InterestDueFromRelatedPartiesLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "InterestDueFromRelatedPartiesLoan",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest due from related parties loan",
        "documentation": "Interest due from related parties loan.",
        "label": "InterestDueFromRelatedPartiesLoan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfLoansPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest expense",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r271",
      "r279",
      "r644",
      "r645",
      "r923"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows",
      "http://verses.ai/role/ScheduleOfOtherIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "negatedLabel": "Interest expense",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r617",
      "r621",
      "r804"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSupplementalCashPaidAndReceivedByCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r150",
      "r151"
     ]
    },
    "us-gaap_InventoryWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryWorkInProcess",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Work in progress",
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares for services",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "VRSSF_JamesHendricksonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "JamesHendricksonMember",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "James Hendrickson [Member]",
        "documentation": "James Hendrickson [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_JaySamitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "JaySamitMember",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Jay Samit [Member]",
        "documentation": "Jay Samit [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_JonathandeVosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "JonathandeVosMember",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Jonathan de Vos [Member]",
        "documentation": "Jonathan de Vos [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_JonhatandeVosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "JonhatandeVosMember",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Jonhatande Vos [Member]",
        "documentation": "Jonhatande Vos [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_July2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "July2024Member",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "July 2024 [Member]",
        "documentation": "July 2024 [Member]",
        "label": "July 2024 [Member] [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_JulyThreeTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "JulyThreeTwoThousandTwentyFourMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "July 3, 2024 [Member]",
        "documentation": "July 3, 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_JulyThreeTwoThousandTwentyNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "JulyThreeTwoThousandTwentyNineMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "July 3, 2029 [Member]",
        "documentation": "July 3, 2029 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_JulyTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "JulyTwoThousandTwentyFourMember",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "July 2024 [Member]",
        "documentation": "July 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_JuneSixteenTwoThousandTwentySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "JuneSixteenTwoThousandTwentySevenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "June 16, 2027 [Member]",
        "documentation": "June 16, 2027 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_JuneTwentyTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "JuneTwentyTwoThousandTwentyFourMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "June 20, 2024 [Member]",
        "documentation": "June 20, 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_KelvinWilsonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "KelvinWilsonMember",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Kelvin Wilson [Member]",
        "documentation": "Kelvin Wilson [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_KevinWilsonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "KevinWilsonMember",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Kevin Wilson [Member]",
        "documentation": "Kevin Wilson [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LegalFees",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal fees",
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
       }
      }
     },
     "auth_ref": [
      "r790",
      "r924",
      "r925"
     ]
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LegalMattersAndContingenciesTextBlock",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaim"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROVISION FOR LEGAL CLAIM",
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r43",
      "r44",
      "r45",
      "r48",
      "r49",
      "r50",
      "r51",
      "r155",
      "r158",
      "r159",
      "r222",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r396",
      "r397",
      "r398",
      "r445",
      "r542",
      "r627",
      "r646",
      "r694",
      "r840",
      "r901",
      "r902"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES",
        "verboseLabel": "Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 DEFICIENCY",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r100",
      "r493",
      "r680",
      "r682",
      "r683",
      "r811",
      "r816",
      "r830",
      "r893"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r124",
      "r155",
      "r158",
      "r159",
      "r222",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r396",
      "r397",
      "r398",
      "r445",
      "r680",
      "r840",
      "r901",
      "r902"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "CURRENT"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation interest",
        "documentation": "Amount awarded to other party in judgment or settlement of litigation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LitigationSettlementExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LitigationSettlementExpense",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative",
      "http://verses.ai/role/ScheduleOfOtherIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal claim expense",
        "verboseLabel": "Plaintiff total",
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "us-gaap_LitigationSettlementInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LitigationSettlementInterest",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative",
      "http://verses.ai/role/ScheduleOfSettlementDiscussionsAreOngoingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Litigation interest",
        "label": "Interest",
        "documentation": "Interest expense (income) directly attributable to an award in settlement of litigation."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "us-gaap_LoansPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LoansPayableMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans Payable [Member]",
        "documentation": "Borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long term loan",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r99",
      "r156",
      "r163",
      "r264",
      "r277",
      "r484",
      "r642",
      "r643",
      "r679",
      "r914"
     ]
    },
    "us-gaap_LongTermLoansPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermLoansPayable",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails",
      "http://verses.ai/role/ScheduleOfLoansPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans payable",
        "periodStartLabel": "Balance, beginning of the year",
        "periodEndLabel": "Balance, end of the period",
        "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingencyAccrualAtCarryingValue",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSettlementDiscussionsAreOngoingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Provision for legal claim",
        "periodEndLabel": "Provision for legal claim",
        "label": "Loss Contingency Accrual",
        "documentation": "Amount of loss contingency liability."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r786"
     ]
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingencyDamagesAwardedValue",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Damage cost",
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter."
       }
      }
     },
     "auth_ref": [
      "r837",
      "r838",
      "r839"
     ]
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingencyDamagesSoughtValue",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Damage value",
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter."
       }
      }
     },
     "auth_ref": [
      "r837",
      "r838",
      "r839"
     ]
    },
    "VRSSF_ManagementFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ManagementFees",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management fees",
        "documentation": "Management fees."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ManagementOfCapitalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ManagementOfCapitalTextBlock",
     "presentation": [
      "http://verses.ai/role/ManagementOfCapital"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MANAGEMENT OF CAPITAL",
        "documentation": "Management Of Capital [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r198",
      "r236",
      "r237",
      "r238",
      "r239",
      "r346",
      "r375",
      "r376",
      "r377",
      "r384",
      "r436",
      "r477",
      "r502",
      "r503",
      "r510",
      "r534",
      "r535",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r602",
      "r603",
      "r604",
      "r605",
      "r608",
      "r609",
      "r637",
      "r647",
      "r662",
      "r665",
      "r666",
      "r667",
      "r674",
      "r675",
      "r676",
      "r677",
      "r681",
      "r842",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908"
     ]
    },
    "VRSSF_MayTwentySixTwoThousandThirtyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "MayTwentySixTwoThousandThirtyMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "May 26, 2023 [Member]",
        "documentation": "May 26, 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_MayTwentySixTwoThousandTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "MayTwentySixTwoThousandTwentyFiveMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "May 26, 2025 [Member]",
        "documentation": "May 26, 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r885",
      "r886",
      "r887"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Term [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r885",
      "r886",
      "r887"
     ]
    },
    "VRSSF_MeasurementInputGrantDateFairValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "MeasurementInputGrantDateFairValueMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Grant Date Fair Value [Member]",
        "documentation": "Measurement Input Grant Date Fair Value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputOptionVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputOptionVolatilityMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Option Volatility [Member]",
        "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r885",
      "r886",
      "r887"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r885",
      "r886",
      "r887"
     ]
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputSharePriceMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Share Price [Member]",
        "documentation": "Measurement input using share price of saleable stock."
       }
      }
     },
     "auth_ref": [
      "r885",
      "r886",
      "r887"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r434",
      "r435",
      "r436",
      "r665",
      "r666",
      "r667",
      "r674"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r435",
      "r436",
      "r665",
      "r666",
      "r667",
      "r674"
     ]
    },
    "VRSSF_MichaelBlumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "MichaelBlumMember",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Michael Blum [Member]",
        "documentation": "Michael Blum [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r198",
      "r236",
      "r237",
      "r238",
      "r239",
      "r346",
      "r375",
      "r376",
      "r377",
      "r384",
      "r436",
      "r477",
      "r502",
      "r503",
      "r510",
      "r534",
      "r535",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r602",
      "r603",
      "r604",
      "r605",
      "r608",
      "r609",
      "r637",
      "r647",
      "r662",
      "r665",
      "r666",
      "r667",
      "r674",
      "r675",
      "r676",
      "r681",
      "r842",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908"
     ]
    },
    "us-gaap_MinorityInterestDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterestDescription",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest description",
        "documentation": "Description of noncontrolling interest which might include background information, terms of the ownership arrangement, and type and terms of equity interest owned by the noncontrolling interest holders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest, percentage",
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_Minus10percentageFluctuationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "Minus10percentageFluctuationMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minus 10 Percentage Fluctuation [Member]",
        "documentation": "Minus 10 Percentage Fluctuation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://verses.ai/role/NatureOfBusinessAndGoingConcern"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NATURE OF BUSINESS AND GOING CONCERN",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r195",
      "r624",
      "r625"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVESTING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72",
      "r74"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash provided by (used in): OPERATING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://verses.ai/role/InterimStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows",
      "http://verses.ai/role/InterimStatementsOfComprehensiveLoss",
      "http://verses.ai/role/InterimStatementsOfOperations",
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency",
      "http://verses.ai/role/NatureOfBusinessAndGoingConcernDetailsNarrative",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET LOSS",
        "label": "Net Loss",
        "verboseLabel": "Net loss",
        "terseLabel": "Net Income (Loss)",
        "negatedLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r74",
      "r102",
      "r119",
      "r122",
      "r136",
      "r138",
      "r142",
      "r155",
      "r158",
      "r159",
      "r162",
      "r167",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r178",
      "r179",
      "r185",
      "r222",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r281",
      "r284",
      "r287",
      "r291",
      "r383",
      "r390",
      "r393",
      "r431",
      "r445",
      "r497",
      "r565",
      "r584",
      "r585",
      "r617",
      "r619",
      "r621",
      "r692",
      "r840"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "VRSSF_NotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "NotionalAmount",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notional value",
        "documentation": "Notional amount."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ObligationToIssueSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ObligationToIssueSharesMember",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Obligation to Issue Shares [Member]",
        "documentation": "Obligation to Issue Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "OPERATING INCOME (EXPENSE)",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r617",
      "r621",
      "r628",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCommitment",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/CommitmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitment balance",
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions."
       }
      }
     },
     "auth_ref": [
      "r812",
      "r817",
      "r911"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfComprehensiveLoss",
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in foreign currency translation",
        "negatedTerseLabel": "Foreign exchange difference",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r9",
      "r92"
     ]
    },
    "VRSSF_OtherConsultantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "OtherConsultantMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Consultant [Member]",
        "documentation": "Other Consultant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCurrentLiabilitiesMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Current Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherIncomeAndExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r487",
      "r538",
      "r539",
      "r646",
      "r682",
      "r683",
      "r694",
      "r915",
      "r920"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for legal claim",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r680"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfOperations",
      "http://verses.ai/role/ScheduleOfOtherIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income/(expense), net",
        "totalLabel": "Other income",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r668"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherPrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/ScheduleOfPrepaidExpensesDetails": {
       "parentTag": "us-gaap_PrepaidExpenseCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://verses.ai/role/ScheduleOfPrepaidExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscriptions",
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r797",
      "r831"
     ]
    },
    "us-gaap_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsDetailsNarrative",
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due from related parties",
        "documentation": "Amount due from parties in nontrade transactions, classified as other."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r552",
      "r633",
      "r682",
      "r683",
      "r917"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "us-gaap_OtherRestrictedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherRestrictedAssets",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts receivable",
        "label": "Other Restricted Assets",
        "documentation": "Total assets that cannot be used for operating purposes because of contract or regulatory requirements that are in effect for a period that extends beyond one year."
       }
      }
     },
     "auth_ref": [
      "r606",
      "r607",
      "r793"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r715",
      "r726",
      "r736",
      "r762"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r718",
      "r729",
      "r739",
      "r765"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r718",
      "r729",
      "r739",
      "r765"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r743"
     ]
    },
    "VRSSF_PaymentForCashFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "PaymentForCashFee",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for cash fee",
        "documentation": "Payment for cash fee."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForLegalSettlements",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative",
      "http://verses.ai/role/ScheduleOfSettlementDiscussionsAreOngoingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial good faith payments",
        "negatedLabel": "Payments in the year",
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRepurchaseOfPrivatePlacement",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Private placement issuance costs",
        "label": "Payments for Repurchase of Private Placement",
        "documentation": "The cash outflow associated with the repurchase of amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRepurchaseOfWarrants",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Special warrant issuance costs",
        "label": "Payments for Repurchase of Warrants",
        "documentation": "The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investment in equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Due from related parties",
        "label": "Payments to Fund Long-Term Loans to Related Parties",
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates."
       }
      }
     },
     "auth_ref": [
      "r806",
      "r897"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "VRSSF_PercentageOfBrokerageFees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "PercentageOfBrokerageFees",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of brokerage fees",
        "documentation": "Percentage of brokerage fees."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_PlaceOfIncorporation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "PlaceOfIncorporation",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Place of Incorporation",
        "documentation": "Place of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "srt_PlatformOperatorCryptoAssetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "PlatformOperatorCryptoAssetLineItems",
     "presentation": [
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto Asset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "srt_PlatformOperatorCryptoAssetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "PlatformOperatorCryptoAssetTable",
     "presentation": [
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto Asset [Table]"
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "VRSSF_Plus10percentageFluctuationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "Plus10percentageFluctuationMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plus 10 Percentage Fluctuation [Member]",
        "documentation": "Plus 10 Percentage Fluctuation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "VRSSF_PostConsolidationExerciseTermsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "PostConsolidationExerciseTermsMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Consolidation Exercise Terms [Member]",
        "documentation": "Post-Consolidation Exercise Terms [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r702"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r704"
     ]
    },
    "VRSSF_PreConsolidationExerciseTermsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "PreConsolidationExerciseTermsMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Consolidation Exercise Terms [Member]",
        "documentation": "Pre-Consolidation Exercise Terms [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_PrepaidDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "PrepaidDeposit",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/ScheduleOfPrepaidExpensesDetails": {
       "parentTag": "us-gaap_PrepaidExpenseCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/ScheduleOfPrepaidExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposit",
        "documentation": "Prepaid deposit."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      },
      "http://verses.ai/role/ScheduleOfPrepaidExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/ScheduleOfPrepaidExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses",
        "totalLabel": "Prepaid expenses",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r225",
      "r226",
      "r612"
     ]
    },
    "us-gaap_PrepaidExpenseCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseCurrentAndNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Prepaid expenses",
        "label": "Prepaid Expense",
        "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r134",
      "r557",
      "r912"
     ]
    },
    "VRSSF_PrepaidExpensesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "PrepaidExpensesDisclosureTextBlock",
     "presentation": [
      "http://verses.ai/role/PrepaidExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PREPAID EXPENSES",
        "documentation": "Prepaid Expenses Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/ScheduleOfPrepaidExpensesDetails": {
       "parentTag": "us-gaap_PrepaidExpenseCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://verses.ai/role/ScheduleOfPrepaidExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r613",
      "r638",
      "r831"
     ]
    },
    "us-gaap_PrepaidRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidRent",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/ScheduleOfPrepaidExpensesDetails": {
       "parentTag": "us-gaap_PrepaidExpenseCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/ScheduleOfPrepaidExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retainer",
        "documentation": "Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r614",
      "r639",
      "r831"
     ]
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of convertible debentures",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "VRSSF_ProceedsFromDeferredGrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ProceedsFromDeferredGrant",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred grant",
        "documentation": "Proceeds from deferred grant.",
        "label": "ProceedsFromDeferredGrant"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ProceedsFromGrantReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ProceedsFromGrantReceived",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/DeferredGrantDetailsNarrative",
      "http://verses.ai/role/ScheduleOfDeferredGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grant received",
        "documentation": "Proceeds from grant received."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromInterestAndDividendsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromInterestAndDividendsReceived",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSupplementalCashPaidAndReceivedByCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash received for interest",
        "documentation": "Cash received for dividends and interest on the entity's equity and debt investments during the current period."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r149"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative",
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of debt",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/LoansPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans recieved",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r512"
     ]
    },
    "VRSSF_ProceedsFromIssuanceOfUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ProceedsFromIssuanceOfUnits",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of Units",
        "documentation": "Proceeds from issuance of units."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of special warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromLegalSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromLegalSettlements",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows",
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for contract settlement",
        "verboseLabel": "Proceeds from insurance",
        "documentation": "Cash received for the settlement of litigation during the current period."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromOtherEquity",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of equity instruments",
        "documentation": "Amount of cash inflow from the issuance of equity classified as other."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_PropertyPlantAndEquipmentAccumulatedDepreciationAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "PropertyPlantAndEquipmentAccumulatedDepreciationAdditions",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated depreciation, Equipment, Additions",
        "documentation": "Property plant and equipment accumulated depreciation additions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentAdditions",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost, Equipment, Additions",
        "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://verses.ai/role/Equipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EQUIPMENT",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r112",
      "r113",
      "r114"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cost, Equipment, Balance",
        "periodEndLabel": "Cost, Equipment, Balance",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r126",
      "r496"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/ScheduleOfEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment",
        "verboseLabel": "Net book value",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r459",
      "r485",
      "r496",
      "r680"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://verses.ai/role/EquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF EQUIPMENT",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "VRSSF_ProvisionForContractSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ProvisionForContractSettlement",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/RevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Provision for contract settlement",
        "documentation": "Provision for contract settlement.",
        "label": "ProvisionForContractSettlement"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ProvisionForLegalClaim": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ProvisionForLegalClaim",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Provision for legal claim",
        "documentation": "Provision for legal claim.",
        "label": "ProvisionForLegalClaim"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ProvisionForLegalClaimAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ProvisionForLegalClaimAbstract",
     "auth_ref": []
    },
    "VRSSF_ProvisionForLegalClaimLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ProvisionForLegalClaimLineItems",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ProvisionForLegalClaimLineItems [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ProvisionForLegalClaimTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ProvisionForLegalClaimTable",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ProvisionForLegalClaimTable [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForOtherLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProvisionForOtherLosses",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows",
      "http://verses.ai/role/ScheduleOfOtherIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for losses on related party transactions",
        "negatedLabel": "Provision for losses on related party transactions",
        "documentation": "Amount of expense related to other loss."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r64",
      "r101"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r198",
      "r236",
      "r237",
      "r238",
      "r239",
      "r316",
      "r346",
      "r375",
      "r376",
      "r377",
      "r382",
      "r384",
      "r436",
      "r475",
      "r476",
      "r477",
      "r502",
      "r503",
      "r510",
      "r534",
      "r535",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r602",
      "r603",
      "r604",
      "r605",
      "r608",
      "r609",
      "r637",
      "r647",
      "r662",
      "r665",
      "r666",
      "r667",
      "r674",
      "r675",
      "r676",
      "r677",
      "r681",
      "r686",
      "r835",
      "r842",
      "r886",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "auth_ref": [
      "r198",
      "r236",
      "r237",
      "r238",
      "r239",
      "r316",
      "r346",
      "r375",
      "r376",
      "r377",
      "r382",
      "r384",
      "r436",
      "r475",
      "r476",
      "r477",
      "r502",
      "r503",
      "r510",
      "r534",
      "r535",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r602",
      "r603",
      "r604",
      "r605",
      "r608",
      "r609",
      "r637",
      "r647",
      "r662",
      "r665",
      "r666",
      "r667",
      "r674",
      "r675",
      "r676",
      "r677",
      "r681",
      "r686",
      "r835",
      "r842",
      "r886",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r710",
      "r721",
      "r731",
      "r757"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsDetailsNarrative",
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r161",
      "r162",
      "r221",
      "r323",
      "r342",
      "r464",
      "r465",
      "r488",
      "r494",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r563",
      "r591",
      "r922"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsDetailsNarrative",
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r161",
      "r162",
      "r464",
      "r465",
      "r466",
      "r467",
      "r488",
      "r494",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r563",
      "r591"
     ]
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Related party transactions",
        "label": "Related Party Transaction, Amounts of Transaction",
        "documentation": "Amount of transactions with related party during the financial reporting period."
       }
      }
     },
     "auth_ref": [
      "r464"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsDetailsNarrative",
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r161",
      "r162",
      "r221",
      "r323",
      "r342",
      "r464",
      "r465",
      "r488",
      "r494",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r563",
      "r591",
      "r900",
      "r922"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalances"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS AND BALANCES",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r462",
      "r463",
      "r465",
      "r468",
      "r517",
      "r518",
      "r519",
      "r569",
      "r570",
      "r571",
      "r589",
      "r590"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfLoansPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r515"
     ]
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of related party debt",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfShortTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayments of loans",
        "label": "Repayments of Short-Term Debt",
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "VRSSF_ResearchAndDevelopmentTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ResearchAndDevelopmentTaxCredits",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOtherIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "R&amp;D tax credits",
        "documentation": "R&amp;D tax credits."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r711",
      "r722",
      "r732",
      "r758"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r712",
      "r723",
      "r733",
      "r759"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r719",
      "r730",
      "r740",
      "r766"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/DeferredGrantDetailsNarrative",
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash",
        "verboseLabel": "Restricted cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r792",
      "r809",
      "r910",
      "r916"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and restricted cash",
        "documentation": "Amount of cash and cash equivalent restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r125",
      "r152"
     ]
    },
    "VRSSF_RestrictedShareUnitLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "RestrictedShareUnitLiability",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/ScheduleOfFairValueHierarchyDetails",
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted share unit liability",
        "documentation": "Restricted share unit liability."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_RestrictedStockExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "RestrictedStockExpenses",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted shares units",
        "documentation": "Restricted stock expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://verses.ai/role/CommitmentsDetailsNarrative",
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails",
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative",
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/NatureOfBusinessAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deficit",
        "negatedLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r83",
      "r492",
      "r507",
      "r509",
      "r516",
      "r544",
      "r680"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r164",
      "r165",
      "r166",
      "r168",
      "r175",
      "r177",
      "r179",
      "r223",
      "r224",
      "r227",
      "r280",
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r419",
      "r421",
      "r422",
      "r424",
      "r429",
      "r457",
      "r458",
      "r504",
      "r506",
      "r520",
      "r926"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://verses.ai/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "REVENUE",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r315"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation",
     "presentation": [
      "http://verses.ai/role/CommitmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue description",
        "documentation": "Description of when remaining performance obligation is expected to be recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfOperations",
      "http://verses.ai/role/ScheduleOfRevenueFromContactWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "REVENUE",
        "verboseLabel": "Total",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104",
      "r143",
      "r155",
      "r158",
      "r159",
      "r190",
      "r204",
      "r205",
      "r210",
      "r214",
      "r217",
      "r219",
      "r220",
      "r222",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r445",
      "r481",
      "r483",
      "r632",
      "r668",
      "r682",
      "r683",
      "r840"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of stock",
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetailsParenthetical"
     ],
     "auth_ref": [
      "r120",
      "r121",
      "r180",
      "r347",
      "r786"
     ]
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "presentation": [
      "http://verses.ai/role/SupplementalCashFlowInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF SUPPLEMENTAL CASH PAID AND RECEIVED BY THE COMPANY",
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://verses.ai/role/DeferredGrantDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r394"
     ]
    },
    "VRSSF_ScheduleOfContractualCashFlowRequirementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfContractualCashFlowRequirementAbstract",
     "auth_ref": []
    },
    "VRSSF_ScheduleOfContractualCashFlowRequirementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfContractualCashFlowRequirementLineItems",
     "presentation": [
      "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfContractualCashFlowRequirementLineItems [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ScheduleOfContractualCashFlowRequirementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfContractualCashFlowRequirementTable",
     "presentation": [
      "http://verses.ai/role/ScheduleOfContractualCashFlowRequirementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfContractualCashFlowRequirementTable [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ScheduleOfContractualCashFlowRequirementsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfContractualCashFlowRequirementsTableTextBlock",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF CONTRACTUAL CASH FLOW REQUIREMENT",
        "documentation": "Schedule Of Contractual Cash Flow Requirements [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ScheduleOfCostOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfCostOfRevenueTableTextBlock",
     "presentation": [
      "http://verses.ai/role/CostOfRevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF COST OF REVENUE",
        "documentation": "Schedule of Cost of Revenue [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://verses.ai/role/LoansPayableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF LOANS PAYABLE",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsDetailsNarrative",
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan [Table]",
        "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r32",
      "r33",
      "r34",
      "r35",
      "r324",
      "r325",
      "r326",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF FAIR VALUE HIERARCHY",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r883",
      "r884"
     ]
    },
    "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF FOREIGN EXCHANGE RISK EXPOSURE OF FINANCIAL INSTRUMENTS",
        "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts."
       }
      }
     },
     "auth_ref": [
      "r876",
      "r878",
      "r879"
     ]
    },
    "VRSSF_ScheduleOfPrepaidExpensesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfPrepaidExpensesTextBlock",
     "presentation": [
      "http://verses.ai/role/PrepaidExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF PREPAID EXPENSES",
        "documentation": "Schedule of Prepaid Expenses [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF RELATED PARTY TRANSACTIONS",
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r897",
      "r898"
     ]
    },
    "VRSSF_ScheduleOfSettlementDiscussionsAreOngoingTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfSettlementDiscussionsAreOngoingTableTextBlock",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF SETTLEMENT DISCUSSIONS ARE ONGOING",
        "documentation": "Schedule of Settlement Discussions Are Ongoing [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF RECONCILIATION SHARE BASED PAYMENTS",
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r14",
      "r89"
     ]
    },
    "VRSSF_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantTableTextBlock",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF CONSOLIDATES THE POSITION OF OPTIONS GRANTED RELATED TO STRATEGIC CONSULTANTS",
        "documentation": "Schedule of Share Based Compensation Arrangement by Share Based Payment Award Options Grants In Period Grant [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://verses.ai/role/CommitmentsDetailsNarrative",
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails",
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r382"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF OPTIONS TO PURCHASE SUBORDINATE VOTING SHARES",
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock awards granted to nonemployee directors that were outstanding at the beginning and end of the year, and the number of awards that were granted, exercised or converted, forfeited, and expired during the year."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF POSITION OF THE RSUS GRANTED RELATED TO STRATEGIC CONSULTANTS",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF OPTIONS",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r14",
      "r85"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF THE BLACK-SCHOLES OPTION PRICING MODEL WITH THE FOLLOWING WEIGHTED AVERAGE ASSUMPTIONS",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF RESTRICTED SHARES",
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r81",
      "r82",
      "r83",
      "r129",
      "r130",
      "r131",
      "r192",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r418",
      "r512",
      "r513",
      "r514",
      "r515",
      "r647",
      "r785",
      "r811",
      "r813"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://verses.ai/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF WARRANTS OUTSTANDING",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "VRSSF_ScheduleOfSubsidiariesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfSubsidiariesAbstract",
     "auth_ref": []
    },
    "VRSSF_ScheduleOfSubsidiariesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfSubsidiariesLineItems",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfSubsidiariesLineItems [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ScheduleOfSubsidiariesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfSubsidiariesTable",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfSubsidiariesTable [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ScheduleOfSubsidiariesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfSubsidiariesTableTextBlock",
     "presentation": [
      "http://verses.ai/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF SUBSIDIARIES",
        "documentation": "Schedule of subsidiaries table text block."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ScheduleOfWarrantsOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfWarrantsOutstandingAbstract",
     "auth_ref": []
    },
    "VRSSF_ScheduleOfWarrantsOutstandingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfWarrantsOutstandingLineItems",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfWarrantsOutstandingLineItems [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ScheduleOfWarrantsOutstandingSharePurchaseWarrantsExpireTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfWarrantsOutstandingSharePurchaseWarrantsExpireTableTextBlock",
     "presentation": [
      "http://verses.ai/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE OF OUTSTANDING SHARE PURCHASE WARRANTS EXPIRE",
        "documentation": "Schedule of Warrants Outstanding Share Purchase Warrants Expire [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ScheduleOfWarrantsOutstandingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ScheduleOfWarrantsOutstandingTable",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfWarrantsOutstandingTable [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r696"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r699"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r705"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://verses.ai/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENT REPORTING",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r190",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r207",
      "r208",
      "r209",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r629",
      "r630",
      "r631",
      "r632",
      "r634",
      "r635",
      "r636"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Selling, general and administrative expenses",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r616",
      "r617",
      "r618",
      "r621",
      "r805"
     ]
    },
    "VRSSF_SeptemberFourTwoThousandTwentySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "SeptemberFourTwoThousandTwentySevenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "September 4, 2027 [Member]",
        "documentation": "September 4, 2027 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_SeptemberNineteenTwoThousandAndThirtyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "SeptemberNineteenTwoThousandAndThirtyMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "September 19, 2030 [Member]",
        "documentation": "September 19, 2030 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_SeptemberNineteenTwoThousandTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "SeptemberNineteenTwoThousandTwentyFiveMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "September 19, 2025 [Member]",
        "documentation": "September 19, 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_SeptemberSixteenTwoThousandTwentySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "SeptemberSixteenTwoThousandTwentySevenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "September 16, 2027 [Member]",
        "documentation": "September 16, 2027 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_SeptemberThirteenTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "SeptemberThirteenTwoThousandTwentyFourMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "September 13, 2024 [Member]",
        "documentation": "September 13, 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://verses.ai/role/InterimStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share based payments",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Milestones",
        "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payment award, award expiration year",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payment award, award vesting rights description",
        "verboseLabel": "Share-based payment award, award rights description",
        "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedInPeriod",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Converted",
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options converted in period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancelled",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted",
        "verboseLabel": "Issued",
        "terseLabel": "Issuance of shares granted",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisable",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Exercisable, September 30, 2025",
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options nonvested exercisable.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning balance",
        "periodEndLabel": "Outstanding, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock exercise price",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual terms",
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted share unit fair value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected dividends",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeituresRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeituresRate",
     "presentation": [
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected forfeitures",
        "documentation": "Share based compensation arrangement by share based payment award fair value assumptions expected forfeitures rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://verses.ai/role/CommitmentsDetailsNarrative",
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails",
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r382"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of warrants, Exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised",
        "documentation": "Number of non-option equity instruments exercised by participants."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, warrants exercised",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments exercised weighted average grant date fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of warrants, Expired",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations",
        "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, warrants expired",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments expired weighted average grant date fair value."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average exercise price, warrants expired",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments forfeitures weighted average grant date fair value.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresWeightedAverageGrantDateFairValue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of warrants, issued",
        "verboseLabel": "Restricted stock granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, warrants issued",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average grant date fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of warrants outstanding, Balance beginning",
        "periodEndLabel": "Number of warrants outstanding, Balance ending",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r87"
     ]
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life in Years",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual terms."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average exercise price, Balance beginning",
        "periodEndLabel": "Weighted average exercise price, Balance ending",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments weighted average grant date fair value.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageGrantDateFairValue"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantInPeriod",
     "presentation": [
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Previous years graded vesting",
        "documentation": "Share based compensation arrangement by share based payment award option grant in period.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantInPeriod"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://verses.ai/role/SummaryOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of stock options, Exercisable ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r357"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://verses.ai/role/SummaryOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted- Average Exercise Price, Exercisable ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r357"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://verses.ai/role/SummaryOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of stock options, Expired",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancelled options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative",
      "http://verses.ai/role/SummaryOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of stock options, Cancelled",
        "label": "Stock options cancelled",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r361"
     ]
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriod",
     "presentation": [
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New grants Q1 2026",
        "documentation": "Share based compensation arrangement by share based payment award options grant in period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previous years graded vesting",
        "verboseLabel": "Issuance of shares granted",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative",
      "http://verses.ai/role/SummaryOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of stock options, Granted",
        "verboseLabel": "New grants Q2 2026",
        "terseLabel": "Number of stock options, granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalGrossAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalGrossAmount",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total granted amount",
        "documentation": "Share based compensation arrangement by share based payment award options grants in period total gross amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grant date fair value per option",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMilestoneConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMilestoneConversion",
     "presentation": [
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "RSU milestone conversion",
        "documentation": "Share based compensation arrangement by share based payment award options milestone conversion.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMilestoneConversion"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative",
      "http://verses.ai/role/SummaryOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding",
        "periodStartLabel": "Number of stock options, Outstanding beginning balance",
        "periodEndLabel": "Number of stock options, Outstanding ending balance",
        "verboseLabel": "Stock option, shares",
        "terseLabel": "Stock options outstanding",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r356"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative",
      "http://verses.ai/role/SummaryOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted- Average Exercise Price, Outstanding beginning balance",
        "periodEndLabel": "Weighted- Average Exercise Price, Outstanding ending balance",
        "label": "Exercise price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r356"
     ]
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsStockOptionsGrantedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsStockOptionsGrantedPercentage",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of the total",
        "documentation": "Share based compensation arrangement by share based payment award options granted percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected to vesting shares",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting shares",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantedPercentage",
     "presentation": [
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Percentage of the total",
        "documentation": "Share based compensation arrangement by share based payment award other than options granted percentage.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantedPercentage"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodTotalGrossAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodTotalGrossAmount",
     "presentation": [
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total granted amount",
        "documentation": "Share based compensation arrangement by share based payment award other than options grants in period total gross amount.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodTotalGrossAmount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://verses.ai/role/CommitmentsDetailsNarrative",
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails",
      "http://verses.ai/role/ScheduleOfRestrictedSharesDetails",
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative",
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative",
      "http://verses.ai/role/SummaryOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted- Average Exercise Price, Exercised",
        "verboseLabel": "Exercise price, per share",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://verses.ai/role/SummaryOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted- Average Exercise Price, Expired",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://verses.ai/role/SummaryOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted- Average Exercise Price, Cancelled",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r361"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://verses.ai/role/SummaryOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted- Average Exercise Price, Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "VRSSF_ShareBasedCompensationAwardTrancheMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ShareBasedCompensationAwardTrancheMember",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Award Tranche [Member]",
        "documentation": "Share Based Compensation Award Tranche [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": [
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative",
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price at grant date",
        "verboseLabel": "Share price",
        "terseLabel": "Exercise price, per share",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options expiration period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r664"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://verses.ai/role/ScheduleOfBlack-scholesOptionPricingModelWithFollowingWeightedAverageAssumptionsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected life",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Remaining Contractual Life in Years",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock option fair value",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options are vested on the grant date",
        "verboseLabel": "Shares vested",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subordinate voting shares percentage",
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value."
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOptionsToPurchaseSubordinateVotingSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercise Price",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r87"
     ]
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "presentation": [
      "http://verses.ai/role/ShareCapital"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHARE CAPITAL",
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)."
       }
      }
     },
     "auth_ref": [
      "r843",
      "r846"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "periodEndLabel": "Balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://verses.ai/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r703"
     ]
    },
    "VRSSF_SorbieBornholmLPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "SorbieBornholmLPMember",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sorbie Bornholm LP [Member]",
        "documentation": "Sorbie Bornholm LP [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/InterimBalanceSheetParenthetical",
      "http://verses.ai/role/InterimStatementsOfOperations",
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency",
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails",
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r129",
      "r130",
      "r131",
      "r155",
      "r159",
      "r183",
      "r184",
      "r186",
      "r188",
      "r192",
      "r193",
      "r222",
      "r242",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250",
      "r282",
      "r283",
      "r285",
      "r286",
      "r288",
      "r290",
      "r292",
      "r293",
      "r295",
      "r296",
      "r298",
      "r445",
      "r512",
      "r513",
      "r514",
      "r515",
      "r520",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r533",
      "r543",
      "r566",
      "r586",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r785",
      "r813",
      "r815",
      "r822"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency",
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r53",
      "r56",
      "r57",
      "r117",
      "r118",
      "r119",
      "r140",
      "r141",
      "r142",
      "r164",
      "r165",
      "r166",
      "r168",
      "r175",
      "r177",
      "r179",
      "r191",
      "r223",
      "r224",
      "r227",
      "r280",
      "r300",
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r457",
      "r458",
      "r460",
      "r498",
      "r504",
      "r505",
      "r506",
      "r520",
      "r586"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/InterimBalanceSheetParenthetical",
      "http://verses.ai/role/InterimStatementsOfOperations",
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r165",
      "r166",
      "r191",
      "r282",
      "r283",
      "r285",
      "r288",
      "r458",
      "r478",
      "r511",
      "r521",
      "r533",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r543",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r553",
      "r554",
      "r555",
      "r556",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r567",
      "r568",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r586",
      "r619",
      "r621",
      "r687",
      "r922"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r120",
      "r121",
      "r180",
      "r347",
      "r786",
      "r788"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/InterimBalanceSheetParenthetical",
      "http://verses.ai/role/InterimStatementsOfOperations",
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r165",
      "r166",
      "r191",
      "r221",
      "r282",
      "r283",
      "r285",
      "r288",
      "r458",
      "r478",
      "r511",
      "r521",
      "r533",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r543",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r553",
      "r554",
      "r555",
      "r556",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r567",
      "r568",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r586",
      "r619",
      "r621",
      "r687",
      "r922"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r714",
      "r725",
      "r735",
      "r761"
     ]
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payments for stock options granted",
        "verboseLabel": "Share-based payment",
        "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "VRSSF_StockGrantedDuringPeriodValueSharebasedCompensationDerecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensationDerecognized",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derecognized share-based payments for stock options granted",
        "documentation": "Stock granted during period value sharebased compensation derecognized."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_StockGrantedDuringPeriodValueSharebasedCompensationRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensationRecognized",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognized share-based payments for stock options granted",
        "documentation": "Stock granted during period value sharebased compensation recognized."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_StockIssuedDuringInceptionPeriodSharesRestrictedStockConverted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockIssuedDuringInceptionPeriodSharesRestrictedStockConverted",
     "presentation": [
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Converted Inception",
        "documentation": "Stock issued during inception period shares restricted stock converted.",
        "label": "StockIssuedDuringInceptionPeriodSharesRestrictedStockConverted"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_StockIssuedDuringInceptionPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockIssuedDuringInceptionPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of stock options, Exercised",
        "documentation": "Stock issued during inception period shares stock options exercised.",
        "label": "StockIssuedDuringInceptionPeriodSharesStockOptionsExercised"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_StockIssuedDuringPeriodSharesConversionOfClassASubordinateVotingSharesIntoClassBProportionateVotingShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockIssuedDuringPeriodSharesConversionOfClassASubordinateVotingSharesIntoClassBProportionateVotingShares",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Class A Subordinate Voting shares into Class B Proportionate Voting shares, shares",
        "documentation": "Stock issued during period shares conversion of class A subordinate voting shares into class B proportionate voting shares."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_StockIssuedDuringPeriodSharesConversionOfClassBProportionateVotingSharesIntoClassSubordinateVotingShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockIssuedDuringPeriodSharesConversionOfClassBProportionateVotingSharesIntoClassSubordinateVotingShares",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Class B Proportionate Voting shares into Class A Subordinate Voting shares, shares",
        "documentation": "Stock issued during period shares conversion of class b proportionate voting shares into class subordinate voting shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of convertible securities, shares",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r27",
      "r53",
      "r56",
      "r83",
      "r268"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange of notional value, shares",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r27",
      "r52",
      "r53",
      "r83"
     ]
    },
    "VRSSF_StockIssuedDuringPeriodSharesExerciseOfOptionsAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockIssuedDuringPeriodSharesExerciseOfOptionsAndWarrants",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of options and warrants, shares",
        "documentation": "Stock issued during period shares exercise of options and warrants."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_StockIssuedDuringPeriodSharesFinanceFeeWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockIssuedDuringPeriodSharesFinanceFeeWarrants",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued to finance fee shares",
        "documentation": "Stock issued during period shares finance fee warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued for services, shares",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency",
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of units for cash (net), shares",
        "verboseLabel": "Issuance of shares",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r52",
      "r53",
      "r83",
      "r512",
      "r586",
      "r598"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional interest convertible debenture, shares",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RSUs converted, shares",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r83"
     ]
    },
    "VRSSF_StockIssuedDuringPeriodSharesRestrictedStockConverted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockConverted",
     "presentation": [
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Converted Inception",
        "documentation": "Stock issued during period shares restricted stock converted.",
        "label": "StockIssuedDuringPeriodSharesRestrictedStockConverted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation warrants",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r52",
      "r53",
      "r83"
     ]
    },
    "VRSSF_StockIssuedDuringPeriodSharesSpecialWarrantsConvertedToShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockIssuedDuringPeriodSharesSpecialWarrantsConvertedToShares",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Special warrants converted to shares, shares",
        "documentation": "Stock issued during period shares special warrants converted to shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative",
      "http://verses.ai/role/SummaryOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of stock options, Exercised",
        "label": "Stock option, excercise",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r52",
      "r53",
      "r83",
      "r360"
     ]
    },
    "VRSSF_StockIssuedDuringPeriodSharesStockOptionsRevaluationRSUs": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsRevaluationRSUs",
     "presentation": [
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previous years RSUs revaluation",
        "documentation": "Stock issued during period shares stock options revaluation RSUs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockSplits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockSplits",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock option splits",
        "documentation": "Number of shares issued during the period as a result of a stock split."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r52",
      "r53",
      "r83"
     ]
    },
    "VRSSF_StockIssuedDuringPeriodValueConversionOfClassASubordinateVotingSharesIntoClassBProportionateVotingShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockIssuedDuringPeriodValueConversionOfClassASubordinateVotingSharesIntoClassBProportionateVotingShares",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Class A Subordinate Voting shares into Class B Proportionate Voting shares",
        "documentation": "Stock issued during period value conversion of class A subordinate voting shares into class B proportionate voting shares."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_StockIssuedDuringPeriodValueConversionOfClassBProportionateVotingSharesIntoClassSubordinateVotingShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockIssuedDuringPeriodValueConversionOfClassBProportionateVotingSharesIntoClassSubordinateVotingShares",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Class B Proportionate Voting shares into Class A Subordinate Voting shares",
        "documentation": "Stock issued during period value conversion of class B proportionate voting shares into class subordinate voting shares."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_StockIssuedDuringPeriodValueExerciseOfOptionsAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockIssuedDuringPeriodValueExerciseOfOptionsAndWarrants",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of options and warrants",
        "documentation": "Stock issued during period value exercise of options and warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued for services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency",
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Units for cash (net)",
        "verboseLabel": "Subordinate voting shares, value",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r52",
      "r53",
      "r83",
      "r520",
      "r586",
      "r598",
      "r693"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional interest convertible debenture",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures",
     "crdr": "debit",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock cancelled",
        "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r52",
      "r53",
      "r83"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RSUs converted",
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r52",
      "r53",
      "r83"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares granted",
        "verboseLabel": "Compensation warrants",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r52",
      "r53",
      "r83"
     ]
    },
    "VRSSF_StockIssuedDuringPeriodValueSpecialWarrantsConvertedToShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockIssuedDuringPeriodValueSpecialWarrantsConvertedToShares",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Special warrants converted to shares",
        "documentation": "Stock issued during period value special warrants converted to shares."
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_StockOptiosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StockOptiosMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfReconciliationShareBasedPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Optios [Member]",
        "documentation": "Stock Optios [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://verses.ai/role/InterimBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet",
      "http://verses.ai/role/InterimStatementsOfShareholdersDeficiency"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL SHAREHOLDERS\u2019 DEFICIENCY",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r56",
      "r57",
      "r75",
      "r545",
      "r564",
      "r587",
      "r588",
      "r680",
      "r694",
      "r811",
      "r815",
      "r816",
      "r830",
      "r893",
      "r926"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://verses.ai/role/InterimBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS\u2019 DEFICIENCY"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_StrategicConsultantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "StrategicConsultantsMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfConsolidatesPositionOfOptionsGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ScheduleOfPositionOfRsusGrantedRelatedToStrategicConsultantsDetails",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Strategic Consultants [Member]",
        "documentation": "Strategic Consultants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r470"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r470"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r470"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r470"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r470"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://verses.ai/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r469",
      "r471"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowElementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r755"
     ]
    },
    "VRSSF_ThreeIndependentDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "ThreeIndependentDirectorsMember",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Three Independent Directors [Member]",
        "documentation": "Three Independent Directors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRevenueFromContactWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of Transfer of Good or Service [Axis]",
        "documentation": "Information by timing of transfer of good or service to customer."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r648",
      "r655"
     ]
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRevenueFromContactWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r648",
      "r655"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative",
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative",
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r899"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://verses.ai/role/ProvisionForLegalClaimDetailsNarrative",
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://verses.ai/role/ShareBasedPaymentsDetailsNarrative",
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "us-gaap_TradingActivitiesGainLossByTypeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TradingActivitiesGainLossByTypeTable",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Activity, Gain (Loss) [Table]",
        "documentation": "Disclosure of information about gain (loss) on trading activity by income statement location and type. Includes, but is not limited to, fixed and variable income interest rates, foreign exchange, equity, commodity, and credit."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r672"
     ]
    },
    "us-gaap_TradingActivityByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TradingActivityByTypeAxis",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Activity [Axis]",
        "documentation": "Information by type of trading activity."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r672",
      "r880"
     ]
    },
    "us-gaap_TradingActivityByTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TradingActivityByTypeDomain",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gains and losses on trading activities (including both derivative and nonderivative instruments) recognized in the statement of financial performance, separately by major types of items (such as fixed income/interest rates, foreign exchange, equity, commodity, and credit)."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r672",
      "r880"
     ]
    },
    "us-gaap_TradingActivityGainsAndLossesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TradingActivityGainsAndLossesLineItems",
     "presentation": [
      "http://verses.ai/role/ScheduleOfForeignExchangeRiskExposureOfFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Activity, Gains and Losses, Net [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r672"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransferredAtPointInTimeMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRevenueFromContactWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transferred at Point in Time [Member]",
        "documentation": "Contract with customer in which good or service is transferred at point in time."
       }
      }
     },
     "auth_ref": [
      "r648",
      "r649",
      "r655"
     ]
    },
    "us-gaap_TransferredOverTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransferredOverTimeMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfRevenueFromContactWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transferred over Time [Member]",
        "documentation": "Contract with customer in which good or service is transferred over time."
       }
      }
     },
     "auth_ref": [
      "r648",
      "r649",
      "r655"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r778"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r778"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "VRSSF_TwoIndependentDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "TwoIndependentDirectorsMember",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Independent Directors [Member]",
        "documentation": "Two Independent Directors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://verses.ai/role/DeferredGrantDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r394"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "us-gaap_UnsecuredDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnsecuredDebt",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured loan",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r99",
      "r914"
     ]
    },
    "VRSSF_UnsecuredLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "UnsecuredLoanMember",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured Loan [Member]",
        "documentation": "Unsecured Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://verses.ai/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r111",
      "r194",
      "r196",
      "r197",
      "r198",
      "r481",
      "r483",
      "r626"
     ]
    },
    "VRSSF_VersesGlobalBVVbvMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "VersesGlobalBVVbvMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Verses Global BV (\u0093VBV\u0094) [Member]",
        "documentation": "Verses Global BV (\u201cVBV\u201d) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_VersesHealthIncVHEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "VersesHealthIncVHEMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Verses Health Inc. (\u0093VHE\u0094) [Member]",
        "documentation": "Verses Health Inc. (\u201cVHE\u201d) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_VersesIncVINCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "VersesIncVINCMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Verses Inc. (\u0093VINC\u0094) [Member]",
        "documentation": "Verses Inc. (\u201cVINC\u201d) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_VersesLogisticsIncVLOGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "VersesLogisticsIncVLOGMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Verses Logistics Inc. (\u0093VLOG\u0094) [Member]",
        "documentation": "Verses Logistics Inc. (\u201cVLOG\u201d)\t [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_VersesOperationsCanadaIncVOCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "VersesOperationsCanadaIncVOCMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Verses Operations Canada Inc. (\u0093VOC\u0094) [Member]",
        "documentation": "Verses Operations Canada Inc. (\u201cVOC\u201d) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_VersesRealitiesIncVRIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "VersesRealitiesIncVRIMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Verses Realities Inc. (\u0093VRI\u0094) [Member]",
        "documentation": "Verses Realities Inc. (\u201cVRI\u201d) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_VersesSolutionsIncVSIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "VersesSolutionsIncVSIMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Verses Solutions Inc (\u0093VSI\u0094) [Member]",
        "documentation": "Verses Solutions Inc (\u201cVSI\u201d) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_VersesTechnologiesUSAIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "VersesTechnologiesUSAIncMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Verses Technologies USA, Inc. (\u0093VTU\u0094) [Member]",
        "documentation": "Verses Technologies USA, Inc. (\u201cVTU\u201d) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VestingAxis",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VestingDomain",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWarrantsOutstandingDetails",
      "http://verses.ai/role/ShareCapitalDetailsNarrative",
      "http://verses.ai/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r684",
      "r685",
      "r688",
      "r689",
      "r690",
      "r691"
     ]
    },
    "VRSSF_WarrantShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantShareMember",
     "presentation": [
      "http://verses.ai/role/ShareCapitalDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Share [Member]",
        "documentation": "Warrant Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsAbstract",
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants expire date",
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r885",
      "r886",
      "r887"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grant date fair value per warrant",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r885",
      "r886",
      "r887"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://verses.ai/role/ScheduleOfWeightedAverageAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected life",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r885",
      "r886",
      "r887"
     ]
    },
    "VRSSF_WarrantsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsDisclosureTextBlock",
     "presentation": [
      "http://verses.ai/role/Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "WARRANTS",
        "documentation": "Warrants [Disclosure Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireEightMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Eight [Member]",
        "documentation": "Warrants Expire Eight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireEighteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireEighteenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Eighteen [Member]",
        "documentation": "Warrants Expire Eighteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireElevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireElevenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Eleven [Member]",
        "documentation": "Warrants Expire Eleven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireFifteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireFifteenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Fifteen [Member]",
        "documentation": "Warrants Expire Fifteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireFiveMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Five [Member]",
        "documentation": "Warrants Expire Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireFourMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Four [Member]",
        "documentation": "Warrants Expire Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireFourteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireFourteenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Fourteen [Member]",
        "documentation": "Warrants Expire Fourteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireNineMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Nine [Member]",
        "documentation": "Warrants Expire Nine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireNineteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireNineteenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Nineteen [Member]",
        "documentation": "Warrants Expire Nineteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireOneMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire One [Member]",
        "documentation": "Warrants Expire One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireSevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireSevenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Seven [Member]",
        "documentation": "Warrants Expire Seven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireSeventeenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireSeventeenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Seventeen [Member]",
        "documentation": "Warrants Expire Seventeen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireSixMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Six [Member]",
        "documentation": "Warrants Expire Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireSixteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireSixteenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Sixteen [Member]",
        "documentation": "Warrants Expire Sixteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireTenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireTenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Ten [Member]",
        "documentation": "Warrants Expire Ten [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireThirteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireThirteenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Thirteen [Member]",
        "documentation": "Warrants Expire Thirteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireThreeMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Three [Member]",
        "documentation": "Warrants Expire Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireTwelveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireTwelveMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Twelve [Member]",
        "documentation": "Warrants Expire Twelve [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireTwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireTwentyEightMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Twenty Eight [Member]",
        "documentation": "Warrants Expire Twenty Eight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireTwentyFiveMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Twenty Five [Member]",
        "documentation": "Warrants Expire Twenty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireTwentyFourMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Twenty Four [Member]",
        "documentation": "Warrants Expire Twenty Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireTwentyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireTwentyMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Twenty [Member]",
        "documentation": "Warrants Expire Twenty [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireTwentyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireTwentyOneMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Twenty One [Member]",
        "documentation": "Warrants Expire Twenty One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireTwentySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireTwentySevenMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Twenty Seven [Member]",
        "documentation": "Warrants Expire Twenty Seven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireTwentySixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireTwentySixMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Twenty Six [Member]",
        "documentation": "Warrants Expire Twenty Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireTwentyThreeMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Twenty Three [Member]",
        "documentation": "Warrants Expire Twenty Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireTwentyTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireTwentyTwoMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Twenty Two [Member]",
        "documentation": "Warrants Expire Twenty Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsExpireTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsExpireTwoMember",
     "presentation": [
      "http://verses.ai/role/ScheduleOfOutstandingSharePurchaseWarrantsExpireDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Expire Two [Member]",
        "documentation": "Warrants Expire Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsLineItems",
     "presentation": [
      "http://verses.ai/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "WarrantsLineItems [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_WarrantsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WarrantsTable",
     "presentation": [
      "http://verses.ai/role/WarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "WarrantsTable [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Voting Shares Shares used in computing earnings per share - Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r188"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://verses.ai/role/InterimStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Voting Shares Shares used in computing earnings per share - Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r188"
     ]
    },
    "VRSSF_WorkingCapitalDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "WorkingCapitalDeficit",
     "crdr": "credit",
     "presentation": [
      "http://verses.ai/role/FinancialInstrumentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital deficit",
        "documentation": "Working capital deficit."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://verses.ai/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r783"
     ]
    },
    "VRSSF_XYZGlobalTechnologiesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "XYZGlobalTechnologiesIncMember",
     "presentation": [
      "http://verses.ai/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "XYZ Global Technologies Inc [Member]",
        "documentation": "XYZ Global Technologies Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_YearsEighteenAndNineteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "YearsEighteenAndNineteenMember",
     "presentation": [
      "http://verses.ai/role/CommitmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Years 18 and 19 [Member]",
        "documentation": "Years 18 and 19 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_YearsElevenThroughFourteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "YearsElevenThroughFourteenMember",
     "presentation": [
      "http://verses.ai/role/CommitmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Years 11 Through 14 [Member]",
        "documentation": "Years 11 Through 14 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_YearsFifteenThroughSeventeenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "YearsFifteenThroughSeventeenMember",
     "presentation": [
      "http://verses.ai/role/CommitmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Years 15 Through 17 [Member]",
        "documentation": "Years 15 Through 17 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_YearsOneThroughTenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "YearsOneThroughTenMember",
     "presentation": [
      "http://verses.ai/role/CommitmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Years 1 Through 10 [Member]",
        "documentation": "Years 1 Through 10 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "VRSSF_YearsTwentyToTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://verses.ai/20250930",
     "localname": "YearsTwentyToTwentyFiveMember",
     "presentation": [
      "http://verses.ai/role/CommitmentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Years 20 to 25 [Member]",
        "documentation": "Years 20 to 25 [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "710",
   "SubTopic": "10",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483043/710-10-30-2"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "30",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480513/718-10-30-3"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/230/tableOfContent"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483070/710-10-25-9"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-16"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481003/205-10-S50-2"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SAB Topic 1.B.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-7"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-2"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.FF.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476188/405-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(j)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(j)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(j)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(j)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-7"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/825/tableOfContent"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-4"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478600/954-210-50-2"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-4"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481639/420-10-35-4"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "181",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-181"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-23"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r789": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "SubTopic": "310",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r790": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "610",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/610/tableOfContent"
  },
  "r792": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-4"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479035/940-320-45-2"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}